,Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
0,prerank,Negative Regulation Of Blood Coagulation (GO:0030195),0.6254343803906155,2.9629511546874463,0.0,0.0011555311163390283,0.001,11/16,8.42%,VTN;FGB;APOE;FGA;F2;PLG;TFPI;APOH;KRT1;FGG;SERPINF2
1,prerank,Positive Regulation Of Response To External Stimulus (GO:0032103),0.5343311346452211,2.8859326599135096,0.0,0.0005777655581695141,0.001,16/22,21.51%,VTN;F2;POLR3B;PLG;APOH;TGFB1;THBS1;SERPINF2;MDK;DHX9;RARRES2;APP;AGT;PLA2G2A;SERPINE1;EMILIN1
2,prerank,Protein Activation Cascade (GO:0072376),0.8914319248826292,2.8805223004201848,0.0,0.0005777655581695141,0.002,7/7,11.22%,FGB;FGA;FBLN1;F13A1;FLNA;FGG;F13B
3,prerank,"Blood Coagulation, Fibrin Clot Formation (GO:0072378)",0.8914319248826292,2.8805223004201848,0.0,0.0005777655581695141,0.002,7/7,11.22%,FGB;FGA;FBLN1;F13A1;FLNA;FGG;F13B
4,prerank,Positive Regulation Of Blood Coagulation (GO:0030194),0.7890716803760284,2.8617792329262857,0.0,0.0004622124465356114,0.002,9/9,21.51%,VTN;F2;PLG;APOH;THBS1;SERPINF2;CNTN1;SERPINE1;EMILIN1
5,prerank,Fibrinolysis (GO:0042730),0.7999916647939033,2.709454961510998,0.0,0.0015407081551187048,0.008,7/8,8.42%,FGB;FGA;F2;PLG;KRT1;FGG;SERPINF2
6,prerank,Antibacterial Humoral Response (GO:0019731),0.7968291250733999,2.705961056242364,0.0,0.0018158346113899017,0.01,8/8,20.69%,FGB;FGA;LTF;H2BC11;H2BC12;DMBT1;JCHAIN;HLA-A
7,prerank,Defense Response To Bacterium (GO:0042742),0.5369811865046168,2.6450752981624763,0.0,0.002744386401305192,0.017,13/18,20.69%,LTF;H2BC11;H2BC12;LYZ;ANG;DMBT1;JCHAIN;RARRES2;ANKRD17;RPL30;PLA2G2A;SERPINE1;HLA-A
8,prerank,Defense Response To Gram-negative Bacterium (GO:0050829),0.632131567665208,2.5093809578013864,0.0,0.0066764020055143855,0.047,9/11,20.46%,LTF;F2;H2BC11;H2BC12;LYZ;DMBT1;RARRES2;RPL30;SERPINE1
9,prerank,Antimicrobial Humoral Response (GO:0019730),0.590117999665612,2.5030580627391723,0.0,0.006702080474766365,0.05,11/13,27.24%,GAPDH;LTF;F2;H2BC11;H2BC12;LYZ;JCHAIN;RARRES2;RPL30;HLA-A;REG3A
10,prerank,Retina Homeostasis (GO:0001895),0.6534422580095357,2.500431986400533,0.0,0.0060928004316057865,0.05,8/10,16.54%,ALB;LTF;KRT1;LYZ;JCHAIN;PRDX1;ZG16B;PIGR
11,prerank,Regulation Of Substrate Adhesion-Dependent Cell Spreading (GO:1900024),0.5016377445040066,2.489834670312732,0.0,0.0060665383607799,0.055,14/18,29.34%,FGB;FGA;APOA1;FBLN1;FLNA;FGG;MDK;CORO1C;RAC1;P4HB;C1QBP;LIMS1;ACTN4;ILK
12,prerank,Positive Regulation Of Cell-Substrate Adhesion (GO:0010811),0.5041447269991459,2.482135941635936,0.0,0.006399864644339235,0.06,14/18,29.34%,FN1;FGB;FGA;APOA1;FLNA;FGG;MDK;NPNT;RAC1;P4HB;C1QBP;RSU1;LIMS1;ILK
13,prerank,Chaperone-Mediated Protein Complex Assembly (GO:0051131),0.7251908396946566,2.4701614230598143,0.0,0.006685572887390092,0.067,8/8,27.82%,CLU;HSPA1A;HSP90AB1;HSP90AA1;CCT2;HSPD1;HSPA4;PTGES3
14,prerank,Platelet Aggregation (GO:0070527),0.4950645017413675,2.4610673891194157,0.0,0.0062109797503222776,0.071,12/18,19.23%,HBB;FGB;FGA;TLN1;PPIA;CLIC1;FLNA;FGG;FGL1;MYH9;ACTN1;FERMT3
15,prerank,Homotypic Cell-Cell Adhesion (GO:0034109),0.4950645017413675,2.4610673891194157,0.0,0.0062109797503222776,0.071,12/18,19.23%,HBB;FGB;FGA;TLN1;PPIA;CLIC1;FLNA;FGG;FGL1;MYH9;ACTN1;FERMT3
16,prerank,Regulation Of Blood Coagulation (GO:0030193),0.6845335082373417,2.4560177998934547,0.0,0.006049545256127855,0.073,8/9,21.51%,VTN;APOE;F2;TFPI;APOH;THBS1;SERPINE1;EMILIN1
17,prerank,Positive Regulation Of Cell Differentiation (GO:0045597),0.3206206759572626,2.419287344123779,0.0,0.008088717814373198,0.102,21/42,20.86%,APOB;ACTB;LTF;HSP90AB1;LAMB1;TGFB1;MACROH2A1;LAMC1;SERPINF2;MDK;CCN2;NID1;KCTD11;RARRES2;PA2G4;NPNT;AGT;LAMB2;TNXB;PLA2G2A;COL1A1
18,prerank,Negative Regulation Of Fibrinolysis (GO:0051918),0.7982404692082112,2.380417826303009,0.0,0.010703867182929948,0.136,6/6,20.46%,VTN;F2;PLG;THBS1;SERPINF2;SERPINE1
19,prerank,Regulation Of Telomerase RNA Localization To Cajal Body (GO:1904872),0.646886016451234,2.34658170888596,0.0,0.013261095192271706,0.187,9/9,35.65%,CCT3;TCP1;CCT4;CCT7;CCT8;CCT5;RUVBL1;RUVBL2;CCT6A
20,prerank,Positive Regulation Of Telomerase RNA Localization To Cajal Body (GO:1904874),0.646886016451234,2.34658170888596,0.0,0.013261095192271706,0.187,9/9,35.65%,CCT3;TCP1;CCT4;CCT7;CCT8;CCT5;RUVBL1;RUVBL2;CCT6A
21,prerank,Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000377),0.5820980153565739,2.3143403142498746,0.0,0.01591481492048753,0.235,10/11,33.72%,F2;THBS1;AKR1C3;DCXR;AGT;RAC1;EIF6;ARF4;SORD;CBR1
22,prerank,Positive Regulation Of DNA Biosynthetic Process (GO:2000573),0.4581598053711152,2.3006385938779266,0.0,0.016629599978618192,0.247,13/18,27.82%,HSP90AB1;HSP90AA1;XRCC5;CCT3;TCP1;CCT4;CCT7;CCT8;CCT2;CCT5;PCNA;HNRNPA1;PTGES3
23,prerank,Positive Regulation Of Cytokine Production (GO:0001819),0.33249744974217177,2.2513433352697305,0.0017241379310344827,0.02412171205357722,0.347,19/35,23.79%,C3;GAPDH;C5;HSPA1A;C1QTNF3;TGFB1;SERPINF2;CNTN1;MDK;SPTBN1;DHX9;RPS3;APP;AGT;SERPINE1;HLA-A;HSPD1;CHIA;CD74
24,prerank,Protein-Containing Complex Assembly (GO:0065003),0.27406336782024787,2.247029738655453,0.0016611295681063123,0.02440481717708028,0.362,29/51,31.97%,FN1;FGB;FGA;CLU;PARD3;HSPA1A;HSP90AB1;HSP90AA1;TGFB1;LAMC1;FMOD;FGG;CLTC;JCHAIN;SLC2A1;DHX9;TCP1;CCT2;FERMT3;CAND1;HSPD1;CD74;CAPZA1;HSPA4;PPP2R1A;PTGES3;DARS1;AP2M1;PSMD11
25,prerank,Regulation Of DNA Replication (GO:0006275),0.6848591549295776,2.2282839976626074,0.0,0.027243868242916327,0.401,7/7,31.79%,PPP2CA;DHX9;ANKRD17;PCNA;PPP2R1A;RUVBL1;RUVBL2
26,prerank,Cytoplasmic Translation (GO:0002181),0.24829320352353726,2.225613352324142,0.004739336492890996,0.02666281057330425,0.406,57/66,63.18%,RPS27A;RACK1;RPSA;RPS10;RPL22;RPS18;RPLP1;RPS9;RPS16;RPS3;EIF4A1;RPS25;RPLP0;RPS13;RPL10A;RPL30;RPS14;RPS2;RPL12;RPS26;RPL27A;RPS4X;RPLP2;RPS5;SARS1;RPL18;RPS11;RPL11;RPS3A;RPL5;RPS15A;RPS7;ETF1;EIF4A2;RPL14;RPL9;RPS8;RPL15;RPL27;RPL4;RPS23;RPL7;RPL29;RPL13;RPL28;RPL26;RPL8;RPS6;RPS17;RPS27;RPS20;EIF3I;RPS19;RPL35A;RPL7A;RPL17;RPL18A
27,prerank,Translation (GO:0006412),0.21629962738143188,2.217394167117866,0.003189792663476874,0.02798036060278076,0.44,74/92,60.84%,EEF1A1;EEF2;RPS27A;RACK1;EEF1G;RPSA;RPS10;RPL22;VARS1;RPS18;RPLP1;RARS1;RPS9;RPS16;RPS3;RPS25;RPLP0;RPS13;RPL10A;RPL30;RRBP1;RPS14;RPS2;RPL12;RPS26;HARS1;RPL27A;RPS4X;RPLP2;DARS1;RPS5;SARS1;RPL18;RPS11;RPL11;RPS3A;RPL5;IARS1;RPS15A;RPS7;ETF1;NARS1;QARS1;RPL14;EEF1B2;GARS1;RPL9;FARSB;RPS8;RPL15;RPL27;RPL4;EIF5A;RPS23;RPL7;EPRS1;WARS1;RPL29;RPL13;RPL28;RPL26;RPL8;RPS6;RPS17;RPS27;RPS20;MARS1;IARS2;LARS1;EEF1D;RPS19;TUFM;RPL35A;RPL7A
28,prerank,Positive Regulation Of Substrate Adhesion-Dependent Cell Spreading (GO:1900026),0.5093338088164399,2.211102076165283,0.0,0.028569510703968393,0.46,11/14,29.34%,FGB;FGA;APOA1;FLNA;FGG;MDK;RAC1;P4HB;C1QBP;LIMS1;ILK
29,prerank,Negative Regulation Of Endopeptidase Activity (GO:0010951),0.407984843740051,2.1834422299141134,0.0017857142857142857,0.03535925215997427,0.539,15/22,29.57%,GAPDH;VTN;SERPINF1;LTF;SERPIND1;SPOCK2;SERPINA7;SERPINF2;SERPINA1;SERPINA5;CST3;SERPINE1;SERPING1;SERPINH1;SERPINA11
30,prerank,Cellular Response To Organic Cyclic Compound (GO:0071407),0.3940282742841747,2.170016358933629,0.0,0.03794615085268164,0.565,17/23,36.29%,ACTB;CLU;HSPA1A;TFPI;TGFB1;RAP1B;H2AZ1;HSP90B1;HSPA8;EZR;TGM2;CDH1;RUVBL2;AKR1B1;ROCK2;DIAPH1;MSN
31,prerank,Negative Regulation Of Peptidase Activity (GO:0010466),0.3923531134077698,2.167638899041665,0.0034965034965034965,0.037193657807162474,0.569,16/24,29.57%,GAPDH;VTN;SERPINF1;SERPIND1;SPOCK2;SERPINA7;SERPINF2;SERPINA1;CTSB;SERPINA5;CST3;SERPINE1;LRP1;SERPING1;SERPINH1;SERPINA11
32,prerank,Regulation Of Smooth Muscle Cell Proliferation (GO:0048660),0.5035818351247393,2.167287505574231,0.0,0.03610159336198601,0.569,8/13,13.21%,APOE;TGFB1;OGN;THBS1;SERPINF2;ANG;XRCC5;XRCC6
33,prerank,Macromolecule Biosynthetic Process (GO:0009059),0.21779595050924044,2.163072292424198,0.003105590062111801,0.03650118879259166,0.578,69/82,64.17%,APOE;EEF1A1;EEF2;RPS27A;EEF1G;EXT1;RPSA;RPS10;B4GAT1;RPL22;RPS18;RPLP1;RPS9;RPS16;RPS3;RPS25;RPLP0;RPS13;RPL10A;RPL30;RRBP1;RPS14;RPS2;RPL12;RPS26;EXT2;HARS1;RPL27A;RPS4X;RPLP2;DARS1;RPS5;SARS1;RPL18;RPS11;RPL11;RPS3A;RPL5;RPS15A;RPS7;RPL14;EEF1B2;RPL9;FARSB;RPS8;RPL15;RPL27;RPL4;EIF5A;RPS23;RPL7;WARS1;RPL29;RPL13;RPL28;RPL26;RPL8;RPS6;RPS17;RPS27;RPS20;EEF1D;RPS19;TUFM;RPL35A;RPL7A;RPL17;RPL18A;COL5A1
34,prerank,Protein Modification By Small Protein Conjugation (GO:0032446),-0.2704057009072092,-2.1612406394418504,0.002551020408163265,0.8541074077924041,0.583,33/44,47.52%,SUMO2;COPS2;CUL4A;NEDD4;UBE2I;UBA6;SKP1;ARRB1;MYCBP2;CUL5;CUL3;NAE1;CUL4B;CUL1;RANGAP1;CUL2;UBE2D2;SAE1;UBE2M;UCHL3;COPS5;ARRDC1;COPS4;RBX1;UFL1;TRIM28;USP9X;OS9;COPS6;FBXO2;UBA2;COPS3;USP7
35,prerank,Protein K48-linked Ubiquitination (GO:0070936),-0.6165590135055784,-2.1609592948586696,0.0,0.4282703811152796,0.584,8/8,38.69%,SKP1;TRIM25;MYCBP2;CUL3;CUL1;UBE2D2;NT5C2;RBX1
36,prerank,Positive Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000379),0.5735509047513732,2.1440969916075243,0.0038240917782026767,0.041235953265927036,0.624,9/10,33.72%,F2;TGFB1;THBS1;AKR1C3;DCXR;AGT;SORD;GSTP1;CBR1
37,prerank,Positive Regulation Of Establishment Of Protein Localization (GO:1904951),0.6657463334612215,2.1395467965156207,0.0,0.03658242412214778,0.636,6/7,19.70%,CCT3;TCP1;CCT4;CCT7;CCT8;CCT5
38,prerank,Positive Regulation Of Protein Localization To Cajal Body (GO:1904871),0.6657463334612215,2.1395467965156207,0.0,0.03658242412214778,0.636,6/7,19.70%,CCT3;TCP1;CCT4;CCT7;CCT8;CCT5
39,prerank,Regulation Of Establishment Of Protein Localization To Telomere (GO:0070203),0.6657463334612215,2.1395467965156207,0.0,0.03658242412214778,0.636,6/7,19.70%,CCT3;TCP1;CCT4;CCT7;CCT8;CCT5
40,prerank,"Positive Regulation Of Protein Localization To Chromosome, Telomeric Region (GO:1904816)",0.6657463334612215,2.1395467965156207,0.0,0.03658242412214778,0.636,6/7,19.70%,CCT3;TCP1;CCT4;CCT7;CCT8;CCT5
41,prerank,Positive Regulation Of Establishment Of Protein Localization To Telomere (GO:1904851),0.6657463334612215,2.1395467965156207,0.0,0.03658242412214778,0.636,6/7,19.70%,CCT3;TCP1;CCT4;CCT7;CCT8;CCT5
42,prerank,Regulation Of Protein Localization To Cajal Body (GO:1904869),0.6657463334612215,2.1395467965156207,0.0,0.03658242412214778,0.636,6/7,19.70%,CCT3;TCP1;CCT4;CCT7;CCT8;CCT5
43,prerank,Positive Regulation Of Actin Filament Bundle Assembly (GO:0032233),0.5006312213451192,2.124609177070019,0.0017921146953405018,0.0400308993874592,0.676,12/13,43.31%,APOA1;PFN1;SERPINF2;CCN2;RAC1;TPM1;ROCK2;RHOC;PLEK;PFN2;VIL1;CDC42
44,prerank,Defense Response To Gram-positive Bacterium (GO:0050830),0.5429320765807994,2.12248318621481,0.0017889087656529517,0.03979864147204886,0.684,8/11,20.69%,H2BC11;H2BC12;LYZ;ANG;DMBT1;RARRES2;PLA2G2A;HLA-A
45,prerank,Regulation Of Fibrinolysis (GO:0051917),0.6640759752574028,2.117908352133766,0.0,0.04033854078856245,0.696,6/7,20.46%,VTN;F2;PLG;THBS1;SERPINF2;SERPINE1
46,prerank,Peptide Cross-Linking (GO:0018149),0.562996302332341,2.1097496191894987,0.0,0.041804547942220854,0.713,7/10,15.43%,FN1;F13A1;KRT1;THBS1;F13B;KRT10;KRT2
47,prerank,Negative Regulation Of DNA Metabolic Process (GO:0051053),0.5574445922409962,2.0842325964475026,0.001838235294117647,0.04873326881951555,0.765,7/10,15.78%,H1-2;H1-1;SUB1;H1-0;XRCC5;H1-5;RPS3
48,prerank,Intrinsic Apoptotic Signaling Pathway (GO:0097193),-0.4455197218787935,-2.07629316299312,0.002347417840375587,0.5128970410200033,0.776,11/15,28.35%,CUL4A;DNAJC10;DDX3X;AIFM1;CUL5;CUL3;CASP6;CUL1;BAG6;CYCS;CUL2
49,prerank,Regulation Of Notch Signaling Pathway (GO:0008593),-0.6609970674486804,-2.0686521790131804,0.0021929824561403508,0.4063701911718846,0.791,6/6,34.19%,TSPAN14;SRC;NIBAN2;STAT3;ARRB1;ARRDC1
50,prerank,Positive Regulation Of Nitric Oxide Metabolic Process (GO:1904407),0.6711789029668511,2.0605323578289876,0.0,0.055200684370112336,0.816,5/6,17.71%,HBB;CLU;HSP90AB1;HSP90AA1;ASS1
51,prerank,Positive Regulation Of Nitric Oxide Biosynthetic Process (GO:0045429),0.6711789029668511,2.0605323578289876,0.0,0.055200684370112336,0.816,5/6,17.71%,HBB;CLU;HSP90AB1;HSP90AA1;ASS1
52,prerank,Protein Localization To Chromatin (GO:0071168),0.684457478005865,2.0457269149093547,0.0,0.05966313723138249,0.846,6/6,31.79%,H2BC11;MACROH2A1;H1-5;MACROH2A2;PARP1;RUVBL2
53,prerank,Antimicrobial Humoral Immune Response Mediated By Antimicrobial Peptide (GO:0061844),0.5612272693215465,2.035773504851595,0.0,0.06221379530369329,0.86,5/9,2.10%,GAPDH;LTF;F2;H2BC11;H2BC12
54,prerank,Nuclear-Transcribed mRNA Catabolic Process (GO:0000956),-0.4757188477920094,-2.0329289451241985,0.0,0.4096146637560913,0.851,8/12,18.18%,EXOSC6;UPF1;XRN2;GSPT1;DCPS;EXOSC4;MRTO4;NCBP1
55,prerank,Substrate Adhesion-Dependent Cell Spreading (GO:0034446),0.5260929506820915,2.0319828011688936,0.005474452554744526,0.06221742049935239,0.869,8/10,29.34%,FN1;LAMB1;LAMC1;LAMA5;FERMT3;RAC1;PARVB;ILK
56,prerank,Macromolecule Catabolic Process (GO:0009057),-0.37958005011391427,-2.0296681280646234,0.0045351473922902496,0.34932154823291744,0.856,16/19,45.82%,CLN5;EXOSC6;XRN2;PNPT1;NEDD4;PABPC4;EXOSC4;NCBP1;PPT1;IDE;UCHL3;MTREX;TPP1;SLC16A3;SH3GLB1;RNASET2
57,prerank,Plasminogen Activation (GO:0031639),0.7351245126667681,2.0148141665900257,0.003929273084479371,0.06822077936847726,0.897,4/5,8.12%,FGB;FGA;PGK1;FGG
58,prerank,Negative Regulation Of Cellular Process (GO:0048523),0.22274913241899796,2.0046926691026212,0.0031545741324921135,0.07201357126920398,0.909,32/65,29.75%,ACTB;APOA1;CLU;TGFBI;FBLN1;HSPA1A;PLG;NPM1;ENO1;TGFB1;DHRS2;RACK1;THBS1;PPP2CA;MDK;CCN2;LMNA;MYH9;COL18A1;APP;HMGA1;FTH1;EMILIN1;VPS35;RBBP4;RTN4;APLP2;PLXNB2;PPP2R1A;BRD9;ANXA6;NME1
59,prerank,Positive Regulation Of Phagocytosis (GO:0050766),0.5146600454348679,2.003063096990204,0.007233273056057866,0.07136474579612333,0.914,8/11,23.09%,C3;AHSG;C4A;APOA1;C4B;COLEC10;APLP2;LMAN2
60,prerank,Positive Regulation Of Cellular Biosynthetic Process (GO:0031328),0.28292086730426663,1.9972419389219624,0.005244755244755245,0.0725883637627517,0.919,26/38,41.96%,HBB;CLU;NPM1;HSP90AB1;HSP90AA1;EEF2;THBS1;IGF2;ASS1;APOC2;TYRP1;EIF6;PLXNB2;EIF3C;RPS4X;EIF4A3;PRKDC;HNRNPD;LDLR;DDB1;RPL5;SSB;EIF3E;APOA4;APOA5;ADSL
61,prerank,Peptide Biosynthetic Process (GO:0043043),0.2167513975957298,1.9887719549276357,0.008012820512820512,0.07535713637268092,0.929,54/72,55.17%,EEF1A1;RPS27A;RPSA;RPS10;RPL22;RPS18;RPLP1;RPS9;RPS16;RPS3;RPS25;RPLP0;RPS13;RPL10A;RPL30;RRBP1;RPS14;RPS2;RPL12;RPS26;HARS1;RPL27A;RPS4X;RPLP2;DARS1;RPS5;SARS1;RPL18;RPS11;RPL11;RPS3A;RPL5;RPS15A;RPS7;RPL14;RPL9;FARSB;RPS8;RPL15;RPL27;RPL4;RPS23;RPL7;PCSK5;WARS1;RPL29;RPL13;RPL28;RPL26;RPL8;RPS6;RPS17;RPS27;RPS20
62,prerank,Positive Regulation Of Protein Metabolic Process (GO:0051247),0.2499636686226188,1.979421239014245,0.005084745762711864,0.07879911314403164,0.939,29/49,36.47%,APOE;CLU;C4BPA;GPC3;NPM1;VCP;HSP90AA1;TGFB1;EEF2;THBS1;EZR;APP;AGT;VPS35;EIF6;PLXNB2;EIF3C;RPS4X;EIF4A3;PRKDC;HNRNPD;NSF;DDB1;ROCK2;RAB7A;RPL5;SSB;MSN;C4BPB
63,prerank,Positive Regulation Of Protein Localization To Nucleus (GO:1900182),0.3739940026251377,1.9744761269327067,0.0016778523489932886,0.07977149292795638,0.945,11/20,19.70%,F2;TGFB1;FLNA;RAN;CCT3;TCP1;CCT4;CCT7;CCT8;CCT2;CCT5
64,prerank,Positive Regulation Of mRNA Metabolic Process (GO:1903313),-0.6992966002344665,-1.9673246024442954,0.004106776180698152,0.4463467283701453,0.944,5/5,30.33%,MOV10;UPF1;PNPT1;KHSRP;NUDT21
65,prerank,Negative Regulation Of Response To External Stimulus (GO:0032102),0.4126232373344867,1.9572844396221671,0.008695652173913044,0.08782036484176615,0.961,12/16,35.18%,APOE;APOA1;LTF;C1QTNF3;YWHAZ;SERPINE1;VPS35;C1QBP;REG3A;PARP1;PRKDC;PTPRS
66,prerank,Actin Cytoskeleton Reorganization (GO:0031532),0.6533724340175955,1.9504860820120962,0.001869158878504673,0.09026623903801712,0.965,6/6,34.89%,FLNA;MYH9;EZR;PARVB;PTK7;PLEK
67,prerank,Response To Peptide (GO:1901652),-0.6299749326287593,-1.9294251858340075,0.004454342984409799,0.4910306476660273,0.976,5/6,19.64%,EIF2B4;MMP2;STAT5B;STAT1;STAT3
68,prerank,Positive Regulation Of Phosphorylation (GO:0042327),0.31007632041422917,1.929412023128408,0.015151515151515152,0.1011373873792471,0.973,18/29,33.49%,C3;RELN;F2;HSP90AA1;PPIA;TGFB1;RACK1;THBS1;ANG;IGF2;RARRES2;APP;RAC1;CD74;PTGES3;ILK;AKR1B1;ROCK2
69,prerank,Regulation Of Plasminogen Activation (GO:0010755),0.6364651579330324,1.9270115931852498,0.015444015444015444,0.10077349590395365,0.976,5/6,20.46%,ENO1;THBS1;SERPINF2;CLEC3B;SERPINE1
70,prerank,Positive Regulation Of Integrin-Mediated Signaling Pathway (GO:2001046),0.5921174605234933,1.925749378435671,0.0037593984962406013,0.10005432126395873,0.979,6/7,27.29%,LAMB1;FLNA;LAMC1;NID1;LAMB2;LIMS1
71,prerank,Negative Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043154),-0.526390812991118,-1.925046053263649,0.006696428571428571,0.44683597423601773,0.979,8/9,35.65%,CD44;SRC;DDX3X;VEGFA;PARK7;RPS6KA3;CSNK2A1;FABP1
72,prerank,Regulation Of Protein Phosphorylation (GO:0001932),0.27366396815250443,1.9216073762892756,0.008517887563884156,0.10134368993767134,0.98,21/38,30.57%,C3;FN1;RELN;F2;FBLN1;NPM1;HSP90AA1;PPIA;TGFB1;RACK1;PPP2CA;IGF2;RARRES2;CORO1C;APP;RAC1;CD74;PLXNB2;ILK;PRKDC;SORD
73,prerank,Positive Regulation Of Protein Secretion (GO:0050714),0.40571704789543694,1.919325449678969,0.007155635062611807,0.10140229980919721,0.981,8/17,9.06%,FGB;FGA;GLUD1;C1QTNF3;PPIA;TGFB1;FGG;ANG
74,prerank,Negative Regulation Of Nitrogen Compound Metabolic Process (GO:0051172),0.6480938416422288,1.9180251454157669,0.007207207207207207,0.10067127149923354,0.981,6/6,35.42%,APOE;HSP90AB1;TGFB1;CLTC;LDLR;AP2A1
75,prerank,Cellular Response To Molecule Of Bacterial Origin (GO:0071219),-0.4774596828113402,-1.9135683216299457,0.00881057268722467,0.43005484103659325,0.984,8/10,31.39%,SHPK;HMGB2;VIM;UPF1;PABPN1;MAPK14;HMGB1;PDCD4
76,prerank,Negative Regulation Of Defense Response (GO:0031348),0.4595737259413013,1.9115376945802423,0.0055762081784386614,0.10375634620739693,0.984,9/12,30.51%,APOE;APOA1;C1QTNF3;YWHAZ;VPS35;C1QBP;REG3A;PARP1;PRKDC
77,prerank,Phosphorylation (GO:0016310),-0.2572328196251399,-1.9103026406646852,0.00975609756097561,0.3998075079901939,0.985,24/37,38.22%,MAP4K4;COPS2;CTBP1;SHPK;SRPK1;GMFB;CSK;JAK2;GALK2;PRKAA1;CDK1;TOLLIP;STAT3;PRKAG1;MAPK1;CSNK2B;ILF3;CDK16;HK2;PRKACA;CSNK2A1;HK1;CDK11A;MAP2K1
78,prerank,G1/S Transition Of Mitotic Cell Cycle (GO:0000082),-0.4604141694133356,-1.9077234353877905,0.00641025641025641,0.37115414499747473,0.986,9/12,28.35%,BRD4;CUL4A;GSPT1;CUL5;CUL3;CUL4B;CUL1;CDK16;CUL2
79,prerank,Response To Lipopolysaccharide (GO:0032496),-0.3926459992032889,-1.9056697429018978,0.0069767441860465115,0.34703377910302813,0.986,12/15,40.21%,SHPK;HMGB2;VIM;UPF1;JAK2;PABPN1;MAPK14;RPS6KA3;HMGB1;PDCD4;HNRNPA0;SCARB1
80,prerank,Regulation Of Extracellular Matrix Organization (GO:1903053),0.5176263219741482,1.902850511994136,0.0018867924528301887,0.10817810421491553,0.986,9/9,48.51%,LAMB1;LAMC1;NID1;AGT;LAMB2;LRP1;TIE1;EFEMP2;LAMA2
81,prerank,Extracellular Matrix Assembly (GO:0085029),0.6260806678947322,1.893076075569467,0.009596928982725527,0.11367746692332356,0.99,5/6,21.51%,QSOX1;TGFB1;FBLN5;TNXB;EMILIN1
82,prerank,Negative Regulation Of Hemostasis (GO:1900047),0.6421653567888288,1.8920365252116658,0.013725490196078431,0.11099608751312921,0.99,5/6,20.46%,VTN;APOE;TFPI;APOH;SERPINE1
83,prerank,Negative Regulation Of Coagulation (GO:0050819),0.6421653567888288,1.8920365252116658,0.013725490196078431,0.11099608751312921,0.99,5/6,20.46%,VTN;APOE;TFPI;APOH;SERPINE1
84,prerank,Regulation Of Stress Fiber Assembly (GO:0051492),0.4874361431472917,1.8907870181178572,0.0036429872495446266,0.11038531969694218,0.99,10/11,43.31%,APOA1;PFN1;SERPINF2;CCN2;RAC1;TPM1;ROCK2;RHOC;PFN2;CDC42
85,prerank,Regulation Of Programmed Cell Death (GO:0043067),0.2906162390379229,1.8803162589596814,0.0136986301369863,0.11609130420863609,0.991,20/32,35.77%,ALB;ACTB;CLU;VCP;HSP90AA1;CTSB;ACTN1;RPS3;PRDX2;PSMC5;AGT;RTN4;ACTN4;TGM2;RUVBL1;NME1;XPNPEP1;RUVBL2;APEX1;ETFA
86,prerank,Negative Regulation Of DNA Recombination (GO:0045910),0.6234604105571848,1.876506751149035,0.010968921389396709,0.11742694587661477,0.992,6/6,37.87%,H1-2;H1-1;H1-0;H1-5;MSH3;H1-10
87,prerank,Positive Regulation Of Cell-Cell Adhesion (GO:0022409),0.5509476706735983,1.8750267198481385,0.0055762081784386614,0.1167856781579978,0.992,5/8,10.75%,FGB;FGA;FGG;SERPINF2;MDK
88,prerank,Zymogen Activation (GO:0031638),0.416112969252522,1.873157072673644,0.009363295880149813,0.11654139482550858,0.993,8/15,14.03%,FGB;FGA;PGK1;APOH;C1R;FGG;F9;MASP1
89,prerank,Regulation Of Primary Metabolic Process (GO:0080090),0.5525907771359614,1.8726699121417123,0.0037243947858473,0.11522295988637742,0.993,7/8,33.49%,APOE;MACROH2A1;ANGPTL8;PSAP;VPS35;LDLR;ROCK2
90,prerank,Positive Regulation Of Protein Processing (GO:0010954),0.5810080695409685,1.8716225920056146,0.007736943907156673,0.11448646752651297,0.994,5/7,15.66%,GSN;ENO1;ANGPTL8;CLEC3B;MYH9
91,prerank,Response To Steroid Hormone (GO:0048545),0.5820950908203921,1.866241100893542,0.007518796992481203,0.1165038650840552,0.995,5/7,14.55%,HSPA1A;TFPI;TGFB1;THBS1;HSPA8
92,prerank,Protein Modification Process (GO:0036211),-0.17568364957387708,-1.8648243686858543,0.010101010101010102,0.409556726745659,0.997,57/85,48.92%,PTPRK;ST3GAL1;MAP4K4;COPS2;CTBP1;LOXL2;PPP1R12A;SRPK1;GMFB;ST3GAL6;CSK;JAK2;UBE2I;PPP2R5D;PPM1G;PRKAA1;PPP1CC;CDK1;PRKAG1;SDHAF2;MAPK1;PDPR;PARK7;CSNK2B;PPP3CA;ILF3;CDK16;GMPPB;UBE2D2;UBE2M;UCHL3;PTPRM;DSP;PIGH;COPS5;PHPT1;PRKACA;RABGGTA;CSNK2A1;PPP2R2A;COL3A1;PTPN11;CDK11A;MAP2K1;RBX1;ERO1A;P3H1;FBXO22;LOX;PPP1CB;MANBA;FBXO2;PPP1CA;FN3K;MAPK3;APOA2;PMM2
93,prerank,Positive Regulation Of Endocytosis (GO:0045807),0.356032374948336,1.8632997930629542,0.013223140495867768,0.1172864083084114,0.995,7/20,2.57%,C3;VTN;AHSG;APOE;APOA1;CLU;GPC3
94,prerank,Regulation Of Phosphorylation (GO:0042325),0.4220557370878151,1.861426980512354,0.016544117647058824,0.11723647795153253,0.995,11/14,37.58%,FN1;THBS1;ANG;PPP2CA;CORO1C;APP;PLXNB2;PTGES3;ILK;SRPX2;HSPB1
95,prerank,Positive Regulation Of Chemotaxis (GO:0050921),0.5768814637936062,1.860666902309457,0.005825242718446602,0.11638453036395166,0.995,5/7,15.25%,TGFB1;THBS1;CNTN1;MDK;RARRES2
96,prerank,Regulation Of Cell Adhesion (GO:0030155),0.279421582674124,1.8576945630420372,0.015332197614991482,0.11700100604473729,0.996,19/32,33.49%,VTN;TGFBI;FBLN1;LAMB1;LAMC1;PPP2CA;MDK;NID1;LAMB2;TNXB;TNC;P4HB;C1QBP;PLXNB2;PPP2R1A;RSU1;TGM2;TPM1;ROCK2
97,prerank,Positive Regulation Of Multicellular Organismal Process (GO:0051240),0.21357709693491964,1.8523600092427839,0.00819672131147541,0.11943239466732672,0.998,25/58,24.43%,GAPDH;FGB;APOE;FGA;ACTB;ENO1;PPIB;C1QTNF3;TGFB1;MACROH2A1;FGG;MDK;DYNC1H1;APOC2;AGT;TNXB;SERPINE1;LRP1;COL1A1;RBBP4;RTN4;APLP2;CFL1;MACROH2A2;C1QBP
98,prerank,Positive Regulation Of Transferase Activity (GO:0051347),0.29307456483223576,1.8488077977277284,0.012195121951219513,0.12077339338301092,0.998,24/30,52.25%,APOE;APOA1;HSP90AB1;HSP90AA1;TGFB1;IGF2;XRCC5;TCP1;CCT4;AGT;CCT2;CD74;RPS2;PCNA;PTGES3;HNRNPD;HNRNPA2B1;TIE1;APOA4;MAPK15;UBE2N;APOA2;MAPK3;SERINC5
99,prerank,Regulation Of Heterotypic Cell-Cell Adhesion (GO:0034114),0.6247143031142242,1.845382700853697,0.014842300556586271,0.12161293179051796,0.998,4/6,8.12%,FGB;FGA;APOA1;FGG
100,prerank,Defense Response To Symbiont (GO:0140546),-0.4643726990048873,-1.8415560208205428,0.004434589800443459,0.43892306610009146,1.0,9/11,35.01%,MOV10;G3BP1;EXOSC4;NCBP1;STAT1;IGF2BP1;SAMHD1;IFITM1;DHX15
101,prerank,Vacuolar Acidification (GO:0007035),-0.5929618768328446,-1.8413666383936313,0.011013215859030838,0.41184523865773337,1.0,6/6,40.97%,CLN5;ATP6AP2;PPT1;ATP6V1B2;GRN;ATP6V1A
102,prerank,Mucosal Immune Response (GO:0002385),0.6565001986884094,1.8351663407283447,0.01509433962264151,0.1275865736040541,0.999,4/5,16.54%,LTF;H2BC11;H2BC12;PIGR
103,prerank,Positive Regulation Of Autophagy (GO:0010508),-0.5964809384164222,-1.8343773713808307,0.012526096033402923,0.40360284690888476,1.0,6/6,40.62%,PRKAA1;PARK7;CDK16;HMGB1;UFL1;SH3GLB1
104,prerank,Positive Regulation Of Locomotion (GO:0040017),0.6614669310836944,1.8339227379698617,0.015180265654648957,0.12701650554940253,1.0,4/5,15.25%,SPOCK2;TGFB1;THBS1;RARRES2
105,prerank,Regulation Of Actin Filament Bundle Assembly (GO:0032231),0.56924882629108,1.8318001579720973,0.018484288354898338,0.12706947231022553,1.0,7/7,43.31%,PFN1;RAC1;ROCK2;PLEK;PFN2;VIL1;CDC42
106,prerank,Positive Regulation Of Protein Kinase B Signaling (GO:0051897),0.35401987118492984,1.8255599400638705,0.014234875444839857,0.13054933767705823,1.0,9/20,11.86%,GDF15;HSP90AB1;HSP90AA1;TGFB1;F10;THBS1;AKR1C3;CNTN1;IGF2
107,prerank,Positive Regulation Of Neutrophil Migration (GO:1902624),0.6129032258064516,1.8195267925062089,0.014925373134328358,0.13362257073885273,1.0,6/6,38.92%,THBS4;MDK;RAC1;CD74;C1QBP;DNM1L
108,prerank,Positive Regulation Of Telomere Maintenance Via Telomerase (GO:0032212),0.40779885864088106,1.8163104792470453,0.01838235294117647,0.13479521674511363,1.0,9/14,24.84%,XRCC5;CCT3;TCP1;CCT4;CCT7;CCT8;CCT2;CCT5;HNRNPA1
109,prerank,Positive Regulation Of Peptide Hormone Secretion (GO:0090277),0.5645034349027018,1.8149871877240475,0.015065913370998116,0.13435223613950445,1.0,5/7,17.65%,FGB;FGA;GLUD1;FGG;FLNB
110,prerank,Protein Stabilization (GO:0050821),0.23255668207672991,1.8006342158758393,0.014975041597337771,0.1443799251212967,1.0,29/48,39.33%,GAPDH;APOA1;CLU;PFN1;HSPA1A;HSP90AB1;PPIB;HSP90AA1;FLNA;H1-5;CCT3;TCP1;CCT4;CCT7;CCT8;CCT2;CCT5;HSPD1;RTN4;PTGES3;RUVBL1;RUVBL2;RPL11;RPL5;CCT6A;HSP90AB4P;PFN2;GPI;RPS7
111,prerank,Chromosome Organization (GO:0051276),0.5223335484342306,1.7959714533903013,0.016453382084095063,0.14630240281395615,1.0,5/8,12.04%,H3-3A;H1-2;H1-1;H1-0;H1-5
112,prerank,Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043281),-0.45252886502216444,-1.7957814162254635,0.007211538461538462,0.47635166232845333,1.0,9/11,35.65%,CD44;SRC;DDX3X;VEGFA;CYCS;RPS6KA3;HMGB1;CSNK2A1;FABP1
113,prerank,Regulation Of Protein Kinase B Signaling (GO:0051896),0.29755431527757387,1.7938720469653255,0.017482517482517484,0.14641542186612438,1.0,11/28,11.86%,GDF15;HSP90AB1;HSP90AA1;TGFB1;RACK1;F10;THBS1;AKR1C3;CNTN1;PPP2CA;IGF2
114,prerank,Positive Regulation Of Telomere Maintenance Via Telomere Lengthening (GO:1904358),0.3890275361901141,1.7925021370163272,0.018018018018018018,0.1462521187143737,1.0,11/15,35.65%,XRCC5;CCT3;TCP1;CCT4;CCT7;CCT8;CCT2;CCT5;HNRNPA1;HNRNPA2B1;CCT6A
115,prerank,Regulation Of Lipoprotein Lipase Activity (GO:0051004),0.4970622796709754,1.7855791544548185,0.024574669187145556,0.15006576038415118,1.0,9/9,50.56%,APOH;APOC3;APOC2;PCSK6;APOA4;APOA5;APOC1;ANGPTL4;PCSK5
116,prerank,Cytoskeleton-Dependent Cytokinesis (GO:0061640),0.41782404797804495,1.784301252911637,0.01903114186851211,0.14934364276321083,1.0,10/13,36.24%,SPTBN1;SEPTIN9;CFL1;ROCK2;PDCD6IP;SEPTIN11;MYH10;RHOC;SEPTIN7;SEPTIN2
117,prerank,Regulation Of Cell Development (GO:0060284),-0.5917888563049853,-1.7830483954229532,0.015625,0.4825299160432621,1.0,6/6,41.09%,ANXA2;HMGB2;CTNNB1;GRN;FBXO22;RPS19
118,prerank,Positive Regulation Of Stress Fiber Assembly (GO:0051496),0.4783244345985551,1.7798286043556326,0.022018348623853212,0.1518598993092751,1.0,9/10,43.31%,APOA1;SERPINF2;CCN2;RAC1;TPM1;ROCK2;RHOC;PFN2;CDC42
119,prerank,Regulation Of Cell Morphogenesis (GO:0022604),-0.4993265658277849,-1.7725511269362302,0.014989293361884369,0.4846025363585678,1.0,5/8,10.64%,SPARC;MOV10;FERMT2;CD44;MACF1
120,prerank,Defense Response To Virus (GO:0051607),-0.3980688097438725,-1.771495318141713,0.020134228187919462,0.4639982042151744,1.0,13/14,53.07%,MOV10;G3BP1;EXOSC4;TRIM25;NCBP1;STAT1;IGF2BP1;SAMHD1;IFITM1;DHX15;TRIM28;SERINC5;UBE2N
121,prerank,Regulation Of Phosphatidylinositol 3-Kinase Signaling (GO:0014066),-0.5457264140568476,-1.7699025351270323,0.014705882352941176,0.44655740840808084,1.0,5/7,14.96%,PDGFC;JAK2;SLC9A3R1;NEDD4;SRC
122,prerank,Regulation Of G0 To G1 Transition (GO:0070316),-0.6207502930832356,-1.7656973240418257,0.017167381974248927,0.43634629656944623,1.0,5/5,38.16%,SMARCA4;HLA-G;RRM2B;ACTL6A;RRM1
123,prerank,Cellular Component Assembly (GO:0022607),0.2367155317112126,1.7555871001002177,0.024955436720142603,0.17266609512661998,1.0,23/44,30.92%,FGB;FGA;PARD3;GSN;QSOX1;TGFB1;LAMC1;FGG;YWHAZ;JCHAIN;SLC2A1;SPTBN1;DHX9;EZR;PARVB;RTN4;CD74;CAPZA1;PPP2R1A;FSCN1;DARS1;AP2M1;PTPRD
124,prerank,Positive Regulation Of Protein Catabolic Process (GO:0045732),0.29478468460953555,1.752759980037611,0.02142857142857143,0.17391876174545845,1.0,16/25,36.47%,APOE;C4BPA;GPC3;VCP;HSP90AA1;EZR;PSMC5;PSMC3;VPS35;PSMC2;PSMC6;NSF;DDB1;RAB7A;MSN;C4BPB
125,prerank,Regulation Of Endopeptidase Activity (GO:0052548),0.30343583940733154,1.7478605580842057,0.015901060070671377,0.17696454203040615,1.0,15/26,29.57%,GAPDH;VTN;AHSG;SERPINF1;SERPIND1;SPOCK2;SERPINA7;SERPINF2;SERPINA1;SERPINA5;SERPINE1;PSME2;SERPING1;SERPINH1;SERPINA11
126,prerank,tRNA Aminoacylation (GO:0043039),0.4423529411764706,1.747815394326918,0.023593466424682397,0.17528518164773568,1.0,11/11,56.05%,VARS1;RARS1;HARS1;IARS1;NARS1;QARS1;GARS1;EPRS1;MARS1;IARS2;LARS1
127,prerank,Positive Regulation Of Release Of Sequestered Calcium Ion Into Cytosol (GO:0051281),0.5730205278592375,1.747571802649689,0.03177570093457944,0.1738689153051458,1.0,6/6,42.90%,F2;CEMIP;GSTO1;CALM1;APEX1;GSTM2
128,prerank,Nucleobase-Containing Compound Catabolic Process (GO:0034655),-0.47700215576603955,-1.7474282862365698,0.024175824175824177,0.4607151069573462,1.0,6/9,18.18%,EXOSC6;XRN2;PNPT1;PABPC4;EXOSC4;NCBP1
129,prerank,Chaperone Cofactor-Dependent Protein Refolding (GO:0051085),0.4354258554499333,1.746646992682887,0.023985239852398525,0.17312254394886897,1.0,8/11,30.68%,HSPA1A;HSPA5;HSPA8;HSPE1;HSPA13;HSPA9;PTGES3;ST13
130,prerank,Negative Regulation Of Protein Phosphorylation (GO:0001933),0.32122354311449297,1.7355530657041984,0.02456140350877193,0.18207714599510297,1.0,19/22,55.58%,PARD3;FBLN1;PPIA;TGFB1;RACK1;CORO1C;LRP1;EMILIN1;YWHAG;CALM1;PRKDC;SORD;GSTP1;HSPB1;QARS1;WARS1;MVP;DKK1;DNAJC3
131,prerank,Peptidyl-Serine Modification (GO:0018209),-0.4118026007594519,-1.731661340929698,0.033185840707964605,0.48089572643111167,1.0,9/12,33.26%,SRPK1;MAPK14;CDK1;MAPK1;PCK1;GALNT2;RPS6KA3;PRKACA;CSNK2A1
132,prerank,Positive Regulation Of Wound Healing (GO:0090303),0.4494491673769554,1.729621629401779,0.014814814814814815,0.18689645870564953,1.0,7/10,27.24%,VTN;F2;APOH;THBS1;SERPINE1;EMILIN1;REG3A
133,prerank,Extracellular Matrix Organization (GO:0030198),0.2324994290039974,1.7293304347793494,0.03278688524590164,0.18549984838257172,1.0,19/44,22.56%,MATN3;TGFBI;GSN;QSOX1;LUM;PLG;SPOCK2;TGFB1;LAMC1;SERPINF2;ADAMTS13;NID1;COL18A1;SMOC1;NPNT;APP;COL1A1;PLOD3;COL2A1
134,prerank,Positive Regulation Of Protein Kinase Activity (GO:0045860),0.33346189654828245,1.7288846700740326,0.03616636528028933,0.18424418408609292,1.0,12/20,29.11%,RELN;CLU;LTF;HSP90AB1;HSP90AA1;PPP2CA;XRCC5;XRCC6;AGT;CALM1;HMGA2;IQGAP1
135,prerank,Visual Perception (GO:0007601),0.4247180467524787,1.727124388864552,0.02333931777378815,0.18458308309736318,1.0,9/12,34.48%,LUM;EFEMP1;OAT;COL18A1;EML2;COL1A1;COL2A1;REEP6;CRYZ
136,prerank,'De Novo' Post-Translational Protein Folding (GO:0051084),0.4003847708310737,1.723216652028153,0.02909090909090909,0.18706191669949038,1.0,9/13,30.68%,HSPA1A;HSPA5;HSPA8;HSPE1;CCT2;HSPA13;HSPA9;PTGES3;ST13
137,prerank,Regulation Of ERK1 And ERK2 Cascade (GO:0070372),0.2600585787045938,1.7194551818858266,0.025817555938037865,0.18893445049097246,1.0,16/34,23.79%,FN1;FGB;APOE;FGA;FBLN1;TGFB1;FGG;SERPINF2;CCN2;YWHAZ;EZR;NPNT;APP;PLA2G2A;EMILIN1;CD74
138,prerank,Negative Regulation Of Wound Healing (GO:0061045),0.5393490645855262,1.716764921459536,0.025735294117647058,0.1901862310163964,1.0,4/7,5.44%,VTN;APOE;TFPI;APOH
139,prerank,Regulation Of Telomere Maintenance Via Telomerase (GO:0032210),0.35459802690978826,1.7159015911507587,0.026690391459074734,0.1893563816296434,1.0,10/17,24.84%,XRCC5;CCT3;TCP1;CCT4;HNRNPC;CCT7;CCT8;CCT2;CCT5;HNRNPA1
140,prerank,Regulation Of Nitrogen Compound Metabolic Process (GO:0051171),0.6318874560375146,1.7122056340453597,0.02631578947368421,0.19146951368234885,1.0,5/5,37.00%,APOE;VPS35;LDLR;ROCK2;ALDH2
141,prerank,Positive Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043280),0.381555628686659,1.7115072120610078,0.018148820326678767,0.19065275786161198,1.0,8/14,21.22%,GSN;VCP;RACK1;CNTN1;CTSD;RPS3;HSPE1;HSPD1
142,prerank,Positive Regulation Of Cell Adhesion (GO:0045785),0.31839922619307326,1.7108857000140234,0.033216783216783216,0.1896735779014461,1.0,13/21,31.68%,LAMB1;LAMC1;MDK;NID1;NPNT;LAMB2;RAC1;P4HB;C1QBP;RSU1;LIMS1;TGM2;TPM1
143,prerank,Positive Regulation Of Cell Growth (GO:0030307),-0.3730670103860686,-1.705855432872156,0.042316258351893093,0.528100306783177,1.0,10/14,33.26%,MTPN;MACF1;DDX3X;EXOSC4;NCBP1;TWF2;LGI1;SEMA7A;RPS6KA3;CSNK2A1
144,prerank,Skeletal System Development (GO:0001501),0.2751056332903222,1.705585689019041,0.027210884353741496,0.19332326886717408,1.0,23/29,53.36%,AHSG;MATN3;PPIB;COMP;OGN;NOTUM;LAMA5;EXT1;PRDX1;COL18A1;COL1A1;COL2A1;TGM2;CDH11;CHI3L1;SPP2;HYAL1;FBN1;COL1A2;PCSK5;TCOF1;RPL13;CHRD
145,prerank,Positive Regulation Of Amide Metabolic Process (GO:0034250),0.3094622617876454,1.702046192822323,0.024955436720142603,0.19537142349502123,1.0,15/22,38.87%,CLU;NPM1;EEF2;THBS1;EIF6;PLXNB2;EIF3C;RPS4X;EIF4A3;PRKDC;HNRNPD;ROCK2;RPL5;SSB;EIF3E
146,prerank,Negative Regulation Of Endothelial Cell Migration (GO:0010596),0.5214786466684664,1.7017327464393786,0.0216998191681736,0.19408147832527337,1.0,4/7,7.60%,APOE;APOH;TGFB1;THBS1
147,prerank,Sensory Perception Of Light Stimulus (GO:0050953),0.43179636511658814,1.6987034219099333,0.028469750889679714,0.19589093891904744,1.0,7/11,22.56%,LUM;EFEMP1;OAT;COL18A1;EML2;COL1A1;COL2A1
148,prerank,Positive Regulation Of Granulocyte Chemotaxis (GO:0071624),0.6125439624853458,1.6976025721488053,0.03598484848484849,0.19382170716722139,1.0,5/5,38.92%,THBS4;MDK;RAC1;CD74;DNM1L
149,prerank,Positive Regulation Of Neutrophil Chemotaxis (GO:0090023),0.6125439624853458,1.6976025721488053,0.03598484848484849,0.19382170716722139,1.0,5/5,38.92%,THBS4;MDK;RAC1;CD74;DNM1L
150,prerank,Regulation Of Lipid Metabolic Process (GO:0019216),0.47462373497156296,1.69600473608392,0.027829313543599257,0.1939073655706197,1.0,6/9,20.92%,MACROH2A1;ANGPTL8;APOC3;RARRES2;APOC2;PSAP
151,prerank,Regulation Of Basement Membrane Organization (GO:0110011),0.6112514180041903,1.6947054884344182,0.02099236641221374,0.19384493020680987,1.0,4/5,19.81%,LAMB1;LAMC1;NID1;LAMB2
152,prerank,Negative Regulation Of Metabolic Process (GO:0009892),0.5741935483870967,1.693684384203543,0.028469750889679714,0.19329214988587656,1.0,6/6,42.78%,APOC3;ALDH1A1;APOC2;ACOT13;GSTP1;APOC1
153,prerank,Positive Regulation Of Protein Phosphorylation (GO:0001934),0.21068952659858625,1.6900557038138784,0.021848739495798318,0.195131289684907,1.0,20/52,20.05%,C3;VTN;RELN;F2;GDF15;THBS4;HSP90AB1;HSP90AA1;CEMIP;PPIA;TGFB1;RACK1;IGF2;XRCC5;XRCC6;RARRES2;APP;AGT;TNXB;RAC1
154,prerank,Positive Regulation Of Cholesterol Efflux (GO:0010875),0.6138800011911385,1.6874437009388024,0.01845018450184502,0.19322950102689126,1.0,4/5,20.81%,APOE;APOA1;PLTP;LRP1
155,prerank,Positive Regulation Of Cholesterol Transport (GO:0032376),0.6138800011911385,1.6874437009388024,0.01845018450184502,0.19322950102689126,1.0,4/5,20.81%,APOE;APOA1;PLTP;LRP1
156,prerank,Regulation Of Cholesterol Efflux (GO:0010874),0.6138800011911385,1.6874437009388024,0.01845018450184502,0.19322950102689126,1.0,4/5,20.81%,APOE;APOA1;PLTP;LRP1
157,prerank,Positive Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903052),0.5056423368679664,1.6824322074820033,0.023722627737226276,0.1968517288872404,1.0,5/7,22.21%,CLU;PSMC5;PSMC3;PSMC2;PSMC6
158,prerank,"Phagocytosis, Engulfment (GO:0006911)",0.6086562366657032,1.6776215095769167,0.02835538752362949,0.20021965846641288,1.0,4/5,20.05%,GSN;THBS1;MYH9;RAC1
159,prerank,SCF-dependent Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0031146),-0.5519061583577712,-1.6758966212484954,0.026785714285714284,0.5944895182302377,1.0,6/6,45.06%,SKP1;CUL5;CUL1;CUL2;RBX1;FBXO2
160,prerank,Lysosomal Lumen Acidification (GO:0007042),-0.5926143024618992,-1.673934627849569,0.02927927927927928,0.5785879546817829,1.0,5/5,40.97%,CLN5;ATP6AP2;PPT1;GRN;ATP6V1A
161,prerank,Positive Regulation Of Translation (GO:0045727),0.2698441045192335,1.6730738313788653,0.03595890410958904,0.2034942036072268,1.0,23/29,53.71%,PKM;NPM1;EEF2;THBS1;DHX9;EIF6;C1QBP;PLXNB2;EIF3C;RPS4X;EIF4A3;PRKDC;HNRNPD;YBX1;KHDRBS1;RPL5;SSB;EIF3E;HNRNPU;EIF5A;RPL26;EIF3D;PABPC1
162,prerank,Ribosomal Small Subunit Biogenesis (GO:0042274),0.2791436625220781,1.6720213045143717,0.03620689655172414,0.2030139779061413,1.0,24/28,59.03%,NPM1;RPSA;RPS9;RPS16;RPS25;RPS13;RPS14;RPS4X;FBL;RPS5;RPS11;RPS3A;RPS15A;RPS7;RPS8;NOP56;NOP58;RPS23;RPS6;RPS17;RPS27;SNU13;RRP9;RPS19
163,prerank,High-Density Lipoprotein Particle Assembly (GO:0034380),0.5946590938771825,1.6707584950156336,0.032490974729241874,0.20298263506867198,1.0,3/5,3.21%,APOE;APOA1;APOM
164,prerank,Regulation Of Fibroblast Migration (GO:0010762),0.6116271787211767,1.6678297276666902,0.03262955854126679,0.20452057305831214,1.0,4/5,20.05%,TGFB1;THBS1;CORO1C;RAC1
165,prerank,Regulation Of Cell-Substrate Adhesion (GO:0010810),0.4942732561569442,1.6655957340641476,0.03697183098591549,0.2055170704306168,1.0,6/8,27.29%,PLG;CORO1C;NPNT;RAC1;RSU1;LIMS1
166,prerank,Phospholipid Efflux (GO:0033700),0.48913681738109194,1.6605825915566264,0.03231597845601436,0.2095418512118097,1.0,8/8,51.32%,APOE;APOA1;APOC3;APOC2;APOA4;APOA5;APOC1;APOA2
167,prerank,Positive Regulation Of Defense Response (GO:0031349),0.37508378036883394,1.6569960075193062,0.03914590747330961,0.21169330051330998,1.0,8/14,21.51%,POLR3B;MDK;DHX9;APP;AGT;PLA2G2A;SERPINE1;EMILIN1
168,prerank,Cholesterol Transport (GO:0030301),0.35426237490529644,1.6549183976153372,0.038128249566724434,0.2124292345150635,1.0,13/17,42.78%,APOB;APOE;APOA1;CLU;APOM;APOC3;APOC2;LCAT;TSKU;LDLR;APOA4;APOA5;APOC1
169,prerank,Protein Sumoylation (GO:0016925),-0.5413489736070382,-1.6529601969613035,0.04008438818565401,0.6165896389554818,1.0,6/6,46.11%,SUMO2;UBE2I;RANGAP1;SAE1;TRIM28;UBA2
170,prerank,Cellular Response To Lipopolysaccharide (GO:0071222),-0.3992252764566485,-1.6503724252783243,0.017777777777777778,0.6042019069938859,1.0,8/11,31.39%,SHPK;HMGB2;VIM;UPF1;PABPN1;MAPK14;HMGB1;PDCD4
171,prerank,Axon Development (GO:0061564),0.5872356969319297,1.6448066384142566,0.03907637655417407,0.22235022692146209,1.0,4/5,22.85%,PARD3;APP;RTN4;APLP2
172,prerank,Fatty Acid Metabolic Process (GO:0006631),-0.3607545702497108,-1.6437709950436168,0.04308390022675737,0.6025822872119312,1.0,10/14,34.25%,ACAA1;CES1;ACSL4;ACSL1;PCCA;PCCB;LIPC;ACOT1;HSD17B10;GGT1
173,prerank,Regulation Of Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0010803),0.5978686812566012,1.6423383721190747,0.0421455938697318,0.22355890814430462,1.0,3/5,2.81%,APOA1;H2BC11;HSPA1A
174,prerank,Mitotic Cytokinesis (GO:0000281),0.5164870954078582,1.6416994976451074,0.036101083032490974,0.22276874528255394,1.0,6/7,34.83%,SPTBN1;CFL1;ROCK2;PDCD6IP;MYH10;RHOC
175,prerank,Positive Regulation Of T Cell Differentiation (GO:0045582),-0.5062790323138421,-1.6364809972721148,0.027253668763102725,0.6044351034608758,1.0,6/7,34.13%,VNN1;SMARCA4;HLA-G;PCK1;PNP;ACTL6A
176,prerank,Regulation Of Peptidase Activity (GO:0052547),0.5117370892018781,1.6345708981543163,0.02952029520295203,0.22971161674808613,1.0,7/7,49.04%,CTSB;CST3;CTSH;PSMA3;ECM1;HDAC1;CTSV
177,prerank,Negative Regulation Of Response To Stimulus (GO:0048585),0.507601934681009,1.633922868720274,0.03356890459363958,0.22887430700200015,1.0,5/7,22.85%,APOA1;CLU;AMBP;RPS3;APLP2
178,prerank,Positive Regulation Of Gene Expression (GO:0010628),0.17388301396977118,1.629800206388521,0.044657097288676235,0.2318451343217912,1.0,36/70,36.29%,GAPDH;FN1;CLU;GSN;HSPA1A;NPM1;C1QTNF3;TGFB1;MACROH2A1;EEF2;THBS1;CNTN1;RPS3;EZR;APP;AGT;TNC;EMILIN1;VPS35;CD74;EIF6;PLXNB2;HMGA2;LIMS1;EIF3C;RPS4X;EIF4A3;CTSH;PRKDC;HNRNPD;AKR1B1;ROCK2;RPL11;RPL5;SSB;MSN
179,prerank,Negative Regulation Of Carbohydrate Metabolic Process (GO:0045912),0.47621843805049935,1.6257334946018047,0.043795620437956206,0.23479923825448382,1.0,8/8,52.60%,C1QTNF3;TGFB1;CLTC;PLEK;AP2A1;MST1;FBP1;USP7
180,prerank,Monocarboxylic Acid Transport (GO:0015718),-0.5873388042203985,-1.6211797625265854,0.030837004405286344,0.6313202903435465,1.0,5/5,41.50%,ACSL1;SLC9A3R1;FABP1;SLC16A3;LYPLA1
181,prerank,Embryonic Organ Development (GO:0048568),0.5010929870770751,1.6194458524957525,0.04061895551257253,0.24058312947026403,1.0,5/7,22.56%,TGFB1;IGF2;RARRES2;COL18A1;COL2A1
182,prerank,Negative Regulation Of Cell Population Proliferation (GO:0008285),0.233109961078979,1.617260316541479,0.04040404040404041,0.2415368174779593,1.0,17/39,22.85%,APOE;FBLN1;HSPA1A;PLG;NPM1;TGFB1;DHRS2;OGN;THBS1;ANG;LMNA;COL18A1;APP;HMGA1;FTH1;RBBP4;APLP2
183,prerank,Protein Polyubiquitination (GO:0000209),-0.3155937407696226,-1.6167844058978746,0.031042128603104215,0.6258253625109809,1.0,13/18,40.09%,THOP1;NEDD4;SKP1;TRIM25;MYCBP2;CUL3;CUL1;TPP2;UBE2D2;CTNNB1;NT5C2;RBX1;FBXO22
184,prerank,Positive Regulation Of Protein Transport (GO:0051222),0.3431017764269114,1.6162256614205512,0.03508771929824561,0.2411463346892415,1.0,7/17,9.06%,FGB;FGA;PPIA;TGFB1;RACK1;FGG;ANG
185,prerank,Protein Neddylation (GO:0045116),-0.4074074074074074,-1.6135778150093787,0.0332541567695962,0.6178634540538133,1.0,10/10,59.56%,COPS2;NAE1;UBE2M;COPS5;COPS4;RBX1;COPS6;COPS3;GPS1;COPS8
186,prerank,Regulation Of Macromolecule Biosynthetic Process (GO:0010556),-0.4412455934195064,-1.61226363554664,0.03854389721627409,0.6044182051661663,1.0,9/9,56.17%,EIF2B4;MTPN;PDGFA;NOLC1;ELP3;ELP1;EIF4E;TCOF1;EIF2S1
187,prerank,Regulation Of Organelle Assembly (GO:1902115),0.4441331447504506,1.608656609242213,0.03383458646616541,0.24854562051044868,1.0,8/9,45.35%,GSN;NPM1;EZR;PDCD6IP;MSN;RAB1B;MAPK15;RAB5A
188,prerank,Protein Phosphorylation (GO:0006468),-0.20699449708463294,-1.6066397057373047,0.035443037974683546,0.6035376669986058,1.0,24/40,38.22%,MAP4K4;COPS2;CTBP1;USP15;SRPK1;GMFB;CSK;JAK2;PRKAA1;SRC;MAPK14;CDK1;PRKAG1;MAPK1;PCK1;CSNK2B;ILF3;CDK16;RPS6KA3;BMP4;PRKACA;CSNK2A1;CDK11A;MAP2K1
189,prerank,Modulation By Host Of Viral Process (GO:0044788),0.4434915082785368,1.6049132905281784,0.042435424354243544,0.2516641036513014,1.0,8/9,45.35%,LTF;IGF2R;PPIB;FASN;CFL1;ROCK2;CDC42;RAB5A
190,prerank,Hydrogen Peroxide Catabolic Process (GO:0042744),0.48209042865531426,1.6045073053890972,0.039399624765478425,0.25060768671822864,1.0,8/8,52.02%,HBB;HBE1;PRDX1;PRDX2;GPX3;CAT;PRDX4;PRDX3
191,prerank,Regulation Of Macrophage Chemotaxis (GO:0010758),0.5335140888738782,1.6023692535564342,0.04780114722753346,0.2514584809942931,1.0,4/6,15.25%,C5;THBS1;MDK;RARRES2
192,prerank,Response To Ionizing Radiation (GO:0010212),-0.5243401759530791,-1.601949990666734,0.0515695067264574,0.6011452722961333,1.0,6/6,47.81%,SMPD1;BABAM2;PRKAA1;MAPK14;EEF1D;FIGNL1
193,prerank,Bone Development (GO:0060348),0.509030617058504,1.6001547213653984,0.061567164179104475,0.2525502141767896,1.0,4/7,8.07%,LTF;PPIB;OGN;NOTUM
194,prerank,Negative Regulation Of Cell Adhesion (GO:0007162),0.3979054568197964,1.599990786954869,0.04864864864864865,0.251206576635461,1.0,8/12,28.87%,TGFBI;FBLN1;PLG;TGFB1;MDK;SERPINE1;PLXNB2;CDH1
195,prerank,Regulation Of Cellular Component Biogenesis (GO:0044087),0.4187959222331163,1.5970969728862627,0.04093567251461988,0.252812655883592,1.0,8/10,39.51%,APOE;HSP90AA1;RAP1B;HSPA8;EZR;ROCK2;MSN;TIE1
196,prerank,Glycolytic Process (GO:0006096),0.32987194973435935,1.5915446458588993,0.050816696914700546,0.25790146368253525,1.0,8/17,16.19%,GAPDH;PKM;PGK1;ENO1;LDHA;PGAM1;ALDOC;TPI1
197,prerank,Gene Expression (GO:0010467),0.14993636429978688,1.590875301237173,0.053208137715179966,0.2571273395938652,1.0,76/101,62.13%,EEF1A1;RPS27A;RPSA;RPS10;DDX39B;RPL22;RPS18;SRSF3;RPLP1;RPS9;RPS16;RPS3;RPS25;RPLP0;RPS13;RPL10A;RPL30;HNRNPK;HSPD1;RRBP1;RPS14;RPS2;RPL12;RPS26;HARS1;RPL27A;RPS4X;RPLP2;TGM2;DNAJB11;EIF4A3;DARS1;RPS5;HNRNPD;SARS1;RPL18;RPS11;HNRNPA2B1;RPL11;RPS3A;RPL5;RPS15A;RPS7;RPL14;HNRNPU;DDX17;RPL9;HNRNPF;TPR;FARSB;RPS8;RPL15;RPL27;RPL4;XPO1;MAGOH;RPS23;RPL7;WARS1;RPL29;RPL13;RPL28;RPL26;RPL8;RPS6;RPS17;RPS27;RPS20;HNRNPH1;SORL1;RPS19;RPL35A;RPL7A;ALYREF;RPL17;HNRNPL
198,prerank,ncRNA Processing (GO:0034470),-0.24057117689915436,-1.5885689673013732,0.036231884057971016,0.6239370354243583,1.0,28/31,66.34%,EBNA1BP2;RPS24;EMG1;RPP30;XRN2;EXOSC4;MRTO4;DDX27;RPS28;MTREX;NOLC1;RPL35A;RPS19;RRP9;RPS27;RPS17;RPS6;RPL26;RPL7;NOP58;NOP56;KARS1;RPL27;RPL14;RPS7;SSB;RPL5;RPL11
199,prerank,Dephosphorylation (GO:0016311),-0.29748495499462846,-1.5860334556099018,0.05066079295154185,0.6157806185287735,1.0,16/20,49.68%,PTPRK;PPP1R12A;PSPH;PPP2R5D;PPM1G;PPP1CC;SDHAF2;PDPR;PPP3CA;PTPRM;PHPT1;PPP2R2A;PTPN11;PPP1CB;PPP1CA;FBP1
200,prerank,Negative Regulation Of Cellular Component Organization (GO:0051129),0.3216481227357518,1.5831082007999036,0.045454545454545456,0.2651620937462447,1.0,8/18,14.55%,APOA1;CLU;HSPA1A;APOM;HSPA5;APOC3;XRCC5;HSPA8
201,prerank,Sterol Homeostasis (GO:0055092),0.3114299951826495,1.5808181427646435,0.04063604240282685,0.2649994396310995,1.0,18/20,59.91%,APOB;APOE;APOA1;APOM;APOC3;APOC2;LCAT;TSKU;LDLR;EHD1;APOA4;APOA5;RALY;ANGPTL3;APOA2;MTTP;PCSK9;SCARB1
202,prerank,Cholesterol Homeostasis (GO:0042632),0.3114299951826495,1.5808181427646435,0.04063604240282685,0.2649994396310995,1.0,18/20,59.91%,APOB;APOE;APOA1;APOM;APOC3;APOC2;LCAT;TSKU;LDLR;EHD1;APOA4;APOA5;RALY;ANGPTL3;APOA2;MTTP;PCSK9;SCARB1
203,prerank,Regulation Of Protein Secretion (GO:0050708),0.3235671126774099,1.5793848139326834,0.039383561643835614,0.2649689217136921,1.0,7/18,9.06%,FGB;APOE;FGA;PPIA;TGFB1;FGG;ANG
204,prerank,Negative Regulation Of Response To Biotic Stimulus (GO:0002832),0.5354711591689169,1.579336471530014,0.047080979284369114,0.26339806555531636,1.0,5/6,30.51%,LTF;YWHAZ;C1QBP;PARP1;PRKDC
205,prerank,Cell Cycle G1/S Phase Transition (GO:0044843),-0.4097355593519645,-1.5782337663913324,0.04904051172707889,0.6221078346522119,1.0,7/10,28.35%,CUL4A;GSPT1;CUL5;CUL3;CUL4B;CUL1;CUL2
206,prerank,Positive Regulation Of Response To Stimulus (GO:0048584),0.33844857216964114,1.5781494007605843,0.049910873440285206,0.2635098217410477,1.0,11/16,36.70%,C9;C7;C8B;DHX9;RPS3;PCNA;REG3A;ILK;RUVBL1;RUVBL2;C6
207,prerank,rRNA Metabolic Process (GO:0016072),-0.23683708890260485,-1.576169243898009,0.05048076923076923,0.6132825677623024,1.0,27/30,66.34%,EBNA1BP2;RPS24;EXOSC6;EMG1;XRN2;EXOSC4;MRTO4;DDX27;RPS28;MTREX;NOLC1;RPL35A;RPS19;RRP9;MARS1;RPS27;RPS17;RPS6;RPL26;RPL7;NOP58;NOP56;RPL27;RPL14;RPS7;RPL5;RPL11
208,prerank,Negative Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001243),0.39928365687113837,1.573553119034739,0.056074766355140186,0.2679171546386059,1.0,5/11,8.36%,CLU;HSPA1A;ENO1;PPIA;HYOU1
209,prerank,Endodermal Cell Differentiation (GO:0035987),0.4253691474010539,1.5726919230768317,0.05575539568345324,0.26594993077587487,1.0,7/9,37.29%,VTN;FN1;LAMB1;COL6A1;HMGA2;COL12A1;LAMA3
210,prerank,Endoderm Formation (GO:0001706),0.4253691474010539,1.5726919230768317,0.05575539568345324,0.26594993077587487,1.0,7/9,37.29%,VTN;FN1;LAMB1;COL6A1;HMGA2;COL12A1;LAMA3
211,prerank,Regulation Of Tau-Protein Kinase Activity (GO:1902947),0.5713575597143917,1.5715973600202324,0.03804347826086957,0.26573817054867244,1.0,3/5,5.03%,CLU;HSP90AB1;HSP90AA1
212,prerank,Regulation Of Receptor-Mediated Endocytosis (GO:0048259),0.3172247604531858,1.5710359723408118,0.06260869565217392,0.26488692531797414,1.0,9/18,20.98%,C3;VTN;CLU;APOC3;ARF1;APOC2;RAC1;SERPINE1;HNRNPK
213,prerank,Proteasomal Protein Catabolic Process (GO:0010498),0.20768785091408357,1.5694320526495174,0.054009819967266774,0.2653220370789375,1.0,30/45,47.57%,VCP;PSMD14;PRPF19;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;DDB1;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMD1;PSMA5;PSMB4;PCBP2
214,prerank,Cholesterol Efflux (GO:0033344),0.403529411764706,1.5686596358989795,0.05516014234875445,0.26483704487192183,1.0,11/11,59.91%,APOE;APOA1;APOM;APOC3;APOC2;TSKU;APOA4;APOA5;APOC1;APOA2;SCARB1
215,prerank,Positive Regulation Of Cellular Component Biogenesis (GO:0044089),0.2649460783101345,1.5672095634425087,0.06408094435075885,0.2649553157964265,1.0,22/26,59.50%,CLU;PFN1;VCP;SDC1;TGFB1;RACK1;SDC4;RPS3;EMILIN1;PDCD6IP;RAB7A;RHOC;PLEK;PFN2;VIL1;TPR;HYAL1;WARS1;TFRC;SDCBP;CDH5;SH3GLB1
216,prerank,Positive Regulation Of Programmed Cell Death (GO:0043068),-0.225028770451427,-1.5646272627382776,0.06651376146788991,0.6312762761805826,1.0,18/32,32.73%,SMPD1;UBE2Z;LGALS1;BCLAF1;CTNNBL1;DNAJA1;DDX3X;ADAMTSL4;AIFM1;IGF2BP1;CASP6;CCAR2;HMGB1;PTPA;CTNNB1;BMP4;EEF1E1;ITGB1
217,prerank,Negative Regulation Of Epithelial Cell Migration (GO:0010633),0.5159871580275982,1.5643360799963073,0.050816696914700546,0.2671521910626329,1.0,4/6,16.83%,APOE;APOH;THBS1;CORO1C
218,prerank,Cell-Matrix Adhesion (GO:0007160),0.24317988860014758,1.560235226261872,0.05396290050590219,0.271011439887741,1.0,13/30,21.51%,VTN;FN1;FGB;FGA;FGG;FGL1;ADAMTS13;FBLN5;NPNT;FERMT3;THBS3;RAC1;EMILIN1
219,prerank,Lytic Vacuole Organization (GO:0080171),-0.5416178194607268,-1.5576348743954436,0.05032822757111598,0.6361931440542964,1.0,5/5,46.05%,CLN5;MBTPS1;GRN;TPP1;GAA
220,prerank,Supramolecular Fiber Organization (GO:0097435),0.17633951487344493,1.5564866741012822,0.05573770491803279,0.27404367045516037,1.0,28/66,27.00%,GSN;LUM;HSP90AB1;KRT1;KRT9;SERPINF2;KRT19;FBLN5;CCDC13;KRT10;KRT2;ACTN1;COL18A1;CORO1C;DYNC1H1;ALDOA;CST3;APP;TNXB;RAC1;COL1A1;EMILIN1;PLOD3;COL2A1;TAGLN2;HNRNPA1;CORO1A;SERPINH1
221,prerank,Response To Endoplasmic Reticulum Stress (GO:0034976),0.2989359571263981,1.55588624686401,0.05235602094240838,0.2732441585271126,1.0,8/20,12.39%,THBS4;VCP;PDIA6;HSPA5;HSP90B1;THBS1;HYOU1;PDIA3
222,prerank,tRNA Aminoacylation For Protein Translation (GO:0006418),0.29832109077359814,1.552165601416875,0.03723404255319149,0.2764237005678056,1.0,17/20,56.05%,VARS1;RARS1;HARS1;DARS1;SARS1;TARS1;IARS1;NARS1;QARS1;GARS1;FARSB;KARS1;EPRS1;WARS1;MARS1;IARS2;LARS1
223,prerank,Regulation Of Fatty Acid Biosynthetic Process (GO:0042304),0.45398808296473514,1.550229494715513,0.05504587155963303,0.277160557871229,1.0,7/8,42.78%,APOC3;APOC2;EIF6;ACADVL;APOA4;APOA5;APOC1
224,prerank,Positive Regulation Of Axonogenesis (GO:0050772),-0.5531173854502716,-1.5471607384267396,0.054945054945054944,0.6530222069623511,1.0,4/5,23.79%,PLXNA1;MACF1;TWF2;SEMA7A
225,prerank,Regulation Of Receptor Internalization (GO:0002090),-0.42036200845715294,-1.5437739701816213,0.049891540130151846,0.6487358198127574,1.0,8/9,46.35%,FLOT1;ANXA2;VEGFA;ARRB1;CD63;PCSK9;SDCBP;DKK1
226,prerank,Negative Regulation Of Blood Vessel Endothelial Cell Migration (GO:0043537),0.5500603980882722,1.5437196465198009,0.06563706563706563,0.2844585632636359,1.0,3/5,7.60%,APOE;TGFB1;THBS1
227,prerank,Positive Regulation Of Canonical Wnt Signaling Pathway (GO:0090263),0.40260101467980036,1.5304467188806274,0.06630824372759857,0.30050158096882534,1.0,7/10,31.91%,GPC3;VCP;TGFB1;COL1A1;ILK;RUVBL1;PTK7
228,prerank,Positive Regulation Of Hydrolase Activity (GO:0051345),0.3027884544040909,1.5279818141582704,0.07666098807495741,0.3025281492618535,1.0,12/19,34.83%,APOA1;AGRN;RACK1;RPS3;PSAP;CALM1;RSU1;LIMS1;TGM2;CTSH;CCL20;RHOC
229,prerank,Positive Regulation Of Exocytosis (GO:0045921),0.3848194392275051,1.5251237411707284,0.07020872865275142,0.30479645217607826,1.0,5/11,9.59%,FGB;FGA;SDC1;FGG;SDC4
230,prerank,Regulation Of Integrin-Mediated Signaling Pathway (GO:2001044),0.4126604358838828,1.5235733134154459,0.06367041198501873,0.30527882870848655,1.0,8/9,48.51%,LAMB1;FLNA;LAMC1;NID1;LAMB2;LIMS1;TIMP1;LAMA2
231,prerank,Telomere Organization (GO:0032200),0.3567697682595966,1.5196620128219736,0.06542056074766354,0.3091356362851078,1.0,9/13,35.01%,H3-3A;XRCC5;XRCC6;PTGES3;PARP1;RUVBL1;PRKDC;RUVBL2;APEX1
232,prerank,Protein Polymerization (GO:0051258),0.36742953047931487,1.5196545229210638,0.06282722513089005,0.3074886838510502,1.0,9/12,40.09%,FGB;FGA;GSN;FGG;ANG;RAC1;DIAPH1;KRT5;VIL1
233,prerank,Positive Regulation Of Nervous System Development (GO:0051962),0.39899624366392084,1.5179977492071453,0.07102803738317758,0.308342414799275,1.0,7/10,31.74%,SERPINF1;CLSTN1;CLSTN3;TGM2;PTPRD;NAP1L1;SRPX2
234,prerank,Reverse Cholesterol Transport (GO:0043691),0.37424961172524324,1.5178930709004723,0.06878306878306878,0.3068087961911382,1.0,7/12,23.32%,APOE;APOA1;CLU;APOM;APOC3;APOC2;LCAT
235,prerank,Positive Regulation Of Signal Transduction (GO:0009967),0.2123322553180475,1.517562018347038,0.06196213425129088,0.30560757155808516,1.0,19/39,29.98%,C3;VTN;RELN;LAMB1;TGFB1;FLNA;LAMC1;CNTN1;IGF2;NID1;VWF;RPS3;LAMB2;TNXB;VPS35;CD74;LIMS1;ILK;CTSH
236,prerank,Negative Regulation Of Cell Motility (GO:2000146),0.3047435607168883,1.5171856684367584,0.07233273056057866,0.3045762226228903,1.0,15/18,54.12%,FBLN1;SERPINE1;EMILIN1;RBBP4;CD74;CDH1;CDH11;TPM1;SF3B3;HDAC1;MAPK15;VCL;DAG1;CHRD;CLIC4
237,prerank,Regulation Of Innate Immune Response (GO:0045088),0.36753580426043,1.514734938383706,0.05740740740740741,0.30649861021769637,1.0,10/12,47.57%,POLR3B;YWHAZ;DHX9;CFH;APLP2;PARP1;PRKDC;TKFC;CDC37;PCBP2
238,prerank,Regulation Of Nitric Oxide Biosynthetic Process (GO:0045428),0.3816967350585807,1.5142925477662317,0.03963963963963964,0.30557511458917785,1.0,8/11,36.53%,HBB;CLU;HSP90AB1;HSP90AA1;ASS1;RAC1;ROCK2;GLA
239,prerank,Positive Regulation Of Collagen Biosynthetic Process (GO:0032967),0.5432327319063637,1.5132296835827659,0.061567164179104475,0.3040587544126763,1.0,3/5,8.42%,F2;TGFB1;SERPINF2
240,prerank,Positive Regulation Of Collagen Metabolic Process (GO:0010714),0.5432327319063637,1.5132296835827659,0.061567164179104475,0.3040587544126763,1.0,3/5,8.42%,F2;TGFB1;SERPINF2
241,prerank,Chromosome Condensation (GO:0030261),0.4692456484230633,1.5130436356345733,0.06704980842911877,0.3027963170161862,1.0,4/7,12.04%,H1-2;H1-1;H1-0;H1-5
242,prerank,Positive Regulation Of Biosynthetic Process (GO:0009891),0.4481831976136801,1.5120025345899615,0.06679035250463822,0.3029603155274661,1.0,4/8,8.42%,APOE;F2;TGFB1;SERPINF2
243,prerank,Positive Regulation Of Heterotypic Cell-Cell Adhesion (GO:0034116),0.5608885757042862,1.5113933395316057,0.05927342256214149,0.30232312333187217,1.0,3/5,8.12%,FGB;FGA;FGG
244,prerank,Regulation Of Establishment Of Cell Polarity (GO:2000114),0.542288408755714,1.5109297690122176,0.055865921787709494,0.301471680894923,1.0,3/5,7.42%,GSN;RAP1B;RACK1
245,prerank,Regulation Of Neutrophil Chemotaxis (GO:0090022),0.48108987589428454,1.5099303419848729,0.05671077504725898,0.30141451404145386,1.0,5/7,24.43%,THBS4;MDK;RAC1;CD74;C1QBP
246,prerank,Positive Regulation Of Telomerase Activity (GO:0051973),0.3739703898876554,1.5070170362301305,0.07142857142857142,0.3038356966648457,1.0,7/11,27.82%,HSP90AB1;HSP90AA1;XRCC5;TCP1;CCT4;CCT2;PTGES3
247,prerank,Synaptic Vesicle Recycling (GO:0036465),0.5480656506447832,1.506921194719057,0.07889546351084813,0.3024459685740632,1.0,5/5,45.35%,AP3D1;AP2M1;AP2B1;DNM2;RAB5A
248,prerank,Regulation Of Lysosomal Lumen pH (GO:0035751),-0.4897360703812317,-1.5066333957338602,0.06935123042505593,0.7525278033741041,1.0,6/6,51.26%,CLN5;ATP6AP2;PPT1;GRN;ATP6V1A;SLC45A2
249,prerank,Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010389),-0.4909090909090909,-1.504492941838429,0.07472527472527472,0.7435925603928646,1.0,6/6,51.14%,BRD4;RRM2B;CDK1;FHL1;RRM1;RCC2
250,prerank,Regulation Of Type I Interferon Production (GO:0032479),-0.4535443030966428,-1.5028094885008323,0.06140350877192982,0.7337970672719244,1.0,6/7,38.69%,G3BP1;DDX3X;CUL3;NPLOC4;PTPN11;RBX1
251,prerank,Regulation Of Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:1902041),0.44246933046056725,1.50211429672947,0.08190476190476191,0.3077355823227614,1.0,5/8,20.46%,FGB;FGA;THBS1;FGG;SERPINE1
252,prerank,Translational Elongation (GO:0006414),0.4394852102103595,1.5014774927953929,0.07116104868913857,0.3071333734810529,1.0,4/8,7.77%,EEF1A1;EEF2;RACK1;EEF1G
253,prerank,Regulation Of Extracellular Matrix Disassembly (GO:0010715),0.5268722256234488,1.499157828359647,0.0705244122965642,0.3090904817778079,1.0,4/5,28.35%,TGFB1;CST3;LRP1;FSCN1
254,prerank,Positive Regulation Of Proteasomal Protein Catabolic Process (GO:1901800),0.3335653331143946,1.4989655677174092,0.08226691042047532,0.307842464391679,1.0,8/15,22.21%,CLU;HSPA1A;VCP;RACK1;PSMC5;PSMC3;PSMC2;PSMC6
255,prerank,Negative Regulation Of Cell Migration (GO:0030336),0.2625871914961255,1.4979131825890286,0.07534246575342465,0.30765597301832304,1.0,19/24,54.12%,CORO1C;RAC1;SERPINE1;LRP1;EMILIN1;RBBP4;CD74;CDH1;CDH11;TPM1;SF3B3;TIMP1;PFN2;HDAC1;MAPK15;VCL;DAG1;CHRD;CLIC4
256,prerank,Positive Regulation Of Cell-Matrix Adhesion (GO:0001954),-0.4179091447879378,-1.4962946304770353,0.07079646017699115,0.7399181951912506,1.0,5/8,18.94%,RRAS;MAP4K4;FERMT2;GFUS;VEGFA
257,prerank,Regulation Of Transport (GO:0051049),-0.475878681498215,-1.4940760043827104,0.06471816283924843,0.7326464414905106,1.0,5/6,35.30%,DNAJA1;GAPVD1;SAR1B;MBTPS1;SCFD1
258,prerank,Positive Regulation Of Phosphatidylinositol 3-Kinase Signaling (GO:0014068),-0.49555795146736226,-1.4936480428217382,0.05907172995780591,0.7200389373055952,1.0,4/6,14.96%,PDGFC;JAK2;NEDD4;SRC
259,prerank,Negative Regulation Of Multicellular Organismal Process (GO:0051241),0.24653262600458933,1.4898222191290544,0.07465277777777778,0.31760439385145317,1.0,18/28,41.38%,APOA1;GDF15;APOM;PPP2CA;MDK;APOC3;ALDH1A1;CORO1C;EMILIN1;RBBP4;ACOT13;REG3A;PARP1;SF3B3;TIMP1;PFN2;HDAC1;APOA4
260,prerank,Lipid Catabolic Process (GO:0016042),-0.5288638275251665,-1.4864135220212085,0.07142857142857142,0.7290574762567785,1.0,4/5,26.53%,CES1;PPT1;LIPC;PLA1A
261,prerank,Cytoskeleton Organization (GO:0007010),0.34534659359693276,1.4859096818016624,0.06878306878306878,0.3216523146184481,1.0,9/13,36.35%,APOE;MDK;DPYSL2;RAC1;CFL1;CAPZB;TPM1;DIAPH1;KRT13
262,prerank,Regulation Of Cell Death (GO:0010941),0.4103935760783445,1.485188190511551,0.081374321880651,0.3211661174636194,1.0,6/9,28.11%,HBB;CLU;HBE1;CCN2;VPS35;HP
263,prerank,Protein Ubiquitination (GO:0016567),-0.20095609836059528,-1.4832822965612042,0.06175771971496437,0.7260108235418743,1.0,26/38,47.52%,CUL4A;THOP1;BABAM2;NEDD4;UBA6;SKP1;TRIM25;ARRB1;MYCBP2;CUL5;CUL3;NAE1;CUL4B;CUL1;TPP2;CUL2;UBE2D2;UCHL3;CTNNB1;ARRDC1;RBX1;FBXO22;USP9X;OS9;FBXO2;USP7
264,prerank,Negative Regulation Of Intracellular Signal Transduction (GO:1902532),-0.25110390550017775,-1.4806049223138629,0.0861244019138756,0.7216444407408394,1.0,10/22,18.76%,GPD1L;CD2AP;HLA-G;SLC9A3R1;CPNE1;PRKAA1;SRC;MAPK14;DDX3X;STAT1
265,prerank,Negative Regulation Of Endothelial Cell Apoptotic Process (GO:2000352),0.4828487551718381,1.4767125752453512,0.06170598911070781,0.331927682281083,1.0,4/6,20.46%,FGB;FGA;FGG;SERPINE1
266,prerank,Cellular Response To Virus (GO:0098586),-0.4919894943551444,-1.4755907934084056,0.06926406926406926,0.7241546933928409,1.0,4/6,15.78%,GBF1;JAK2;MAPK14;DDX3X
267,prerank,Purine Nucleobase Metabolic Process (GO:0006144),0.4595070422535211,1.4731584781691798,0.08608058608058608,0.3360088264048856,1.0,7/7,54.24%,SHMT2;PAICS;GMPS;SHMT1;TTR;DPYD;PRPS1
268,prerank,Regulation Of Protein Localization To Plasma Membrane (GO:1903076),0.36798413355164455,1.4696271825704783,0.06968641114982578,0.3397478483185352,1.0,8/11,37.93%,ACTB;TGFB1;CLTC;SPTBN1;LRP1;AP2M1;AKR1B1;KIF5B
269,prerank,Macromolecule Modification (GO:0043412),-0.2791507561502343,-1.4695931277877683,0.07300884955752213,0.7307605290208983,1.0,14/19,45.06%,ST3GAL1;LOXL2;ST3GAL6;UBE2I;ST6GAL1;UBE2D2;UBE2M;PIGH;RABGGTA;ERO1A;FBXO22;LOX;MANBA;FBXO2
270,prerank,Positive Regulation Of MAPK Cascade (GO:0043410),0.22099631060933472,1.4690482044891284,0.0989399293286219,0.3391213842549362,1.0,14/35,20.28%,FGB;APOE;FGA;GDF15;PPIA;TGFB1;THBS1;FGG;SERPINF2;CCN2;IGF2;NPNT;APP;PLA2G2A
271,prerank,Regulation Of Amyloid-Beta Formation (GO:1902003),0.49337428115544124,1.4690103126401175,0.08768656716417911,0.33761931937760503,1.0,5/6,35.01%,APOE;CLU;RTN4;ROCK2;APEX1
272,prerank,Cellular Response To Heat (GO:0034605),0.362671521766678,1.467347624277858,0.07915057915057915,0.3387685552878193,1.0,5/12,7.60%,HSPA1A;VCP;HSP90AB1;HSP90AA1;THBS1
273,prerank,Regulation Of Cholesterol Transport (GO:0032374),0.4885630498533724,1.4655887827031668,0.09461966604823747,0.33996577447203963,1.0,6/6,51.32%,APOA1;APOC2;LRP1;APOA4;APOC1;APOA2
274,prerank,ATP Metabolic Process (GO:0046034),0.35577484114595614,1.463381712133086,0.0831858407079646,0.34185168938556404,1.0,11/12,56.81%,HSPA1A;TGFB1;ATP5F1B;HSPA8;ALDOA;OLA1;PARP1;ATP5F1A;NDUFS1;FIGNL1;AK4
275,prerank,Regulation Of Protein Catabolic Process (GO:0042176),0.23415316056911892,1.4621348016270164,0.08159722222222222,0.342126909198808,1.0,17/29,37.17%,APOE;C4BPA;GPC3;VCP;HSP90AA1;EEF1A1;FLNA;PSMD14;EZR;VPS35;PSME2;NSF;DDB1;RAB7A;MSN;C4BPB;SF3B3
276,prerank,Regulation Of Apoptotic Cell Clearance (GO:2000425),0.5386626181990672,1.4611363244208149,0.09706959706959707,0.34187438559723193,1.0,4/5,27.94%,C3;C4A;C4B;TGM2
277,prerank,Regulation Of Gluconeogenesis (GO:0006111),0.475659824046921,1.4571916544258918,0.09021113243761997,0.3464083598176168,1.0,6/6,52.60%,C1QTNF3;DDB1;NNMT;MST1;FBP1;USP7
278,prerank,Regulation Of Cell Differentiation (GO:0045595),0.2194497667178369,1.4571005492599074,0.07678883071553229,0.3449676789881491,1.0,16/33,28.76%,RELN;SPOCK2;HSP90AB1;TGFB1;SERPINF2;PPP2CA;MDK;CCN2;IGF2;SMOC1;PA2G4;TNXB;RBBP4;YWHAG;PPP2R1A;BRD9
279,prerank,Mitotic Cell Cycle Phase Transition (GO:0044772),-0.32921083627797404,-1.4570065258596836,0.09010989010989011,0.7567732302662042,1.0,13/13,67.39%,CUL4A;GSPT1;CDK1;CUL5;CUL3;CUL4B;CUL1;CUL2;PPME1;EIF4E;DNM2;RCC1;KHDRBS1
280,prerank,Positive Regulation Of Lipid Catabolic Process (GO:0050996),0.4885630498533723,1.4554767213195445,0.07561436672967864,0.34596497988112807,1.0,6/6,51.32%,FLNB;APOC2;APOA4;APOA5;ANGPTL3;APOA2
281,prerank,Regulation Of Cell Motility (GO:2000145),0.30294289930008883,1.455064154362892,0.09523809523809523,0.34502405202724656,1.0,9/17,24.55%,FBLN1;SPOCK2;TGFB1;FLNA;LMNA;TNXB;RAC1;TNC;PLXNB2
282,prerank,Renal System Development (GO:0072001),-0.3902669018052928,-1.4535183085773382,0.11226611226611227,0.7546010833666082,1.0,8/9,49.56%,STAT1;VEGFA;BAG6;LRP4;ARL3;BMP4;PCSK9;PCSK5
283,prerank,"RNA Splicing, Via Transesterification Reactions (GO:0000375)",-0.37505058036832617,-1.4527759508419023,0.08501118568232663,0.7441873803666359,1.0,7/10,31.56%,SRSF10;PRPF8;DDX23;KHSRP;SNRNP40;SF3A3;TRA2B
284,prerank,Regulation Of Autophagy (GO:0010506),-0.2428553919085787,-1.4509877877093518,0.08391608391608392,0.7375457410991435,1.0,17/24,45.59%,PIP4K2A;NEDD4;SNX6;CAPNS1;PRKAA1;STAT3;CDK16;HMGB1;ATP6V1B2;PRKACA;CTSA;VPS29;UFL1;SH3GLB1;ATP6V1A;SNX5;EIF4E
285,prerank,Establishment Of Spindle Orientation (GO:0051294),-0.4325117370892019,-1.4503129831439991,0.09316770186335403,0.7282925172991966,1.0,7/7,56.98%,ITGB1;MAP4;NUMA1;NSFL1C;MAPRE1;DCTN1;PAFAH1B1
286,prerank,Positive Regulation Of Muscle Cell Differentiation (GO:0051149),0.4854984809666746,1.449956847908868,0.1,0.3514303944887261,1.0,4/6,19.81%,LAMB1;LAMC1;NID1;LAMB2
287,prerank,mRNA Catabolic Process (GO:0006402),-0.35930653783464567,-1.4454913361537631,0.09029345372460497,0.7312551958935947,1.0,6/11,16.89%,RNH1;UPF1;XRN2;PNPT1;EXOSC4;MRTO4
288,prerank,Negative Regulation Of Hydrolase Activity (GO:0051346),0.4885630498533724,1.44488970091179,0.0898876404494382,0.3579538846184913,1.0,6/6,51.32%,CTSB;SERPINA5;CST3;ECM1;RCC2;APOA2
289,prerank,Negative Regulation Of Cysteine-Type Endopeptidase Activity (GO:2000117),-0.35383176238302366,-1.4446175181721534,0.08796296296296297,0.7225034885955214,1.0,8/11,35.65%,CD44;CAST;SRC;DDX3X;VEGFA;RPS6KA3;CSNK2A1;FABP1
290,prerank,Protein-Containing Complex Organization (GO:0043933),0.24727921005066955,1.4435562198267828,0.08839779005524862,0.35833172631036664,1.0,17/25,45.06%,FGB;FGA;PARD3;LAMC1;FGG;JCHAIN;SLC2A1;DHX9;CD74;CAPZA1;PPP2R1A;DARS1;AP2M1;DNM1L;VIL1;TPR;ELOB
291,prerank,O-glycan Processing (GO:0016266),-0.5112598123679785,-1.4430340410232065,0.10087719298245613,0.7161174930379531,1.0,4/5,27.64%,ST3GAL1;GALNT2;ST6GAL1;GALNT7
292,prerank,Regulation Of Oxidative Phosphorylation (GO:0002082),0.5188576385217215,1.442289311355634,0.08163265306122448,0.35870625360143604,1.0,3/5,9.99%,VCP;MACROH2A1;SHMT2
293,prerank,Positive Regulation Of Cell Communication (GO:0010647),0.5185919622444839,1.4395734313744233,0.09021113243761997,0.36131792832076914,1.0,4/5,29.34%,CLSTN1;TNXB;CLSTN3;ILK
294,prerank,Positive Regulation Of Kinase Activity (GO:0033674),0.4002497546941477,1.4372012869852135,0.09851301115241635,0.36346477657194354,1.0,7/9,39.51%,RELN;F2;XRCC5;XRCC6;CD74;IQGAP1;TIE1
295,prerank,Glycerophospholipid Metabolic Process (GO:0006650),0.3843865877848397,1.4351223619524163,0.11153846153846154,0.3651278235663133,1.0,9/10,52.25%,APOA1;PRDX6;PLA2G2A;LCAT;PLA2G7;PLEK;APOA4;PAFAH1B1;SERINC5
296,prerank,Response To Unfolded Protein (GO:0006986),0.32093935541729585,1.4338304895898442,0.09532710280373832,0.3654665999676403,1.0,8/14,27.00%,HSPA1A;HSP90AB1;HSP90AA1;HSPA8;HSPE1;HSPD1;HSPA4;SERPINH1
297,prerank,Positive Regulation Of Protein Autophosphorylation (GO:0031954),-0.468294522062804,-1.4319874054356527,0.10450819672131148,0.739002369066345,1.0,5/6,35.77%,PDGFC;RAD50;DDX3X;VEGFA;PDGFA
298,prerank,Negative Regulation Of Cell-Cell Adhesion (GO:0022408),0.45015234642201823,1.427248579375749,0.07692307692307693,0.3743028131955873,1.0,5/7,28.87%,APOA1;PLG;TGFB1;ASS1;CDH1
299,prerank,Regulation Of Collagen Biosynthetic Process (GO:0032965),0.4748721620964983,1.4270417613026591,0.08801498127340825,0.37305877655960784,1.0,4/6,21.51%,F2;TGFB1;SERPINF2;EMILIN1
300,prerank,Negative Regulation Of Protein Kinase Activity (GO:0006469),0.3495105637314273,1.4223419822151158,0.11214953271028037,0.3790092890055147,1.0,11/12,57.39%,NPM1;PPIA;MACROH2A1;CORO1C;YWHAG;GSTP1;HSPB1;QARS1;WARS1;MVP;SORL1
301,prerank,Regulation Of Cytoplasmic Transport (GO:1903649),-0.5205158264947245,-1.4220281715300003,0.11252653927813164,0.7587586537878829,1.0,5/5,48.16%,SRC;MAPK1;MAP2K1;USP7;MAPK3
302,prerank,Positive Regulation Of Supramolecular Fiber Organization (GO:1902905),0.26982248520710067,1.4216878216076334,0.08586762075134168,0.3785196780119545,1.0,21/21,73.35%,APOE;CLU;GSN;PFN1;RPS3;APP;TNXB;RAC1;PLEK;PFN2;VIL1;EFEMP2;VASP;DCTN1;MAPRE1;SLAIN1;NUMA1;DRG1;ARF6;NCKAP1;COLGALT1
303,prerank,Regulation Of Small Molecule Metabolic Process (GO:0062012),0.5140391610311648,1.4196760301540634,0.10546875,0.3804720281161016,1.0,4/5,30.10%,APOE;PGAM1;EIF6;ACADVL
304,prerank,Triglyceride Homeostasis (GO:0070328),0.34718561174695683,1.4178151043398477,0.10948905109489052,0.38192245464107977,1.0,10/12,49.74%,APOE;APOA1;C1QTNF3;ANGPTL8;APOC3;APOC2;APOA4;APOA5;ANGPTL4;ANGPTL3
305,prerank,Regulation Of Endothelial Cell Apoptotic Process (GO:2000351),0.3892088759915532,1.4159899989554587,0.09576427255985268,0.3833994225714168,1.0,4/9,8.12%,FGB;FGA;THBS1;FGG
306,prerank,Protein Dephosphorylation (GO:0006470),-0.26835555007363654,-1.413984822416229,0.08830022075055188,0.7734250086763237,1.0,12/19,35.24%,PTPRK;PPP1R12A;PPP2R5D;PPM1G;PPP1CC;SDHAF2;PDPR;PPP3CA;PTPRM;PHPT1;PPP2R2A;PTPN11
307,prerank,Negative Regulation Of Endocytosis (GO:0045806),0.4787964067685474,1.4130183939866567,0.1016949152542373,0.386789967629566,1.0,4/6,20.05%,RACK1;APOC3;APOC2;RAC1
308,prerank,Positive Regulation Of Cysteine-Type Endopeptidase Activity (GO:2001056),-0.4568060508493902,-1.4129093841966378,0.1,0.7656249978600724,1.0,5/6,36.88%,DDX3X;CYCS;ASPH;HMGB1;CYFIP2
309,prerank,Positive Regulation Of Immune Response (GO:0050778),0.36036691077112604,1.4109026120698647,0.10237659963436929,0.3887043654377124,1.0,9/11,47.52%,POLR3B;C9;C7;C8B;DHX9;CD74;C6;CD81;KARS1
310,prerank,Positive Regulation Of Myeloid Cell Differentiation (GO:0045639),-0.41344892148578655,-1.4098362408449416,0.1032258064516129,0.753631575475159,1.0,5/8,19.64%,HMGB2;STAT5B;MAPK14;STAT1;STAT3
311,prerank,Positive Regulation Of Erythrocyte Differentiation (GO:0045648),-0.41344892148578655,-1.4098362408449416,0.1032258064516129,0.753631575475159,1.0,5/8,19.64%,HMGB2;STAT5B;MAPK14;STAT1;STAT3
312,prerank,Regulation Of NIK/NF-kappaB Signaling (GO:1901222),0.3912293447905377,1.407612858032945,0.11278195488721804,0.39285670494542796,1.0,6/9,29.34%,C1QTNF3;RPS3;EZR;APP;LIMS1;ILK
313,prerank,Positive Regulation Of ATP-dependent Activity (GO:0032781),0.34424745317606076,1.4045743338684904,0.09265734265734266,0.39671332885473165,1.0,9/12,41.79%,PFN1;DHX9;DNAJB11;MSH3;TPM1;RGN;PFN2;SSBP1;HNRNPU
314,prerank,Regulation Of Small GTPase Mediated Signal Transduction (GO:0051056),-0.46052468070115016,-1.4031227143950475,0.12582781456953643,0.7640845591104756,1.0,4/6,18.12%,OBSCN;CD2AP;SRC;ARHGAP1
315,prerank,Neuron Development (GO:0048666),-0.25270879254614437,-1.4027686260855265,0.09954751131221719,0.7548509913721365,1.0,13/20,38.34%,CLN5;NEDD4;CNTN4;PPT1;TBCD;LGI1;CDK16;HMGB1;ARL3;PTPRM;HS6ST1;MAP4;PRMT1
316,prerank,Phospholipid Transport (GO:0015914),0.33230118862533353,1.4009687931779529,0.09363957597173145,0.40101665520227975,1.0,12/13,59.91%,APOE;APOA1;APOC3;APOC2;PLTP;LDLR;APOA4;APOA5;APOC1;APOA2;MTTP;SCARB1
317,prerank,Intracellular Iron Ion Homeostasis (GO:0006879),-0.3768445107229941,-1.399375243880827,0.11699779249448124,0.755392137206711,1.0,8/9,50.91%,B2M;ATP6AP1;BOLA2;CP;ATP6V1A;TFRC;GLRX3;FTL
318,prerank,Extracellular Matrix Disassembly (GO:0022617),0.46492630083465103,1.398765292577803,0.11795774647887323,0.4013873553751476,1.0,3/6,6.78%,GSN;PLG;LAMC1
319,prerank,Cellular Component Disassembly (GO:0022411),0.46492630083465103,1.398765292577803,0.11795774647887323,0.4013873553751476,1.0,3/6,6.78%,GSN;PLG;LAMC1
320,prerank,MAPK Cascade (GO:0000165),-0.2798845107797726,-1.3973277173265675,0.1053864168618267,0.7514198505022633,1.0,13/16,52.60%,MAP4K4;PABPN1;PPP1CC;MAPK14;CDK1;MAPK1;NRAS;MAP2K1;RBX1;PPP1CB;PLVAP;MAPK3;KARS1
321,prerank,Activation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0006919),0.3811961982524118,1.3964390781054974,0.10594795539033457,0.4036499424290042,1.0,6/9,30.57%,VCP;RACK1;CNTN1;HSPE1;HSPD1;SORD
322,prerank,Post-Transcriptional Regulation Of Gene Expression (GO:0010608),-0.34430191252125386,-1.3954352446153262,0.11373390557939914,0.7471358659782483,1.0,10/11,56.17%,EIF2B4;MTPN;ZC3H7A;NUDT21;NOLC1;ELP3;ELP1;EIF4E;TCOF1;EIF2S1
323,prerank,GMP Biosynthetic Process (GO:0006177),0.49824150058616645,1.3927970818758735,0.09981167608286252,0.40831717063765355,1.0,5/5,50.32%,ATIC;PAICS;GMPS;GART;PFAS
324,prerank,Positive Regulation Of Transport (GO:0051050),0.38167013863792404,1.3905899294269086,0.11713286713286714,0.4101764208026414,1.0,5/9,20.81%,APOE;ACTB;GPC3;DYNC1H1;LRP1
325,prerank,Peptidyl-Serine Phosphorylation (GO:0018105),-0.3262818332721496,-1.3900163698786125,0.10491071428571429,0.753697301712346,1.0,8/12,33.26%,SRPK1;MAPK14;CDK1;MAPK1;PCK1;RPS6KA3;PRKACA;CSNK2A1
326,prerank,Organelle Disassembly (GO:1903008),-0.3750171601589216,-1.3885218174531309,0.11448598130841121,0.7487660383115916,1.0,7/9,39.16%,GBF1;MCTS1;PRKAA1;CDK1;KLC1;MAP4;UFL1
327,prerank,Positive Regulation Of Cold-Induced Thermogenesis (GO:0120162),-0.3286448657288395,-1.3884609339198715,0.1309255079006772,0.7393803930584635,1.0,7/12,24.08%,PDGFC;MFAP2;SMARCA4;ACSL1;JAK2;VEGFA;FH
328,prerank,Purine Ribonucleoside Triphosphate Metabolic Process (GO:0009205),0.43368544600938974,1.3883871541773019,0.11764705882352941,0.41224728106511177,1.0,7/7,56.81%,HSPA1A;RAN;HSPA8;OLA1;NDUFS1;FIGNL1;AK4
329,prerank,Positive Regulation Of NF-kappaB Transcription Factor Activity (GO:0051092),0.2619582083743474,1.3881818412588403,0.12283737024221453,0.4109501398406509,1.0,9/21,18.88%,CLU;LTF;HSPA1A;NPM1;PPIA;DHX9;RPS3;APP;AGT
330,prerank,Glucose Homeostasis (GO:0042593),-0.3534759917288538,-1.387828032477121,0.0957683741648107,0.7319732929506747,1.0,7/10,33.78%,ASPSCR1;PRKAA1;STAT3;PARK7;PCK1;HK2;HK1
331,prerank,Intracellular Glucose Homeostasis (GO:0001678),-0.4016677322691138,-1.3876801115412243,0.10021786492374728,0.7234172482353636,1.0,6/8,33.78%,PRKAA1;PCK1;HK2;TRA2B;PRKACA;HK1
332,prerank,Glycoprotein Metabolic Process (GO:0009100),0.3335544830372936,1.3853756796910326,0.11460258780036968,0.4139919496331462,1.0,7/12,26.88%,MAN1A1;ADAMTS13;GANAB;B4GAT1;MAN2B1;MAN2A1;PCSK6
333,prerank,Regulation Of Peptidyl-Threonine Phosphorylation (GO:0010799),0.45757814149626796,1.3847593017680266,0.11610486891385768,0.4133512928494655,1.0,3/6,6.20%,PARD3;CEMIP;TGFB1
334,prerank,Ribonucleoprotein Complex Biogenesis (GO:0022613),0.19855525226381698,1.3790833445990796,0.12457337883959044,0.4215732360542864,1.0,30/38,60.72%,NPM1;RPS9;RPS16;RPS25;RPS13;RPS14;RPS4X;FBL;RPS5;RPS11;RPL11;RPS3A;RPL5;RPS15A;RPS7;RPL14;RPS8;XPO1;NOP56;NOP58;RPS23;RPL7;RPL26;RPS6;RPS17;RPS27;SNU13;RRP9;RPS19;RPL35A
335,prerank,Response To Peptide Hormone (GO:0043434),-0.3541885975698077,-1.3790797189630342,0.09513274336283185,0.7404717338675074,1.0,6/10,23.20%,EIF2B4;SRC;STAT5B;STAT1;STAT3;PCK1
336,prerank,IMP Biosynthetic Process (GO:0006188),0.49824150058616645,1.3776891432916671,0.10984848484848485,0.42220388094283773,1.0,5/5,50.32%,ATIC;PAICS;AMPD2;GART;PFAS
337,prerank,Nuclear Migration (GO:0007097),0.43526110257479844,1.375255465656706,0.126953125,0.42487886113232964,1.0,6/7,43.19%,LMNA;DYNC1H1;LMNB2;LMNB1;PAFAH1B1;DCTN1
338,prerank,Regulation Of Chromosome Organization (GO:0033044),0.4965905136599487,1.3747749224286585,0.1076923076923077,0.4241473631467934,1.0,4/5,31.79%,XRCC5;RUVBL1;HNRNPD;RUVBL2
339,prerank,Regulation Of Protein-Containing Complex Assembly (GO:0043254),0.2223905358179029,1.373786434212575,0.11443661971830986,0.4242635506102602,1.0,8/29,7.42%,APOE;CLU;GSN;VCP;HSP90AA1;TGFB1;HSPA5;RACK1
340,prerank,Endoplasmic Reticulum Organization (GO:0007029),0.4173573891370197,1.3729506523899757,0.10869565217391304,0.42407991969642345,1.0,6/7,44.77%,RTN4;REEP6;RAB18;DNM1L;SEC31A;MAPK15
341,prerank,Positive Regulation Of Growth (GO:0045927),-0.33441398658166005,-1.3717380571269784,0.1288888888888889,0.7539196579933478,1.0,10/11,56.81%,MTPN;DDX3X;EXOSC4;NCBP1;LGI1;RPS6KA3;CSNK2A1;SDCBP;HYAL1;CDC42
342,prerank,Double-Strand Break Repair Via Nonhomologous End Joining (GO:0006303),0.43124691641164925,1.3716994798625635,0.13953488372093023,0.42461324175011833,1.0,4/7,15.84%,PSMD14;XRCC5;XRCC6;PRPF19
343,prerank,Regulation Of Inflammatory Response (GO:0050727),0.21918933215069444,1.3704515771162529,0.1360544217687075,0.42520445955676867,1.0,14/30,27.24%,AHSG;APOE;APOA1;C1QTNF3;MDK;DHX9;APP;AGT;PLA2G2A;SERPINE1;TNC;VPS35;PSMA6;REG3A
344,prerank,Establishment Or Maintenance Of Epithelial Cell Apical/Basal Polarity (GO:0045197),0.43598708251672,1.3704005185607533,0.11313868613138686,0.423691802374905,1.0,6/7,43.31%,PARD3;WDR1;EZR;PDCD6IP;MSN;CDC42
345,prerank,Positive Regulation Of Phosphate Metabolic Process (GO:0045937),0.4351625138943842,1.370273909368234,0.13523809523809524,0.4223136706136543,1.0,5/7,29.34%,THBS1;ANG;APP;PTGES3;ILK
346,prerank,Pyruvate Metabolic Process (GO:0006090),0.24973120494607987,1.3699160576084388,0.12975778546712802,0.42127863214166217,1.0,22/23,71.24%,GAPDH;PKM;PGK1;ENO1;LDHA;PGAM1;ALDOC;TPI1;LDHB;PCK2;PGM1;GPI;PKLR;PFKL;ME2;ENO3;ENO2;ME1;ALDOB;HK1;PDHA1;HK2
347,prerank,Negative Regulation Of Kinase Activity (GO:0033673),0.3753611102082918,1.3689896004382989,0.14821428571428572,0.42135897095455344,1.0,8/9,52.02%,PPIA;YWHAG;GSTP1;HSPB1;QARS1;HNRNPU;WARS1;PRDX3
348,prerank,Negative Regulation Of Epithelial Cell Apoptotic Process (GO:1904036),0.37710906946148093,1.3650364304126437,0.1303538175046555,0.4262736911766911,1.0,5/9,20.46%,FGB;FGA;FGG;MDK;SERPINE1
349,prerank,Telomere Maintenance (GO:0000723),0.32982608702997435,1.358560431192399,0.13883677298311445,0.43567418134688124,1.0,8/12,35.01%,XRCC5;XRCC6;PTGES3;PARP1;RUVBL1;PRKDC;RUVBL2;APEX1
350,prerank,Cellular Response To Organonitrogen Compound (GO:0071417),0.29820986710598985,1.3577244487786118,0.12724014336917563,0.43564816590962346,1.0,10/15,38.81%,ACTB;CLU;RAP1B;HSP90B1;EZR;CDH1;CAPN2;ROCK2;DIAPH1;SHMT1
351,prerank,Protein Modification By Small Protein Removal (GO:0070646),-0.2614917991203893,-1.357684166497759,0.12709832134292565,0.7886675545091644,1.0,16/17,67.91%,COPS2;USP15;CDK1;UCHL3;COPS5;COPS4;USP9X;COPS6;COPS3;USP7;USP14;USP5;GPS1;COPS8;EIF3F;HINT1
352,prerank,Regulation Of Phagocytosis (GO:0050764),0.4028185554903111,1.3576649616170056,0.13430127041742287,0.43412745605745306,1.0,8/8,59.91%,AHSG;APOA1;RACK1;LMAN2;TGM2;APOA2;CALR;SCARB1
353,prerank,mRNA 3'-End Processing (GO:0031124),-0.3866403224829859,-1.3574259000482296,0.12043010752688173,0.7801048051732197,1.0,7/8,48.33%,CSTF2;CPSF1;NCBP1;NUDT21;CPSF6;PABPC1;CSTF3
354,prerank,Regulation Of Autophagosome Assembly (GO:2000785),-0.44457478005865103,-1.356112220412214,0.125,0.7749290724888724,1.0,6/6,55.76%,PIP4K2A;RAB3GAP2;SCFD1;SH3GLB1;RAB5A;RAB1B
355,prerank,Regulation Of mRNA Catabolic Process (GO:0061013),-0.32944245711982634,-1.3550655878267963,0.12556053811659193,0.7691357895956814,1.0,5/11,10.99%,CAPRIN1;MOV10;VIM;UPF1;PNPT1
356,prerank,Regulation Of Telomerase Activity (GO:0051972),0.3282355363736827,1.3547319424128585,0.12410071942446044,0.43759963375759003,1.0,6/12,18.94%,HSP90AB1;HSP90AA1;XRCC5;TCP1;CCT4;CCT2
357,prerank,Response To Reactive Oxygen Species (GO:0000302),0.3295507025083907,1.3541645236337334,0.13653136531365315,0.43694000031221125,1.0,10/12,52.02%,HBB;APOE;RPS3;HP;GSTP1;TPM1;CAT;HYAL1;MAPK3;PRDX3
358,prerank,Cellular Response To Tumor Necrosis Factor (GO:0071356),0.3243040616980407,1.3527565006893185,0.13893967093235832,0.4377891068744603,1.0,11/13,53.24%,DHX9;RPS3;NPNT;LIMS1;ACTN4;ILK;CCL20;CHI3L1;HYAL1;EIF5A;PLVAP
359,prerank,ATP Biosynthetic Process (GO:0006754),0.48817374422635107,1.3524314796537489,0.13736263736263737,0.4366807113936442,1.0,4/5,32.50%,TGFB1;ATP5F1B;ALDOA;ATP5F1A
360,prerank,Regulation Of Muscle Cell Differentiation (GO:0051147),0.3758306726328069,1.3516233239503288,0.15469613259668508,0.43662628856908264,1.0,5/9,19.81%,LAMB1;LAMC1;IGF2;NID1;LAMB2
361,prerank,Positive Regulation Of Signaling (GO:0023056),0.41829266730309467,1.3515282547160556,0.13970588235294118,0.4351856242072745,1.0,5/7,31.44%,CLSTN1;TNXB;CLSTN3;ILK;NSF
362,prerank,Negative Regulation Of Protein Metabolic Process (GO:0051248),0.2154223552477273,1.3514482051796515,0.13087248322147652,0.4337302792006316,1.0,9/31,9.70%,GAPDH;APOE;CLU;F2;HSP90AB1;FLNA;RACK1;NCL;GRB7
363,prerank,Negative Regulation Of Signal Transduction (GO:0009968),0.2052908453031416,1.3487785714442038,0.13322368421052633,0.4367824187911972,1.0,9/32,9.70%,AHSG;LTF;GPC3;GDF15;VCP;RACK1;THBS1;NOTUM;GRB7
364,prerank,Negative Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001237),0.30001039867802104,1.348311223512146,0.11733800350262696,0.4360467329480064,1.0,5/14,8.12%,FGB;FGA;HSPA1A;THBS1;FGG
365,prerank,Nucleotide Biosynthetic Process (GO:0009165),-0.3605524069013099,-1.3456960140366592,0.1286031042128603,0.7890889145850354,1.0,8/9,52.72%,RRM2B;PNP;PPAT;RRM1;ME1;PRPS1;PFAS;GART
366,prerank,Positive Regulation Of Chemokine Production (GO:0032722),0.44824244420970094,1.3439897876719313,0.13577981651376148,0.4419885811553838,1.0,4/6,23.79%,C5;APP;CHIA;CD74
367,prerank,Positive Regulation Of Cell Migration (GO:0030335),0.17275940017907343,1.3431346372790236,0.13106796116504854,0.44187509888804444,1.0,13/50,10.75%,VTN;FN1;PFN1;CEMIP;LAMB1;TGFB1;HSPA5;RACK1;F10;THBS1;CNTN1;GRB7;MDK
368,prerank,Aortic Valve Morphogenesis (GO:0003180),0.4465686815340843,1.3428899468480446,0.1294559099437148,0.44072203509793245,1.0,5/6,39.51%,TGFB1;EMILIN1;CDH11;ROCK2;TIE1
369,prerank,Sterol Transport (GO:0015918),0.48827667057444324,1.3422460375921856,0.12903225806451613,0.4402860387216747,1.0,5/5,51.32%,APOB;APOA1;LCAT;LDLR;APOA2
370,prerank,Positive Regulation Of Catabolic Process (GO:0009896),0.2448288684497657,1.3401615665835473,0.13454545454545455,0.44253166921845905,1.0,13/22,36.47%,CLU;C4BPA;GPC3;VCP;HSP90AA1;EZR;FLNB;VPS35;NSF;DDB1;RAB7A;MSN;C4BPB
371,prerank,Substantia Nigra Development (GO:0021762),0.3562180886012078,1.3400738348912282,0.14313346228239845,0.44114841629164253,1.0,6/10,26.18%,GLUD1;HSPA5;G6PD;YWHAQ;YWHAE;CALM1
372,prerank,Carbohydrate Catabolic Process (GO:0016052),0.250276492277583,1.339006825673718,0.122040072859745,0.44153452129586035,1.0,19/21,66.34%,GAPDH;PKM;PGK1;ENO1;LDHA;PGAM1;ALDOC;TPI1;PGM1;GPI;PKLR;PFKL;ENO3;NEU1;MANBA;ENO2;NAGA;ALDOB;HK1
373,prerank,Positive Regulation Of Cellular Process (GO:0048522),0.12870308941865047,1.337943390486542,0.13312202852614896,0.4416391442824704,1.0,27/88,19.99%,HBB;FN1;ACTB;PARD3;H3-3A;NPM1;SPOCK2;HSP90AB1;LAMB1;TGFB1;LAMC1;CLEC11A;THBS1;SERPINF2;AKR1C3;HBE1;MDK;CCN2;IGF2;NID1;RPS9;PA2G4;DYNC1H1;CRLF1;ANKRD17;LAMB2;TNXB
374,prerank,Brain Development (GO:0007420),0.2538308474368587,1.337768845750555,0.1452991452991453,0.4404224311989326,1.0,14/21,43.13%,RELN;CNTN1;HSPG2;UGP2;FLNB;PHGDH;RBBP4;RTN4;MACROH2A2;PLXNB2;RAB18;APEX1;QARS1;PAFAH1B1
375,prerank,Negative Regulation Of Blood Vessel Morphogenesis (GO:2000181),0.2735403786620571,1.3375491360992509,0.13333333333333333,0.4392703391632969,1.0,6/17,10.46%,SERPINF1;PGK1;THBS4;APOH;THBS1;HSPG2
376,prerank,"Regulation Of Alternative mRNA Splicing, Via Spliceosome (GO:0000381)",0.3168433451118964,1.3365102897294148,0.1408199643493761,0.4393537219954375,1.0,13/13,68.56%,HNRNPA1;KHDRBS1;HNRNPU;DDX5;DDX17;MAGOH;PTBP1;RBMX;SMU1;HNRNPL;RBM25;HNRNPA0;TRA2B
377,prerank,Regulation Of Gene Expression (GO:0010468),0.11775926118876878,1.3359266947574835,0.15256797583081572,0.43874719569381637,1.0,56/114,39.57%,FN1;APOE;CLU;LTF;GSN;ACTA1;HSPA1A;TGFB1;EFEMP1;MACROH2A1;RACK1;CNTN1;METTL16;PPP2CA;IGF2;SRSF1;PRDX6;RPS3;EZR;APP;AHNAK2;HMGA1;PPIE;TNC;LRP1;EMILIN1;VPS35;RBBP4;CD74;HNRNPA1;SFPQ;PPP2R1A;HMGA2;LIMS1;TSKU;CDH1;HNRNPAB;RUVBL1;CTSH;SORD;HNRNPD;YBX1;RUVBL2;PRMT5;HINT1;AKR1B1;ROCK2;RPL11;RPL5;UBE2V1;MSN;SF3B3;DNM2;GPI;RPS7;PSPC1
378,prerank,Actin Filament Organization (GO:0007015),0.2502288740282578,1.334885736643322,0.14505119453924914,0.4389668137003926,1.0,12/22,31.68%,GSN;ACTA1;FLNA;ACTN1;ARPC4;CORO1C;ALDOA;RAC1;TAGLN2;CORO1A;FAT1;TPM1
379,prerank,Diterpenoid Metabolic Process (GO:0016101),0.4207746478873239,1.3341539933013102,0.15254237288135594,0.4372364104954234,1.0,7/7,58.09%,AKR1C3;ALDH1A1;RARRES2;LRP1;AKR1B1;AKR1B10;LRP2
380,prerank,Retinoid Metabolic Process (GO:0001523),0.4207746478873239,1.3341539933013102,0.15254237288135594,0.4372364104954234,1.0,7/7,58.09%,AKR1C3;ALDH1A1;RARRES2;LRP1;AKR1B1;AKR1B10;LRP2
381,prerank,Establishment Of Mitotic Spindle Orientation (GO:0000132),-0.432258064516129,-1.3339259633225478,0.15416666666666667,0.8180627755717936,1.0,6/6,56.98%,ITGB1;NUMA1;NSFL1C;MAPRE1;DCTN1;PAFAH1B1
382,prerank,Negative Chemotaxis (GO:0050919),-0.386895614144526,-1.3322143726959006,0.15098468271334792,0.8145068174173927,1.0,7/8,48.45%,ITGB3;SEMA7A;SEMA3F;PDGFA;SEMA3C;SEMA3A;SEMA4B
383,prerank,Negative Regulation Of Cytokine Production (GO:0001818),0.2563072467418949,1.3279266667890368,0.1514629948364888,0.4468210864962113,1.0,11/19,34.37%,FN1;APOA1;F2;C1QTNF3;THBS1;EZR;RAC1;APLP2;C1QBP;SARS1;ANXA4
384,prerank,Regulation Of Filopodium Assembly (GO:0051489),0.41234728435023654,1.325510599804678,0.14522058823529413,0.4494702678188288,1.0,6/7,45.35%,CLU;AGRN;FSCN1;CAPZB;CDC42;RAB5A
385,prerank,Response To Transforming Growth Factor Beta (GO:0071559),0.47586948521998085,1.3247858088814335,0.15678776290630975,0.44909170301528883,1.0,4/5,33.49%,TGFB1;CLEC3B;LIMS1;ROCK2
386,prerank,Positive Regulation Of Apoptotic Process (GO:0043065),-0.17906165000598878,-1.3237691133015506,0.1488833746898263,0.8316902414482289,1.0,26/37,51.49%,SMPD1;UBE2Z;LGALS1;BCLAF1;CTNNBL1;DNAJA1;DDX3X;ADAMTSL4;AIFM1;IGF2BP1;CASP6;CCAR2;HMGB1;PTPA;CARM1;CTNNB1;BMP4;EEF1E1;ITGB1;GRN;PPID;PCSK9;RPS6;KNG1;CTSV;HTRA1
387,prerank,Actin Filament Polymerization (GO:0030041),0.44640609153371313,1.3235584173788766,0.13176895306859207,0.4497389355626049,1.0,5/6,40.09%,GSN;ANG;RAC1;DIAPH1;VIL1
388,prerank,DNA-templated Transcription (GO:0006351),-0.2887448438420742,-1.3230189769259124,0.1580135440180587,0.8249776865472443,1.0,14/14,71.42%,COPS2;RO60;POLR2H;MMS19;DEK;DDX21;DRAP1;RBMX;TFAM;GARS1;DDX5;SUPT16H;PRMT5;PARP1
389,prerank,Positive Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000060),0.351960375961475,1.3226943350506093,0.15752212389380532,0.4498777335118716,1.0,4/10,7.42%,CLU;HSPA1A;VCP;RACK1
390,prerank,Central Nervous System Development (GO:0007417),0.1881466561119561,1.31714247414635,0.1584,0.45840962841361266,1.0,22/39,39.92%,C3;RELN;GSN;CNTN1;HSPG2;UGP2;SLC2A1;SPTBN1;FLNB;PHGDH;APP;RBBP4;RTN4;APLP2;MACROH2A2;PLXNB2;GSTP1;NPTX1;RAB18;APEX1;ALDH5A1;QARS1
391,prerank,Acylglycerol Homeostasis (GO:0055090),0.3319857917833298,1.3167923356135893,0.15636363636363637,0.4574478065659067,1.0,9/11,49.74%,APOE;APOA1;ANGPTL8;APOC3;APOC2;APOA4;APOA5;ANGPTL4;ANGPTL3
392,prerank,Regulation Of Protein Localization To Membrane (GO:1905475),0.48027505463375786,1.3164536715086266,0.16022099447513813,0.4565806719586367,1.0,4/5,33.37%,GSN;GPC3;SPTBN1;AKR1B1
393,prerank,Regulation Of Chemotaxis (GO:0050920),0.4654241166708156,1.3112092989707365,0.15267175572519084,0.4645043774584162,1.0,3/5,15.25%,TGFB1;THBS1;RARRES2
394,prerank,Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001242),-0.3961983459709773,-1.3098913938485361,0.14192139737991266,0.8583287108320709,1.0,4/7,15.78%,BCLAF1;SLC9A3R1;SRC;DDX3X
395,prerank,Insulin Receptor Signaling Pathway (GO:0008286),0.46474558333664306,1.307728100423609,0.15028901734104047,0.4690312242122259,1.0,3/5,15.25%,GRB7;IGF2;RARRES2
396,prerank,Regulation Of Nucleic Acid-Templated Transcription (GO:1903506),0.19198509452948864,1.3062834769620038,0.16552901023890784,0.4700616957304801,1.0,20/35,39.57%,EFEMP1;PPP2CA;IGF2;HMGA1;PPIE;RBBP4;SFPQ;PPP2R1A;HMGA2;ACTN4;RUVBL1;HNRNPD;YBX1;RUVBL2;PRMT5;HINT1;UBE2V1;DNM2;GPI;PSPC1
397,prerank,Nucleosome Assembly (GO:0006334),0.3174046323030868,1.3062680708929544,0.1541095890410959,0.4670158307839226,1.0,9/12,45.24%,H2BC11;H3-3A;NPM1;MACROH2A1;RBBP4;SSRP1;NAP1L1;SUPT16H;NAP1L4
398,prerank,protein-DNA Complex Assembly (GO:0065004),0.3174046323030868,1.3062680708929544,0.1541095890410959,0.4670158307839226,1.0,9/12,45.24%,H2BC11;H3-3A;NPM1;MACROH2A1;RBBP4;SSRP1;NAP1L1;SUPT16H;NAP1L4
399,prerank,Positive Regulation Of Extracellular Matrix Organization (GO:1903055),0.43514874210744814,1.3045957864720186,0.15879017013232513,0.46850576258290405,1.0,5/6,40.74%,TGFB1;TNXB;EMILIN1;FSCN1;EFEMP2
400,prerank,Positive Regulation Of Secretion By Cell (GO:1903532),0.2708642807159302,1.304354975449785,0.1431064572425829,0.4674198400079444,1.0,13/18,47.28%,FGB;FGA;PPIA;TGFB1;FGG;ANG;EZR;MYH10;DNM1L;ACHE;BAIAP3;RAB5A;TTN
401,prerank,Negative Regulation Of Transferase Activity (GO:0051348),-0.3955399061032864,-1.3014358079359547,0.15065502183406113,0.876292351978562,1.0,7/7,60.67%,SRC;PARK7;PHPT1;BUB3;PRDX3;HNRNPU;EIF4A2
402,prerank,Sensory Perception Of Sound (GO:0007605),0.35756335817370294,1.3008123488524774,0.1773308957952468,0.47070746400056823,1.0,6/9,32.67%,CEMIP;WDR1;EML2;COL1A1;COL2A1;ALDH7A1
403,prerank,Sensory Perception Of Mechanical Stimulus (GO:0050954),0.35756335817370294,1.3008123488524774,0.1773308957952468,0.47070746400056823,1.0,6/9,32.67%,CEMIP;WDR1;EML2;COL1A1;COL2A1;ALDH7A1
404,prerank,Cellular Response To Ketone (GO:1901655),0.3478172137133647,1.3001722585708484,0.15476190476190477,0.4703457507596182,1.0,8/10,46.29%,AKR1C3;PCK2;AKR1B1;ROCK2;MSN;POSTN;AKR1C2;GNB1
405,prerank,Regulation Of Proteasomal Protein Catabolic Process (GO:0061136),0.2831817708097696,1.2988490186747093,0.17773788150807898,0.47129373594991675,1.0,8/16,23.55%,APOE;HSP90AB1;PSMD14;PSMC5;PSMC3;PSMC2;PSMC6;PSME2
406,prerank,Purine Ribonucleotide Biosynthetic Process (GO:0009152),0.2732721787192001,1.2984918320532468,0.16551724137931034,0.47040084275299143,1.0,13/17,50.32%,TGFB1;ATP5F1B;ATIC;ALDOA;PAICS;ATP5F1A;GMPS;ADSL;ACOT7;IMPDH2;AMPD2;GART;PFAS
407,prerank,Positive Regulation Of ERK1 And ERK2 Cascade (GO:0070374),0.22727127844977102,1.2979434626974031,0.16847826086956522,0.46980803960606915,1.0,11/25,23.79%,FGB;APOE;FGA;TGFB1;FGG;SERPINF2;CCN2;NPNT;APP;PLA2G2A;CD74
408,prerank,Positive Regulation Of Protein-Containing Complex Assembly (GO:0031334),0.24646274333934395,1.2972159114760533,0.18592057761732853,0.4696885494406874,1.0,7/21,10.64%,CLU;VCP;HSP90AA1;TGFB1;RAP1B;RACK1;PPP2CA
409,prerank,Neuron Differentiation (GO:0030182),-0.3098558147626791,-1.2961979057501076,0.15432098765432098,0.8846481405126863,1.0,8/11,40.68%,ACSL4;MTPN;PPT1;VEGFA;CTNNB1;HS6ST1;MAP2K1;PCSK9
410,prerank,Regulation Of Granulocyte Chemotaxis (GO:0071622),0.4645840117559521,1.2952613208304913,0.15737051792828685,0.46882586361654544,1.0,3/5,15.25%,THBS1;MDK;RARRES2
411,prerank,Positive Regulation Of Macrophage Chemotaxis (GO:0010759),0.4645840117559521,1.2952613208304913,0.15737051792828685,0.46882586361654544,1.0,3/5,15.25%,THBS1;MDK;RARRES2
412,prerank,Positive Regulation Of Macrophage Migration (GO:1905523),0.4645840117559521,1.2952613208304913,0.15737051792828685,0.46882586361654544,1.0,3/5,15.25%,THBS1;MDK;RARRES2
413,prerank,Response To Calcium Ion (GO:0051592),0.25155647627594035,1.29444209309195,0.16044776119402984,0.4688775789934917,1.0,6/19,8.88%,FGB;FGA;CLU;THBS1;FGG;AKR1C3
414,prerank,rRNA Processing (GO:0006364),-0.1808667121073613,-1.2926755201850377,0.15676959619952494,0.8869069978233683,1.0,31/35,70.43%,EBNA1BP2;RPS24;EMG1;XRN2;NEDD4;EXOSC4;MRTO4;DDX27;RPS28;LSM6;NOP2;MTREX;NOLC1;RPL35A;RPS19;RRP9;SNU13;RPS27;RPS17;RPS6;RPL26;RPL7;NOP58;NOP56;RPL27;RPL14;RPS7;RPL5;RPL11;PRKDC;FBL
415,prerank,Positive Regulation Of Cell Population Proliferation (GO:0008284),0.14508024084573604,1.2902547306458356,0.18506493506493507,0.47510745158700723,1.0,52/64,68.26%,FN1;ACTB;LTF;NPM1;LAMB1;TGFB1;LAMC1;CLEC11A;THBS1;SERPINF2;AKR1C3;MDK;IGF2;DHX9;RPS9;CRLF1;AGT;TNXB;CD74;HMGA2;REG3A;RPS4X;BRD9;NME1;CTSH;NAP1L1;AKR1B1;TIMP1;RPS15A;HDAC1;HNRNPU;HYAL1;MAPK15;AKR1C2;CD81;ADAM10;PRDX3;CHRD;RPS6;SDCBP;CALR;UFL1;DNAJA2;PRMT1;RPL17;PDGFA;GRN;NAMPT;ACTL6A;CSNK2A1;DPP4;NOP2
416,prerank,Regulation Of Keratinocyte Differentiation (GO:0045616),0.4735361661826179,1.2894417977981654,0.1607843137254902,0.4750204830213879,1.0,4/5,33.49%,MACROH2A1;MACROH2A2;REG3A;ROCK2
417,prerank,Regulation Of Aerobic Respiration (GO:1903715),0.42077153950684143,1.2891647510527255,0.15482695810564662,0.47400460569179165,1.0,3/6,9.99%,VCP;MACROH2A1;SHMT2
418,prerank,Purine Nucleobase Biosynthetic Process (GO:0009113),0.4589683470105511,1.2877675034480505,0.18647166361974407,0.4750699661397057,1.0,5/5,54.24%,SHMT2;PAICS;GMPS;SHMT1;PRPS1
419,prerank,protein-RNA Complex Assembly (GO:0022618),0.15675987760806137,1.2873989190201796,0.1497584541062802,0.47422426381903676,1.0,30/57,38.87%,HSP90AB1;HSP90AA1;EIF5;RPSA;DDX39B;SNRPD3;XRCC5;SRSF1;DHX9;PRPF19;HNRNPC;RPLP0;SNRPD1;RPS14;EIF6;SF3B1;EIF3C;PTGES3;SNRPD2;PRKDC;RPS5;PRMT5;RPL11;EIF3K;RPL5;EIF3F;WDR77;EIF3L;EIF3B;EIF3E
420,prerank,Protein Targeting To Vacuole (GO:0006623),-0.46509787891421733,-1.2846120637910827,0.1838074398249453,0.9046308700444058,1.0,3/5,12.27%,AP3M1;SCARB2;NEDD4
421,prerank,Positive Regulation Of Intracellular Signal Transduction (GO:1902533),0.13553363503914118,1.2841003888017168,0.18122977346278318,0.47859254454476186,1.0,15/73,8.94%,GAPDH;FN1;RELN;LTF;GDF15;HSP90AB1;HSP90AA1;PPIA;TGFB1;FLNA;RACK1;F10;THBS1;AKR1C3;CNTN1
422,prerank,Negative Regulation Of Angiogenesis (GO:0016525),0.2550404002927082,1.283448923692388,0.1738382099827883,0.47828000037108626,1.0,8/18,21.51%,SERPINF1;PGK1;THBS4;APOH;THBS1;HSPG2;SERPINE1;EMILIN1
423,prerank,Ethanol Metabolic Process (GO:0006067),-0.4554513481828839,-1.280792438695377,0.18329938900203666,0.9081626385257046,1.0,5/5,54.65%,SULT1A3;ACSS2;SULT1E1;SULT2A1;SULT1A1
424,prerank,Regulation Of Arp2/3 Complex-Mediated Actin Nucleation (GO:0034315),-0.42428367560194447,-1.2768338149242222,0.18997912317327767,0.9126553903346789,1.0,5/6,39.80%,ARFIP1;RNH1;GMFB;NCKAP1;CORO1B
425,prerank,Regulation Of DNA Metabolic Process (GO:0051052),0.2686146507092238,1.2765917261969595,0.19202898550724637,0.48907589468976825,1.0,10/16,37.17%,SUB1;PPP2CA;XRCC5;ANKRD17;PPP2R1A;RUVBL1;HNRNPD;RUVBL2;UBE2V1;SF3B3
426,prerank,High-Density Lipoprotein Particle Remodeling (GO:0034375),0.331973773837383,1.2761951159789229,0.18198198198198198,0.4884232742964723,1.0,6/11,23.32%,APOE;APOA1;APOM;APOC3;PLTP;LCAT
427,prerank,Negative Regulation Of Cell-Substrate Adhesion (GO:0010812),0.37573758363248017,1.274180722516557,0.1908256880733945,0.49080218297026096,1.0,5/8,27.35%,FBLN1;PLG;THBS1;CORO1C;ACTN4
428,prerank,Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0007178),-0.212722902634231,-1.2712260197189011,0.18313253012048192,0.922898337759046,1.0,20/24,61.08%,PTPRK;LTBP2;USP15;FERMT2;NUP93;SRC;FKBP1A;STAT3;BMP4;PDCD4;ITGB1;COL3A1;INHBE;USP9X;CDH5;MAPK3;COL1A2;GARS1;DDX5;GPI
429,prerank,Triglyceride Metabolic Process (GO:0006641),0.35706796161129617,1.270850668643904,0.18938053097345134,0.4955057491239492,1.0,4/9,11.34%,APOB;APOE;APOH;APOC3
430,prerank,Positive Regulation Of Osteoblast Differentiation (GO:0045669),-0.3924614028226433,-1.2683013506684382,0.19724770642201836,0.9239599388256456,1.0,5/7,30.27%,FERMT2;FBN2;PPP3CA;IFITM1;BMP4
431,prerank,Regulation Of Protein Kinase Activity (GO:0045859),0.29125810982993383,1.2679094291965167,0.19237749546279492,0.4995978928343264,1.0,11/14,50.85%,RELN;PPIA;XRCC5;XRCC6;YWHAG;IQGAP1;GSTP1;HSPB1;QARS1;TTN;WARS1
432,prerank,Regulation Of BMP Signaling Pathway (GO:0030510),-0.38758385548003504,-1.2678684669641536,0.16968325791855204,0.9164283186807072,1.0,6/7,46.76%,BMP4;NUMA1;LRP2;SORL1;CDH5;CHRD
433,prerank,Regulation Of Lipid Catabolic Process (GO:0050994),0.3704512257426737,1.2678668969133637,0.1669724770642202,0.4981557291814943,1.0,7/8,51.32%,APOC3;RARRES2;FLNB;APOA5;APOC1;ANGPTL3;APOA2
434,prerank,Negative Regulation Of Protein Ubiquitination (GO:0031397),-0.3408562955481015,-1.2677844144079067,0.18609406952965235,0.9078223289013208,1.0,7/9,42.43%,DNAJA1;ARRB1;PARK7;BAG2;UFL1;BUB3;U2AF2
435,prerank,RNA Catabolic Process (GO:0006401),-0.26940263269223735,-1.2646645051557863,0.19775280898876405,0.9102071464899968,1.0,7/15,18.18%,RNH1;EXOSC6;XRN2;PNPT1;PABPC4;EXOSC4;NCBP1
436,prerank,3'-Phosphoadenosine 5'-Phosphosulfate Metabolic Process (GO:0050427),-0.4554513481828839,-1.2643203595906933,0.1913978494623656,0.9027126970777098,1.0,5/5,54.65%,SULT1A3;PAPSS1;SULT1E1;SULT2A1;SULT1A1
437,prerank,Proteolysis Involved In Protein Catabolic Process (GO:0051603),0.26652714736952593,1.2627224956545775,0.18114602587800369,0.5060428174980085,1.0,10/16,37.23%,VCP;RPS27A;CTSB;PRPF19;PSMA6;CTSH;CAPN2;DDB1;PDCD6IP;CTSZ
438,prerank,Negative Regulation Of Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:1902042),0.3941032381309635,1.2624375253018272,0.18666666666666668,0.5050743477341868,1.0,4/7,20.46%,FGB;FGA;FGG;SERPINE1
439,prerank,RNA Modification (GO:0009451),0.45230672229516294,1.2624082982604472,0.19245283018867926,0.5036011565802442,1.0,4/5,35.83%,AARS1;HNRNPAB;SARS1;SSB
440,prerank,Cortical Cytoskeleton Organization (GO:0030865),0.46039912339451683,1.2605480448944038,0.18375241779497098,0.505369470282452,1.0,4/5,34.89%,EZR;RAC1;ROCK2;PLEK
441,prerank,Post-Translational Protein Modification (GO:0043687),-0.37988648941476494,-1.2602950776580493,0.18876404494382024,0.9079166795191524,1.0,6/7,47.40%,JAK2;UBE2M;UCHL3;COPS5;RBX1;FN3K
442,prerank,Regulation Of Protein Localization To Cell Surface (GO:2000008),-0.413185365007503,-1.2601673837119225,0.18354430379746836,0.8998484067949812,1.0,3/6,6.43%,GPD1L;GOPC;GBF1
443,prerank,Protein Transport (GO:0015031),0.13649096629099866,1.2599976185288269,0.20317460317460317,0.5048813759472519,1.0,41/72,45.35%,APOB;APOE;CLU;NPM1;KRT18;HSP90B1;FGG;CLTC;ARF1;SPTBN1;MYH9;COPA;SEPTIN9;USO1;RAB11B;LRP1;VPS35;HSPA9;CD74;ARF4;PRF1;AP3D1;ARF5;RAB14;SIL1;NSF;RAB18;RAB7A;RAB5C;AP2A1;COPB2;EHD1;ARCN1;DNM2;COPG1;SEC31A;PDIA4;RAB1B;AFM;AP3B1;RAB5A
444,prerank,Regulation Of Mitotic Spindle Organization (GO:0060236),0.34418799106948844,1.2585871209156605,0.19090909090909092,0.5058901552407813,1.0,7/9,44.30%,HSPA1A;CLTC;DYNC1H1;PDCD6IP;HNRNPU;DCTN1;TPR
445,prerank,Triglyceride-Rich Lipoprotein Particle Remodeling (GO:0034370),0.43001852508639293,1.2581394640102235,0.20186915887850468,0.5052295636099433,1.0,5/6,41.44%,APOE;APOC2;LCAT;APOA4;APOA5
446,prerank,Cardiac Muscle Contraction (GO:0060048),0.4607268464243846,1.256184093789845,0.20643939393939395,0.5073427338705112,1.0,5/5,54.06%,GSN;TPM1;TTN;MYLK2;GAA
447,prerank,Positive Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901992),-0.3363427167419145,-1.2556087091541914,0.19331742243436753,0.9067624941069248,1.0,5/9,20.69%,BRD4;RRM2B;DDX3X;CDK1;CUL3
448,prerank,Regulation Of Myoblast Differentiation (GO:0045661),-0.44459799151918283,-1.2548425902518543,0.2052980132450331,0.9011001701072323,1.0,4/5,34.13%,SMARCA4;MAPK14;BMP4;ACTL6A
449,prerank,Epidermis Development (GO:0008544),0.28766487197516855,1.2545197697211357,0.1813380281690141,0.5089894304943913,1.0,10/13,49.39%,PLOD1;KRT9;CCN2;KRT2;YBX1;KRT5;LAMA3;HDAC1;KRT14;SVEP1
450,prerank,Positive Regulation Of Cell Death (GO:0010942),0.4261787713348097,1.2543483637906678,0.19480519480519481,0.5078424106471862,1.0,3/6,10.29%,HBB;CLU;HBE1
451,prerank,Cytoplasmic Microtubule Organization (GO:0031122),0.3937793427230045,1.2524275754920071,0.18867924528301888,0.510111401089863,1.0,7/7,60.78%,CCDC13;EZR;DYNC1H1;KPNB1;SLAIN1;TBCB;NUMA1
452,prerank,Negative Regulation Of Amyloid-Beta Formation (GO:1902430),0.4623374837901455,1.2516248270542043,0.20522388059701493,0.5085844126391298,1.0,4/5,35.01%,APOE;CLU;RTN4;APEX1
453,prerank,Negative Regulation Of Amyloid Precursor Protein Catabolic Process (GO:1902992),0.4623374837901455,1.2516248270542043,0.20522388059701493,0.5085844126391298,1.0,4/5,35.01%,APOE;CLU;RTN4;APEX1
454,prerank,Negative Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032435),-0.3080220652859359,-1.2516122524304303,0.16772823779193205,0.9037552121320939,1.0,9/11,50.32%,SGTA;CCAR2;PARK7;BAG6;EIF3H;USP9X;SDCBP;USP7;USP14
455,prerank,Positive Regulation Of Cell Motility (GO:2000147),0.1722679528505111,1.2464140853789933,0.19701986754966888,0.5167294694926007,1.0,11/42,10.75%,SPOCK2;CEMIP;LAMB1;TGFB1;HSPA5;RACK1;F10;THBS1;CNTN1;GRB7;MDK
456,prerank,Negative Regulation Of Supramolecular Fiber Organization (GO:1902904),0.28114832567825004,1.2457546461297542,0.19464285714285715,0.5164591378473196,1.0,9/14,38.16%,APOE;CLU;PFN1;HSPA8;EML2;EMILIN1;CORO1A;LDLR;PFN2
457,prerank,Regulation Of Protein Autophosphorylation (GO:0031952),-0.375934233888763,-1.2445311682436713,0.1947261663286004,0.9191941584850366,1.0,6/7,47.57%,PDGFC;RAD50;DDX3X;VEGFA;PDGFA;MVP
458,prerank,Cellular Response To Amino Acid Starvation (GO:0034198),-0.44021101992966,-1.2421948405108854,0.21095334685598377,0.9102540107872371,1.0,5/5,56.17%,MAPK1;SH3GLB1;LARS1;MAPK3;EIF2S1
459,prerank,Response To Amino Acid Starvation (GO:1990928),-0.44021101992966,-1.2421948405108854,0.21095334685598377,0.9102540107872371,1.0,5/5,56.17%,MAPK1;SH3GLB1;LARS1;MAPK3;EIF2S1
460,prerank,Regulation Of Vesicle-Mediated Transport (GO:0060627),-0.2518596560904256,-1.2394823140785571,0.18663594470046083,0.9111773959457411,1.0,12/16,49.33%,RAB4A;SRC;MAPK1;RAB8B;MBTPS1;SCFD1;RAB21;MAP2K1;RAB5B;USP7;MAPK3;PACSIN2
461,prerank,Regulation Of Erythrocyte Differentiation (GO:0045646),-0.34316519962038483,-1.2378138678531614,0.1875,0.9087203452261263,1.0,5/9,19.64%,HMGB2;STAT5B;MAPK14;STAT1;STAT3
462,prerank,Focal Adhesion Assembly (GO:0048041),-0.43224424318819854,-1.2374913442645943,0.1843220338983051,0.9019424012160201,1.0,3/5,14.96%,PTPRK;FERMT2;SRC
463,prerank,Protein Deneddylation (GO:0000338),-0.4064516129032258,-1.2371017614873236,0.19111111111111112,0.8956408164504857,1.0,6/6,59.56%,COPS5;COPS4;COPS6;COPS3;GPS1;COPS8
464,prerank,Protein Autophosphorylation (GO:0046777),-0.4484173505275498,-1.2359898847892643,0.23542116630669546,0.8916800500493397,1.0,5/5,55.35%,JAK2;SRC;MAPK3;MYLK2;MAPK15
465,prerank,Negative Regulation Of MAPK Cascade (GO:0043409),0.27044045825729074,1.2358467407125373,0.20066889632107024,0.5336461847706732,1.0,9/16,31.15%,APOE;FBLN1;PPIA;PEBP1;EZR;AGT;EMILIN1;PPP2R1A;GSTP1
466,prerank,BMP Signaling Pathway (GO:0030509),-0.3187374569155252,-1.2352512945618366,0.2100456621004566,0.8865725819910939,1.0,9/10,57.69%,USP15;BMP4;PDCD4;INHBE;USP9X;CHRD;MAPK3;GARS1;DDX5
467,prerank,Positive Regulation Of DNA-binding Transcription Factor Activity (GO:0051091),0.20538596959465505,1.2352085856824917,0.23333333333333334,0.5334348816174705,1.0,10/27,18.88%,RELN;CLU;LTF;HSPA1A;NPM1;PPIA;DHX9;RPS3;APP;AGT
468,prerank,Positive Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032436),0.3150728660415798,1.232418178979279,0.199288256227758,0.5372031144685391,1.0,4/11,7.42%,CLU;HSPA1A;VCP;RACK1
469,prerank,Organelle Transport Along Microtubule (GO:0072384),-0.38028169014084506,-1.2313886896032484,0.21428571428571427,0.8913174527425244,1.0,7/7,62.19%,LRPPRC;RAB1A;RAB6A;CDC42;PAFAH1B1;COPG1;KIF5B
470,prerank,Cellular Response To Organic Substance (GO:0071310),-0.40297635335180604,-1.2313882721016003,0.21656050955414013,0.8839511928025034,1.0,4/6,24.61%,STAT5B;STAT3;PARK7;KHSRP
471,prerank,Negative Regulation Of Apoptotic Process (GO:0043066),0.1326231880829288,1.2309818278921325,0.21303656597774245,0.5382832656388762,1.0,14/74,7.60%,ALB;APOE;CLU;LTF;HSPA1A;NPM1;KRT18;COMP;APOH;FLNA;HSPA5;HSP90B1;DHRS2;THBS1
472,prerank,Positive Regulation Of Small Molecule Metabolic Process (GO:0062013),0.45003978456047333,1.2300967057329888,0.2113970588235294,0.5384971967671067,1.0,3/5,18.29%,APOE;APOA1;APP
473,prerank,Glucose Metabolic Process (GO:0006006),0.23403114327645208,1.2298158911853645,0.22007042253521128,0.537469274764037,1.0,11/21,30.57%,PGK1;ENO1;PGAM1;DCXR;TPI1;MDH2;G6PD;PCK2;PGM1;GALM;SORD
474,prerank,Regulation Of Interleukin-6 Production (GO:0032675),0.336134768014246,1.2293352363403989,0.2388888888888889,0.5368649793906215,1.0,5/9,23.79%,C1QTNF3;DHX9;APP;HSPD1;CD74
475,prerank,Positive Regulation Of Metabolic Process (GO:0009893),-0.28218596180145966,-1.227975617036607,0.22323462414578588,0.8879948601729397,1.0,7/13,24.08%,PDGFC;MFAP2;SMARCA4;ACSL1;JAK2;VEGFA;FH
476,prerank,Positive Regulation Of Epithelial Cell Proliferation (GO:0050679),0.24523714678032962,1.2276728447622003,0.20632279534109818,0.5384416950244668,1.0,6/18,10.75%,THBS4;LAMB1;LAMC1;CNTN1;ANG;MDK
477,prerank,Vesicle-Mediated Transport (GO:0016192),-0.14990969295605058,-1.2272957703679506,0.21836228287841192,0.8830240994219697,1.0,50/50,85.51%,RAB4A;AP1G2;ANXA2;STXBP2;PIP4K2A;AP3M1;EPS15L1;NAPA;CPNE1;TINAGL1;AP1S1;AP2A2;ARHGAP1;AP1S2;TSG101;CDK16;GDI1;ARF6;EEA1;RAB5B;RAB2A;RAB1A;LRP2;RAB5A;AP3B1;AP1G1;CDC42;AP1M1;DNM2;EHD1;AP2A1;RAB5C;RAB7A;AP2B1;ACTR1A;LDLR;NSF;AP2M1;RAB14;ARF5;AP3D1;ARF4;GDI2;AP1B1;SEPTIN9;APP;EHD3;CORO1C;DPYSL2;ARF1
478,prerank,Positive Regulation Of Endothelial Cell Proliferation (GO:0001938),0.2900168263244737,1.2267929051084152,0.20640569395017794,0.5385586470620447,1.0,5/13,11.86%,THBS4;CNTN1;ANG;MDK;IGF2
479,prerank,Positive Regulation Of Macromolecule Biosynthetic Process (GO:0010557),0.20559225152911198,1.2255699056497928,0.22359154929577466,0.5394841393657559,1.0,15/26,38.87%,NPM1;EEF2;THBS1;IGF2;EIF6;PLXNB2;EIF3C;RPS4X;EIF4A3;PRKDC;HNRNPD;AKR1B1;RPL5;SSB;EIF3E
480,prerank,Positive Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071902),0.27410511189551434,1.2255481377830726,0.21978021978021978,0.5379997946128192,1.0,5/14,10.64%,LTF;CEMIP;TGFB1;THBS1;PPP2CA
481,prerank,Epidermal Growth Factor Receptor Signaling Pathway (GO:0007173),0.3637075017219114,1.2249585107916598,0.2224334600760456,0.5376052190648846,1.0,6/8,40.09%,TGFB1;EFEMP1;GRB7;PIGR;IQGAP1;VIL1
482,prerank,Positive Regulation Of Type I Interferon Production (GO:0032481),0.31855267556165856,1.224028534508248,0.19851576994434136,0.5378804758038788,1.0,5/10,21.22%,GAPDH;POLR3B;HSP90AA1;DHX9;HSPD1
483,prerank,Positive Regulation Of Epithelial To Mesenchymal Transition (GO:0010718),0.3148443623502745,1.223203015266966,0.22823984526112184,0.5379493488727243,1.0,5/10,20.86%,TGFB1;MDK;AGT;TNXB;COL1A1
484,prerank,Heterophilic Cell-Cell Adhesion Via Plasma Membrane Cell Adhesion Molecules (GO:0007157),0.3988269794721408,1.2200053670109738,0.22324723247232472,0.5426559262672684,1.0,6/6,60.26%,REG3A;PTPRD;HMCN1;VCAM1;FAT4;ICAM1
485,prerank,Lipid Biosynthetic Process (GO:0008610),-0.32908351389775914,-1.2198388930570472,0.22247706422018348,0.8999159592182091,1.0,6/9,32.38%,ACSL1;PRKAA1;LIPC;ACSS2;DHRS11;PCYT2
486,prerank,Cellular Response To Hormone Stimulus (GO:0032870),0.29859644625395454,1.2189770363997758,0.24727272727272728,0.5431028079606557,1.0,9/12,46.81%,HSPA1A;TFPI;AKR1C3;CTSB;HSPA8;CTSH;AKR1B1;AKR1C2;ATP1A1
487,prerank,Protein Homotetramerization (GO:0051289),0.2649973764553374,1.214331737358925,0.23580034423407917,0.5504740718860894,1.0,10/15,41.73%,CLU;SHMT2;ALDOA;ACOT13;APLP2;ALDH9A1;MAT1A;CRYZ;SHMT1;SSBP1
488,prerank,Regulation Of Anatomical Structure Morphogenesis (GO:0022603),-0.2732093786557531,-1.2132405162604882,0.24565217391304348,0.9140393053678697,1.0,5/12,12.27%,SPARC;RNH1;PDLIM5;FERMT2;NEDD4
489,prerank,Actin Polymerization Or Depolymerization (GO:0008154),0.31887468142696407,1.2124819595143075,0.2277580071174377,0.5525908090266979,1.0,7/10,40.09%,GSN;ANG;WDR1;RAC1;CFL1;DIAPH1;VIL1
490,prerank,Regulation Of Blood Vessel Endothelial Cell Migration (GO:0043535),0.3097614391641257,1.2117412422352873,0.21626617375231053,0.5525333049406029,1.0,4/11,7.60%,APOE;TGFB1;ATP5F1B;THBS1
491,prerank,Regulation Of Axon Extension Involved In Axon Guidance (GO:0048841),-0.36809773418942227,-1.2107290662000838,0.23127753303964757,0.914864019399036,1.0,6/7,48.45%,VEGFA;SEMA7A;SEMA3F;SEMA3C;SEMA3A;SEMA4B
492,prerank,Regulation Of Epithelial To Mesenchymal Transition (GO:0010717),0.2748644241166722,1.2103277588512038,0.24545454545454545,0.5537166571706109,1.0,6/13,20.86%,TGFB1;PPP2CA;MDK;AGT;TNXB;COL1A1
493,prerank,Regulation Of Transcription Elongation By RNA Polymerase II (GO:0034243),-0.3589990749972125,-1.2053729274229597,0.2348993288590604,0.925160080035119,1.0,5/7,34.66%,NELFB;NCBP1;MED6;SUPT6H;TCERG1
494,prerank,Neuromuscular Process (GO:0050905),-0.4320046893317702,-1.2039028993581111,0.26258205689277897,0.9227799652046066,1.0,5/5,56.98%,NRXN1;MYCBP2;TPP1;DCTN1;PAFAH1B1
495,prerank,RNA Metabolic Process (GO:0016070),-0.20141203702778787,-1.2007840673812453,0.22115384615384615,0.9252468706174315,1.0,19/24,58.33%,EXOSC6;XRN2;PNPT1;PABPC4;PABPN1;DDX3X;EXOSC4;HNRNPUL1;NCBP1;SNRNP40;MTREX;HNRNPL;FTO;HNRNPH1;RNASET2;PCBP2;HNRNPF;DDX17;HNRNPU
496,prerank,Protein N-linked Glycosylation Via Asparagine (GO:0018279),-0.41910902696365765,-1.2003303466265043,0.23110151187904968,0.9195209665862939,1.0,5/5,58.27%,ST6GAL1;UGGT1;MGAT1;PSMD2;MGAT2
497,prerank,Protein Processing (GO:0016485),0.2275593328705145,1.2002140589092931,0.22852233676975944,0.5720569832523829,1.0,7/20,14.03%,XPNPEP3;C1R;CNTN1;F9;ADAMTS13;CPN1;MASP1
498,prerank,Response To Insulin (GO:0032868),0.3122970266161346,1.1987362443759355,0.22138836772983114,0.5733031412568228,1.0,9/10,59.44%,PKM;SLC2A1;PCK2;EIF6;PARP1;PRKDC;PKLR;EPRS1;PCSK9
499,prerank,Regulation Of Apoptotic Signaling Pathway (GO:2001233),0.373491611883287,1.1977828803492487,0.24615384615384617,0.5735650464087683,1.0,6/7,49.04%,PPIA;RPS3;CTSH;ETFA;QARS1;CTSV
500,prerank,Regulation Of Protein Modification Process (GO:0031399),0.33242824053390374,1.1963971168755931,0.2340823970037453,0.574741243576616,1.0,5/9,24.55%,FN1;PPIB;PPP2CA;CORO1C;PLXNB2
501,prerank,Myeloid Cell Development (GO:0061515),-0.4274088376228476,-1.195984358518331,0.25910064239828695,0.9267922621168355,1.0,3/5,14.96%,ANXA2;ATP6AP1;SRC
502,prerank,Myelination (GO:0042552),-0.43580004103848957,-1.1955839600047746,0.2505643340857788,0.9208280201395934,1.0,4/5,34.42%,EIF2B4;ADGRG6;GPC1;GAL3ST1
503,prerank,Regulation Of Amide Metabolic Process (GO:0034248),-0.32275326392372966,-1.1952382458589368,0.23173277661795408,0.9148375919907688,1.0,8/9,56.17%,EIF2B4;MTPN;NOLC1;ELP3;ELP1;EIF4E;TCOF1;EIF2S1
504,prerank,Dicarboxylic Acid Metabolic Process (GO:0043648),0.22248520710059153,1.195049004666924,0.22126929674099485,0.5759142233702184,1.0,21/21,78.02%,SHMT2;ACLY;MDH2;ASS1;IDH1;HAAO;ALDH5A1;SHMT1;DLST;NIT2;IDH2;SDHA;ME2;ME1;GCLC;GGT1;MDH1;OGDH;FH;PCK1;ALDH18A1
505,prerank,Negative Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000059),-0.2622419309798495,-1.194255443615825,0.24190064794816415,0.9112730777275678,1.0,13/14,66.34%,SGTA;CCAR2;PARK7;BAG6;EIF3H;CSNK2A1;RPL17;USP9X;SDCBP;USP7;RPS7;RPL5;RPL11
506,prerank,acyl-CoA Metabolic Process (GO:0006637),-0.40117302052785925,-1.193780542958223,0.234375,0.9059648945966406,1.0,6/6,60.08%,SUCLA2;OGDH;ACOT1;HMGCS1;ACOT7;DLST
507,prerank,Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060338),-0.42555685814771393,-1.193656363946668,0.24696356275303644,0.8997208752997801,1.0,5/5,57.63%,IGF2BP1;SAMHD1;PTPN11;TTLL12;CDC37
508,prerank,Positive Regulation Of Protein Binding (GO:0032092),0.25655946161132953,1.1929034044576319,0.2550091074681239,0.5785741201570866,1.0,7/16,20.81%,VTN;APOE;SUB1;RAN;PPP2CA;APP;LRP1
509,prerank,RNA Processing (GO:0006396),-0.13159871138135626,-1.1922663799277247,0.21158690176322417,0.8973275717790988,1.0,35/56,48.68%,EXOSC6;PRPF8;SRPK1;DDX23;XRN2;PABPC4;PABPN1;FUS;EXOSC4;HNRNPUL1;NCBP1;CCAR2;KHSRP;SNRNP40;LSM6;SF3B2;SF3A3;NUDT21;PRKACA;SNRPB;TCERG1;HNRNPA0;DHX15;SF3A1;SNRPF;HNRNPL;PRMT1;CPSF6;U2AF2;HNRNPH1;SMU1;SNRPA1;LSM3;CSTF3;HNRNPR
510,prerank,Cell-Cell Junction Organization (GO:0045216),0.31193715676079553,1.192209815124703,0.2523540489642185,0.5784391030448135,1.0,6/10,30.45%,TLN1;TGFB1;LIMS1;FSCN1;CDH1;CDH11
511,prerank,Positive Regulation Of Smooth Muscle Cell Proliferation (GO:0048661),0.36637729293551047,1.1898229345174047,0.23572744014732966,0.5816080843083802,1.0,3/7,8.42%,TGFB1;THBS1;SERPINF2
512,prerank,"mRNA Splicing, Via Spliceosome (GO:0000398)",-0.1199026171637249,-1.1874258560376991,0.24396782841823056,0.9056780644116602,1.0,68/68,88.54%,SRSF10;SNRNP70;PRPF8;SRPK1;DDX23;CTNNBL1;SART3;DCPS;NCBP1;STRAP;HNRNPM;HNRNPA3;PRPF40A;SNRNP40;LSM6;CDC5L;SF3B2;SF3A3;EFTUD2;TRA2B;SNRPB;DHX15;SF3A1;MTREX;SNRPF;SNRPE;U2AF2;SNRPA;SNU13;HNRNPH1;SMU1;SNRPA1;RBMX;SNRPGP15;LSM3;PABPC1;HNRNPR;SNRNP200;MAGOH;RALY;HNRNPF;DDX17;DDX5;HNRNPU;DDX1;SRSF4;SF3B3;WDR77;HNRNPA2B1;SRSF2;PRMT5;SRSF7;SNRPD2;EIF4A3;SF3B1;SFPQ;HNRNPA1;SNRPD1;HNRNPK;PPIE;HNRNPC;PRPF19;DHX9;HSPA8;SRSF3;SRSF1;SNRPD3;DDX39B
513,prerank,Chromatin Organization (GO:0006325),0.1780618707604232,1.1867914479374084,0.22818791946308725,0.5858235437733464,1.0,19/33,41.79%,H2BC11;H3-3A;NPM1;MACROH2A1;H1-5;HNRNPC;RBBP4;SFPQ;SSRP1;HMGA2;SF3B1;BRD9;RUVBL1;NAP1L1;RUVBL2;SUPT16H;HDAC1;TOP1;HNRNPU
514,prerank,Modification-Dependent Protein Catabolic Process (GO:0019941),-0.1857937817191435,-1.1850650300202585,0.24396135265700483,0.9068475934327994,1.0,18/27,47.05%,NEDD4;UBE2I;UBA6;TRIM25;TOLLIP;ARRB1;CUL3;NAE1;NPLOC4;BAG6;UBE2D2;UBR4;PCYOX1L;ARRDC1;RBX1;FBXO22;OS9;COPS3
515,prerank,Positive Regulation Of Cellular Component Organization (GO:0051130),0.19771269517765805,1.1850355528081837,0.2587646076794658,0.5878802867740733,1.0,7/28,7.42%,RELN;APOE;CLU;GPC3;VCP;TGFB1;RACK1
516,prerank,Intermediate Filament Organization (GO:0045109),0.2830823826445492,1.1847042773676508,0.26519337016574585,0.5869822944545993,1.0,9/12,48.28%,KRT1;KRT9;KRT19;KRT10;KRT2;KRT13;KRT5;KRT74;KRT14
517,prerank,RNA Export From Nucleus (GO:0006405),0.2850630104176197,1.1841822999050469,0.24909090909090909,0.5864427126737382,1.0,9/12,47.81%,RAN;DDX39B;SRSF3;HNRNPA1;EIF4A3;HNRNPA2B1;TPR;XPO1;MAGOH
518,prerank,Positive Regulation Of Protein Polymerization (GO:0032273),0.272673733804476,1.1839242452662035,0.25220458553791886,0.5854407174790924,1.0,13/13,72.94%,PFN1;HSP90AA1;RPS3;RAC1;PFN2;VASP;DCTN1;MAPRE1;SLAIN1;NUMA1;DRG1;ARF6;NCKAP1
519,prerank,Positive Regulation Of Signal Transduction By P53 Class Mediator (GO:1901798),-0.39413489736070384,-1.1833486038581935,0.24528301886792453,0.9054685675406043,1.0,6/6,60.78%,EEF1E1;RPL17;RPS20;EIF5A;DDX5;RPS7
520,prerank,Positive Regulation Of Developmental Process (GO:0051094),0.16513997641858633,1.1806561972949297,0.24459234608985025,0.590327788835856,1.0,16/41,24.43%,RELN;APOE;HSP90AB1;SERPINF2;MDK;CCN2;KRT10;KRT2;CORO1C;PA2G4;TNXB;VPS35;RBBP4;RTN4;CFL1;C1QBP
521,prerank,Regulation Of Cell Migration (GO:0030334),0.12470830759130751,1.1803464173947968,0.25391849529780564,0.5894902665646192,1.0,51/75,57.39%,RELN;CEMIP;LAMB1;TGFB1;FLNA;HSPA5;RACK1;F10;THBS1;CNTN1;GRB7;MDK;LMNA;CORO1C;SEMA3B;FERMT3;TNXB;RAC1;SERPINE1;TNC;COL1A1;EMILIN1;RBBP4;APLP2;CD74;PLXNB2;ACTN4;CDH1;CTSH;CDH11;TPM1;ROCK2;RHOC;KRT5;SF3B3;VIL1;HDAC1;CDC42;MAPK15;RCC2;VCL;ADAM10;ANGPTL3;SEMA4B;DAG1;CHRD;CLIC4;ENPP2;SDCBP;CDH5;SORL1
522,prerank,Neuromuscular Junction Development (GO:0007528),-0.38858643539820803,-1.1791070974567637,0.261758691206544,0.912876081409878,1.0,4/6,26.65%,NEDD4;DNAJA3;GPHN;LRP4
523,prerank,Protein N-linked Glycosylation (GO:0006487),-0.26711932520902815,-1.1788265523888846,0.26036866359447003,0.9072813431557489,1.0,12/13,65.58%,ST3GAL1;ST6GAL1;PGM3;GAL3ST1;FUT3;MOGS;UGGT1;PMM2;MGAT1;PSMD2;MGAT2;GFPT1
524,prerank,Regulation Of Protein Tyrosine Kinase Activity (GO:0061097),0.4304746426418329,1.17856871017771,0.2476007677543186,0.5915021983070902,1.0,3/5,18.88%,RELN;APP;AGT
525,prerank,Negative Regulation Of Epithelial Cell Proliferation (GO:0050680),0.2861356083839709,1.1784339292554142,0.24731182795698925,0.5901875176701588,1.0,4/12,7.60%,APOE;APOH;TGFB1;THBS1
526,prerank,Regulation Of DNA Binding (GO:0051101),-0.33761143103818614,-1.1779079205864809,0.252212389380531,0.903795484431653,1.0,5/8,27.12%,HMGB2;JAK2;CPNE1;CSNK2B;HMGB1
527,prerank,Eye Morphogenesis (GO:0048592),-0.36120285017261866,-1.1769809600485435,0.2557651991614256,0.9003355093524459,1.0,4/7,19.64%,MFAP2;FBN2;VEGFA;STAT3
528,prerank,Regulation Of Macromolecule Metabolic Process (GO:0060255),0.2390332987850653,1.1767979555120387,0.2582322357019064,0.5918330239936208,1.0,10/18,33.49%,APOE;APP;VPS35;TSKU;CDH1;HNRNPAB;HNRNPD;YBX1;LDLR;ROCK2
529,prerank,Regulation Of Endothelial Cell Proliferation (GO:0001936),0.21830169961885293,1.1761155862622086,0.25249169435215946,0.5916229507537974,1.0,6/21,9.06%,APOE;THBS4;APOH;THBS1;CNTN1;ANG
530,prerank,Positive Regulation Of NIK/NF-kappaB Signaling (GO:1901224),0.3878163880899077,1.1756453596582324,0.26851851851851855,0.5911392632601666,1.0,4/6,29.34%,RPS3;APP;LIMS1;ILK
531,prerank,Intracellular Steroid Hormone Receptor Signaling Pathway (GO:0030518),-0.4249706916764361,-1.1753330158813273,0.26582278481012656,0.8996586840910159,1.0,5/5,57.69%,NEDD4;SRC;MAPK1;DDX17;DDX5
532,prerank,Peptide Metabolic Process (GO:0006518),-0.25343260876512147,-1.175134992070866,0.2505399568034557,0.8941521995509001,1.0,12/14,59.67%,CLN5;THOP1;AEBP1;DNPEP;ACE;IDE;GGT1;TPP1;CPQ;PCSK5;NPEPPS;CPE
533,prerank,Respiratory Tube Development (GO:0030323),-0.4155920281359906,-1.1722204485848897,0.24458874458874458,0.8969532064596911,1.0,5/5,58.62%,VEGFA;BAG6;BMP4;PCSK5;CHI3L1
534,prerank,Regulation Of Triglyceride Catabolic Process (GO:0010896),0.4273153575615475,1.1712851908435964,0.25996204933586337,0.5983923842307619,1.0,5/5,57.39%,APOC3;APOC2;APOA4;APOA5;SORL1
535,prerank,Chordate Embryonic Development (GO:0043009),0.40787914114595436,1.1708269054318576,0.25576923076923075,0.5977393145352305,1.0,3/5,20.86%,TGFB1;IGF2;COL1A1
536,prerank,Amino Acid Catabolic Process (GO:0009063),0.4275334773939933,1.17052682442972,0.24772313296903462,0.5968021925861251,1.0,4/5,38.40%,ETFB;ECHS1;ETFA;ALDH5A1
537,prerank,U2-type Prespliceosome Assembly (GO:1903241),0.28663919952913475,1.1703515290586548,0.28342245989304815,0.5956807234565914,1.0,12/12,71.54%,SNRPD3;SNRPD1;SF3B1;SNRPD2;SF3B3;SNRPA1;SNRPE;SNRPF;SF3A1;SNRPB;SF3A3;SF3B2
538,prerank,Anterograde Trans-Synaptic Signaling (GO:0098916),-0.3311802701115678,-1.1703382674247944,0.24511930585683298,0.8967294741562137,1.0,8/8,67.10%,PCDHB2;NRXN1;MAPK1;RPS6KA3;SDCBP;PAFAH1B1;APEX1;NPTX1
539,prerank,Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167),0.4187956038241163,1.1693439988789853,0.2559852670349908,0.5962304737632583,1.0,4/5,39.51%,PTPRF;LRP1;PTPRD;TIE1
540,prerank,Positive Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903322),-0.372660393869161,-1.1670497547249508,0.2703296703296703,0.900787529284975,1.0,4/6,28.70%,FKBP1A;MYCBP2;CUL3;SAE1
541,prerank,Fatty Acid Catabolic Process (GO:0009062),-0.2622693541990608,-1.1665591694287376,0.2505353319057816,0.8961936246638716,1.0,12/13,65.98%,ACAA1;PCCA;ACAA2;PCCB;HADHB;BDH2;HSD17B10;HADHA;ACAT2;ACAT1;DECR1;ECHS1
542,prerank,mRNA Processing (GO:0006397),0.12943927052584436,1.166010006192781,0.2866141732283465,0.6012113727285152,1.0,57/66,74.52%,DDX39B;SNRPD3;SRSF1;SRSF3;HSPA8;PRPF19;HNRNPC;PPIE;HNRNPK;SNRPD1;HNRNPA1;SFPQ;SF3B1;EIF4A3;SNRPD2;SRSF7;SRSF2;HNRNPA2B1;SF3B3;SRSF4;HNRNPU;DDX5;HNRNPF;RALY;MAGOH;SNRNP200;HNRNPR;PABPC1;LSM3;SNRPGP15;RBMX;SNRPA1;SMU1;HNRNPH1;SNU13;SNRPA;U2AF2;CPSF6;SNRPE;ALYREF;SNRPF;MTREX;SF3A1;DHX15;HNRNPA0;TCERG1;SNRPB;PRKACA;TRA2B;EFTUD2;NUDT21;SF3A3;SF3B2;CDC5L;LSM6;SNRNP40;PRPF40A
543,prerank,Regulation Of Fibroblast Proliferation (GO:0048145),0.33444547549877646,1.1654016187306604,0.27695167286245354,0.6009524338186928,1.0,5/8,31.15%,FN1;DHX9;FTH1;CD74;GSTP1
544,prerank,Organelle Organization (GO:0006996),-0.14679936446851566,-1.1650027451147138,0.25,0.89467405838169,1.0,35/40,72.47%,COG2;GBF1;SH3BGRL3;SLC9A3R1;DNAJA3;TOR1B;NPLOC4;PARK7;CNN2;PRPF40A;SAR1B;HSD17B10;NUMA1;PPID;RAB2A;RAB1A;NSFL1C;PRDX3;PACSIN2;SAR1A;MAPK15;RAB1B;CDC42;SEC31A;DNM1L;KRT13;RAB7A;RAB18;DIAPH1;PDCD6IP;TPM1;REEP6;PARP1;CAPZB;RAB14
545,prerank,Negative Regulation Of Neuron Death (GO:1901215),0.30831320862990813,1.1645210986552137,0.2611111111111111,0.6012038247621935,1.0,5/10,21.62%,APOE;CLU;MDK;CRLF1;VPS35
546,prerank,Positive Regulation Of Interferon-Beta Production (GO:0032728),0.3820013174645146,1.1644974682863465,0.25636363636363635,0.599732321411434,1.0,3/6,14.85%,POLR3B;HSP90AA1;DHX9
547,prerank,Regulation Of Protein Neddylation (GO:2000434),-0.33881385789782736,-1.164130694323349,0.2534883720930233,0.8914028336000035,1.0,8/8,66.34%,COPS5;COPS4;COPS6;COPS3;GPS1;COPS8;RPL5;RPL11
548,prerank,Positive Regulation Of Protein Import Into Nucleus (GO:0042307),0.3613296036206477,1.1630861380658486,0.27289377289377287,0.6011381396914346,1.0,3/7,8.65%,TGFB1;FLNA;RAN
549,prerank,Negative Regulation Of T Cell Activation (GO:0050868),0.424477797665151,1.1618396427100737,0.28932038834951457,0.6021681688047642,1.0,3/5,20.28%,FGL1;SDC4;PLA2G2A
550,prerank,Regulation Of Hydrolase Activity (GO:0051336),-0.3746036911013481,-1.1618196164005141,0.25910064239828695,0.8923518934500296,1.0,3/6,10.05%,PLXNA1;SCARB2;RAB3GAP2
551,prerank,Positive Regulation Of Intracellular Protein Transport (GO:0090316),0.23341530450553788,1.1598843476236196,0.2818181818181818,0.6046323806413868,1.0,18/19,72.06%,CEMIP;TGFB1;FLNA;RAN;YWHAE;CDH1;HUWE1;TPR;NPEPPS;CD81;SAR1A;SORL1;SH3GLB1;TRIM28;NMT1;SAR1B;SAE1;B3GAT3
552,prerank,Vitamin Transport (GO:0051180),0.4202813599062133,1.1591803122242694,0.27204502814258913,0.6045709912407888,1.0,5/5,58.09%,APOA1;SLC2A1;SLC2A14;AFM;LRP2
553,prerank,RNA Methylation (GO:0001510),0.3395783280197956,1.159111761734147,0.2664359861591695,0.6031785978577783,1.0,5/8,29.81%,METTL16;SNRPD3;SNRPD1;FBL;SNRPD2
554,prerank,Positive Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050731),0.2323545332112179,1.157511129154737,0.2746478873239437,0.6048601758377025,1.0,8/18,23.79%,VTN;RELN;THBS4;TGFB1;IGF2;CRLF1;AGT;CD74
555,prerank,Regulation Of Potassium Ion Transmembrane Transport (GO:1901379),-0.3770663639859846,-1.1572594197206458,0.2757201646090535,0.9008415072074459,1.0,4/6,27.35%,NEDD4;FHL1;CD63;GNB2
556,prerank,Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050730),0.23202000410089843,1.1571874050960085,0.29285714285714287,0.6039298793521287,1.0,8/18,23.79%,VTN;RELN;THBS4;TGFB1;IGF2;APP;AGT;CD74
557,prerank,GMP Metabolic Process (GO:0046037),0.3794721407624634,1.15682248382111,0.2873134328358209,0.6031185973161209,1.0,6/6,62.19%,PAICS;GMPR2;GMPS;GART;PFAS;NT5C2
558,prerank,Response To Hydrogen Peroxide (GO:0042542),0.35680751173708913,1.1545821251223825,0.2692307692307692,0.6061402666929504,1.0,7/7,64.47%,HBB;CLU;RPS3;HP;CAT;PRDX3;FABP1
559,prerank,Regulation Of DNA Recombination (GO:0000018),0.2989261128094477,1.1533034515409029,0.2743682310469314,0.6072202170931413,1.0,4/10,12.04%,H1-2;H1-1;H1-0;H1-5
560,prerank,Carboxylic Acid Metabolic Process (GO:0019752),-0.330735725163996,-1.1531440613296962,0.2709677419354839,0.9069870778946758,1.0,5/8,27.06%,ST3GAL1;GNE;GRHPR;PCK1;ST6GAL1
561,prerank,Aortic Valve Development (GO:0003176),0.41423655506037793,1.1529693684204072,0.24304267161410018,0.606409669797879,1.0,4/5,39.51%,TGFB1;EMILIN1;ROCK2;TIE1
562,prerank,Regulation Of Macroautophagy (GO:0016241),-0.2795144529447479,-1.1504053121358135,0.27973568281938327,0.9095494128651536,1.0,8/11,42.90%,NEDD4;SNX6;CAPNS1;ATP6V1B2;PRKACA;SH3GLB1;ATP6V1A;SNX5
563,prerank,Transcription By RNA Polymerase II (GO:0006366),-0.2504859245572917,-1.1487564959384202,0.25675675675675674,0.9087829704654282,1.0,10/14,45.30%,COPS2;ANXA2;POLR2H;XRN2;NCBP1;DEK;SUPT6H;DDX21;DRAP1;RBMX
564,prerank,Positive Regulation Of Viral Life Cycle (GO:1903902),-0.38101243349956565,-1.1487558144974188,0.2668024439918534,0.9030311795131153,1.0,4/6,27.12%,SMPD1;LGALS1;TSG101;HMGB1
565,prerank,Positive Regulation Of Pattern Recognition Receptor Signaling Pathway (GO:0062208),-0.37049569683556016,-1.1487290277120887,0.2801724137931034,0.8974384614563214,1.0,4/6,27.12%,FLOT1;USP15;DDX3X;HMGB1
566,prerank,Positive Regulation Of Interleukin-6 Production (GO:0032755),0.3492700981050183,1.148164190270545,0.2942271880819367,0.6145981125028207,1.0,4/7,23.79%,DHX9;APP;HSPD1;CD74
567,prerank,Tube Closure (GO:0060606),0.4202813599062134,1.1480490806524868,0.28014842300556586,0.6103537848592604,1.0,5/5,58.09%,TGFB1;PLXNB2;MTHFD1;VASP;LRP2
568,prerank,Neural Tube Closure (GO:0001843),0.4202813599062134,1.1480490806524868,0.28014842300556586,0.6103537848592604,1.0,5/5,58.09%,TGFB1;PLXNB2;MTHFD1;VASP;LRP2
569,prerank,Primary Neural Tube Formation (GO:0014020),0.4202813599062134,1.1480490806524868,0.28014842300556586,0.6103537848592604,1.0,5/5,58.09%,TGFB1;PLXNB2;MTHFD1;VASP;LRP2
570,prerank,Cellular Response To Steroid Hormone Stimulus (GO:0071383),0.32041116448140416,1.147455456579996,0.2876190476190476,0.6100503122476175,1.0,4/9,14.55%,HSPA1A;TFPI;AKR1C3;HSPA8
571,prerank,Regulation Of Peptidyl-Serine Phosphorylation (GO:0033135),0.2801670314077758,1.145940122015928,0.3017543859649123,0.6114494301056052,1.0,4/12,7.42%,HSP90AB1;HSP90AA1;TGFB1;RACK1
572,prerank,Antigen Processing And Presentation Of Peptide Antigen Via MHC Class I (GO:0002474),-0.3273552668253761,-1.145845236389853,0.2918454935622318,0.9003107251868722,1.0,6/8,41.20%,B2M;ACE;IDE;SAR1B;TAPBP;CALR
573,prerank,Negative Regulation Of Type I Interferon Production (GO:0032480),-0.40856419014580836,-1.143975559990356,0.26824034334763946,0.9003764081236991,1.0,4/5,38.69%,CUL3;NPLOC4;PTPN11;RBX1
574,prerank,Water-Soluble Vitamin Metabolic Process (GO:0006767),0.3853443431674106,1.142483990061419,0.3048327137546468,0.6168638187436135,1.0,5/6,46.58%,SHMT2;GSTO1;SLC2A1;SHMT1;NNMT
575,prerank,Receptor Metabolic Process (GO:0043112),0.4167817746597478,1.1420633221288774,0.2888015717092338,0.6162433521374395,1.0,3/5,20.16%,TGFB1;EHD3;RAB11B
576,prerank,Regulation Of Smooth Muscle Cell Migration (GO:0014910),0.41040201087745,1.1417065264263209,0.29333333333333333,0.6154369836497785,1.0,3/5,20.81%,VTN;SERPINE1;LRP1
577,prerank,Negative Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001960),0.4046917874975455,1.1410343657220121,0.3103448275862069,0.6152662838227901,1.0,2/5,1.93%,APOA1;H2BC11
578,prerank,Epithelial Structure Maintenance (GO:0010669),-0.4082609873677354,-1.1410206739325337,0.2662337662337662,0.9033853386161109,1.0,4/5,38.46%,SERPINA3;STRAP;LSR;MUC6
579,prerank,Protein Peptidyl-Prolyl Isomerization (GO:0000413),0.4148117100711246,1.1406051875198027,0.2784313725490196,0.6146762076081714,1.0,3/5,20.11%,PPIB;PPIA;PPIE
580,prerank,Regulation Of DNA Repair (GO:0006282),0.24469522429420953,1.14024653376523,0.2743682310469314,0.6138407432120698,1.0,9/15,37.17%,ACTB;DHX9;RPS3;PCNA;PARP1;RUVBL1;RUVBL2;UBE2V1;SF3B3
581,prerank,Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903320),0.30099941211052306,1.1401440750619076,0.30363636363636365,0.6126103238562614,1.0,10/10,70.08%,HSPA1A;HSP90AB1;HSP90AA1;COPS8;GPS1;COPS3;COPS6;COPS4;COPS5;CTNNB1
582,prerank,Positive Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120034),0.30244425039879896,1.1399469310194628,0.2877959927140255,0.6115778807875202,1.0,6/10,31.33%,PFN1;AGRN;RAC1;ACTR3;FSCN1;ARPC2
583,prerank,Negative Regulation Of Cell Cycle (GO:0045786),-0.36237481994980664,-1.1394422175129348,0.2958963282937365,0.9025854015275901,1.0,3/6,11.63%,PTPRK;IPO5;SLC9A3R1
584,prerank,Cilium Assembly (GO:0060271),0.2502427968484539,1.1388275068276161,0.2835820895522388,0.6124041094057434,1.0,10/15,43.19%,GSN;FLNA;CCDC13;EHD3;ACTR3;ARF4;SEPTIN7;SEPTIN2;EHD1;DCTN1
585,prerank,Regulation Of Vascular Endothelial Growth Factor Receptor Signaling Pathway (GO:0030947),-0.4082493469684235,-1.138740640438064,0.2749003984063745,0.8990354397359,1.0,3/5,16.48%,NEDD4;ITGB3;NIBAN2
586,prerank,Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0017015),0.22396228437801202,1.1370582306362502,0.2934027777777778,0.6143874261261123,1.0,8/19,21.68%,HSPA1A;HSP90AB1;TGFB1;THBS1;LTBP4;TNXB;EMILIN1;RBBP4
587,prerank,Small GTPase Mediated Signal Transduction (GO:0007264),-0.2904003561617021,-1.136991444572901,0.27292110874200426,0.8986255043417609,1.0,7/10,40.04%,RRAS;G3BP1;ARHGAP1;PARK7;ARL3;NRAS;NUCB1
588,prerank,Regulation Of Double-Strand Break Repair (GO:2000779),-0.29570840681951793,-1.1356108832393443,0.30735930735930733,0.8973751860049795,1.0,10/10,70.66%,SMARCA4;RPA2;DEK;ACTL6A;ACTR2;FIGNL1;OTUB1;UBE2N;RUVBL2;RUVBL1
589,prerank,Regulation Of Interleukin-12 Production (GO:0032655),0.3485359274658555,1.1352896280231737,0.3031423290203327,0.616372288815879,1.0,4/7,24.43%,THBS1;MDK;HSPD1;C1QBP
590,prerank,Muscle Tissue Morphogenesis (GO:0060415),-0.4079718640093786,-1.1350712564024392,0.2633832976445396,0.8935024933171052,1.0,5/5,59.38%,BMP4;MYLK;MYLK2;TTN;EFEMP2
591,prerank,Positive Regulation Of Peptidase Activity (GO:0010952),0.3562206572769953,1.135019721831342,0.30174081237911027,0.6154875316003088,1.0,7/7,64.52%,VCP;PSME2;CTSH;CTSV;PSME3;PSME1;GRN
592,prerank,Endocytic Recycling (GO:0032456),0.3143490440618889,1.1350152067420516,0.31521739130434784,0.6140590002742471,1.0,6/9,36.59%,EHD3;RAB11B;VPS35;RAB14;RAB7A;EHD1
593,prerank,Purine Nucleotide Biosynthetic Process (GO:0006164),0.31257344300822565,1.1348357189761853,0.28390596745027125,0.6129943733275973,1.0,9/9,68.91%,HAAO;MTHFD1;ADSL;GART;PFAS;PRPS1;PPAT;NAMPT;NADSYN1
594,prerank,Regulation Of Tumor Necrosis Factor Production (GO:0032680),0.29325789953363285,1.1347050140452222,0.2864864864864865,0.6118294275500037,1.0,5/11,18.29%,CLU;LTF;THBS1;DHX9;APP
595,prerank,Lysosome Organization (GO:0007040),-0.36721849138224544,-1.1345040115354363,0.29777777777777775,0.8898304028080962,1.0,5/6,46.05%,CLN5;MBTPS1;GRN;TPP1;GAA
596,prerank,Regulation Of Pathway-Restricted SMAD Protein Phosphorylation (GO:0060393),0.30195319812286875,1.1341748916311198,0.32541133455210236,0.6113621540065695,1.0,5/10,21.51%,GDF15;TGFB1;TNXB;LRP1;EMILIN1
597,prerank,Ribosomal Small Subunit Assembly (GO:0000028),0.32963718719218904,1.1338001289088075,0.29259259259259257,0.6107170059568379,1.0,5/8,30.80%,RPSA;XRCC5;RPS14;PRKDC;RPS5
598,prerank,Positive Regulation Of Lipid Metabolic Process (GO:0045834),0.3540291372028194,1.1333792042860407,0.3054003724394786,0.6101740503604799,1.0,6/7,51.32%,APOE;F2;FLNB;APOA5;ANGPTL3;APOA2
599,prerank,Positive Regulation Of Nucleocytoplasmic Transport (GO:0046824),0.27428932250665816,1.1329093958183505,0.2943327239488117,0.6097272278665861,1.0,7/12,32.73%,TGFB1;FLNA;RAN;DHX9;YWHAE;CDH1;KHDRBS1
600,prerank,Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),-0.11888715348429243,-1.1323530691822103,0.28,0.8905069345359298,1.0,30/63,34.66%,BRD4;NOTCH4;PPP1R12A;ANXA2;STXBP2;HMGB2;SMARCA4;BCLAF1;STAT5B;DDX3X;HCFC1;NCBP1;STAT1;VEGFA;STAT3;ARRB1;MED6;PARK7;DEK;SUPT6H;PPP3CA;RPS6KA3;HMGB1;CDC5L;CTNNB1;BMP4;COPS5;ACTR2;NAMPT;TCERG1
601,prerank,Negative Regulation Of Stress-Activated MAPK Cascade (GO:0032873),0.40938405960250557,1.1308557509964932,0.2974910394265233,0.6125462441723931,1.0,4/5,39.92%,PPIA;EZR;GSTP1;QARS1
602,prerank,Protein Targeting (GO:0006605),0.27258913959111475,1.1298839675880747,0.30671506352087113,0.6130172447601334,1.0,10/12,57.39%,PARD3;MAN1A1;AP3D1;NACA;RPL11;APEX1;CDC37;SRP14;SDCBP;SORL1
603,prerank,Double-Strand Break Repair (GO:0006302),0.21294365474861954,1.1284384805505003,0.29743589743589743,0.6144397250480812,1.0,10/20,30.51%,VCP;PSMD14;XRCC5;XRCC6;FEN1;PRPF19;SFPQ;FSCN1;PARP1;PRKDC
604,prerank,Macroautophagy (GO:0016236),-0.3205425948030393,-1.1284308314073956,0.3053763440860215,0.8962187534221218,1.0,6/8,41.20%,PIP4K2A;SRC;VPS36;TSG101;VPS25;CALR
605,prerank,Regulation Of Wound Healing (GO:0061041),0.327657075748679,1.1281790828693374,0.30902111324376197,0.613605574881103,1.0,8/8,67.39%,VTN;F2;SERPINE1;REG3A;VIL1;CD109;MYLK;ITGB1
606,prerank,Cellular Response To BMP Stimulus (GO:0071773),-0.3065847357806661,-1.1279373066783926,0.3257918552036199,0.89226316432363,1.0,8/9,57.69%,USP15;BMP4;PDCD4;INHBE;USP9X;MAPK3;GARS1;DDX5
607,prerank,Peptidyl-Threonine Modification (GO:0018210),-0.30611045828437133,-1.1262254177073054,0.3111587982832618,0.8921167813806393,1.0,9/9,69.61%,CDK1;MAPK1;CSNK2B;GALNT2;CSNK2A1;MYLK2;GPI;ROCK2;PRKDC
608,prerank,Positive Regulation Of Double-Strand Break Repair (GO:2000781),-0.2880658436213992,-1.1257903754314478,0.3218884120171674,0.8882868949872981,1.0,10/10,71.42%,SMARCA4;MMS19;FUS;ACTL6A;ACTR2;UBE2N;RUVBL2;PRKDC;RUVBL1;PARP1
609,prerank,Purine Ribonucleoside Monophosphate Metabolic Process (GO:0009167),-0.3270698766881973,-1.124079926597033,0.2966292134831461,0.8880811379557636,1.0,8/8,67.50%,ADSS2;NT5C2;AK4;PFAS;GART;AMPD2;GMPS;GMPR2
610,prerank,Cellular Response To Salt (GO:1902075),0.25730570487433174,1.1240674746759838,0.3007246376811594,0.6203139590688536,1.0,8/14,33.49%,CLU;HSP90B1;AKR1C3;HNRNPA1;TGM2;CDH1;IQGAP1;ROCK2
611,prerank,tRNA Processing (GO:0008033),-0.31650029359953025,-1.1204765872494622,0.28507795100222716,0.8932264772362674,1.0,8/8,68.56%,RPP30;OSGEP;FAM98B;RTCB;KARS1;DDX1;SSB;SARS1
612,prerank,Positive Regulation Of Peptidyl-Threonine Phosphorylation (GO:0010800),0.3976334787719319,1.1200385189679287,0.30798479087452474,0.6270497517410425,1.0,4/5,41.50%,CEMIP;TGFB1;CALM1;CHI3L1
613,prerank,Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169),-0.19964482103509656,-1.1198005386432508,0.3063457330415755,0.8901560790334049,1.0,12/21,35.77%,PDGFC;MMP2;JAK2;SRC;MAPK14;VEGFA;STAT3;MAPK1;IDE;NAMPT;PTPN11;PDGFA
614,prerank,Regulation Of Metal Ion Transport (GO:0010959),-0.39859320046893315,-1.1197031367701362,0.3185483870967742,0.8854064865355278,1.0,5/5,60.32%,B2M;SRI;YWHAH;ATP1A1;CACNA2D1
615,prerank,Myofibril Assembly (GO:0030239),0.374404878141911,1.1194489132744951,0.32007575757575757,0.6268058775966496,1.0,5/6,47.28%,KRT19;WDR1;TMOD2;TPM1;TTN
616,prerank,Positive Regulation Of Triglyceride Metabolic Process (GO:0090208),0.40211019929660025,1.1193789719602705,0.31663685152057247,0.6255336387947201,1.0,5/5,59.91%,APOC2;LDLR;APOA4;APOA5;SCARB1
617,prerank,Hexose Biosynthetic Process (GO:0019319),0.24985297840787787,1.1188010514173021,0.2926391382405745,0.6253047895612126,1.0,12/15,56.11%,PGK1;ENO1;PGAM1;TPI1;MDH2;PCK2;PGM1;SORD;GPI;FBP1;ENO3;ENO2
618,prerank,Purine-Containing Compound Biosynthetic Process (GO:0072522),0.28582532636644725,1.1181971086256741,0.2867383512544803,0.6251057334063177,1.0,10/11,62.83%,SHMT2;PAICS;MTHFD1;GMPS;SHMT1;ADSL;GART;PFAS;PRPS1;PPAT
619,prerank,Regulation Of Cholesterol Metabolic Process (GO:0090181),0.4143591794471842,1.1178497415958202,0.32897196261682243,0.6243676324912142,1.0,2/5,1.64%,APOE;APOA1
620,prerank,Regulation Of Intracellular Transport (GO:0032386),0.35328638497652576,1.1178314042883302,0.3163841807909605,0.6230134500358888,1.0,7/7,64.82%,DYNC1H1;RAB11B;REEP6;APEX1;MYLK2;NUMA1;SCFD1
621,prerank,Regulation Of Cold-Induced Thermogenesis (GO:0120161),-0.24312408570727911,-1.1173024297965828,0.3333333333333333,0.8872402170055596,1.0,7/14,24.08%,PDGFC;MFAP2;SMARCA4;ACSL1;JAK2;VEGFA;FH
622,prerank,Cellular Response To Lipid (GO:0071396),0.2046614055221108,1.1167637465020608,0.30434782608695654,0.6238232107773913,1.0,12/22,36.29%,HSPA1A;TFPI;H2AZ1;AKR1C3;HSPA8;SERPINE1;GSTP1;RUVBL2;PTK7;AKR1B1;ROCK2;MSN
623,prerank,Cholesterol Metabolic Process (GO:0008203),0.23637446571978823,1.1163977679294816,0.29250457038391225,0.6231059046626375,1.0,8/16,28.52%,APOB;APOE;APOA1;ACLY;G6PD;LCAT;GLB1;TSKU
624,prerank,Response To Lipid (GO:0033993),-0.2547680270818707,-1.115833291911396,0.31712962962962965,0.8864705686812366,1.0,8/13,34.89%,HMGB2;JAK2;STRN3;STAT5B;STAT3;RPS6KA3;CTNNB1;HNRNPA0
625,prerank,Negative Regulation Of Smooth Muscle Cell Proliferation (GO:0048662),0.35836576878869664,1.1158028438958671,0.31868131868131866,0.6228622926763024,1.0,3/7,9.06%,APOE;OGN;ANG
626,prerank,Regulation Of Signal Transduction By P53 Class Mediator (GO:1901796),-0.3217850851438638,-1.1146235034784213,0.3159041394335512,0.8849479221900575,1.0,8/8,68.03%,PAK1IP1;NOP2;RPL17;RPS20;USP7;RPL5;RPL11;PRMT5
627,prerank,Regulation Of Cell Cycle Process (GO:0010564),-0.2630959387875221,-1.1144463396620596,0.288981288981289,0.8805875024057704,1.0,12/12,73.93%,SMARCA4;PRPF40A;CTNNB1;ACTL6A;RPL17;SH3GLB1;CDC42;RCC1;PRMT5;SND1;HMGA2;CALM1
628,prerank,Positive Regulation Of Focal Adhesion Assembly (GO:0051894),-0.3903653454796862,-1.1140449520872298,0.3289760348583878,0.8768811095853932,1.0,3/5,18.94%,MAP4K4;FERMT2;VEGFA
629,prerank,Nucleic Acid Metabolic Process (GO:0090304),-0.3585969938969543,-1.113531576805472,0.2967741935483871,0.8735698109580483,1.0,3/6,12.10%,MMS19;XRN2;RAD50
630,prerank,Regulation Of Immune Response (GO:0050776),0.24927439826465908,1.111665314896946,0.33797909407665505,0.6298882653100925,1.0,5/14,13.03%,C9;C7;FGL1;AMBP;C8B
631,prerank,Positive Regulation Of Blood Vessel Endothelial Cell Migration (GO:0043536),0.3082906648364588,1.111054618198183,0.3068391866913124,0.6296512215025012,1.0,6/9,37.58%,TGFB1;ATP5F1B;THBS1;SRPX2;ATP5F1A;HSPB1
632,prerank,Regulation Of Viral Entry Into Host Cell (GO:0046596),-0.31950772628121393,-1.1099725817840094,0.31446540880503143,0.8788068369898363,1.0,5/8,28.64%,SMPD1;LGALS1;TRIM25;HMGB1;IFITM1
633,prerank,Positive Regulation Of Telomere Maintenance (GO:0032206),-0.29553466509988247,-1.1079827746657862,0.3237113402061856,0.8800807261557018,1.0,9/9,70.66%,RAD50;MAPK1;ACTL6A;MAPK3;MAPK15;HNRNPA2B1;RUVBL2;HNRNPD;RUVBL1
634,prerank,Negative Regulation Of Response To Wounding (GO:1903035),0.36637564029711456,1.1073008980634504,0.32342007434944237,0.6356140137003712,1.0,5/6,47.63%,MDK;SERPINE1;REG3A;PTPRS;CD109
635,prerank,Extracellular Structure Organization (GO:0043062),0.21526831845809374,1.1069863872206815,0.32545454545454544,0.6334892567156243,1.0,8/20,20.86%,MATN3;TGFBI;SPOCK2;ADAMTS13;SMOC1;NPNT;APP;COL1A1
636,prerank,External Encapsulating Structure Organization (GO:0045229),0.21526831845809374,1.1069863872206815,0.32545454545454544,0.6334892567156243,1.0,8/20,20.86%,MATN3;TGFBI;SPOCK2;ADAMTS13;SMOC1;NPNT;APP;COL1A1
637,prerank,Ubiquitin-Dependent Protein Catabolic Process (GO:0006511),-0.11837325896117783,-1.1058674498960672,0.32142857142857145,0.8812842265353826,1.0,56/59,83.23%,CUL4A;PSMD4;RAD23B;NEDD4;UBE2I;UBA6;SKP1;TRIM25;TOLLIP;ARRB1;TSG101;CUL3;NAE1;NPLOC4;CUL1;BAG6;UBE2D2;CTNNB1;UBR4;ARRDC1;RBX1;PSMB6;PSMB5;FBXO22;USP9X;NSFL1C;OS9;PSMD7;COPS3;PCBP2;PSMB4;PSMA5;PSMD1;PSMD2;PSMD6;PSMB1;PSMD3;PSMA2;PSMA3;PSMB3;PSMD8;PSMA4;PSMA1;DDB1;PSMD11;PSMD12;PSMA7;PSMA6;PSMB2;PSMC6;PSMC2;PSMC1;PSMD13;PSMC4;PSMC3;PSMC5
638,prerank,Protein Deubiquitination (GO:0016579),-0.24771089158026496,-1.1038862973825494,0.28809523809523807,0.8819847143414632,1.0,10/13,51.32%,USP15;BABAM2;CDK1;UCHL3;COPS5;USP9X;USP7;OTUB1;USP14;USP5
639,prerank,Regulation Of Cellular Localization (GO:0060341),0.24416060534355138,1.1025124677837006,0.3327239488117002,0.6408937790683182,1.0,10/15,44.30%,GSN;HSP90AB1;HSP90AA1;RACK1;RAB14;PARP1;REEP6;KRT5;RSL1D1;TPR
640,prerank,Positive Regulation Of Synapse Assembly (GO:0051965),0.3663421568457297,1.099638858190955,0.32684824902723736,0.6452928622390974,1.0,4/6,31.74%,CLSTN1;CLSTN3;PTPRD;SRPX2
641,prerank,Regulation Of Apoptotic Process (GO:0042981),0.09742608766363389,1.0986461068637021,0.3375,0.6458606259110491,1.0,44/112,31.79%,ALB;ACTB;CLU;LTF;HSPA1A;NPM1;KRT18;VCP;COMP;HSP90AA1;PPIA;FLNA;HSPA5;HSP90B1;DHRS2;RACK1;THBS1;CTSB;YWHAZ;CTSD;ACTN1;RPS3;PRDX2;PA2G4;AGT;HNRNPK;HSPD1;EMILIN1;HSPA9;RTN4;CFL1;CD74;C1QBP;ANXA5;ARF4;HMGA2;ACTN4;TGM2;RUVBL1;NME1;CTSH;PRKDC;GSTP1;RUVBL2
642,prerank,Long-Chain Fatty Acid Metabolic Process (GO:0001676),-0.3123899001761597,-1.0983681643863101,0.32891832229580575,0.8927131799778845,1.0,8/8,68.97%,ACAA1;ACSL4;ACSL1;ACOT1;GSTM2;GSTA1;EPHX1;GSTP1
643,prerank,Regulation Of Wnt Signaling Pathway (GO:0030111),0.2344195835558845,1.0981720633753178,0.3223570190641248,0.6454097415457292,1.0,8/16,28.52%,GPC3;RACK1;NOTUM;PPP2CA;APP;LRP1;PPP2R1A;TSKU
644,prerank,Ribosome Biogenesis (GO:0042254),0.14539176906183962,1.0980440774799711,0.34983498349834985,0.6442629604202803,1.0,34/45,62.59%,NPM1;RPS9;RPS16;RPS25;RPS13;RPS14;RPS4X;FBL;RPS5;RPS11;RPL11;RPS3A;RPL5;RPS15A;RPS7;RPL14;EIF2S1;RPS8;RPL27;XPO1;NOP56;NOP58;RPS23;RPL7;RPL26;RPS6;RPS17;RPS27;SNU13;RRP9;RPS19;RPL35A;NOLC1;MTREX
645,prerank,Intracellular Calcium Ion Homeostasis (GO:0006874),0.32472108044627124,1.0974121960747052,0.32922535211267606,0.6441682294597476,1.0,8/8,67.68%,F2;YWHAE;ANXA6;RGN;STC2;CDH5;CALR;PRKACA
646,prerank,Regulation Of Rho Protein Signal Transduction (GO:0035023),0.32776964815246123,1.0966999910024895,0.34622823984526113,0.6441796461436752,1.0,4/8,20.05%,APOE;APOA1;APOC3;RAC1
647,prerank,Cartilage Development (GO:0051216),0.3185570985595204,1.096577953672963,0.34057971014492755,0.6429952896868524,1.0,6/8,44.65%,TGFB1;OGN;COL2A1;HMGA2;CHI3L1;HYAL1
648,prerank,Base-Excision Repair (GO:0006284),0.35846305595239714,1.095964359436677,0.30377358490566037,0.6428212080468746,1.0,5/6,48.33%,FEN1;HMGA2;HUWE1;APEX1;RPA1
649,prerank,Phagocytosis (GO:0006909),0.2691689597936521,1.0958092644058801,0.33754512635379064,0.6417249558037602,1.0,7/12,32.96%,GSN;MYH9;CORO1C;LRP1;CORO1A;TGM2;LDLR
650,prerank,Nuclear Export (GO:0051168),0.2677032390484375,1.0953656005319052,0.3448275862068966,0.6413047950828519,1.0,6/12,24.84%,TGFB1;RAN;DDX39B;NUTF2;CSE1L;HNRNPA1
651,prerank,Regulation Of Mononuclear Cell Migration (GO:0071675),0.3626182770797205,1.0919787120257165,0.3182711198428291,0.6466416876621619,1.0,3/6,15.25%,THBS1;MDK;RARRES2
652,prerank,Wound Healing (GO:0042060),-0.22088318962345788,-1.0919698275476502,0.33715596330275227,0.9060361356613202,1.0,15/16,71.60%,SMPD1;MACF1;KRT6A;ITGB3;PPP3CA;DSP;COL3A1;PDGFA;CORO1B;SCARB1;PRCP;PLEC;TPM1;ANXA6;TSKU
653,prerank,Protein Localization To Cytoplasmic Stress Granule (GO:1903608),0.39424741646782724,1.091668696777469,0.3285198555956679,0.6458250984153063,1.0,4/5,41.67%,DHX9;YBX1;SSB;DDX1
654,prerank,Cell-Cell Adhesion Via Plasma-Membrane Adhesion Molecules (GO:0098742),-0.19698606022125326,-1.09164531278807,0.3357142857142857,0.9021640234245284,1.0,20/21,75.57%,PCDHB2;CNTN4;HMCN2;PTPRM;ITGB1;CDH6;ICAM1;PCDHGC3;CDH5;SDK1;FAT4;VCAM1;HMCN1;PTPRS;PTK7;PTPRD;CDH11;CDH1;REG3A;PLXNB2
655,prerank,"Negative Regulation Of Gene Expression, Epigenetic (GO:0045814)",0.28889747235395574,1.0908041911597732,0.333955223880597,0.6461576262376403,1.0,7/10,42.72%,MACROH2A1;H1-0;LMNA;MACROH2A2;HMGA2;LMNB2;LMNB1
656,prerank,Recombinational Repair (GO:0000725),0.2766021189617497,1.089581393576054,0.3339317773788151,0.6472038230899043,1.0,6/11,28.35%,PSMD14;XRCC5;XRCC6;FEN1;SFPQ;FSCN1
657,prerank,Regulation Of Protein Transport (GO:0051223),-0.39299303189149537,-1.0889445945245848,0.3405511811023622,0.9050507233946857,1.0,4/5,39.74%,DNAJA1;GAPVD1;SCFD1;P3H1
658,prerank,post-Golgi Vesicle-Mediated Transport (GO:0006892),-0.27058823529411763,-1.0886393913863504,0.3370288248337029,0.9011691585581101,1.0,11/11,73.17%,AP1G2;GOPC;GBF1;MON2;ARL3;SCFD1;SORL1;DNM2;AP2A1;RAB14;AP3D1
659,prerank,Negative Regulation Of Growth (GO:0045926),0.22683514207190025,1.0885757258066457,0.3118466898954704,0.6478060521378672,1.0,5/16,10.64%,HSPA1A;ENO1;TGFB1;RACK1;PPP2CA
660,prerank,"RNA Splicing, Via Transesterification Reactions With Bulged Adenosine As Nucleophile (GO:0000377)",-0.1192493946731235,-1.0884082745570027,0.33159268929503916,0.8971555071188664,1.0,59/59,88.54%,SRSF10;SNRNP70;PRPF8;DDX23;CTNNBL1;SART3;NCBP1;HNRNPM;HNRNPA3;PRPF40A;SNRNP40;LSM6;CDC5L;SF3B2;SF3A3;EFTUD2;TRA2B;SNRPB;DHX15;SF3A1;MTREX;SNRPF;SNRPE;U2AF2;SNRPA;SNU13;HNRNPH1;SMU1;SNRPA1;RBMX;SNRPGP15;LSM3;PABPC1;HNRNPR;SNRNP200;MAGOH;RALY;HNRNPF;DDX5;HNRNPU;SRSF4;SF3B3;HNRNPA2B1;SRSF2;SRSF7;SNRPD2;EIF4A3;SF3B1;HNRNPA1;SNRPD1;HNRNPK;PPIE;HNRNPC;PRPF19;HSPA8;SRSF3;SRSF1;SNRPD3;DDX39B
661,prerank,Positive Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090100),0.2521586331237181,1.0876767338732314,0.37213403880070545,0.6482554200852063,1.0,4/13,7.60%,GDF15;HSP90AB1;TGFB1;THBS1
662,prerank,Negative Regulation Of Cell Growth (GO:0030308),0.2255130175162238,1.0875100447862063,0.3403141361256545,0.6472695255288851,1.0,5/16,10.64%,HSPA1A;ENO1;TGFB1;RACK1;PPP2CA
663,prerank,RNA 3'-End Processing (GO:0031123),-0.3589442815249267,-1.0867366270211152,0.34394904458598724,0.896987962977486,1.0,6/6,64.29%,PNPT1;NCBP1;NUDT21;CPSF6;CSTF3;SSB
664,prerank,RNA Transport (GO:0050658),0.2816620544277864,1.0865538811314368,0.35195530726256985,0.6477156710974513,1.0,6/10,33.43%,DDX39B;KPNB1;HNRNPA1;TST;YBX1;HNRNPA2B1
665,prerank,Secondary Alcohol Metabolic Process (GO:1902652),0.2375364028879604,1.0856398866886274,0.3368421052631579,0.6482039930832991,1.0,11/15,51.32%,APOB;APOE;APOA1;IDH1;LCAT;GLB1;TSKU;APOA4;IDH2;ANGPTL3;APOA2
666,prerank,Negative Regulation Of Ubiquitin-Protein Transferase Activity (GO:0051444),-0.33861502347417843,-1.084624454510794,0.367170626349892,0.8982613519992678,1.0,7/7,66.34%,PARK7;BAG2;RPL17;BUB3;RPS7;RPL5;RPL11
667,prerank,Negative Regulation Of Proteasomal Protein Catabolic Process (GO:1901799),-0.2935784852880548,-1.084601635308411,0.33760683760683763,0.8937611530753994,1.0,7/9,47.52%,CCAR2;PARK7;BAG6;EIF3H;USP9X;SDCBP;USP7
668,prerank,Negative Regulation Of Protein Localization (GO:1903828),0.3120436419920096,1.0842528515649215,0.329608938547486,0.6495965970991472,1.0,5/8,33.49%,VCP;MACROH2A1;YWHAZ;GDI2;ROCK2
669,prerank,Endothelial Cell Migration (GO:0043542),-0.30573929264904165,-1.0836538015772474,0.3616557734204793,0.8916494141665112,1.0,6/8,43.48%,LOXL2;STAT1;VEGFA;DPP4;CORO1B;CDH5
670,prerank,Protein Alkylation (GO:0008213),-0.320535546189445,-1.0826373844439594,0.35394456289978676,0.889935889132646,1.0,5/7,38.34%,PCMT1;GSPT1;FAM98B;SNRPB;PRMT1
671,prerank,Nucleosome Organization (GO:0034728),0.241311161314972,1.0822532924792811,0.33043478260869563,0.6520218404557733,1.0,8/15,31.50%,H2BC11;H3-3A;NPM1;MACROH2A1;HMGA1;RBBP4;SSRP1;NAP1L1
672,prerank,Establishment Of Mitotic Spindle Localization (GO:0040001),0.3274647887323944,1.0821152645463321,0.34689922480620156,0.6509532500327977,1.0,7/7,67.39%,KPNB1;PAFAH1B1;DCTN1;MAPRE1;NSFL1C;NUMA1;ITGB1
673,prerank,Negative Regulation Of Catabolic Process (GO:0009895),0.23114928988269834,1.079926067982781,0.34774774774774775,0.6539772049475551,1.0,11/15,51.32%,FLNA;APOC3;CST3;RPL11;RPL5;SF3B3;RPS7;APOC1;NQO1;FBP1;APOA2
674,prerank,Glycogen Metabolic Process (GO:0005977),0.40152403282532234,1.0789959929974233,0.3675373134328358,0.6545199562619372,1.0,5/5,59.96%,PYGB;UGP2;PYGL;GAA;GYS1
675,prerank,Positive Regulation Of Microtubule Polymerization Or Depolymerization (GO:0031112),0.335093896713615,1.0786034999612892,0.3521400778210117,0.6539411669706839,1.0,7/7,66.63%,RPS3;RAC1;DCTN1;MAPRE1;SLAIN1;NUMA1;DRG1
676,prerank,Positive Regulation Of Angiogenesis (GO:0045766),0.19965522340573005,1.077561562808223,0.33154121863799285,0.6546192331263593,1.0,15/22,49.74%,PKM;THBS1;CNTN1;MDK;SERPINE1;EMILIN1;HMGA2;CTSH;HSPB1;ECM1;CHI3L1;GARS1;HYAL1;ANGPTL4;ANGPTL3
677,prerank,Very-Low-Density Lipoprotein Particle Remodeling (GO:0034372),0.3989324956578575,1.0765690205389966,0.3492647058823529,0.6552968813628782,1.0,4/5,41.44%,APOE;APOC2;LCAT;APOA5
678,prerank,Negative Regulation Of ERK1 And ERK2 Cascade (GO:0070373),0.37146689715439457,1.0760065427030876,0.35645472061657035,0.6550636230329748,1.0,4/6,31.15%,FBLN1;EZR;EMILIN1;GSTP1
679,prerank,Response To Molecule Of Bacterial Origin (GO:0002237),-0.3431724339327429,-1.0756733037835438,0.3609341825902335,0.9048899252881715,1.0,5/6,48.10%,HMGB2;JAK2;RPS6KA3;HNRNPA0;PRDX3
680,prerank,Modulation Of Chemical Synaptic Transmission (GO:0050804),0.29207051724596067,1.0750385389625698,0.3770491803278688,0.6557375374803245,1.0,7/10,42.31%,RELN;CLSTN1;APP;CLSTN3;NPTX1;CNTNAP4;BAIAP3
681,prerank,Regulation Of Spindle Assembly (GO:0090169),0.3350938967136151,1.0746159512765094,0.3493282149712092,0.65521485181184,1.0,7/7,66.63%,HSPA1A;DYNC1H1;PDCD6IP;HNRNPU;TPR;NUMA1;DRG1
682,prerank,Cellular Response To Insulin Stimulus (GO:0032869),0.24867526689731387,1.074432731451091,0.33849129593810445,0.6542526457194181,1.0,7/13,30.51%,PKM;GRB7;IGF2;RARRES2;PCK2;PARP1;PRKDC
683,prerank,Positive Regulation Of Fibroblast Proliferation (GO:0048146),0.3884424297310123,1.0743339459944734,0.3521400778210117,0.6530799790325926,1.0,3/5,23.79%,FN1;DHX9;CD74
684,prerank,Epigenetic Regulation Of Gene Expression (GO:0040029),0.3876118062521692,1.0741249483367852,0.3346456692913386,0.652099971381908,1.0,3/5,23.73%,MACROH2A1;IGF2;MACROH2A2
685,prerank,Aminoglycan Biosynthetic Process (GO:0006023),0.3314035943918334,1.0739152609557547,0.3691148775894539,0.6511761889876112,1.0,4/7,25.72%,EXT1;UGDH;B4GAT1;EXT2
686,prerank,Positive Regulation Of Cellular Metabolic Process (GO:0031325),0.27004504894621734,1.0738164965854953,0.3313840155945419,0.6500028281821265,1.0,7/12,33.72%,F2;THBS1;AKR1C3;DCXR;AGT;SORD;CBR1
687,prerank,Cell Junction Assembly (GO:0034329),0.25459956491091523,1.0737792024715067,0.36278195488721804,0.6487232030804106,1.0,7/13,30.45%,FN1;SPOCK2;TLN1;CAPZA1;FSCN1;CDH1;CDH11
688,prerank,Negative Regulation Of Mitochondrion Organization (GO:0010823),0.3955322273398424,1.0732693740278254,0.3777372262773723,0.6483213448424681,1.0,2/5,2.81%,CLU;HSPA1A
689,prerank,Positive Regulation Of Cell Junction Assembly (GO:1901890),0.2455888019795463,1.0725756583728814,0.34767025089605735,0.6482811973525413,1.0,7/13,31.74%,CLSTN1;AGT;RAC1;CLSTN3;LIMS1;PTPRD;SRPX2
690,prerank,Negative Regulation Of Telomere Maintenance Via Telomere Lengthening (GO:1904357),0.3936870811794435,1.0717617163223374,0.3596153846153846,0.6486334360240138,1.0,4/5,41.79%,HNRNPC;HNRNPA1;PARP1;HNRNPU
691,prerank,Semaphorin-Plexin Signaling Pathway Involved In Neuron Projection Guidance (GO:1902285),-0.36897153018720574,-1.0708208274827573,0.35555555555555557,0.913732702708662,1.0,4/5,42.08%,NELL2;PLXNA1;SEMA3F;SEMA3A
692,prerank,Unsaturated Fatty Acid Metabolic Process (GO:0033559),0.3883053932525199,1.0707075655594713,0.3738656987295826,0.6495374005902391,1.0,4/5,42.90%,GSTP1;EPHX1;GSTA1;GSTM2
693,prerank,Endosome Organization (GO:0007032),-0.37967792320595783,-1.0699808232874513,0.3576017130620985,0.9114506359286936,1.0,4/5,40.97%,ATP6AP2;ATP6AP1;EEA1;ATP6V1A
694,prerank,Intracellular Protein Transport (GO:0006886),-0.10297064321267614,-1.0670091372485984,0.3333333333333333,0.9151219633827757,1.0,68/74,81.65%,RAB6D;LTBP2;ARFIP1;IPO4;IPO5;ASPSCR1;STXBP2;NUP93;RAB3GAP2;ATP6AP1;TNPO3;NAPA;SNX6;VPS36;STAT3;TSG101;COPZ1;XPO7;SEC13;ARF6;SNX1;SAR1B;VPS25;SCFD1;CTSA;RAB21;VPS29;RAB5B;TNPO1;CALR;RAB1A;SORL1;RAB6A;SAR1A;YWHAH;XPO1;RAB5A;AP3B1;RAB1B;TPR;IPO7;CDC37;SEC31A;ARCN1;EHD1;COPB2;AP2A1;RAB5C;APEX1;RAB7A;RAB18;RPL11;NSF;SIL1;RAB14;ARF5;AP3D1;ARF4;CSE1L;CD74;APLP2;KPNB1;HSPA9;VPS35;NUTF2;FAM53C;USO1;SEPTIN9
695,prerank,Negative Regulation Of RNA Splicing (GO:0033119),0.3087403298859231,1.0667055403195824,0.372972972972973,0.65620600443533,1.0,7/8,57.69%,RPS13;RPS26;SRSF7;SRSF4;PTBP1;RBMX;U2AF2
696,prerank,Response To Tumor Necrosis Factor (GO:0034612),0.29752099987977465,1.066518837752749,0.37300177619893427,0.6552445031216199,1.0,7/9,49.50%,DHX9;RPS3;NPNT;CCL20;CHI3L1;HYAL1;ADAM10
697,prerank,Positive Regulation Of Cytoskeleton Organization (GO:0051495),0.2868390102618781,1.0661919863763685,0.3450834879406308,0.6545571240097704,1.0,7/10,42.67%,GSN;PFN1;DYNC1H1;PLEK;PFN2;VIL1;VASP
698,prerank,Regulation Of Cellular Metabolic Process (GO:0031323),0.33447784882785775,1.0659135151627477,0.3712574850299401,0.6537771855064797,1.0,5/7,39.63%,ANGPTL8;PGAM1;EIF6;ARF4;RSL1D1
699,prerank,Glial Cell Differentiation (GO:0010001),-0.34512770671337784,-1.0648907734085775,0.34623655913978496,0.9163717135555722,1.0,4/6,29.92%,ADGRG6;HAPLN1;STAT3;GPC1
700,prerank,Negative Regulation Of Inflammatory Response (GO:0050728),0.2490537236944112,1.0647529439747097,0.35294117647058826,0.6548311303923418,1.0,7/13,31.15%,APOE;APOA1;C1QTNF3;MDK;VPS35;REG3A;GSTP1
701,prerank,Positive Regulation Of Protein Dephosphorylation (GO:0035307),0.2907237842909308,1.0630690895713726,0.3611111111111111,0.6566936595107956,1.0,3/9,6.20%,HSP90AB1;PPIA;TGFB1
702,prerank,Negative Regulation Of Neuron Apoptotic Process (GO:0043524),0.29455907588708974,1.063043718115748,0.38391224862888484,0.6554172491874969,1.0,4/9,17.59%,APOE;CLU;MDK;CRLF1
703,prerank,Regulation Of Cell-Cell Adhesion Mediated By Cadherin (GO:2000047),-0.37911501109539714,-1.0615884576379433,0.36673773987206826,0.9213586446665114,1.0,3/5,18.94%,FLOT1;NOTCH4;VEGFA
704,prerank,Monocarboxylic Acid Metabolic Process (GO:0032787),-0.21512682260140895,-1.061505491678813,0.3638392857142857,0.9170739159693125,1.0,14/17,59.91%,VNN1;ACAA1;ACSL4;PCCA;GRHPR;PCCB;ACOT1;HSD17B10;GGT1;ME1;ME2;ANGPTL3;ABAT;ACADSB
705,prerank,Negative Regulation Of Fatty Acid Metabolic Process (GO:0045922),0.3807516746560011,1.061392129843573,0.368705035971223,0.6572850118581782,1.0,4/5,42.78%,APOC3;APLP2;ACADVL;APOC1
706,prerank,Sterol Metabolic Process (GO:0016125),0.25669683113550046,1.0607452308717231,0.3511586452762923,0.6571933603615352,1.0,3/12,1.64%,APOB;APOE;APOA1
707,prerank,Signal Transduction In Response To DNA Damage (GO:0042770),-0.34459203164115493,-1.0598294617129498,0.3672566371681416,0.9172249994487547,1.0,5/6,48.16%,MAPK14;NDRG1;CDC5L;UFL1;MAPK3
708,prerank,Regulation Of Macrophage Activation (GO:0043030),0.381477364094575,1.0591136374508727,0.35943775100401604,0.6591466512039279,1.0,3/5,23.79%,THBS1;HSPD1;CD74
709,prerank,Peptidyl-Threonine Phosphorylation (GO:0018107),-0.3059307105108632,-1.0583404125083478,0.3795309168443497,0.9169984524500333,1.0,8/8,69.61%,CDK1;MAPK1;CSNK2B;CSNK2A1;MYLK2;GPI;ROCK2;PRKDC
710,prerank,Positive Regulation Of Macromolecule Metabolic Process (GO:0010604),0.1351248615687481,1.058184326773546,0.37919463087248323,0.6596684114809808,1.0,23/48,36.29%,FN1;CLU;GSN;HSPA1A;TGFB1;CNTN1;RPS3;EZR;APP;AGT;TNC;EMILIN1;VPS35;CD74;HMGA2;LIMS1;CTSH;NSF;AKR1B1;ROCK2;RPL11;RPL5;MSN
711,prerank,Nervous System Development (GO:0007399),-0.12782082791821214,-1.0574772870129963,0.392,0.9150894537921924,1.0,27/49,40.85%,CLN5;MARCKS;PCDHB2;PDGFC;GSS;GMFB;SMPD1;ADGRG6;NRXN1;PPP2R5D;CNTN4;IGF2BP2;PPT1;VEGFA;STAT3;IGF2BP1;LGI1;VLDLR;RPS6KA3;NCKAP1;IGSF8;SH3GL1;ACTL6A;TPP1;PAFAH1B3;PCSK9;ELP3
712,prerank,Establishment Of Epithelial Cell Polarity (GO:0090162),0.3816274445864875,1.055146200751853,0.38202247191011235,0.6642519138215266,1.0,4/5,43.31%,PARD3;EZR;MSN;CDC42
713,prerank,Negative Regulation Of Viral Process (GO:0048525),-0.3560880583179462,-1.0543619233197459,0.39111111111111113,0.9194975017772105,1.0,4/6,28.64%,SRPK1;STAT1;ILF3;IFITM1
714,prerank,Adherens Junction Organization (GO:0034332),-0.2896592244418331,-1.0543555354631708,0.37748344370860926,0.9151305296470246,1.0,9/9,71.24%,FERMT2;CSK;TBCD;CTNNB1;CDH6;CDH5;VCL;CDH11;CDH1
715,prerank,Negative Regulation Of Protein Modification Process (GO:0031400),0.23701761857338585,1.0540678367371417,0.37545787545787546,0.6651885664613931,1.0,8/14,35.48%,FBLN1;PPIA;TGFB1;CORO1C;G6PD;PRKDC;SORD;YWHAB
716,prerank,Positive Regulation Of Peptidyl-Serine Phosphorylation (GO:0033138),0.29118215643664286,1.051750610402197,0.3805309734513274,0.6685875689288712,1.0,3/9,6.20%,HSP90AB1;HSP90AA1;TGFB1
717,prerank,DNA Damage Response (GO:0006974),-0.14049202771318742,-1.0517289192068775,0.348780487804878,0.9179166500024116,1.0,15/38,24.20%,ARMT1;CUL4A;MMS19;UPF1;BCLAF1;BABAM2;RAD50;SMC1A;RRM2B;MAPK14;CDK1;NAE1;SAMHD1;PARK7;CUL4B
718,prerank,Fructose 6-Phosphate Metabolic Process (GO:0006002),-0.3460410557184751,-1.0511690353882368,0.37254901960784315,0.9150560496160035,1.0,6/6,65.58%,PFKP;KHSRP;HK2;HK1;PFKL;GFPT1
719,prerank,Ganglion Development (GO:0061548),-0.3698989215634432,-1.0507287008206103,0.3684210526315789,0.9119671688774229,1.0,4/5,42.08%,NELL2;SEMA3F;CTNNB1;SEMA3A
720,prerank,Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071900),0.25347959136044224,1.050585482200838,0.3872832369942196,0.6695438445514968,1.0,6/12,26.77%,ACTB;LTF;MACROH2A1;PPP2CA;CALM1;HMGA2
721,prerank,Regulation Of Secretion By Cell (GO:1903530),-0.31514084507042256,-1.0500629674132753,0.37339055793991416,0.9095325510153645,1.0,7/7,68.67%,ARFIP1;RAB8B;RAB21;P3H1;SEPTIN2;APEX1;NSF
722,prerank,Regulation Of Cytoplasmic Translation (GO:2000765),0.32884260659431663,1.0493650408437505,0.3777372262773723,0.6693538607494603,1.0,6/7,53.71%,PKM;DHX9;HNRNPD;YBX1;HNRNPU;PABPC1
723,prerank,Positive Regulation Of Cytoplasmic Translation (GO:2000767),0.32884260659431663,1.0493650408437505,0.3777372262773723,0.6693538607494603,1.0,6/7,53.71%,PKM;DHX9;HNRNPD;YBX1;HNRNPU;PABPC1
724,prerank,Regulation Of Response To External Stimulus (GO:0032101),-0.20262727892455595,-1.0490148231840435,0.3695150115473441,0.9081618301023031,1.0,11/18,39.16%,BRD4;SHPK;JAK2;IGF2BP1;SAMHD1;PARK7;SEMA7A;GGT1;GRN;NMT1;UFL1
725,prerank,Proton Transmembrane Transport (GO:1902600),-0.3149007923925127,-1.0490122820830567,0.37259100642398285,0.9039573771851627,1.0,6/7,53.30%,ATP6AP2;ATP6AP1;ATP5PO;ATP6V1B2;ATP6V1A;ATP1A1
726,prerank,Negative Regulation Of Lipid Biosynthetic Process (GO:0051055),0.38176172082378446,1.0486826917362584,0.3862332695984704,0.6693600549744306,1.0,4/5,42.78%,AKR1C3;APOC3;ACADVL;APOC1
727,prerank,Regulation Of Transcription Of Nucleolar Large rRNA By RNA Polymerase I (GO:1901836),0.3831280803989705,1.0483149481920018,0.40076335877862596,0.6687230094404039,1.0,3/5,23.73%,MACROH2A1;NCL;MACROH2A2
728,prerank,Positive Regulation Of Wnt Signaling Pathway (GO:0030177),0.24377158290147596,1.0478013635247658,0.36576576576576575,0.6684691195588709,1.0,7/13,31.91%,GPC3;VCP;TGFB1;COL1A1;ILK;RUVBL1;PTK7
729,prerank,Regulation Of RNA Splicing (GO:0043484),0.18480287426132247,1.0460995669882236,0.37168141592920356,0.670623948753918,1.0,10/24,25.19%,HSPA1A;METTL16;SRSF1;PRDX6;SRSF3;RPS13;AHNAK2;HNRNPK;HNRNPA1;RPS26
730,prerank,Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903050),0.32453051643192476,1.0459289967560945,0.38738738738738737,0.6696942287860701,1.0,7/7,67.68%,PSMD14;PSME2;USP14;CTSC;PSME3;PSME1;PRKACA
731,prerank,Cellular Response To Calcium Ion (GO:0071277),-0.28675523325035307,-1.0450668629800077,0.3842696629213483,0.9103885410877957,1.0,4/9,14.03%,SMPD1;ADD1;CPNE1;PRKAA1
732,prerank,Regulation Of Cytokine Production (GO:0001817),0.27682926371113664,1.0446048088286166,0.3956442831215971,0.6709649651458662,1.0,3/10,5.08%,GAPDH;LTF;C1QTNF3
733,prerank,Neural Crest Cell Development (GO:0014032),-0.2815049934251499,-1.0431150803378249,0.38562091503267976,0.9117302826910378,1.0,7/9,48.98%,SEMA7A;SEMA3F;NOLC1;SEMA3C;SEMA3A;SEMA4B;TCOF1
734,prerank,Mitochondrion Organization (GO:0007005),-0.22122022273538217,-1.0423196408735578,0.4018058690744921,0.9096338153065894,1.0,9/15,37.00%,PNPT1;DNAJA3;SFI1;AIFM1;TIMM13;PARK7;HK2;HSD17B10;COX7A2
735,prerank,Negative Regulation Of Cell Projection Organization (GO:0031345),0.3233568075117372,1.0423176206609355,0.3996282527881041,0.6741752964737385,1.0,7/7,67.80%,APOE;DPYSL5;TSKU;PTPRS;YWHAH;SEMA3A;FKBP4
736,prerank,Branching Morphogenesis Of An Epithelial Tube (GO:0048754),-0.3519737351318821,-1.0422301715051758,0.39072847682119205,0.9057461384905843,1.0,4/6,30.27%,NOTCH4;VEGFA;CTNNB1;BMP4
737,prerank,Positive Regulation Of Cation Channel Activity (GO:2001259),0.3799927517034153,1.0420881564434186,0.3713163064833006,0.6720804977056174,1.0,4/5,42.90%,GSTO1;CALM1;APEX1;GSTM2
738,prerank,Positive Regulation Of Calcium Ion Transmembrane Transporter Activity (GO:1901021),0.3799927517034153,1.0420881564434186,0.3713163064833006,0.6720804977056174,1.0,4/5,42.90%,GSTO1;CALM1;APEX1;GSTM2
739,prerank,"Regulation Of mRNA Splicing, Via Spliceosome (GO:0048024)",0.1769379117371995,1.0410215771541615,0.4050420168067227,0.6728946573221247,1.0,23/27,68.56%,NCL;METTL16;PRDX6;SRSF3;HNRNPK;HNRNPA1;SRSF7;PRMT5;KHDRBS1;WDR77;SRSF4;HNRNPU;DDX5;DDX17;MAGOH;PTBP1;RBMX;SMU1;U2AF2;HNRNPL;RBM25;HNRNPA0;TRA2B
740,prerank,Establishment Of Apical/Basal Cell Polarity (GO:0035089),0.3788845904405006,1.040713069752932,0.39571150097465885,0.672179769477453,1.0,4/5,43.31%,EZR;FSCN1;MSN;CDC42
741,prerank,Telomere Maintenance Via Telomere Lengthening (GO:0010833),0.36956207789513906,1.0405630542539115,0.3793103448275862,0.6687062980678066,1.0,2/5,5.03%,HSP90AB1;HSP90AA1
742,prerank,Telomere Maintenance Via Telomerase (GO:0007004),0.36956207789513906,1.0405630542539115,0.3793103448275862,0.6687062980678066,1.0,2/5,5.03%,HSP90AB1;HSP90AA1
743,prerank,RNA-templated DNA Biosynthetic Process (GO:0006278),0.36956207789513906,1.0405630542539115,0.3793103448275862,0.6687062980678066,1.0,2/5,5.03%,HSP90AB1;HSP90AA1
744,prerank,Positive Regulation Of Immune System Process (GO:0002684),0.3270505416217069,1.0404740867301783,0.3973634651600753,0.6675646324847829,1.0,3/7,13.03%,C9;C7;C8B
745,prerank,Response To Metal Ion (GO:0010038),0.2092505063347243,1.039669923471442,0.3817204301075269,0.6679189535161322,1.0,5/17,10.64%,FGB;FGA;THBS1;FGG;PPP2CA
746,prerank,Regulation Of Protein Import Into Nucleus (GO:0042306),0.30739205589260266,1.0384964691959786,0.3897058823529412,0.6688529844218025,1.0,3/8,8.65%,TGFB1;FLNA;RAN
747,prerank,Membrane Protein Proteolysis (GO:0033619),0.34780058651026413,1.038026153724826,0.3736059479553903,0.6684966358611496,1.0,6/6,65.34%,TGFB1;MYH9;CTSH;DAG1;RBMX;MBTPS1
748,prerank,7-Methylguanosine Cap Hypermethylation (GO:0036261),0.37749120750293086,1.038009787697557,0.3875685557586837,0.6659958095204724,1.0,5/5,62.36%,SNRPD3;SNRPD1;SNRPD2;SNRPE;SNRPF
749,prerank,RNA Capping (GO:0036260),0.37749120750293086,1.038009787697557,0.3875685557586837,0.6659958095204724,1.0,5/5,62.36%,SNRPD3;SNRPD1;SNRPD2;SNRPE;SNRPF
750,prerank,Xenobiotic Catabolic Process (GO:0042178),0.3787297745925409,1.0359681622688184,0.4007707129094412,0.6688218453653221,1.0,4/5,42.90%,GSTO1;CRYZ;GSTM3;GSTM2
751,prerank,Modulation By Host Of Symbiont Process (GO:0051851),0.30873765262496133,1.0359409991167223,0.3996023856858847,0.6676341670765205,1.0,6/8,45.35%,FASN;HMGA2;ROCK2;HDAC1;CDC42;RAB5A
752,prerank,Regulation Of Cation Channel Activity (GO:2001257),-0.37286325279991045,-1.035869223237731,0.38377192982456143,0.918615156819572,1.0,4/5,42.14%,FKBP1A;PRKACA;ITGB1;AHNAK
753,prerank,Glutamine Family Amino Acid Biosynthetic Process (GO:0009084),0.3715538621226009,1.0358426544352521,0.383399209486166,0.6665463363030968,1.0,3/5,24.78%,GLUD1;ASS1;PYCR1
754,prerank,Positive Regulation Of Protein Modification Process (GO:0031401),0.1575591230993471,1.0356275477735288,0.3944636678200692,0.6657157579681723,1.0,7/33,7.42%,C3;RELN;F2;HSP90AA1;PPIA;TGFB1;RACK1
755,prerank,Cellular Response To Oxidative Stress (GO:0034599),0.1974390621832316,1.0332105953326456,0.3827392120075047,0.6694844906093961,1.0,15/20,56.93%,HSPA1A;PPIA;DHRS2;RPS3;PRDX2;G6PD;PYCR1;PARP1;TPM1;NQO1;EIF2S1;GSR;MAPK3;PRDX3;PYCR2
756,prerank,Regulation Of Intracellular Signal Transduction (GO:1902531),-0.17733220267115035,-1.0321213467852226,0.38516746411483255,0.9247075696669822,1.0,19/22,68.03%,PAK1IP1;RRAS;MAP4K4;ATP6AP2;OBSCN;CPNE1;ARHGAP1;VEGFA;PDE2A;NOP2;UFL1;USP7;UBE2N;RGN;HSPB1;UBE2V1;RPL5;RPL11;PRMT5
757,prerank,Regulation Of Defense Response (GO:0031347),-0.21352235412663856,-1.0319361522652326,0.41013824884792627,0.9210482972988384,1.0,10/16,39.16%,BRD4;SHPK;JAK2;IGF2BP1;SAMHD1;PARK7;SEMA7A;GGT1;GRN;UFL1
758,prerank,Positive Regulation Of Cellular Catabolic Process (GO:0031331),-0.2213505984390044,-1.0301787580496855,0.376940133037694,0.9217307621563098,1.0,9/14,40.62%,MOV10;UPF1;PNPT1;PRKAA1;KHSRP;CDK16;HMGB1;UFL1;SH3GLB1
759,prerank,Gluconeogenesis (GO:0006094),0.23592702671176885,1.025515746556864,0.4032846715328467,0.6833608372915327,1.0,11/14,56.11%,PGK1;ENO1;PGAM1;TPI1;MDH2;PCK2;PGM1;GPI;FBP1;ENO3;ENO2
760,prerank,Lipoprotein Catabolic Process (GO:0042159),0.32048057845866884,1.0254796152035845,0.41519434628975266,0.682167902122097,1.0,3/7,13.38%,APOE;NOTUM;CTSD
761,prerank,Regulation Of MAPK Cascade (GO:0043408),0.18549698738699372,1.0252660443301267,0.3912248628884826,0.6812972801042543,1.0,12/23,35.77%,FN1;GDF15;PPIA;PEBP1;IGF2;YWHAZ;CD74;PPP2R1A;IQGAP1;GSTP1;ROCK2;ETFA
762,prerank,Regulation Of Type II Interferon Production (GO:0032649),0.37285592882006513,1.0247339802338826,0.40535372848948376,0.6811823773180826,1.0,3/5,24.43%,HLA-A;HSPD1;C1QBP
763,prerank,Ras Protein Signal Transduction (GO:0007265),-0.21782369872331087,-1.0244430077758544,0.40987124463519314,0.9332905636947368,1.0,8/15,30.16%,RRAS;ARHGDIA;G3BP1;ARHGAP1;PARK7;GDI1;NCKAP1;NRAS
764,prerank,Positive Regulation Of DNA Repair (GO:0045739),0.23824563959931863,1.0244268836621557,0.4301270417422868,0.6805093933915551,1.0,7/13,31.79%,ACTB;DHX9;RPS3;PCNA;PARP1;RUVBL1;RUVBL2
765,prerank,Negative Regulation Of Programmed Cell Death (GO:0043069),0.1135232934219231,1.0238433413097683,0.39872408293460926,0.6803814203178986,1.0,27/67,31.15%,ALB;LTF;HSPA1A;NPM1;KRT18;COMP;FLNA;HSPA5;HSP90B1;DHRS2;THBS1;YWHAZ;PRDX2;PSMC5;PA2G4;HNRNPK;HSPD1;HSPA9;CFL1;CD74;ANXA5;ARF4;HMGA2;CTSH;XPNPEP1;PRKDC;GSTP1
766,prerank,Skin Development (GO:0043588),0.255294117647059,1.0228095259825645,0.4198895027624309,0.6810598064843222,1.0,11/11,74.63%,KRT9;AKR1C3;KRT10;COL1A1;COL1A2;CLIC4;COL5A1;PDGFA;COL3A1;DSP;PPP3CA
767,prerank,Positive Regulation Of Neuron Projection Development (GO:0010976),-0.23925153224448906,-1.0224880589130938,0.4038876889848812,0.9346701025907304,1.0,6/12,23.73%,CAPRIN1;TWF1;SCARB2;TUBB2B;TWF2;VLDLR
768,prerank,Positive Regulation Of Tumor Necrosis Factor Production (GO:0032760),0.28267925282738326,1.0221639080646772,0.41316270566727603,0.6798070274669601,1.0,4/9,18.29%,CLU;THBS1;DHX9;APP
769,prerank,Positive Regulation Of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903557),0.28267925282738326,1.0221639080646772,0.41316270566727603,0.6798070274669601,1.0,4/9,18.29%,CLU;THBS1;DHX9;APP
770,prerank,Carbohydrate Derivative Catabolic Process (GO:1901136),-0.31338028169014087,-1.0218953748137203,0.4132762312633833,0.9320390675518175,1.0,7/7,68.85%,DERA;SAMHD1;NAGA;MANBA;FBXO2;FUCA1;BPGM
771,prerank,Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900015),-0.333847169662013,-1.0214987624627865,0.4355179704016913,0.9289366143013986,1.0,4/6,31.39%,MAPK14;STAT3;PLD3;PDCD4
772,prerank,Endosomal Transport (GO:0016197),-0.1647746055352195,-1.0213734046232759,0.41612200435729846,0.9252520326028573,1.0,9/25,18.12%,RAB9A;CLN5;RAB6D;GBF1;ACAP2;EPS15L1;SNX6;TINAGL1;ARHGAP1
773,prerank,Negative Regulation Of Phosphorylation (GO:0042326),0.25792092423636526,1.0213448504306273,0.4306306306306306,0.6800841281003194,1.0,6/11,30.57%,FBLN1;PPIA;TGFB1;CORO1C;PRKDC;SORD
774,prerank,Cellular Respiration (GO:0045333),0.2665168585229164,1.020603166772148,0.41459074733096085,0.6802649776320266,1.0,9/10,63.82%,MDH2;ETFB;NDUFA9;ETFA;NDUFS1;SDHA;NDUFV1;COX7A2;SDHB
775,prerank,Proteasome-Mediated Ubiquitin-Dependent Protein Catabolic Process (GO:0043161),0.1217222445201139,1.0194932763172604,0.42880258899676377,0.6812457989992533,1.0,32/57,45.65%,MAN1A1;VCP;HSPA5;HSP90B1;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;DDB1;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;CALR3;PSMD3;PSMB1;PSMD6;PSMD2;PSMD1;PSMA5;PSMB4
776,prerank,Iron Ion Transport (GO:0006826),0.30301578118639694,1.0179588467237484,0.42385321100917434,0.6829821487590851,1.0,4/8,21.39%,LTF;CLTC;RAB11B;FTH1
777,prerank,Establishment Of Protein Localization To Plasma Membrane (GO:0061951),0.33979893630250624,1.0160700440124522,0.4232209737827715,0.6855035750220567,1.0,4/6,34.77%,KRT18;SPTBN1;NSF;RAB7A
778,prerank,Kidney Development (GO:0001822),-0.27588002651756,-1.0148411629050929,0.41575492341356673,0.9384284289754273,1.0,7/9,49.56%,VEGFA;BAG6;LRP4;ARL3;BMP4;PCSK9;PCSK5
779,prerank,Regulation Of Neuron Migration (GO:2001222),0.37365334157989494,1.0134603432373956,0.4151291512915129,0.6894276813898537,1.0,3/5,24.55%,RELN;MDK;PLXNB2
780,prerank,Regulation Of Platelet Activation (GO:0010543),0.3605389261618798,1.0127760497027212,0.43238095238095237,0.6894662003647333,1.0,2/5,6.31%,F2;FLNA
781,prerank,DNA Repair (GO:0006281),0.1512483114875379,1.0117972556924164,0.43275862068965515,0.6901158389918252,1.0,17/35,35.30%,NPM1;VCP;MACROH2A1;XRCC5;XRCC6;FEN1;RPS3;PCNA;HMGA2;FSCN1;PARP1;MSH3;PRKDC;HUWE1;DDB1;APEX1;UBE2V1
782,prerank,Regulation Of Ras Protein Signal Transduction (GO:0046578),-0.358147713950762,-1.011375498891666,0.4180327868852459,0.9436077992413691,1.0,5/5,64.35%,ARHGDIA;ARHGAP17;ARF6;FBP1;ETFA
783,prerank,Negative Regulation Of Cell Death (GO:0060548),0.2802194930336912,1.0113065310182454,0.44,0.6898061059579091,1.0,5/9,30.04%,ALB;CCN2;PSMC5;VPS35;XPNPEP1
784,prerank,Golgi Vesicle Transport (GO:0048193),-0.13877337649393012,-1.0112001258461842,0.4292682926829268,0.9400684502793538,1.0,37/38,83.69%,COG2;RAB6D;GOPC;GBF1;NAPA;TFG;CUL3;COPZ1;RAB8B;ARL3;SNX1;SAR1B;TAPBP;SCFD1;COPE;RAB2A;RAB1A;SORL1;SEC24A;RAB6A;SAR1A;RAB1B;SEC31A;COPG1;DNM2;ARCN1;SEC24C;COPB2;SNX2;NSF;ARF5;ARF4;COPB1;LMAN2;USO1;EHD3;COPA
785,prerank,Glycoside Catabolic Process (GO:0016139),-0.36576787807737393,-1.0105807388706163,0.44176706827309237,0.9377430878734826,1.0,5/5,63.59%,GUSB;NAGA;FUCA2;FUCA1;GLA
786,prerank,Regulation Of Mitotic Spindle Assembly (GO:1901673),0.36555608768882464,1.0102742573564019,0.4388349514563107,0.6906133920815909,1.0,4/5,44.30%,HSPA1A;PDCD6IP;HNRNPU;TPR
787,prerank,Blood Circulation (GO:0008015),0.3467767792730231,1.0091519670016622,0.4378698224852071,0.6915718398816,1.0,4/6,33.49%,F5;SERPING1;CYB5R3;ROCK2
788,prerank,Cellular Response To Interleukin-1 (GO:0071347),-0.3080985915492958,-1.0090993733631233,0.417607223476298,0.9377323021235856,1.0,7/7,69.37%,UPF1;TOLLIP;IL1RAP;RBMX;MAPK3;HYAL1;CCL20
789,prerank,Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120032),0.26137188235431497,1.0088527655836346,0.4195933456561922,0.6909618851164954,1.0,7/10,45.35%,CLU;RAC1;FSCN1;CAPZB;CDC42;MAPK15;RAB5A
790,prerank,Formation Of Cytoplasmic Translation Initiation Complex (GO:0001732),0.23949509304519628,1.0087338191673552,0.416044776119403,0.6899371335024608,1.0,8/13,38.87%,EIF5;EIF6;EIF3C;EIF3K;EIF3F;EIF3L;EIF3B;EIF3E
791,prerank,Low-Density Lipoprotein Particle Remodeling (GO:0034374),0.3365165814126936,1.0084378205911166,0.43843283582089554,0.6892743108962304,1.0,4/6,34.60%,APOB;AGT;PLA2G2A;PLA2G7
792,prerank,Apoptotic Mitochondrial Changes (GO:0008637),0.31613257626195734,1.0079677252145889,0.4528985507246377,0.6890314219764275,1.0,5/7,41.20%,CLU;HSPD1;VPS35;DNM1L;NDUFS1
793,prerank,Positive Regulation Of Developmental Growth (GO:0048639),0.3735349367502709,1.0064181134494983,0.4416826003824092,0.6906217427158187,1.0,2/5,5.32%,PPIB;AGRN
794,prerank,Negative Regulation Of Proteolysis (GO:0045861),0.2771728372535615,1.0059998547112914,0.4523809523809524,0.6901486833719629,1.0,7/9,51.08%,F2;CTSB;CST3;TIMP1;ECM1;TIMP3;KNG1
795,prerank,Positive Regulation Of Microtubule Polymerization (GO:0031116),0.27967097532314933,1.0059011064429748,0.4362934362934363,0.6891118785862824,1.0,9/9,72.18%,HSPA1A;RPS3;RAC1;DCTN1;MAPRE1;SLAIN1;NUMA1;DRG1;CKAP5
796,prerank,Granulocyte Chemotaxis (GO:0071621),0.3612240411987697,1.0049689947501816,0.4346978557504873,0.6896899326565478,1.0,2/5,5.96%,PPIB;PPIA
797,prerank,Epithelial Cell Differentiation (GO:0030855),0.15665807581337352,1.0045436419038116,0.42495784148397975,0.6893419217594206,1.0,17/31,40.97%,PGK1;KRT9;KRT19;CTSB;DMBT1;KRT10;ALDOC;TAGLN2;PCK2;PCNA;TST;CBR1;ANXA4;KRT13;VIL1;GSTA1;HDAC1
798,prerank,Negative Regulation Of Actin Filament Polymerization (GO:0030837),0.3301568135215795,1.003931238865495,0.4296028880866426,0.6892569267997899,1.0,2/6,2.75%,GSN;PFN1
799,prerank,Aerobic Respiration (GO:0009060),0.36283704572098474,1.0038379361784269,0.45323741007194246,0.6881861517354376,1.0,5/5,63.82%,MDH2;NDUFA9;NDUFS1;NDUFV1;SDHB
800,prerank,Negative Regulation Of Endothelial Cell Proliferation (GO:0001937),0.2831709248788115,1.0036982197142579,0.45985401459854014,0.687269963712951,1.0,3/9,7.60%,APOE;APOH;THBS1
801,prerank,DNA Metabolic Process (GO:0006259),0.1419419954960554,1.0016435944095692,0.43993231810490696,0.6899192111847506,1.0,18/38,35.01%,NPM1;VCP;MACROH2A1;RAN;XRCC5;XRCC6;FEN1;RPS3;PTGES3;FSCN1;PARP1;RUVBL1;MSH3;PRKDC;NAP1L1;RUVBL2;DDB1;APEX1
802,prerank,Aerobic Electron Transport Chain (GO:0019646),-0.28367992420187893,-1.0004836677020392,0.4376321353065539,0.952610145359526,1.0,7/8,58.91%,SDHAF2;CYCS;SDHB;COX7A2;NDUFV1;SDHA;NDUFS1
803,prerank,Mitochondrial ATP Synthesis Coupled Electron Transport (GO:0042775),-0.28367992420187893,-1.0004836677020392,0.4376321353065539,0.952610145359526,1.0,7/8,58.91%,SDHAF2;CYCS;SDHB;COX7A2;NDUFV1;SDHA;NDUFS1
804,prerank,Cellular Response To Hypoxia (GO:0071456),0.2398745596962043,1.0003795563480518,0.4305799648506151,0.6899433025951636,1.0,4/12,11.28%,PGK1;TGFB1;HYOU1;LMNA
805,prerank,Cellular Response To Decreased Oxygen Levels (GO:0036294),0.2398745596962043,1.0003795563480518,0.4305799648506151,0.6899433025951636,1.0,4/12,11.28%,PGK1;TGFB1;HYOU1;LMNA
806,prerank,Chromatin Remodeling (GO:0006338),-0.16473458915073658,-0.998788611802193,0.4431554524361949,0.9533068148105796,1.0,11/26,24.43%,LOXL2;MTA2;USP15;SMARCA4;DDX23;NPM3;SART3;SKP1;HCFC1;DEK;SUPT6H
807,prerank,Regulation Of Cellular Senescence (GO:2000772),-0.30349517099514156,-0.9982768401308497,0.44835164835164837,0.9505827543404317,1.0,3/7,10.99%,B2M;HLA-G;PNPT1
808,prerank,Positive Regulation Of Response To Wounding (GO:1903036),0.32727272727272727,0.9970589047042937,0.4540337711069418,0.6950367887487268,1.0,6/6,67.39%,VTN;MDK;REG3A;GRN;MYLK;ITGB1
809,prerank,Positive Regulation Of Lipid Biosynthetic Process (GO:0046889),0.3128232582983693,0.9969826429112573,0.4418604651162791,0.6939732014147699,1.0,5/7,41.44%,APOE;APOC2;LDLR;APOA4;APOA5
810,prerank,mRNA Destabilization (GO:0061157),-0.30993545098076214,-0.9965378100173297,0.44635193133047213,0.9513058333276331,1.0,4/7,24.61%,MOV10;UPF1;DCPS;KHSRP
811,prerank,Keratan Sulfate Metabolic Process (GO:0042339),-0.3602303557367154,-0.9963926700358107,0.4279475982532751,0.947720580823592,1.0,3/5,21.80%,ST3GAL1;ST3GAL6;GNS
812,prerank,Regulation Of Interferon-Beta Production (GO:0032648),0.30595657588713654,0.9961926384381874,0.45571955719557194,0.6942382547755822,1.0,3/7,14.85%,POLR3B;HSP90AA1;DHX9
813,prerank,Cytokine-Mediated Signaling Pathway (GO:0019221),-0.17751479289940827,-0.9956860004787175,0.4613526570048309,0.9456156703359674,1.0,21/21,82.52%,JAK2;SRC;STAT5B;STAT1;TOLLIP;STAT3;CSNK2B;PRKACA;IL1RAP;PTPN11;PLVAP;MAPK3;EIF5A;CCL20;ILK;ACTN4;LIMS1;TFF2;APLP2;P4HB;CRLF1
814,prerank,Axonogenesis (GO:0007409),0.16619612820962984,0.9954273831526682,0.4271356783919598,0.6944842665218148,1.0,11/29,23.44%,RELN;PARD3;HSP90AB1;HSP90AA1;CNTN1;DPYSL5;APP;SEMA3B;TUBB3;APLP2;NOTCH3
815,prerank,Positive Regulation Of Receptor-Mediated Endocytosis (GO:0048260),0.2237231254818529,0.995140850166097,0.4601449275362319,0.6938009784432804,1.0,3/14,1.69%,C3;VTN;CLU
816,prerank,Regulation Of Translational Initiation (GO:0006446),-0.20251950397762597,-0.9938870454927529,0.43207126948775054,0.9464039383206054,1.0,15/17,67.39%,BZW2;DDX3X;BZW1;NCBP1;EIF4B;EIF3H;EIF5B;DNAJC3;TPR;DDX1;EIF4A2;EIF3E;EIF3B;HSPB1;KHDRBS1
817,prerank,Purine Nucleotide Metabolic Process (GO:0006163),0.24402145279527696,0.9935520177921013,0.4497354497354497,0.6956979404700456,1.0,11/12,68.03%,G6PD;IDH1;MTHFD1;IDH2;AMPD2;GART;PFAS;PRPS1;ME1;PPAT;MDH1
818,prerank,Regulation Of Exosomal Secretion (GO:1903541),0.33296111186124644,0.992461587166175,0.43873517786561267,0.695359841550445,1.0,4/6,34.77%,SDC1;SDC4;PDCD6IP;RAB7A
819,prerank,Positive Regulation Of Exosomal Secretion (GO:1903543),0.33296111186124644,0.992461587166175,0.43873517786561267,0.695359841550445,1.0,4/6,34.77%,SDC1;SDC4;PDCD6IP;RAB7A
820,prerank,Apoptotic Cell Clearance (GO:0043277),0.3085083409948023,0.9923817419431102,0.45251396648044695,0.6943105505716735,1.0,4/7,27.94%,THBS1;RAC1;LRP1;TGM2
821,prerank,Sterol Biosynthetic Process (GO:0016126),0.35751092898595904,0.9922593268388266,0.44274809160305345,0.6909778258409365,1.0,3/5,25.95%,ACLY;G6PD;GLB1
822,prerank,Secondary Alcohol Biosynthetic Process (GO:1902653),0.35751092898595904,0.9922593268388266,0.44274809160305345,0.6909778258409365,1.0,3/5,25.95%,ACLY;G6PD;GLB1
823,prerank,Cholesterol Biosynthetic Process (GO:0006695),0.35751092898595904,0.9922593268388266,0.44274809160305345,0.6909778258409365,1.0,3/5,25.95%,ACLY;G6PD;GLB1
824,prerank,Glucose 6-Phosphate Metabolic Process (GO:0051156),-0.2741390064511482,-0.9915625459477406,0.45161290322580644,0.9491984931616217,1.0,5/8,33.78%,SHPK;DERA;HK2;PGLS;HK1
825,prerank,Negative Regulation Of Microtubule Polymerization Or Depolymerization (GO:0031111),-0.3538575150141405,-0.9914490136022769,0.4479166666666667,0.9456174910895774,1.0,4/5,43.89%,TBCD;FKBP4;CDH5;MAPRE1
826,prerank,Regulation Of Mitochondrial Membrane Potential (GO:0051881),0.3220333763274934,0.9895357098579829,0.4351851851851852,0.6951540416966073,1.0,5/6,52.02%,VCP;PYCR1;PPA2;NDUFS1;PRDX3
827,prerank,Carbohydrate Biosynthetic Process (GO:0016051),0.3614928130719256,0.9891889343714606,0.44652908067542213,0.6946503006960474,1.0,3/5,25.72%,EXT1;B4GALT1;EXT2
828,prerank,mRNA Metabolic Process (GO:0016071),0.15219418212602107,0.9891636423363872,0.47796610169491527,0.6935082954225086,1.0,28/32,73.23%,HSPA1A;ANG;METTL16;SRSF1;SFPQ;HNRNPAB;SND1;SRSF7;SRSF2;HNRNPA2B1;SSB;SRSF4;DDX5;PCBP2;HNRNPR;CSTF3;LSM3;U2AF2;CPSF6;SF3A1;DHX15;HNRNPA0;TCERG1;PRKACA;NUDT21;SF3A3;SF3B2;LSM6
829,prerank,Positive Regulation Of JNK Cascade (GO:0046330),0.3330260032418638,0.9891207568531788,0.46654275092936803,0.692405681907743,1.0,3/6,18.29%,SERPINF2;CCN2;APP
830,prerank,Calcium Ion Transmembrane Import Into Cytosol (GO:0097553),0.35954126402167896,0.988913063245241,0.45185185185185184,0.691621791060173,1.0,2/5,6.31%,CLU;FLNA
831,prerank,Regulation Of Ossification (GO:0030278),0.28869978368905164,0.9876405841010801,0.45454545454545453,0.6927959295365018,1.0,3/8,10.75%,AHSG;NOTUM;MDK
832,prerank,Heterochromatin Formation (GO:0031507),0.3049273617725187,0.9870336372876587,0.4600760456273764,0.6927104955316596,1.0,5/7,42.72%,H1-0;LMNA;HMGA2;LMNB2;LMNB1
833,prerank,Positive Regulation Of DNA Recombination (GO:0045911),-0.28772753963593656,-0.9868647782319031,0.48758465011286684,0.9540470954449006,1.0,8/8,71.42%,MMS19;FUS;ACTL6A;ACTR2;TFRC;RUVBL2;RUVBL1;PARP1
834,prerank,Melanosome Organization (GO:0032438),0.2646935848270964,0.9868528853982554,0.47769516728624534,0.6918419402072821,1.0,7/10,45.30%,APOE;AP1B1;TYRP1;AP3D1;AP1M1;AP1G1;AP3B1
835,prerank,Protein Export From Nucleus (GO:0006611),0.29256427138179425,0.9863649849429599,0.4695817490494297,0.691607858082949,1.0,7/8,58.91%,TGFB1;RAN;NUTF2;CSE1L;TPR;XPO1;CALR
836,prerank,Lamellipodium Organization (GO:0097581),0.3069248826291078,0.9860148882055083,0.45300751879699247,0.6911188664789001,1.0,7/7,69.43%,RAC1;PARVB;SNX2;VCL;ITGB1;PHPT1;SNX1
837,prerank,Peptidyl-Tyrosine Phosphorylation (GO:0018108),0.3655342680179692,0.9850778571660885,0.44341372912801486,0.6917753634895207,1.0,2/5,6.43%,RELN;EFEMP1
838,prerank,Cellular Response To Hexose Stimulus (GO:0071331),-0.32811862249310325,-0.9847848096563908,0.48156182212581344,0.955576309526526,1.0,4/6,32.44%,PRKAA1;PCK1;TRA2B;PRKACA
839,prerank,Purine Ribonucleotide Metabolic Process (GO:0009150),0.18544141323134258,0.98359120073502,0.45207956600361665,0.6935132036613866,1.0,20/21,77.15%,HSPA1A;RAN;ACLY;HSPA8;OLA1;HINT1;GMPR2;ACAT1;NDUFS1;ACOT7;SULT1A1;AMPD2;FIGNL1;AK4;SULT2A1;NT5C2;ADSS1;SULT1E1;ACOT1;SULT1A3
840,prerank,Blood Vessel Diameter Maintenance (GO:0097746),0.3610785463071513,0.983154448568609,0.46934865900383144,0.6932196242791594,1.0,5/5,64.00%,SERPINF2;AGT;ROCK2;KNG1;GCLC
841,prerank,Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042509),0.35781326731164775,0.9831113609729296,0.45300751879699247,0.6921747715506654,1.0,3/5,26.24%,PPP2CA;CRLF1;PPP2R1A
842,prerank,Regulation Of Epithelial Cell Proliferation (GO:0050678),0.2371981189093847,0.9828993332003008,0.44368600682593856,0.6914082691135902,1.0,8/12,44.65%,LAMB1;TGFB1;LAMC1;LIMS1;NME1;PRKDC;TIE1;HYAL1
843,prerank,Sulfur Compound Biosynthetic Process (GO:0044272),0.18890816694107143,0.982607565915972,0.4528301886792453,0.690762202132988,1.0,18/20,72.06%,EXT1;UGDH;METTL16;B4GAT1;EXT2;MAT2A;MAT1A;GSTP1;GSTA1;CHPF;MPST;MAT2B;GLCE;GGT1;XYLT2;GSTM1;PAPSS1;B3GAT3
844,prerank,Neurogenesis (GO:0022008),-0.35052754982415,-0.9820315411454201,0.4557235421166307,0.9590174944803093,1.0,5/5,65.11%,CLN5;LRP4;PCSK9;FAT4;APEX1
845,prerank,Autophagosome Assembly (GO:0000045),-0.3481828839390387,-0.9810600228058675,0.4697286012526096,0.9577146683997617,1.0,5/5,65.34%,LRBA;RAB1A;NSFL1C;RAB1B;RAB7A
846,prerank,Negative Regulation Of Epidermal Growth Factor Receptor Signaling Pathway (GO:0042059),-0.3481828839390387,-0.9810472602102382,0.46008403361344535,0.9538944847723266,1.0,5/5,65.34%,SNX6;TSG101;VPS25;MVP;RAB7A
847,prerank,Purine Ribonucleoside Triphosphate Biosynthetic Process (GO:0009206),0.35159237408769833,0.9787431834045645,0.48576512455516013,0.697153721321417,1.0,4/5,46.00%,TGFB1;ATP5F1B;ATP5F1A;IMPDH2
848,prerank,Phospholipid Catabolic Process (GO:0009395),-0.32235104092156686,-0.9775069689631816,0.46794871794871795,0.9592218305755317,1.0,5/6,50.38%,SMPD1;PLBD2;ENPP2;APOA2;ANGPTL3
849,prerank,Sprouting Angiogenesis (GO:0002040),0.35028705253146164,0.9774028586787848,0.504708097928437,0.6984588573859318,1.0,2/5,7.60%,TGFB1;THBS1
850,prerank,Fatty Acid Derivative Biosynthetic Process (GO:1901570),-0.34994138335287217,-0.977031491450596,0.4543524416135881,0.9567413214123281,1.0,5/5,65.17%,HMGCL;PPT1;GGT1;PAM;ACSS3
851,prerank,Ubiquitin-Dependent ERAD Pathway (GO:0030433),0.21412320750847585,0.9767572360460807,0.47855917667238423,0.6985002943600455,1.0,4/15,7.13%,MAN1A1;VCP;HSPA5;HSP90B1
852,prerank,Regulation Of mRNA Metabolic Process (GO:1903311),-0.3416876608349221,-0.9760778789834824,0.47619047619047616,0.9554167079788176,1.0,3/5,24.43%,SRPK1;NCBP1;SUPT6H
853,prerank,Cellular Response To Oxygen-Containing Compound (GO:1901701),0.12896679555602472,0.9760600443611338,0.4822934232715008,0.698645245962621,1.0,19/43,33.49%,ACTB;CLU;VCP;RAP1B;H2AZ1;HSP90B1;AKR1C3;RPS3;EZR;SERPINE1;TGM2;CDH1;IQGAP1;CAPN2;GSTP1;TPM1;RUVBL2;PTK7;ROCK2
854,prerank,Regulation Of Protein Localization (GO:0032880),0.18177243938554924,0.9759893001656839,0.46409807355516636,0.6975996922145304,1.0,5/21,7.42%,GPC3;VCP;HSP90AB1;HSP90AA1;RACK1
855,prerank,Heart Development (GO:0007507),-0.19798177817812926,-0.9750789435197269,0.48654708520179374,0.9543045438341144,1.0,12/16,53.59%,PDLIM5;SRI;FKBP1A;VEGFA;BMP4;CACYBP;COL3A1;PTPN11;PRMT1;PDLIM1;PCSK5;FBN1
856,prerank,Positive Regulation Of Catalytic Activity (GO:0043085),0.2707437278483125,0.9742270756938113,0.4548736462093863,0.699827141422267,1.0,7/9,51.96%,APOA1;IGF2;XRCC5;MSH3;YWHAB;SSBP1;MAPK3
857,prerank,Regulation Of G Protein-Coupled Receptor Signaling Pathway (GO:0008277),0.3294931425673629,0.9740824178927229,0.4729241877256318,0.6989664475075732,1.0,4/6,35.48%,C3;ROCK2;PLEK;YWHAB
858,prerank,Negative Regulation Of Amide Metabolic Process (GO:0034249),0.17255395381263805,0.973847801910668,0.4536082474226804,0.6982287236393461,1.0,6/24,9.70%,GAPDH;APOE;CLU;RACK1;NCL;GRB7
859,prerank,Regulation Of Cell Junction Assembly (GO:1901888),-0.3391410520688802,-0.9720004624583961,0.4967741935483871,0.9585787863281532,1.0,2/5,3.80%,FLOT1;PDLIM5
860,prerank,Golgi Organization (GO:0007030),-0.24306835726257373,-0.9709160535455934,0.48123620309050774,0.9575679129629002,1.0,9/11,56.81%,COG2;GBF1;CDK1;NPLOC4;RAB2A;RAB1A;NSFL1C;RAB1B;CDC42
861,prerank,Protein Exit From Endoplasmic Reticulum (GO:0032527),0.35053860708932083,0.9688136441754013,0.478515625,0.7066977022344396,1.0,2/5,7.13%,VCP;HSP90B1
862,prerank,Cellular Response To UV (GO:0034644),-0.18648914031815733,-0.9681661335671141,0.4964871194379391,0.9610102446978074,1.0,17/18,75.51%,PTPRK;CUL4A;SMPD1;MMP2;NEDD4;MAPK14;CUL4B;RBX1;PPID;RPL26;HYAL1;EIF2S1;TIMP1;DDB1;RUVBL2;PARP1;PCNA
863,prerank,Regulation Of Protein Metabolic Process (GO:0051246),0.1919971610405056,0.9673755565769334,0.4808362369337979,0.7083006628792403,1.0,15/19,61.13%,APOE;HSP90AB1;TGFB1;ANGPTL8;APP;AGT;VPS35;LDLR;ROCK2;EIF2S1;TCOF1;EIF4E;ELP1;ELP3;NOLC1
864,prerank,Protein Localization To Lysosome (GO:0061462),-0.2917754793531153,-0.9672995390521552,0.47291666666666665,0.9594233666079607,1.0,3/7,12.27%,AP3M1;SCARB2;NEDD4
865,prerank,Regulation Of Organelle Organization (GO:0033043),0.19285213353198832,0.9672959271751406,0.4888888888888889,0.7073045809011757,1.0,13/18,54.12%,EZR;EHD3;VPS35;RUVBL1;CAPN2;RUVBL2;DIAPH1;MSN;DNM1L;MAPK15;SAR1A;MAPK3;CLIC4
866,prerank,Fatty Acid Beta-Oxidation (GO:0006635),-0.20742486741308191,-0.966967908705815,0.47045454545454546,0.9565472282224331,1.0,14/14,79.49%,ACAA1;ACAA2;HADHB;BDH2;HSD17B10;HADHA;ACAT2;ACAT1;ETFA;DECR1;ECHS1;ACADVL;HSD17B4;ETFB
867,prerank,Amino Sugar Metabolic Process (GO:0006040),-0.3458382180539273,-0.9669169832935911,0.44863731656184486,0.9529573427807237,1.0,5/5,65.58%,ST3GAL1;GNE;ST6GAL1;FN3K;GFPT1
868,prerank,Import Into Nucleus (GO:0051170),0.20735385981111726,0.9630500738303273,0.5053571428571428,0.7143625963139256,1.0,7/16,24.84%,RAN;FAM53C;NUTF2;KPNB1;APLP2;CSE1L;HNRNPA1
869,prerank,"Positive Regulation Of DNA-templated Transcription, Elongation (GO:0032786)",-0.2635210832983248,-0.960871468824751,0.5097613882863341,0.9650808489129805,1.0,5/8,34.66%,BRD4;NCBP1;MED6;SUPT6H;TCERG1
870,prerank,Cellular Response To Cytokine Stimulus (GO:0071345),-0.14849030352505505,-0.9593757734335223,0.470873786407767,0.9652678865898067,1.0,10/28,19.64%,SHPK;RO60;ST3GAL6;UPF1;JAK2;PNPT1;STAT5B;STAT1;RPL13A;STAT3
871,prerank,Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090092),0.3484684580360192,0.9588420680662082,0.48014440433212996,0.7210741111510302,1.0,3/5,26.88%,TGFB1;LTBP4;PCSK6
872,prerank,Sarcomere Organization (GO:0045214),0.34305803391258743,0.9580392614582277,0.5141776937618148,0.7213950549340729,1.0,4/5,47.28%,KRT19;WDR1;TPM1;TTN
873,prerank,Acylglycerol Metabolic Process (GO:0006639),0.28431777755677756,0.9575228119112817,0.49119718309859156,0.7211946798334685,1.0,3/8,11.34%,APOE;APOH;APOC3
874,prerank,Positive Regulation Of Epithelial Cell Apoptotic Process (GO:1904037),0.35087206458703485,0.9570158357871421,0.5027726432532348,0.7209159145753967,1.0,2/5,7.60%,GSN;THBS1
875,prerank,Muscle Organ Development (GO:0007517),-0.307961632133578,-0.9560614899694928,0.49567099567099565,0.9703821227901465,1.0,5/6,51.61%,TAGLN;SRI;FHL1;SGCE;LAMA2
876,prerank,Regulation Of Sprouting Angiogenesis (GO:1903670),0.3474538714619342,0.9559593135209989,0.5019455252918288,0.7216827311566756,1.0,2/5,7.60%,PKM;THBS1
877,prerank,Erythrocyte Differentiation (GO:0030218),-0.29308842189710116,-0.9558290091939198,0.47619047619047616,0.9673493700993434,1.0,5/7,41.09%,JAK2;SLC1A5;VEGFA;UFL1;RPS19
878,prerank,Regulation Of Telomere Capping (GO:1904353),-0.31085043988269795,-0.9548317293566079,0.5040485829959515,0.9661062327091519,1.0,6/6,69.08%,RAD50;MAPK1;USP7;MAPK3;MAPK15;HNRNPD
879,prerank,Vacuolar Transport (GO:0007034),0.2514053578708761,0.9541580899314298,0.5036363636363637,0.7239590030084199,1.0,5/10,26.94%,HSPA1A;IGF2R;LRP1;PSAP;AP3D1
880,prerank,Positive Regulation Of MAP Kinase Activity (GO:0043406),0.2928128568559002,0.9514140822420294,0.5047801147227533,0.7279452740335505,1.0,3/7,15.78%,TGFB1;THBS1;RPS3
881,prerank,Peptidyl-Proline Modification (GO:0018208),0.3179934291612286,0.951293808478732,0.518796992481203,0.7269767857018296,1.0,3/6,20.11%,PPIB;PPIA;PPIE
882,prerank,Spindle Assembly (GO:0051225),0.2749795400518317,0.9506190459992175,0.5172413793103449,0.7271240219613871,1.0,7/8,60.78%,FLNA;RPS3;KPNB1;RCC1;MAPRE2;MAPRE1;NUMA1
883,prerank,Positive Regulation Of mRNA Catabolic Process (GO:0061014),-0.2744429263783527,-0.95021945035518,0.49469214437367304,0.9744681581968936,1.0,6/8,46.41%,MOV10;UPF1;PNPT1;KHSRP;FTO;PABPC1
884,prerank,Protein Homooligomerization (GO:0051260),0.15291787415097316,0.9494393815389908,0.52,0.7279976496126432,1.0,16/29,41.73%,CLU;C9;COMP;SHMT2;EHD3;ALDOA;ACOT13;APLP2;ALDH9A1;PRF1;MAT1A;PDCD6IP;CRYZ;EHD1;SHMT1;SSBP1
885,prerank,Regulation Of Synapse Assembly (GO:0051963),0.2587821734567284,0.9477774622685339,0.4936247723132969,0.7299495644189565,1.0,5/9,31.74%,CLSTN1;VPS35;CLSTN3;PTPRD;SRPX2
886,prerank,Negative Regulation Of Cell-Matrix Adhesion (GO:0001953),0.3176676598855199,0.9473354585290235,0.5157116451016636,0.7295395543295617,1.0,3/6,20.46%,THBS1;CORO1C;SERPINE1
887,prerank,Muscle Cell Development (GO:0055001),0.33798039265057456,0.9467320943314192,0.4818355640535373,0.7294925435786338,1.0,4/5,47.28%,SDC1;ACTN4;EFEMP2;TTN
888,prerank,Positive Regulation Of Double-Strand Break Repair Via Homologous Recombination (GO:1905168),-0.2875586854460094,-0.9450997241492651,0.5454545454545454,0.9841912427945247,1.0,7/7,71.42%,MMS19;FUS;ACTL6A;ACTR2;RUVBL2;RUVBL1;PARP1
889,prerank,Vesicle Cargo Loading (GO:0035459),0.289319248826291,0.944983627063924,0.5212569316081331,0.7304472712087297,1.0,7/7,71.19%,SEC23A;SEC24C;SEC31A;SAR1A;SEC24A;RAB1A;SEC13
890,prerank,COPII-coated Vesicle Cargo Loading (GO:0090110),0.289319248826291,0.944983627063924,0.5212569316081331,0.7304472712087297,1.0,7/7,71.19%,SEC23A;SEC24C;SEC31A;SAR1A;SEC24A;RAB1A;SEC13
891,prerank,Odontogenesis (GO:0042476),0.33698928707979303,0.9448614559512737,0.5138632162661737,0.7295019300949149,1.0,4/5,47.17%,LAMB1;COL1A1;HDAC1;COL1A2
892,prerank,Regulation Of Cellular Component Organization (GO:0051128),0.18123176758804313,0.9438005335249376,0.5293040293040293,0.7303306816207005,1.0,7/19,20.57%,APOE;HSP90AA1;RAP1B;HSPA8;LTBP4;AGT;TNC
893,prerank,Positive Regulation Of Inflammatory Response (GO:0050729),0.2096590176735002,0.9427864288011395,0.510989010989011,0.7310703129784614,1.0,6/15,20.46%,MDK;DHX9;APP;AGT;PLA2G2A;SERPINE1
894,prerank,RNA Splicing (GO:0008380),-0.13575973719550583,-0.9425774947103629,0.5076142131979695,0.986799653115965,1.0,18/34,38.34%,SRSF10;PRPF8;SRPK1;DDX23;FUS;NCBP1;CCAR2;KHSRP;SNRNP40;LSM6;SF3B2;SF3A3;TRA2B;SNRPB;TCERG1;DHX15;SNRPF;PRMT1
895,prerank,Peptidyl-Lysine Modification (GO:0018205),-0.21721593740271922,-0.9423246002785503,0.5169300225733634,0.9838045940340162,1.0,9/13,46.11%,SUMO2;LOXL2;UBE2I;PARK7;RANGAP1;SAE1;TRIM28;LOX;UBA2
896,prerank,Ribosome Assembly (GO:0042255),0.19360680266686497,0.9420404303185682,0.5093378607809848,0.7312876954194664,1.0,9/17,35.07%,NPM1;RPSA;RPLP0;RPS14;EIF6;C1QBP;RPS5;RPL11;RPL5
897,prerank,"Nuclear-Transcribed mRNA Catabolic Process, Nonsense-Mediated Decay (GO:0000184)",-0.30524748306495664,-0.9419096587451051,0.5164113785557987,0.9812177626132516,1.0,3/6,18.18%,UPF1;GSPT1;NCBP1
898,prerank,Regulation Of Oxidative Stress-Induced Intrinsic Apoptotic Signaling Pathway (GO:1902175),0.3125764293136795,0.9415083431196879,0.4846153846153846,0.7310550145455744,1.0,4/6,37.58%,PPIA;P4HB;SFPQ;HSPB1
899,prerank,Regulation Of Embryonic Development (GO:0045995),-0.23750734861845973,-0.9408386138750368,0.5178571428571429,0.9802482960685649,1.0,10/10,76.45%,WDR5;NIBAN2;CDK1;BAG6;DAG1;SEPTIN7;RUVBL2;RUVBL1;RAB14;CFL1
900,prerank,Positive Regulation Of T Cell Proliferation (GO:0042102),-0.24060198787968343,-0.9407234153735334,0.534446764091858,0.9769394284411657,1.0,8/10,55.17%,JAK2;PPP3CA;PNP;HMGB1;IGFBP2;TFRC;VCAM1;ICOSLG
901,prerank,Blood Vessel Morphogenesis (GO:0048514),0.33446511169505433,0.9402143604398192,0.5108055009823183,0.7323027370056757,1.0,2/5,8.42%,TGFB1;SERPINF2
902,prerank,Negative Regulation Of Neurogenesis (GO:0050768),-0.3064554701077319,-0.9400259513787528,0.5254988913525499,0.9750087423342154,1.0,5/6,51.72%,B2M;GDI1;LRP4;SORL1;YWHAH
903,prerank,Axonal Transport (GO:0098930),0.29489631616147216,0.9390252218906899,0.5072463768115942,0.7334496072599445,1.0,5/7,43.19%,DYNC1H1;AP3D1;APEX1;PAFAH1B1;DCTN1
904,prerank,Hexose Metabolic Process (GO:0019318),0.1828463259361283,0.9388657884711648,0.5018115942028986,0.7325683926034257,1.0,18/19,76.91%,GALK1;DCXR;ALDOC;ALDOA;G6PD;PGM1;GALM;SORD;FUCA1;FUCA2;FBP1;PMM2;GAA;ALDOB;HK1;HK2;KHSRP;PCK1
905,prerank,Regulation Of Release Of Sequestered Calcium Ion Into Cytosol (GO:0051279),0.25727726552918445,0.9385145122949285,0.5053191489361702,0.7321073341850057,1.0,6/9,42.90%,F2;CEMIP;GSTO1;CALM1;DIAPH1;GSTM2
906,prerank,Positive Regulation Of Synaptic Transmission (GO:0050806),0.2678974347764528,0.9383765779937481,0.5121951219512195,0.731196433876798,1.0,6/9,42.31%,RELN;CLSTN1;APP;CLSTN3;APEX1;BAIAP3
907,prerank,NAD Metabolic Process (GO:0019674),-0.2744953151610422,-0.9379994354387128,0.5192307692307693,0.9765387097863638,1.0,5/7,42.55%,GPD1L;NADSYN1;MDH1;NAMPT;ME1
908,prerank,Cell Projection Organization (GO:0030030),0.2718731650029362,0.937785113264207,0.5091911764705882,0.7311514126265737,1.0,8/8,72.94%,GSN;PARVB;PLEK;PACSIN2;CYFIP2;PDGFA;ITGB1;NCKAP1
909,prerank,Homophilic Cell Adhesion Via Plasma Membrane Adhesion Molecules (GO:0007156),-0.2461809635722679,-0.9376127826891762,0.5188470066518847,0.9739693557253675,1.0,9/9,75.57%,CNTN4;HMCN2;PTPRM;ITGB1;SDK1;HMCN1;PTK7;CDH1;PLXNB2
910,prerank,Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046425),0.3373416789628859,0.9372968152595843,0.5288808664259927,0.7309033624241836,1.0,4/5,47.69%,F2;CALM1;GPI;MST1
911,prerank,Establishment Of Endothelial Barrier (GO:0061028),0.29107981220657275,0.9368178231569771,0.4906015037593985,0.7305782091848065,1.0,7/7,71.01%,RAP1B;EZR;MSN;RAB1B;RAB1A;ICAM1;PDE2A
912,prerank,Regulation Of Bone Mineralization (GO:0030500),0.34597510772806517,0.935728189570217,0.5449438202247191,0.7315940557321056,1.0,2/5,8.07%,AHSG;NOTUM
913,prerank,Negative Regulation Of Cation Channel Activity (GO:2001258),-0.3297706128161251,-0.9356572708094144,0.5174537987679672,0.9753710453873938,1.0,3/5,25.48%,SRI;FKBP1A;PPP3CA
914,prerank,Positive Regulation Of GTPase Activity (GO:0043547),0.21165973865455434,0.9354167878586497,0.5288966725043783,0.7310232890260858,1.0,7/14,30.74%,AGRN;RACK1;CORO1C;RSU1;LIMS1;TGM2;CCL20
915,prerank,Acute Inflammatory Response (GO:0002526),-0.3073280025666321,-0.934545955280423,0.5367965367965368,0.9746025349890141,1.0,3/6,16.54%,VNN1;HPR;APOL2
916,prerank,Nucleus Organization (GO:0006997),0.2756210762267202,0.9337979298695124,0.5203703703703704,0.7327617600148023,1.0,7/8,60.78%,LMNA;PDCD6IP;LMNB2;LMNB1;TPR;RPS19;NUMA1
917,prerank,Regulation Of Protein Dephosphorylation (GO:0035304),0.24507849577825935,0.9337329681111523,0.5493716337522442,0.7317175807628824,1.0,3/10,7.13%,PPIA;TGFB1;HSP90B1
918,prerank,Purine Ribonucleotide Catabolic Process (GO:0009154),-0.306158357771261,-0.9324117962683175,0.5278350515463918,0.9766389558845773,1.0,6/6,69.55%,SUCLA2;PNP;PDE2A;NT5C2;HINT1;SORD
919,prerank,Positive Regulation Of Proteolysis (GO:0045862),0.2701115678214915,0.931950552325456,0.512241054613936,0.7338754757653754,1.0,8/8,73.12%,APOE;ANGPTL8;CTSH;CTSV;CTSC;CYFIP2;BAG2;ASPH
920,prerank,RNA Stabilization (GO:0043489),-0.3126099706744868,-0.9311958630360775,0.5203426124197003,0.97613984109676,1.0,6/6,68.91%,FUS;CIRBP;ELAVL1;PABPC1;HNRNPU;YBX1
921,prerank,Negative Regulation Of Developmental Process (GO:0051093),0.19583486809536643,0.9311655671460216,0.502803738317757,0.7341695656507627,1.0,10/17,40.97%,TGFB1;CST3;RBBP4;PARP1;BRD9;HUWE1;ROCK2;PTPRS;SF3B3;HDAC1
922,prerank,Axon Extension (GO:0048675),0.3077204350036461,0.9311393071966663,0.5252707581227437,0.733076106289922,1.0,2/6,5.03%,HSP90AB1;HSP90AA1
923,prerank,Organic Substance Transport (GO:0071702),0.20648604573200402,0.9309625590796138,0.5517241379310345,0.7322632881701869,1.0,12/14,65.93%,CLU;HSP90B1;MYH9;PLTP;RAB7A;CACNA2D1;APOA4;APOA5;SLC3A2;LRP2;TNPO1;ARRDC1
924,prerank,Negative Regulation Of mRNA Processing (GO:0050686),0.29130254179479115,0.9283824478145936,0.5327272727272727,0.7359911658817608,1.0,6/7,57.69%,C1QBP;SRSF7;SRSF4;PTBP1;RBMX;U2AF2
925,prerank,Positive Regulation Of Cell Cycle G2/M Phase Transition (GO:1902751),-0.30853284492964844,-0.928256410284084,0.5348314606741573,0.9803423935261295,1.0,3/6,17.18%,BRD4;RRM2B;CDK1
926,prerank,Regulation Of Ubiquitin Protein Ligase Activity (GO:1904666),-0.33821805392731535,-0.9279222915980088,0.5219206680584552,0.9777015352970267,1.0,5/5,66.34%,SKP1;RPL17;RPS7;RPL5;RPL11
927,prerank,Protein Localization (GO:0008104),0.10397416770033828,0.9269957929855506,0.5333333333333333,0.7374285736518156,1.0,52/65,71.19%,ACTB;PARD3;NPM1;FLNA;FBLN5;CLTC;ARF1;PRPF19;COPA;SEPTIN9;USO1;VPS35;HSPA9;CD74;ARF4;AP3D1;ARF5;RAB14;SIL1;NSF;RAB18;APEX1;RAB5C;AP2A1;COPB2;EHD1;ARCN1;CPE;SEC31A;RAB1B;AP3B1;RAB5A;CD81;YWHAH;VCL;SAR1A;RAB6A;NBEAL2;MAPRE1;USP9X;RAB1A;CORO1B;RAB5B;VPS29;RAB21;CTSA;SCFD1;SAR1B;SNX1;CTNNB1;ARF6;SEC13
928,prerank,Amyloid Fibril Formation (GO:1990000),-0.29982344934763383,-0.9269393107035595,0.5153374233128835,0.9766382055922161,1.0,3/6,18.00%,B2M;FUS;FKBP1A
929,prerank,Regulation Of Microtubule Polymerization (GO:0031113),0.23868768954840897,0.9265385512521986,0.5457875457875457,0.7370668286008998,1.0,9/10,66.63%,RPS3;EML2;RAC1;DCTN1;MAPRE1;CDH5;SLAIN1;NUMA1;DRG1
930,prerank,Regulation Of Establishment Of Endothelial Barrier (GO:1903140),-0.3352872215709261,-0.9258786406581281,0.5277777777777778,0.97571185097954,1.0,5/5,66.63%,PPP1R12A;VEGFA;CDH5;VCL;ROCK2
931,prerank,Regulation Of Angiogenesis (GO:0045765),0.13501147610297298,0.9254855297195406,0.5360824742268041,0.7378101732628276,1.0,8/36,10.46%,SERPINF1;PGK1;THBS4;APOH;KRT1;THBS1;CNTN1;HSPG2
932,prerank,Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032434),0.17211617403745672,0.9253478308071212,0.5284697508896797,0.7369377506834713,1.0,5/22,7.42%,CLU;HSPA1A;VCP;HSP90AB1;RACK1
933,prerank,Positive Regulation Of Protein Localization (GO:1903829),0.23346138829497004,0.9246614638102452,0.5336879432624113,0.7370268115076396,1.0,3/11,6.20%,F2;HSP90AB1;TGFB1
934,prerank,Maintenance Of Blood-Brain Barrier (GO:0035633),-0.30915754105179305,-0.9236110280425774,0.5513626834381551,0.9781568935848499,1.0,5/6,51.61%,LSR;ITGB1;CDH5;VCL;LAMA2
935,prerank,Positive Regulation Of Cell Projection Organization (GO:0031346),-0.21922365162744578,-0.9230902940057887,0.5391923990498813,0.976117855677359,1.0,4/12,9.35%,CAPRIN1;TWF1;PLXNA1;SCARB2
936,prerank,Positive Regulation Of Vasculature Development (GO:1904018),0.18572573298256953,0.9219147909796167,0.526595744680851,0.7410352035738335,1.0,16/18,71.24%,THBS1;CNTN1;SERPINE1;EMILIN1;HMGA2;CTSH;HSPB1;ECM1;CHI3L1;HYAL1;ANGPTL4;ANGPTL3;CDH5;GRN;ITGB1;HK2
937,prerank,Cellular Response To Metal Ion (GO:0071248),-0.20328476774910448,-0.9207572941447636,0.5475113122171946,0.9785386234538951,1.0,5/14,14.03%,B2M;SMPD1;ADD1;CPNE1;PRKAA1
938,prerank,Negative Regulation Of Protein Kinase B Signaling (GO:0051898),0.2849968807961134,0.9207097215535335,0.5418994413407822,0.7420612338805498,1.0,4/7,30.57%,RACK1;PPP2CA;PPP2R1A;SORD
939,prerank,Lysosomal Transport (GO:0007041),0.20262595170684577,0.9204641622454602,0.5305755395683454,0.7414116984484831,1.0,6/15,21.62%,HSPA1A;IGF2R;EHD3;LRP1;PSAP;VPS35
940,prerank,Regulation Of Interleukin-1 Beta Production (GO:0032651),0.31039553147455046,0.9204479698083705,0.5580524344569289,0.7403043969333366,1.0,4/6,37.58%,APOA1;APP;GSTP1;HSPB1
941,prerank,"Alternative mRNA Splicing, Via Spliceosome (GO:0000380)",0.28921656705775706,0.9198983320858869,0.5640074211502782,0.7401783585897499,1.0,5/7,43.83%,SRSF1;DHX9;SFPQ;DDX5;DDX17
942,prerank,Synapse Assembly (GO:0007416),0.28336867263536175,0.9173371107913296,0.5396825396825397,0.7439460353853894,1.0,4/7,30.92%,SPOCK2;PLXNB2;CDH1;PTPRD
943,prerank,ERAD Pathway (GO:0036503),0.1964997185709223,0.9161964445018471,0.5660377358490566,0.7449475896660671,1.0,4/16,7.13%,MAN1A1;VCP;HSPA5;HSP90B1
944,prerank,Organonitrogen Compound Catabolic Process (GO:1901565),-0.17864951913377575,-0.9148288636990667,0.5519630484988453,0.9897881883002985,1.0,16/18,70.72%,CLN5;PPT1;LIPC;NAGK;IDE;UCHL3;TPP1;SLC16A3;CPQ;MPST;ENPP2;NPEPPS;ACHE;ETFA;PLA2G7;TST
945,prerank,Endomembrane System Organization (GO:0010256),-0.16542335384372256,-0.914534765400098,0.5452322738386308,0.987099695592938,1.0,18/20,73.17%,COG2;GBF1;NUP93;SLC9A3R1;TOR1B;NPLOC4;RAB2A;RAB1A;NSFL1C;MAPK15;RAB1B;CDC42;LMNB1;SEC31A;DNM1L;LMNB2;REEP6;AP3D1
946,prerank,Protein O-linked Glycosylation (GO:0006493),-0.2334327275428314,-0.9138680186168404,0.5466666666666666,0.9852578894145845,1.0,6/10,34.95%,ST3GAL1;GALNT2;ST6GAL1;GALNT7;PGM3;FUT3
947,prerank,Regulation Of Protein Ubiquitination (GO:0031396),-0.18515352791792833,-0.9127165050084406,0.5422222222222223,0.9848349545287173,1.0,10/16,42.43%,DNAJA1;FKBP1A;ARRB1;MYCBP2;CUL3;PARK7;CTNNB1;BAG2;UFL1;U2AF2
948,prerank,Positive Regulation Of DNA Binding (GO:0043388),-0.2810964970038671,-0.9122913849552321,0.5409090909090909,0.9825213951080044,1.0,4/7,27.12%,HMGB2;NIBAN2;PARK7;HMGB1
949,prerank,Activation Of Protein Kinase Activity (GO:0032147),-0.2562588551070713,-0.9118297450050965,0.5438972162740899,0.9802766960433618,1.0,4/8,22.68%,JAK2;ITGB3;VEGFA;PARK7
950,prerank,Cytosolic Transport (GO:0016482),-0.15527929083010422,-0.9111020528508009,0.5694117647058824,0.9787834891254074,1.0,7/23,13.56%,RAB9A;CLN5;RAB6D;PIP4K2A;GBF1;MON2;SNX6
951,prerank,Plasma Membrane Bounded Cell Projection Assembly (GO:0120031),0.152808418856703,0.9086424672140188,0.552772808586762,0.7575364361915977,1.0,13/26,36.59%,GSN;FLNA;RAP1B;EZR;EHD3;RAC1;PARVB;ACTR3;ARF4;FSCN1;SEPTIN7;SEPTIN2;EHD1
952,prerank,Positive Regulation Of Leukocyte Chemotaxis (GO:0002690),0.22550289717267047,0.9084552168104857,0.5596330275229358,0.7567068063820149,1.0,5/11,24.43%,THBS1;MDK;RARRES2;SERPINE1;C1QBP
953,prerank,Nucleotide-Excision Repair (GO:0006289),-0.284037558685446,-0.9080430535039494,0.5352697095435685,0.9829672284832333,1.0,7/7,71.77%,MMS19;RAD23B;RPA2;USP7;RPA1;DDB1;FSCN1
954,prerank,"Negative Regulation Of mRNA Splicing, Via Spliceosome (GO:0048025)",-0.3020527859237537,-0.9078352917238638,0.5643340857787811,0.9801342000088672,1.0,6/6,69.96%,SRSF10;U2AF2;RBMX;PTBP1;SRSF4;SRSF7
955,prerank,Positive Regulation Of Epithelial Cell Migration (GO:0010634),-0.14180356452803847,-0.9066728088039863,0.5783132530120482,0.9797757293696633,1.0,9/26,18.94%,SPARC;RRAS;NELL2;MAP4K4;GLIPR2;ITGB3;SRC;GFUS;VEGFA
956,prerank,Regulation Of Protein Binding (GO:0043393),0.16490522838003036,0.9064489262720544,0.5565371024734982,0.7593759501157044,1.0,6/23,11.46%,VTN;SUB1;RACK1;RAN;PPP2CA;CFHR5
957,prerank,Organonitrogen Compound Biosynthetic Process (GO:1901566),0.1924300831725123,0.90583049994384,0.5828877005347594,0.7593233740370148,1.0,11/16,51.32%,APOE;APOA1;B4GAT1;AKR1A1;ASS1;LCAT;GSTP1;GSTA1;PAM;PCSK5;APOA2
958,prerank,Negative Regulation Of Gene Expression (GO:0010629),0.1163306270824505,0.9038471047736211,0.57,0.761818693600611,1.0,20/49,31.21%,GAPDH;APOE;HSPA1A;TGFB1;MACROH2A1;RACK1;NCL;GRB7;METTL16;RPS3;RPS13;APP;LRP1;EMILIN1;MACROH2A2;RPS26;EIF4A3;SND1;SORD;YBX1
959,prerank,Regulation Of Actin Filament Polymerization (GO:0030833),-0.2456518387594887,-0.9020855886894332,0.5694117647058824,0.9874842778017715,1.0,5/9,29.40%,TWF1;MTPN;TWF2;NCKAP1;ARF6
960,prerank,Glycosaminoglycan Catabolic Process (GO:0006027),0.2835993893109324,0.9019435982880684,0.5673624288425048,0.7641761853854816,1.0,5/7,44.65%,CEMIP;TGFB1;GLB1;FUCA1;HYAL1
961,prerank,Intracellular Monoatomic Cation Homeostasis (GO:0030003),-0.18290360692426993,-0.9005980061876231,0.5450236966824644,0.9878271983147197,1.0,13/16,62.42%,B2M;ATP6AP1;BOLA2;CP;ATP6V1A;CALR;CDH5;TFRC;GLRX3;FTL;ATP1A1;STC2;RGN
962,prerank,Regulation Of Cell-Matrix Adhesion (GO:0001952),0.2821985243853657,0.8970883040879776,0.5595463137996219,0.7718687602388777,1.0,3/7,16.83%,TLN1;THBS1;CORO1C
963,prerank,Regulation Of Phosphoprotein Phosphatase Activity (GO:0043666),-0.2764057651472074,-0.8970229002192868,0.5484581497797357,0.9931161824132251,1.0,4/7,27.41%,PPP1R12A;FKBP1A;CSNK2B;PTPA
964,prerank,Negative Regulation Of Macromolecule Metabolic Process (GO:0010605),0.16277904947058952,0.8964930733066134,0.5919439579684763,0.7717995020392105,1.0,11/23,33.49%,APOE;HSP90AB1;SUB1;TGFB1;RACK1;APP;LRP1;EMILIN1;SORD;LDLR;ROCK2
965,prerank,"Regulation Of Nuclear-Transcribed mRNA Catabolic Process, Deadenylation-Dependent Decay (GO:1900151)",0.3041606969042404,0.8964093484506419,0.5716878402903811,0.7696476317797071,1.0,5/6,53.71%,DHX9;HNRNPD;YBX1;HNRNPU;PABPC1
966,prerank,"Negative Regulation Of Nuclear-Transcribed mRNA Catabolic Process, Deadenylation-Dependent Decay (GO:1900152)",0.3041606969042404,0.8964093484506419,0.5716878402903811,0.7696476317797071,1.0,5/6,53.71%,DHX9;HNRNPD;YBX1;HNRNPU;PABPC1
967,prerank,AMP Metabolic Process (GO:0046033),-0.305978898007034,-0.8959172706158247,0.5689277899343544,0.9926187168868924,1.0,5/5,69.55%,ADSS2;ADSS1;AK4;AMPD2;SORD
968,prerank,Plasma Membrane Bounded Cell Projection Morphogenesis (GO:0120039),-0.3241500586166471,-0.8950732027024414,0.553014553014553,0.9914161912831838,1.0,5/5,67.74%,MAP4K4;NCKAP1;SNX1;DNM2;SNX2
969,prerank,Monoatomic Cation Transmembrane Transport (GO:0098655),-0.23864264969273946,-0.8943635028696899,0.581081081081081,0.9865640753713114,1.0,6/9,40.97%,ATP6AP2;ATP6AP1;FKBP1A;ATP5PO;ATP6V1B2;ATP6V1A
970,prerank,Inorganic Cation Transmembrane Transport (GO:0098662),-0.23864264969273946,-0.8943635028696899,0.581081081081081,0.9865640753713114,1.0,6/9,40.97%,ATP6AP2;ATP6AP1;FKBP1A;ATP5PO;ATP6V1B2;ATP6V1A
971,prerank,Positive Regulation Of Interleukin-1 Production (GO:0032732),-0.3155526662841589,-0.8928805382583388,0.5592105263157895,0.9868015179628169,1.0,3/5,27.12%,JAK2;STAT3;HMGB1
972,prerank,Glycosaminoglycan Biosynthetic Process (GO:0006024),0.20749516882076705,0.8914141570546684,0.5737122557726465,0.777962186411905,1.0,4/13,11.81%,CEMIP;EXT1;UGDH;B4GAT1
973,prerank,Purine Ribonucleoside Monophosphate Biosynthetic Process (GO:0009168),0.2567095347131932,0.889060373920108,0.5914742451154529,0.7811166473061184,1.0,6/8,50.32%,ATIC;PAICS;GMPS;AMPD2;GART;PFAS
974,prerank,Regulation Of Mitotic Cell Cycle (GO:0007346),-0.18396226415094338,-0.8887952722648523,0.5934782608695652,0.9933689226444457,1.0,15/15,81.82%,GBF1;ASNS;SLC9A3R1;NEK9;CDK11A;SDCBP;EIF4E;TTLL12;HNRNPU;RCC1;DDB1;PRMT5;IQGAP1;YWHAE;APP
975,prerank,Negative Regulation Of Cell Junction Assembly (GO:1901889),0.3222874607941902,0.8886774090000249,0.5666041275797373,0.7806283311607297,1.0,4/5,48.98%,THBS1;CORO1C;ROCK2;RCC2
976,prerank,Negative Regulation Of Chemotaxis (GO:0050922),-0.2556798900504749,-0.8870481682094374,0.6193693693693694,0.9943085144864953,1.0,6/8,48.45%,SEMA7A;SEMA3F;SEMA3C;CORO1B;SEMA3A;SEMA4B
977,prerank,Negative Regulation Of Autophagy (GO:0010507),-0.3262581387593383,-0.8852806426328723,0.5809128630705395,0.995326788018053,1.0,4/5,45.59%,SNRNP70;STAT3;CTSA;EIF4E
978,prerank,Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000058),-0.2290321029986373,-0.884619184115378,0.5887445887445888,0.9936910650368848,1.0,9/10,66.34%,RAD23B;SGTA;CSNK2A1;RPL17;UFL1;XPO1;RPS7;RPL5;RPL11
979,prerank,Integrin-Mediated Signaling Pathway (GO:0007229),0.16192173950702304,0.8840093882849027,0.5979020979020979,0.7877185223685282,1.0,7/21,19.23%,FN1;APOA1;FBLN1;LAMA5;ADAMTS13;MYH9;FERMT3
980,prerank,Epithelium Development (GO:0060429),0.12962836504592534,0.8834617541252535,0.5838815789473685,0.7875527466722222,1.0,23/36,52.78%,PGK1;KRT9;TGFB1;KRT19;CTSB;DMBT1;KRT10;ALDOC;TNC;TAGLN2;PCNA;MTHFD1;TST;CBR1;ANXA4;KRT13;VIL1;GSTA1;AKR1C2;KRT14;VCL;FN3K;DAG1
981,prerank,Regulation Of Vascular Associated Smooth Muscle Cell Proliferation (GO:1904705),-0.317116060961313,-0.883075136194362,0.5795454545454546,0.9941569630100262,1.0,5/5,68.44%,MMP2;BMP4;PDCD4;EFEMP2;TPM1
982,prerank,Cell Junction Organization (GO:0034330),0.25028956593322116,0.8830466080119794,0.593065693430657,0.7870861681239414,1.0,5/9,31.91%,TGFB1;APP;CAPZA1;LIMS1;PTK7
983,prerank,Anterograde Axonal Transport (GO:0008089),0.3003433552427956,0.8829651895207465,0.5951940850277264,0.786080810469645,1.0,4/6,37.93%,AP3D1;APEX1;HSPB1;KIF5B
984,prerank,Regulation Of JNK Cascade (GO:0046328),0.23621447947517243,0.8813669884257522,0.5892857142857143,0.7879442082948784,1.0,4/10,18.29%,SERPINF2;AMBP;CCN2;APP
985,prerank,DNA-templated DNA Replication (GO:0006261),-0.2697587399705923,-0.8800516561029234,0.6244635193133047,0.9979614422258132,1.0,6/7,58.39%,RRM2B;RRM1;RECQL;PURA;RPA1;SSBP1
986,prerank,Positive Regulation Of Lymphocyte Proliferation (GO:0050671),-0.2836017125402358,-0.8790812252072411,0.6046511627906976,0.9970264251267077,1.0,5/6,54.53%,JAK2;PNP;TFRC;VCAM1;CD81
987,prerank,Glycolipid Metabolic Process (GO:0006664),-0.31421148081502615,-0.8786899709402373,0.6157112526539278,0.9948794397317567,1.0,2/5,7.07%,SMPD1;ST3GAL6
988,prerank,Regulation Of Canonical Wnt Signaling Pathway (GO:0060828),0.1479473126607465,0.8779668197521163,0.6063829787234043,0.7928136484312044,1.0,5/26,6.20%,APOE;UBAC2;GPC3;VCP;TGFB1
989,prerank,Regulation Of Endocytosis (GO:0030100),-0.22770439182986668,-0.8770967656398642,0.6384976525821596,0.9955643326736966,1.0,4/10,14.96%,FLOT1;RAB4A;SMPD1;SRC
990,prerank,Actin Filament Depolymerization (GO:0030042),0.31862358242958777,0.8756986677541567,0.583969465648855,0.7960077759757489,1.0,2/5,10.52%,GSN;WDR1
991,prerank,Positive Regulation Of Interleukin-12 Production (GO:0032735),-0.3107616900483876,-0.8754976824079723,0.6025369978858351,0.996203386394484,1.0,3/5,27.12%,HLA-G;MAPK14;HMGB1
992,prerank,Cell Morphogenesis Involved In Neuron Differentiation (GO:0048667),0.2939621022109518,0.8753800580898112,0.5996343692870201,0.79544892807267,1.0,3/6,22.85%,PARD3;APP;APLP2
993,prerank,Regulation Of Actin Cytoskeleton Organization (GO:0032956),0.18692533157343316,0.8752015007163336,0.6102003642987249,0.7945896883297933,1.0,8/16,33.49%,CLU;MDK;EZR;RAC1;LRP1;CORO1A;FSCN1;ROCK2
994,prerank,Protein Localization To Nucleus (GO:0034504),0.15161597478797795,0.8748959368707379,0.601063829787234,0.7939735628068667,1.0,15/26,44.30%,RAN;LMNA;FAM53C;COL1A1;NUTF2;YWHAE;KPNB1;APLP2;CSE1L;RPL11;LMNB2;HNRNPU;LMNB1;IPO7;TPR
995,prerank,Negative Regulation Of Cellular Catabolic Process (GO:0031330),0.2438495527289729,0.8740946122097146,0.6021897810218978,0.7942390016053781,1.0,8/9,65.05%,APOC3;HP;TIMP1;APOC1;TIMP3;EIF4E;SORL1;TIMP2
996,prerank,Negative Regulation Of Axon Extension Involved In Axon Guidance (GO:0048843),-0.3085847898404329,-0.8739911142317872,0.5860566448801743,0.9964818910337533,1.0,4/5,48.45%,SEMA7A;SEMA3F;SEMA3C;SEMA4B
997,prerank,Regulation Of mRNA Stability (GO:0043488),-0.17980451790932261,-0.8735772914056958,0.6096997690531177,0.9943072481037536,1.0,14/16,68.91%,VIM;FUS;CIRBP;IGF2BP1;KHSRP;ELAVL1;FTO;PABPC1;SERBP1;HNRNPU;APEX1;ROCK2;CARHSP1;YBX1
998,prerank,Regulation Of Multicellular Organismal Development (GO:2000026),-0.2768328445747801,-0.8722432191144436,0.6365546218487395,0.994174164101731,1.0,6/6,72.47%,WDR5;CDK1;BAG6;RUVBL2;RUVBL1;RAB14
999,prerank,Positive Regulation Of Establishment Of Protein Localization To Mitochondrion (GO:1903749),-0.30656506447831183,-0.8721782747604153,0.6041237113402061,0.9911633458842384,1.0,5/5,69.49%,SAE1;NMT1;SH3GLB1;NPEPPS;HUWE1
1000,prerank,Positive Regulation Of Cell-Substrate Junction Organization (GO:0150117),-0.2616355440749515,-0.8717471461096107,0.5947136563876652,0.9890361461823006,1.0,4/7,29.40%,MAP4K4;FERMT2;VEGFA;ARF6
1001,prerank,Protein Tetramerization (GO:0051262),0.15624553433238825,0.8715102896344291,0.5860927152317881,0.797647587377442,1.0,13/22,45.18%,CLU;KRT1;SHMT2;KRT10;ALDOA;ACOT13;APLP2;ALDH9A1;MAT1A;CRYZ;SHMT1;SSBP1;FARSB
1002,prerank,tRNA Metabolic Process (GO:0006399),0.32282229354228326,0.8711075388715033,0.615678776290631,0.7971562141337073,1.0,4/5,48.92%,ANG;SSB;KARS1;DTD1
1003,prerank,NADP Metabolic Process (GO:0006739),0.3206330597889801,0.8700126543852749,0.632768361581921,0.7980576272581704,1.0,5/5,68.03%,G6PD;IDH1;IDH2;ME1;MDH1
1004,prerank,SMAD Protein Signal Transduction (GO:0060395),0.2930924092545605,0.8699201175312631,0.6078431372549019,0.797074262878365,1.0,2/6,6.20%,GDF15;TGFB1
1005,prerank,Peptide Catabolic Process (GO:0043171),0.2752347417840374,0.8697477516911774,0.6121323529411765,0.7961928506273732,1.0,7/7,72.59%,ADAMTS13;CTSH;XPNPEP1;NPEPPS;CPQ;TPP1;IDE
1006,prerank,Regulation Of Cell-Substrate Junction Assembly (GO:0090109),0.3230002585309396,0.8686188972826171,0.6069364161849711,0.7969290570839813,1.0,4/5,49.09%,TLN1;CORO1C;ROCK2;VCL
1007,prerank,Oxoacid Metabolic Process (GO:0043436),-0.28856304985337244,-0.868599533406884,0.5886075949367089,0.9932179838754344,1.0,6/6,71.30%,GRHPR;SULT1A3;SULT1E1;SULT2A1;SULT1A1;PPA2
1008,prerank,Negative Regulation Of Macromolecule Biosynthetic Process (GO:0010558),0.15174966399760298,0.8685158518642534,0.6016666666666667,0.795970025320978,1.0,16/25,50.67%,GAPDH;TGFB1;RACK1;NCL;GRB7;CLTC;RPS3;EIF4A3;GSTP1;YBX1;AKR1B1;AP2A1;SHMT1;DDX6;SERBP1;EPRS1
1009,prerank,"Fructose 1,6-Bisphosphate Metabolic Process (GO:0030388)",-0.2837822762262405,-0.8657096718655983,0.5838509316770186,0.9966538177283653,1.0,5/6,54.30%,PFKP;KHSRP;ALDOB;FBP1;PFKL
1010,prerank,Negative Regulation Of Translation (GO:0017148),0.150293789894134,0.8655568530178281,0.6178010471204188,0.8000924205678844,1.0,16/25,50.67%,GAPDH;RACK1;NCL;GRB7;METTL16;RPS3;EIF6;EIF4A3;YBX1;ROCK2;SHMT1;EIF3E;TPR;DDX6;SERBP1;EPRS1
1011,prerank,Calcium-Dependent Cell-Cell Adhesion Via Plasma Membrane Cell Adhesion Molecules (GO:0016339),-0.28914956011730203,-0.8652098760949701,0.616557734204793,0.9946911123834647,1.0,6/6,71.24%,PCDHB2;CDH6;PCDHGC3;CDH5;CDH11;CDH1
1012,prerank,Replication Fork Processing (GO:0031297),-0.3086432388708152,-0.8648248494084705,0.629399585921325,0.9924408367010167,1.0,3/5,27.88%,RAD50;SAMHD1;CARM1
1013,prerank,mRNA Polyadenylation (GO:0006378),-0.30796190398066237,-0.8633936442351093,0.605543710021322,0.9896492555193465,1.0,4/5,48.33%,CPSF1;PNPT1;PABPC1;CSTF3
1014,prerank,RNA Polyadenylation (GO:0043631),-0.30796190398066237,-0.8633936442351093,0.605543710021322,0.9896492555193465,1.0,4/5,48.33%,CPSF1;PNPT1;PABPC1;CSTF3
1015,prerank,Negative Regulation Of Protein Binding (GO:0032091),0.2370136302907369,0.8633869357249464,0.6064400715563506,0.8027568176395835,1.0,3/9,11.46%,RACK1;PTPRF;CFHR5
1016,prerank,Positive Regulation Of Lymphocyte Differentiation (GO:0045621),0.3142562859068236,0.8632961623769669,0.6552380952380953,0.8017701839993864,1.0,3/5,30.51%,MDK;XRCC6;PRKDC
1017,prerank,IMP Metabolic Process (GO:0046040),-0.305978898007034,-0.8626557419289741,0.6511156186612576,0.9882039554458071,1.0,5/5,69.55%,ADSS2;PNP;NT5C2;AMPD2;SORD
1018,prerank,Proteoglycan Biosynthetic Process (GO:0030166),0.28035190615835776,0.8616427493230523,0.6172607879924953,0.8034953981885321,1.0,6/6,72.06%,EXT1;UGDH;EXT2;GLCE;XYLT2;B3GAT3
1019,prerank,Regulation Of Actin Nucleation (GO:0051125),-0.27852246119121976,-0.8616239546809901,0.6178861788617886,0.9874741405060893,1.0,2/6,3.33%,ARFIP1;RNH1
1020,prerank,Carbohydrate Derivative Biosynthetic Process (GO:1901137),-0.2570209221969042,-0.8615544524321327,0.621380846325167,0.9846279757651645,1.0,3/7,15.49%,ST3GAL6;GALK2;RRM2B
1021,prerank,B Cell Activation (GO:0042113),-0.3126123604185632,-0.8615473025270237,0.6030042918454935,0.9816557362590287,1.0,4/5,47.98%,FCRLA;ITGB1;CTPS1;VCAM1
1022,prerank,Positive Regulation Of Binding (GO:0051099),0.1666894166127914,0.8613352779250297,0.5989932885906041,0.8028995975957519,1.0,7/20,20.81%,VTN;APOE;SUB1;RAN;DHX9;APP;LRP1
1023,prerank,Receptor Clustering (GO:0043113),-0.31242199924820135,-0.8609163570692153,0.6195426195426196,0.9801216381849234,1.0,3/5,26.65%,NRXN1;DNAJA3;LRP4
1024,prerank,Amide Biosynthetic Process (GO:0043604),0.31056883079927544,0.8601757938740809,0.6476377952755905,0.803813012311623,1.0,4/5,50.56%,GLUD1;ASS1;PAM;PCSK5
1025,prerank,Negative Regulation Of Binding (GO:0051100),-0.21687563097992735,-0.8599305749719083,0.5662393162393162,0.9792998067348149,1.0,7/10,47.11%,JAK2;CPNE1;PARK7;BAG2;SORL1;DKK1;PPP1CA
1026,prerank,Axon Guidance (GO:0007411),-0.13436981646398463,-0.8597778268275111,0.6413043478260869,0.9766965207059408,1.0,13/29,30.10%,NELL2;NRXN1;PLXNA1;LYPLA2;CNTN4;NIBAN2;VEGFA;MYCBP2;LGI1;SEMA7A;SEMA3F;NCAM1;PTPRM
1027,prerank,Positive Regulation By Symbiont Of Entry Into Host (GO:0075294),-0.3118743293784084,-0.8595690482884566,0.6265306122448979,0.971244559875361,1.0,3/5,27.12%,SMPD1;LGALS1;HMGB1
1028,prerank,Positive Regulation Of Viral Entry Into Host Cell (GO:0046598),-0.3118743293784084,-0.8595690482884566,0.6265306122448979,0.971244559875361,1.0,3/5,27.12%,SMPD1;LGALS1;HMGB1
1029,prerank,"Retrograde Transport, Endosome To Golgi (GO:0042147)",-0.17176646481118207,-0.859407533730501,0.6532438478747203,0.9687349156121188,1.0,4/16,6.43%,RAB9A;CLN5;RAB6D;GBF1
1030,prerank,Glutamine Family Amino Acid Metabolic Process (GO:0009064),-0.246380903209384,-0.859128148399137,0.6179039301310044,0.9664581666374471,1.0,7/8,61.72%,ALDH18A1;GGT1;GCLC;DDAH2;NIT2;ADSL;ALDH5A1
1031,prerank,Regulation Of Exocytosis (GO:0017157),0.21540512539649392,0.858210088584738,0.6284658040665434,0.8060235713112505,1.0,3/11,8.12%,FGB;FGA;FGG
1032,prerank,Epithelial To Mesenchymal Transition (GO:0001837),0.21520334660116014,0.8579238551295558,0.6311030741410488,0.8054035325995975,1.0,7/11,43.83%,TGFB1;HMGA2;LIMS1;HNRNPAB;ROCK2;DDX5;DDX17
1033,prerank,Protein Catabolic Process (GO:0030163),0.13978913011653227,0.8575745056311925,0.621160409556314,0.8049026395055172,1.0,26/27,82.88%,APOE;VCP;HSP90AA1;CTSB;CTSD;HSPA8;PRPF19;PSMA6;CTSH;CAPN2;DDB1;RAB7A;CTSZ;CTSV;CTSC;FBXO2;MANBA;PCSK9;SLC16A3;TPP1;UCHL3;IDE;BAG6;CUL4B;PPT1;SFI1
1034,prerank,Prostaglandin Metabolic Process (GO:0006693),0.23182250013384245,0.8525997563404581,0.6305970149253731,0.8124588801741838,1.0,6/9,45.12%,AKR1C3;CD74;PTGES3;GSTP1;GSTA1;AKR1C2
1035,prerank,Negative Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0030512),-0.18787308806204842,-0.8486940883414338,0.667420814479638,0.9866117646930883,1.0,7/14,29.81%,ADAMTSL2;FBN2;SNX6;FKBP1A;STRAP;PEG10;RBBP7
1036,prerank,Eye Development (GO:0001654),0.26274076368770594,0.846839017791268,0.6306818181818182,0.8215892173325491,1.0,5/7,46.52%,EFEMP1;SMOC1;TSKU;RAB18;FBN1
1037,prerank,Negative Regulation Of Smooth Muscle Cell Migration (GO:0014912),0.3024618991793669,0.8457570275849199,0.6560150375939849,0.8222904276772,1.0,5/5,69.84%,SERPINE1;LRP1;TPM1;CORO1B;BMP4
1038,prerank,Negative Regulation Of Cell Differentiation (GO:0045596),-0.14218441018296268,-0.8443902811254085,0.6384439359267735,0.9929313615845939,1.0,15/24,46.76%,NOTCH4;NELFB;FERMT2;SMARCA4;ITGB3;CNTN4;SDHAF2;BMP4;PDCD4;ACTL6A;PTPN11;COL5A1;CALR;PTBP1;CHRD
1039,prerank,COPII-coated Vesicle Budding (GO:0090114),-0.2350506452656986,-0.8432882539414124,0.6513157894736842,0.9923310589593566,1.0,7/8,63.71%,CUL3;SEC13;RAB1A;SEC24A;SAR1A;SEC31A;SEC24C
1040,prerank,Regulation Of Osteoblast Differentiation (GO:0045667),-0.2057849090859868,-0.842605186752046,0.6651162790697674,0.9908490067506718,1.0,6/11,32.44%,FERMT2;FBN2;PPP3CA;IFITM1;BMP4;PRKACA
1041,prerank,Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0033209),-0.27331378299120235,-0.8417711556835512,0.6331236897274634,0.9897072766793943,1.0,6/6,72.82%,JAK2;STAT1;PLVAP;EIF5A;ILK;LIMS1
1042,prerank,Regulation Of Signal Transduction (GO:0009966),0.16988331019836347,0.8405753418991272,0.6556169429097606,0.8302417103754759,1.0,8/18,29.34%,CLU;PPIA;AKR1C3;PPP2CA;APP;YWHAG;PPP2R1A;ILK
1043,prerank,Negative Regulation Of Cellular Biosynthetic Process (GO:0031327),0.12830885147282217,0.8395886010552204,0.656093489148581,0.8307333140204443,1.0,32/33,84.69%,GAPDH;C1QTNF3;RACK1;NCL;AKR1C3;GRB7;APOC3;RPS3;EIF4A3;ACADVL;YBX1;ROCK2;PLEK;GLA;SHMT1;APOC1;DDX6;MST1;SERBP1;EPRS1;USP7;CALR;PDGFA;CSNK2A1;UBR4;ILF3;KHSRP;IGF2BP1;RPL13A;NIBAN2;DDX3X;IGF2BP2
1044,prerank,Phospholipid Metabolic Process (GO:0006644),-0.23869193196080796,-0.8390656707159059,0.6630669546436285,0.9925659889171005,1.0,6/8,50.38%,SMPD1;PLBD2;PCYT2;ENPP2;APOA2;ANGPTL3
1045,prerank,Malate Metabolic Process (GO:0006108),-0.2982147945777631,-0.8390472470027567,0.6704545454545454,0.9896993245407077,1.0,4/5,49.50%,FH;MDH1;ME1;ME2
1046,prerank,Phosphatidylcholine Metabolic Process (GO:0046470),0.23438247735508433,0.8379251244838417,0.6516245487364621,0.8324003618274572,1.0,7/9,55.41%,APOA1;PLA2G2A;LCAT;PLA2G7;APOA4;APOA2;ENPP2
1047,prerank,Fatty Acid Oxidation (GO:0019395),-0.1954090641553855,-0.8373470288720083,0.6651376146788991,0.9905455201964768,1.0,12/12,80.65%,ACAA1;ACAA2;HADHB;BDH2;HSD17B10;HADHA;ACAT2;ACAT1;DECR1;ECHS1;HSD17B4;ADH5
1048,prerank,Ruffle Organization (GO:0031529),0.2936694021101994,0.8366571987543283,0.6833333333333333,0.8334538236983623,1.0,5/5,70.72%,RAC1;TPM1;PLEK;CORO1B;ARF6
1049,prerank,Negative Regulation Of Wnt Signaling Pathway (GO:0030178),0.16030595341643133,0.8362830336460523,0.6738351254480287,0.8329352674710674,1.0,5/20,10.75%,APOE;UBAC2;RACK1;NOTUM;MDK
1050,prerank,Neuron Projection Extension (GO:1990138),-0.22374824650198122,-0.8356239756397439,0.6471861471861472,0.9916815338084813,1.0,6/9,42.49%,NELL2;CPNE1;SEMA3F;CTNNB1;SEMA3A;USP9X
1051,prerank,Apoptotic Process (GO:0006915),0.1610209271025606,0.8355783610381724,0.6808510638297872,0.8330008379683314,1.0,9/21,28.70%,GAPDH;PPIA;PPP2CA;APP;HSPD1;RTN4;PRF1;PPP2R1A;PARP1
1052,prerank,ERK1 And ERK2 Cascade (GO:0070371),-0.30011723329425555,-0.8354363143131568,0.6623655913978495,0.9892185313208015,1.0,5/5,70.13%,CDK1;MAPK1;MAP2K1;KARS1;CTSH
1053,prerank,Regulation Of Activated T Cell Proliferation (GO:0046006),0.25469483568075124,0.8344700517112916,0.6804733727810651,0.8337491114229318,1.0,7/7,74.63%,IGF2;RPS3;ICOSLG;IGFBP2;PRKAR1A;HMGB1;PPP3CA
1054,prerank,Regulation Of Glycolytic Process (GO:0006110),0.2782449397400932,0.833366488854625,0.6686274509803921,0.8345473573406501,1.0,3/6,23.85%,PGAM1;APP;EIF6
1055,prerank,Electron Transport Chain (GO:0022900),0.2821114369501466,0.832382596797922,0.6621359223300971,0.8351808358835874,1.0,6/6,71.89%,DHRS2;ETFB;ETFA;SDHA;SDHB;PDIA5
1056,prerank,Nucleotide-Sugar Biosynthetic Process (GO:0009226),0.23501762632197415,0.8321019801449288,0.6672862453531598,0.8345141854234949,1.0,9/9,76.62%,UGDH;NANS;GFPT1;UXS1;PMM2;PGM3;GMPPB;GNPNAT1;UAP1
1057,prerank,Negative Regulation Of Lipid Metabolic Process (GO:0045833),0.29814688889188856,0.8315154206713711,0.6983546617915904,0.8343015693005397,1.0,4/5,51.32%,APOC3;APOC2;APOC1;APOA2
1058,prerank,Negative Regulation Of Neuron Projection Development (GO:0010977),0.261737089201878,0.8306781598210039,0.6857142857142857,0.8346139073987885,1.0,7/7,73.93%,APOE;TSKU;PTPRS;SEMA3A;FKBP4;LRP4;GDI1
1059,prerank,Epidermal Cell Differentiation (GO:0009913),0.25469483568075124,0.830143168189434,0.6595330739299611,0.834361343349067,1.0,7/7,74.63%,AKR1C3;KRT10;HDAC1;CLIC4;DSP;CTNNB1;PPP3CA
1060,prerank,Protein Glycosylation (GO:0006486),0.15930862827629186,0.8296402530529446,0.6783216783216783,0.8340304051420813,1.0,18/20,74.99%,PLOD1;ALG1;B4GAT1;PLOD2;PLOD3;B4GALT1;GFPT1;MGAT2;PSMD2;MGAT1;PMM2;MOGS;FUT3;GAL3ST1;PGM3;GALNT7;GMPPB;GALNT2
1061,prerank,Regulation Of Stem Cell Population Maintenance (GO:2000036),-0.2175191064079953,-0.8291953637284205,0.7181069958847737,0.9995952784921511,1.0,10/10,78.43%,LOXL2;SMARCA4;RBBP7;ACTL6A;ELAVL1;HDAC1;SF3B3;BRD9;HMGA2;RBBP4
1062,prerank,Cilium Organization (GO:0044782),0.18497107747701216,0.826245293737182,0.6742857142857143,0.8387221961330402,1.0,8/15,36.59%,GSN;FLNA;EHD3;ACTR3;ARF4;SEPTIN7;SEPTIN2;EHD1
1063,prerank,NADPH Regeneration (GO:0006740),-0.2935560615155799,-0.8257772985649848,0.6623376623376623,1.0,1.0,2/5,8.83%,SHPK;DERA
1064,prerank,Response To Estradiol (GO:0032355),-0.2523343315896984,-0.8230898674154191,0.672566371681416,1.0,1.0,4/7,30.04%,STRN3;STAT5B;STAT3;CTNNB1
1065,prerank,Histone H4 Acetylation (GO:0043967),-0.29484173505275496,-0.8224251740548766,0.6837782340862423,1.0,1.0,5/5,70.66%,WDR5;HCFC1;ACTL6A;RUVBL2;RUVBL1
1066,prerank,Histone Acetylation (GO:0016573),-0.29484173505275496,-0.8218082289483484,0.6820083682008368,1.0,1.0,5/5,70.66%,WDR5;ACTL6A;SF3B3;RUVBL2;RUVBL1
1067,prerank,Response To Organic Cyclic Compound (GO:0014070),-0.25030404666859374,-0.8208278837866029,0.6724890829694323,1.0,1.0,4/7,30.04%,STRN3;STAT5B;STAT3;CTNNB1
1068,prerank,Negative Regulation Of Receptor-Mediated Endocytosis (GO:0048261),0.21545249087629367,0.8199841399598164,0.6938775510204082,0.8485380424740999,1.0,4/10,20.05%,APOC3;APP;APOC2;RAC1
1069,prerank,Positive Regulation Of Protein Ubiquitination (GO:0031398),-0.24354460093896715,-0.8194591642295846,0.6821345707656613,1.0,1.0,7/7,75.80%,FKBP1A;MYCBP2;CUL3;RBX1;UBE2N;HUWE1;RPS2
1070,prerank,Regulation Of Cytoskeleton Organization (GO:0051493),-0.1641086186540732,-0.8194124756232132,0.6807095343680709,1.0,1.0,17/17,83.81%,IQGAP2;ARHGAP17;PRKAA1;MAPK1;TWF2;PDGFA;CLIC4;MAPK3;CDC42;DIAPH1;ROCK2;CAPN2;FSCN1;CORO1A;LRP1;RAC1;EZR
1071,prerank,Negative Regulation Of Viral Genome Replication (GO:0045071),-0.29174922209734755,-0.8190977187216,0.7016460905349794,0.9978082147070264,1.0,3/5,28.64%,SRPK1;ILF3;IFITM1
1072,prerank,Regulation Of Cell Growth (GO:0001558),0.12977724506188237,0.8190683966350085,0.6689655172413793,0.8489698361698077,1.0,10/30,22.27%,HSPA1A;H3-3A;ENO1;TGFB1;RACK1;PPP2CA;LTBP4;AGT;TNC;RTN4
1073,prerank,Regulation Of Lamellipodium Organization (GO:1902743),-0.2693943978697665,-0.8183843627416939,0.6869565217391305,0.9964506454850034,1.0,3/6,21.51%,CD44;TWF1;TWF2
1074,prerank,Sulfur Compound Catabolic Process (GO:0044273),-0.2598240469208211,-0.8180653088353657,0.6932270916334662,0.9942804712232766,1.0,6/6,74.17%,SUCLA2;GNS;GPC1;MPST;TST;GLB1
1075,prerank,Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0007179),0.16355493422264702,0.8172734097267682,0.7064056939501779,0.850833610003709,1.0,4/18,7.83%,APOA1;GDF15;TGFB1;FMOD
1076,prerank,Neuron Projection Guidance (GO:0097485),-0.1389532005209549,-0.8163076251944459,0.6907730673316709,0.9950147612429145,1.0,9/23,23.90%,NELL2;NRXN1;LYPLA2;CNTN4;NIBAN2;MYCBP2;LGI1;SEMA7A;SEMA3F
1077,prerank,Positive Regulation Of Viral Process (GO:0048524),0.22455319928714362,0.8155595214994487,0.6889312977099237,0.8525495754922263,1.0,5/9,34.77%,PPIA;DHX9;PPIE;DDB1;RAB7A
1078,prerank,Maturation Of LSU-rRNA (GO:0000470),-0.29062214245477025,-0.8151995059099826,0.7032258064516129,0.9944512382976509,1.0,4/5,50.09%,RPL35;NEDD4;NOP2;RPL7
1079,prerank,Regulation Of GTPase Activity (GO:0043087),0.1781143809433863,0.8141248884254128,0.6916524701873935,0.8537598440688445,1.0,7/15,30.74%,AGRN;RACK1;PLXNB2;RSU1;LIMS1;TGM2;CCL20
1080,prerank,Histone Modification (GO:0016570),-0.21739130434782608,-0.8140725579436815,0.6851441241685144,0.9941032366660902,1.0,9/9,78.43%,MTA2;CARM1;RBBP7;ACTL6A;UBE2N;HDAC1;RUVBL2;RUVBL1;RBBP4
1081,prerank,Regulation Of Interleukin-8 Production (GO:0032677),0.19658622719246577,0.8136424393065623,0.7122040072859745,0.8533733144986532,1.0,12/12,80.48%,HSPA1A;CNTN1;SERPINE1;CD74;ANXA4;CHI3L1;APOA2;RAB1A;HMGB1;PARK7;ARRB1;STAT3
1082,prerank,Regulation Of Cell Population Proliferation (GO:0042127),0.07916232128761423,0.8136165051598433,0.694888178913738,0.8522249467869291,1.0,25/90,21.68%,FN1;ACTB;CLU;HSPA1A;PLG;NPM1;TGFB1;CLEC11A;DHRS2;THBS1;AKR1C3;LMNA;IGF2;XRCC5;XRCC6;RPS9;COL18A1;CRLF1;APP;AGT;HMGA1;TNXB;FTH1;EMILIN1;RBBP4
1083,prerank,Negative Regulation Of Axon Extension (GO:0030517),0.23781561949500896,0.8133075321377214,0.6690909090909091,0.8515977436934584,1.0,8/8,76.33%,SEMA3B;RTN4;PTPRS;SEMA4B;SEMA3A;SEMA3C;SEMA3F;SEMA7A
1084,prerank,Organelle Assembly (GO:0070925),0.1308079268281356,0.8123270586880876,0.6958762886597938,0.8521978317374092,1.0,17/30,45.30%,GSN;FLNA;EHD3;AP1B1;ACTR3;CORO1A;ARF4;AP3D1;PDCD6IP;RAB7A;SEPTIN7;SEPTIN2;EHD1;AP1M1;AP1G1;RAB1B;AP3B1
1085,prerank,Artery Morphogenesis (GO:0048844),-0.28995084747803557,-0.8122523779277222,0.7028824833702882,0.9949986297615786,1.0,4/5,50.38%,VEGFA;BMP4;LRP2;ANGPTL3
1086,prerank,Regulation Of Kinase Activity (GO:0043549),-0.24779467269370112,-0.8112974303948569,0.6957446808510638,0.994156729569541,1.0,6/7,60.61%,SLC9A3R1;RAD50;PRDX3;TTN;HNRNPU;TIE1
1087,prerank,Positive Regulation Of Transcription By RNA Polymerase I (GO:0045943),-0.2548197947714158,-0.8110411540527073,0.6940639269406392,0.9919437168324988,1.0,5/7,44.77%,SMARCA4;DEK;CARM1;DDX21;MARS1
1088,prerank,Endothelial Cell Development (GO:0001885),0.29073856975381024,0.8103358599907737,0.7034220532319392,0.8543157843908952,1.0,5/5,71.01%,RAP1B;MSN;GSTM3;ICAM1;PDE2A
1089,prerank,Neural Crest Cell Migration (GO:0001755),0.23781561949500882,0.8093170436268483,0.6887661141804788,0.854754938003271,1.0,8/8,76.33%,FN1;CORO1C;SEMA3B;SEMA4B;SEMA3A;SEMA3C;SEMA3F;SEMA7A
1090,prerank,Exocytosis (GO:0006887),0.2990764894455392,0.8089992885692618,0.7223264540337712,0.8541102698602496,1.0,3/5,31.44%,MYH9;RAB11B;NSF
1091,prerank,Protein Localization To Plasma Membrane (GO:0072659),0.19085992261869628,0.8075989867680173,0.7065217391304348,0.8552608155406508,1.0,7/13,36.59%,FLNA;SPTBN1;EZR;EHD3;CDH1;ROCK2;EHD1
1092,prerank,Positive Regulation Of Pathway-Restricted SMAD Protein Phosphorylation (GO:0010862),0.24941314553990612,0.805840543340184,0.7137476459510358,0.8570547417069915,1.0,7/7,75.16%,GDF15;TGFB1;TNXB;SDCBP;INHBE;BMP4;CSNK2B
1093,prerank,DNA Geometric Change (GO:0032392),-0.2173240326225232,-0.8044075004961735,0.7050691244239631,1.0,1.0,8/9,66.69%,HMGB2;UPF1;RAD50;HMGB1;HMGB3;DTD1;DDX1;HNRNPA2B1
1094,prerank,Cellular Response To Nutrient Levels (GO:0031669),0.2873062958984294,0.8043743787177924,0.7088353413654619,0.8583686095149295,1.0,2/5,14.55%,ALB;HSPA8
1095,prerank,Response To Cytokine (GO:0034097),-0.1686441942001653,-0.7999325536259068,0.7334851936218679,1.0,1.0,8/15,35.07%,SMPD1;JAK2;SRC;STAT1;KHSRP;IFITM1;COL3A1;TIMP2
1096,prerank,Establishment Of Protein Localization To Membrane (GO:0090150),0.29065379413577386,0.7998007425741523,0.7171903881700554,0.8648354303186779,1.0,3/5,32.85%,PARD3;RAB11B;NACA
1097,prerank,Cardiac Muscle Tissue Morphogenesis (GO:0055008),0.2910381841525012,0.7983976920930576,0.7472324723247232,0.8659524997155494,1.0,4/5,51.90%,TGFB1;TPM1;TTN;MYLK2
1098,prerank,Proteolysis (GO:0006508),0.09876128585398439,0.7982198280096163,0.7108626198083067,0.8650510316567197,1.0,22/53,33.31%,PLG;XPNPEP3;CNTN1;F9;ADAMTS13;CTSB;CPN1;COLEC10;CPA1;CTSD;PSMC4;CFH;CPB2;PSMA6;PCSK6;PCOLCE;HGFAC;CTSH;XPNPEP1;CAPN2;CNDP2;HABP2
1099,prerank,Negative Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903321),-0.19906456243320633,-0.7979713241684192,0.7142857142857143,1.0,1.0,7/11,42.43%,DNAJA1;ARRB1;PARK7;CTNNB1;BAG2;UFL1;U2AF2
1100,prerank,Cell Surface Receptor Signaling Pathway Involved In Cell-Cell Signaling (GO:1905114),-0.2834557051760097,-0.7970067222646943,0.7266811279826464,1.0,1.0,3/5,30.27%,FERMT2;DDX3X;BMP4
1101,prerank,Regulation Of SMAD Protein Signal Transduction (GO:0060390),-0.27865355207566006,-0.7967009557260545,0.734375,1.0,1.0,2/5,10.40%,NUP93;JAK2
1102,prerank,Endocytosis (GO:0006897),0.11789631645941955,0.7966292214406318,0.7041522491349481,0.8665478562876331,1.0,28/36,67.39%,AHSG;APOE;IGF2R;HSPG2;CLTC;DPYSL2;CORO1C;EHD3;APP;LRP1;CORO1A;LDLR;RAB7A;AP2A1;EHD1;DNM2;CDC42;RAB5A;PACSIN2;MAPK3;SNX5;SORL1;LRP2;RAB1A;RAB5B;ANXA11;EEA1;ITGB1
1103,prerank,Regulation Of Cellular Response To Stress (GO:0080135),-0.19727986286728402,-0.7962091733395535,0.7381489841986456,1.0,1.0,10/11,70.66%,BABAM2;RPA2;DNAJB1;ACTL6A;UBE2N;SF3B3;UBE2V1;ROCK2;RUVBL2;RUVBL1
1104,prerank,Regulation Of mRNA Processing (GO:0050684),0.2099190432228478,0.7956629802877668,0.6872791519434629,0.8669697536434837,1.0,4/10,20.98%,METTL16;SRSF3;DHX9;HNRNPK
1105,prerank,L-serine Metabolic Process (GO:0006563),0.28936540277612355,0.79543731962672,0.7129455909943715,0.8661973982820415,1.0,4/5,52.25%,SHMT2;PSAT1;SHMT1;SERINC5
1106,prerank,Regulation Of Neuron Projection Development (GO:0010975),0.1707295022044631,0.794909841893495,0.7288428324697754,0.8659306257760581,1.0,8/16,35.18%,RELN;APOE;MDK;CFL1;PLXNB2;TSKU;PTK7;PTPRS
1107,prerank,Protein Complex Oligomerization (GO:0051259),0.15498832079135477,0.7948739005795914,0.7198581560283688,0.8648275949817695,1.0,10/19,38.92%,C9;COMP;UGDH;SHMT2;EHD3;PRF1;MAT2A;PDCD6IP;EHD1;DNM1L
1108,prerank,Regulation Of Neuron Death (GO:1901214),-0.2359608724099466,-0.794499579074545,0.7178947368421053,1.0,1.0,5/7,46.35%,NAE1;PARK7;PCSK9;SORL1;DKK1
1109,prerank,Regulation Of Neuron Apoptotic Process (GO:0043523),-0.18318660913624246,-0.7933154617171113,0.7396061269146609,1.0,1.0,8/12,46.35%,SNX6;PPT1;NAE1;PARK7;CTNNB1;GRN;PCSK9;DKK1
1110,prerank,Regulation Of Lamellipodium Assembly (GO:0010591),-0.20105820105820105,-0.793176457157716,0.6800847457627118,1.0,1.0,10/10,80.07%,TWF1;TWF2;NCKAP1;ACTR2;CDC42;ARPC2;CAPZB;FSCN1;ACTR3;RAC1
1111,prerank,Regulation Of Epithelial Cell Migration (GO:0010632),0.2067849778957639,0.7927271096368675,0.7360861759425493,0.8672487144199805,1.0,7/11,44.65%,PFN1;CORO1C;RTN4;CTSH;PFN2;VIL1;HYAL1
1112,prerank,Positive Regulation Of Endothelial Cell Migration (GO:0010595),-0.14258215959944853,-0.7919074666807306,0.7721822541966427,1.0,1.0,12/21,41.20%,SPARC;RRAS;NELL2;ITGB3;MAPK14;GFUS;VEGFA;HMGB1;BMP4;GRN;SCARB1;CALR
1113,prerank,Regulation Of Endothelial Cell Migration (GO:0010594),-0.14823201280561962,-0.791667294933743,0.7621359223300971,1.0,1.0,11/19,41.20%,SPARC;RRAS;NELL2;ITGB3;GFUS;VEGFA;PTPRM;BMP4;GRN;SCARB1;CALR
1114,prerank,Regulation Of MAP Kinase Activity (GO:0043405),0.19416399189094602,0.7915869840062125,0.7596330275229358,0.8678957502248745,1.0,3/12,7.60%,APOE;TGFB1;THBS1
1115,prerank,Negative Regulation Of Lipoprotein Particle Clearance (GO:0010985),0.2837181303885653,0.7871073061048179,0.7300380228136882,0.8738816821023102,1.0,3/5,32.96%,APOC3;APOC2;LDLR
1116,prerank,Morphogenesis Of An Epithelium (GO:0002009),-0.2821203227612672,-0.7865629842507204,0.7391304347826086,1.0,1.0,4/5,51.02%,KRT6A;SLC9A3R1;DAG1;VCL
1117,prerank,Membrane Organization (GO:0061024),-0.12329842960702792,-0.7859448675809114,0.7307692307692307,1.0,1.0,9/27,19.99%,ANXA2;NUP93;SLC9A3R1;NAPA;VPS36;ESYT1;PPT1;TOR1B;TSG101
1118,prerank,Nuclear Transport (GO:0051169),-0.2623850568795074,-0.7849705499082209,0.7195652173913043,1.0,1.0,5/6,55.82%,NUP93;RANGAP1;SEC13;XPO1;TPR
1119,prerank,Cellular Response To Chemical Stress (GO:0062197),0.1637388804311904,0.782954147607727,0.7316176470588235,0.8792830760061773,1.0,13/17,61.43%,HSPA1A;PPIA;DHRS2;PRDX2;G6PD;PYCR1;PARP1;NQO1;EIF2S1;GSR;PRDX3;PYCR2;RBX1
1120,prerank,Regulation Of Focal Adhesion Assembly (GO:0051893),-0.17688697683932803,-0.7821095387289955,0.7649667405764967,1.0,1.0,5/13,18.94%,MAP4K4;FERMT2;MACF1;SRC;VEGFA
1121,prerank,Regulation Of Supramolecular Fiber Organization (GO:1902903),0.2790794533215437,0.7818176993240677,0.7346153846153847,0.8799082506953215,1.0,2/5,14.55%,APOE;HSPA8
1122,prerank,Positive Regulation Of Activated T Cell Proliferation (GO:0042104),0.2545454545454545,0.7812687152082365,0.7375745526838966,0.8795915249327283,1.0,6/6,74.63%,IGF2;RPS3;ICOSLG;IGFBP2;HMGB1;PPP3CA
1123,prerank,Positive Regulation Of Protein Localization To Plasma Membrane (GO:1903078),0.24058375153444023,0.7808637257393577,0.748653500897666,0.8790915665713144,1.0,3/7,20.81%,RACK1;SPTBN1;LRP1
1124,prerank,Microtubule Cytoskeleton Organization Involved In Mitosis (GO:1902850),-0.19176462194317445,-0.7797912079911381,0.7347826086956522,1.0,1.0,6/11,33.96%,TUBG1;CDK1;PTPA;CKAP5;DCTN2;MAP4
1125,prerank,Positive Regulation Of Neurogenesis (GO:0050769),0.18962850063185988,0.7797582679814868,0.7402826855123675,0.8796357036915202,1.0,6/12,33.14%,SERPINF1;PLXNB2;TGM2;PTPRD;NAP1L1;VCAN
1126,prerank,Hemopoiesis (GO:0030097),-0.2344916752738979,-0.7784252137642758,0.7510548523206751,1.0,1.0,2/7,3.45%,RRAS;NOTCH4
1127,prerank,Response To UV (GO:0009411),-0.15403164811337744,-0.7782964799299588,0.7125890736342043,1.0,1.0,7/17,24.20%,PTPRK;CUL4A;SMPD1;NEDD4;CIRBP;CCAR2;CUL4B
1128,prerank,Negative Regulation Of Transcription By RNA Polymerase II (GO:0000122),-0.08807581480030259,-0.7781808256562033,0.7433414043583535,1.0,1.0,31/55,46.35%,COPS2;CTBP1;LOXL2;NOTCH4;MTA2;HMGB2;SMARCA4;CRYM;UBE2I;DNAJA3;AEBP1;HCFC1;STAT1;VEGFA;STAT3;ZNF239;HMGB1;PDE2A;RBBP7;BMP4;DNAJB1;TCERG1;RPL17;PPID;CALR;USP9X;DRAP1;SDCBP;PURA;UBA2;DKK1
1129,prerank,Metal Ion Transport (GO:0030001),0.2613253664776456,0.7767039146528987,0.7476979742173112,0.8834012242934243,1.0,5/6,58.09%,CLU;NDUFA9;CACNA2D1;SLC3A2;LRP2
1130,prerank,Maturation Of SSU-rRNA (GO:0030490),0.23943661971830998,0.776194057531888,0.7429643527204502,0.883024524235028,1.0,7/7,76.15%,RPS16;RPS14;RPS8;SNU13;RPS19;LSM6;RPS28
1131,prerank,Regulation Of Low-Density Lipoprotein Particle Clearance (GO:0010988),0.28341877793332737,0.7754467089984627,0.7401574803149606,0.8830581100315759,1.0,3/5,32.96%,APOC3;HNRNPK;LDLR
1132,prerank,Regulation Of miRNA Transcription (GO:1902893),-0.2805104492889198,-0.7747867381229262,0.7723214285714286,1.0,1.0,3/5,30.27%,SMARCA4;STAT3;BMP4
1133,prerank,Vesicle Organization (GO:0016050),-0.25513196480938416,-0.7719397465768747,0.7184873949579832,1.0,1.0,6/6,74.63%,ANXA2;SAR1B;EEA1;SAR1A;AP2M1;CORO1A
1134,prerank,Positive Regulation Of Apoptotic Signaling Pathway (GO:2001235),0.24049322456710698,0.7702843007778776,0.7527272727272727,0.8898265704442418,1.0,5/7,49.04%,RACK1;RPS3;CTSH;DNM1L;CTSV
1135,prerank,Double-Strand Break Repair Via Homologous Recombination (GO:0000724),0.21445358401880155,0.7698426221102475,0.7862453531598513,0.8893569022736404,1.0,9/9,78.67%,PSMD14;FEN1;SFPQ;FSCN1;UBE2N;RPA1;RECQL;SAMHD1;RPA2
1136,prerank,Organic Cyclic Compound Biosynthetic Process (GO:1901362),-0.24809384164222875,-0.7689929572409006,0.7494780793319415,1.0,1.0,6/6,75.34%,PYCR3;GPHN;DHRS11;PYCR2;FDXR;PYCR1
1137,prerank,Regulation Of Cellular Biosynthetic Process (GO:0031326),-0.15751489673891023,-0.7679558090666511,0.7385321100917431,1.0,1.0,12/16,57.86%,CES1;EIF2B4;MTPN;JAK2;PDGFA;NOLC1;ELP3;ELP1;EIF4E;TCOF1;EIF2S1;STC2
1138,prerank,Mitotic Spindle Organization (GO:0007052),0.17858351926660584,0.7673558714437115,0.7340823970037453,0.8921604413573161,1.0,5/13,22.62%,VCP;FLNA;RAN;DYNC1H1;KPNB1
1139,prerank,Negative Regulation Of DNA-templated Transcription (GO:0045892),-0.07032995236859418,-0.7668241436334589,0.7830423940149626,1.0,1.0,45/82,46.70%,PTPRK;COPS2;CTBP1;LOXL2;NOTCH4;MTA2;HMGB2;SMARCA4;CRYM;BCLAF1;UBE2I;DNAJA3;AEBP1;SNX6;NIBAN2;HCFC1;STAT1;VEGFA;STAT3;ZNF239;CCAR2;ILF3;MIDEAS;HMGB1;PDE2A;RBBP7;CTNNB1;BMP4;PDCD4;DNAJB1;TCERG1;GCLC;DKK3;HNRNPL;RPL17;PPID;TRIM28;CALR;USP9X;DRAP1;SDCBP;PURA;UBA2;DKK1;NONO
1140,prerank,Protein Targeting To Membrane (GO:0006612),0.22137404580152678,0.7659136747979719,0.7560553633217993,0.8932071868725907,1.0,8/8,77.97%,PARD3;SIL1;NACA;SRP14;SDCBP;RAB8B;BAG6;SGTA
1141,prerank,Positive Regulation Of Nucleic Acid-Templated Transcription (GO:1903508),0.10040436263486587,0.7650383411160454,0.753448275862069,0.8933860433628937,1.0,22/47,38.63%,APOE;NPM1;TGFB1;XRCC6;PSMC5;AGT;HMGA1;COL1A1;RBBP4;CD74;HMGA2;CDH1;HNRNPAB;ILK;RUVBL1;HNRNPD;RUVBL2;AKR1B1;UBE2V1;SF3B3;ILF2;DNM2
1142,prerank,Non-Membrane-Bounded Organelle Assembly (GO:0140694),0.15975720775979388,0.7647211562567607,0.7576301615798923,0.8926912915156453,1.0,12/17,56.22%,NPM1;GRB7;RPS3;DYNC1H1;TMOD2;RCC1;EIF2S1;DDX6;RPS23;MAPRE2;LSM3;MAPRE1
1143,prerank,Chemical Synaptic Transmission (GO:0007268),-0.17460620027279136,-0.7637589924639605,0.75,1.0,1.0,6/13,26.94%,PCDHB2;STXBP2;NRXN1;NAPA;MAPK1;RPS6KA3
1144,prerank,Plasma Membrane Bounded Cell Projection Organization (GO:0120036),-0.1386104285969822,-0.763107651789863,0.7692307692307693,1.0,1.0,11/20,39.80%,SLC9A3R1;NEDD4;CNTN4;LGI1;CDK16;HMGB1;PTPRM;PHPT1;MAP4;PRMT1;CORO1B
1145,prerank,Limb Development (GO:0060173),0.27121463578994975,0.7626068389026713,0.7915057915057915,0.8947393291814207,1.0,4/5,53.77%,COMP;SMOC1;PCSK5;DKK1
1146,prerank,Oligosaccharide Metabolic Process (GO:0009311),-0.23650234741784038,-0.7623397372022466,0.7724288840262582,1.0,1.0,7/7,76.50%,ST3GAL6;FUT3;NAGA;MANBA;NEU1;GLA;B4GALT1
1147,prerank,Regulation Of Protein Localization To Nucleus (GO:1900180),0.19924708143017505,0.7620868810852004,0.7616487455197133,0.8943886962408503,1.0,3/10,12.22%,F2;TGFB1;YWHAZ
1148,prerank,Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001236),0.21225613253648368,0.7609284947462094,0.7518518518518519,0.8950211874674328,1.0,5/9,35.77%,THBS1;AGT;GSTP1;AKR1B1;ETFA
1149,prerank,AMP Biosynthetic Process (GO:0006167),0.23175008488453455,0.7602097990378588,0.7728085867620751,0.8949383506951549,1.0,3/7,21.10%,ATIC;PAICS;APRT
1150,prerank,Mesenchymal Cell Differentiation (GO:0048762),-0.17958243156187684,-0.7600543012367493,0.7437070938215103,1.0,1.0,11/12,73.35%,LOXL2;NOTCH4;CTNNB1;SEMA3C;TRIM28;DDX17;DDX5;ROCK2;HNRNPAB;LIMS1;HMGA2
1151,prerank,Establishment Of Protein Localization To Extracellular Region (GO:0035592),0.2245045847093299,0.7597959888781716,0.7721280602636534,0.8944250609524104,1.0,6/8,53.95%,FGG;PRF1;COPG1;PDIA4;AFM;MTTP
1152,prerank,Ribosomal Large Subunit Assembly (GO:0000027),0.2533724340175953,0.75924180370125,0.7481751824817519,0.8941236262616404,1.0,6/6,74.75%,RPLP0;RPL11;RPL5;NOP2;RPL6;RPL23A
1153,prerank,Regulation Of Transcription By RNA Polymerase II (GO:0006357),-0.06067421462639544,-0.759058133968302,0.782016348773842,1.0,1.0,48/115,34.66%,BRD4;COPS2;CTBP1;LOXL2;NOTCH4;MTA2;PPP1R12A;ANXA2;STXBP2;HMGB2;SMARCA4;CRYM;BCLAF1;WDR5;UBE2I;DNAJA3;AEBP1;FUS;STAT5B;MAPK14;DDX3X;TIAL1;HCFC1;STAT1;VEGFA;STAT3;ARRB1;ZNF239;MED6;PARK7;DEK;PPP3CA;MIDEAS;RPS6KA3;HMGB1;CDC5L;PDE2A;RBBP7;CTNNB1;BMP4;COPS5;PRKAR1A;DNAJB1;HMGB3;ACTL6A;ACTR2;NAMPT;TCERG1
1154,prerank,Mesenchymal Cell Migration (GO:0090497),0.23767605633802824,0.7580195799666395,0.7713754646840149,0.8948484389089064,1.0,7/7,76.33%,CORO1C;SEMA3B;SEMA4B;SEMA3A;SEMA3C;SEMA3F;SEMA7A
1155,prerank,Cell Projection Assembly (GO:0030031),0.2713950762016414,0.757651264954626,0.7911275415896488,0.894246649707383,1.0,5/5,72.94%,GSN;PARVB;CYFIP2;PDGFA;NCKAP1
1156,prerank,ERBB Signaling Pathway (GO:0038127),0.18434466252840537,0.7570972303570802,0.7644859813084112,0.8939375773255156,1.0,4/12,16.54%,TGFB1;EFEMP1;GRB7;PIGR
1157,prerank,Generation Of Neurons (GO:0048699),-0.1500393774985833,-0.7564669244944452,0.7697368421052632,1.0,1.0,10/17,42.49%,ACSL4;KIAA0319L;MTPN;TUBB2B;LRP4;MAP2K1;PCSK9;ELP3;SEMA3A;USP9X
1158,prerank,Plasma Membrane Organization (GO:0007009),-0.19998868784912888,-0.7558655629167256,0.7780320366132724,1.0,1.0,3/9,11.63%,FLOT1;SMPD1;SLC9A3R1
1159,prerank,Positive Regulation Of Mononuclear Cell Migration (GO:0071677),0.27080890973036353,0.7551838650871868,0.7601476014760148,0.8956013972201168,1.0,5/5,73.00%,SERPINE1;C1QBP;PLA2G7;CALR;HMGB1
1160,prerank,Steroid Metabolic Process (GO:0008202),0.2014197157746293,0.7546163872920721,0.7663551401869159,0.8953184484806258,1.0,9/10,70.78%,AKR1C3;FDXR;CBR1;AKR1C2;LRP2;SULT2A1;HSD17B10;SULT1E1;DHRS11
1161,prerank,Monocarboxylic Acid Biosynthetic Process (GO:0072330),0.2774285652609786,0.7539713857717724,0.758220502901354,0.8951248914619969,1.0,2/5,14.09%,FASN;ACLY
1162,prerank,Actomyosin Structure Organization (GO:0031032),0.17395940810658428,0.7532146021547091,0.7535971223021583,0.8950428882312205,1.0,7/14,34.19%,KRT19;WDR1;MYH9;TMOD2;TPM1;ROCK2;MYH10
1163,prerank,Protein Methylation (GO:0006479),-0.18355008528047745,-0.7531474510378487,0.7640449438202247,1.0,1.0,10/11,72.24%,PCMT1;GSPT1;FAM98B;CARM1;SNRPB;PRMT1;RAB6A;ETF1;PRMT5;BHMT
1164,prerank,Regulation Of Monoatomic Ion Transmembrane Transporter Activity (GO:0032412),0.23497242408797128,0.7529479242530743,0.7804428044280443,0.8942656808091083,1.0,3/7,21.86%,RELN;APP;YWHAE
1165,prerank,Regulation Of Telomere Maintenance (GO:0032204),-0.26283149424860963,-0.7519644236132118,0.8004201680672269,1.0,1.0,2/5,12.10%,UPF1;RAD50
1166,prerank,Muscle Contraction (GO:0006936),-0.1753972925250147,-0.7513899275692745,0.7850678733031674,1.0,1.0,12/12,82.64%,PABPN1;TPM3;ASPH;TPM4;MYLK;MYLK2;TTN;ROCK2;TPM1;TMOD2;MYL6;ALDOA
1167,prerank,Membrane Fission (GO:0090148),-0.25067301080374843,-0.7513716306822329,0.7510822510822511,1.0,1.0,4/6,40.62%,VPS36;TSG101;VPS25;SH3GLB1
1168,prerank,Keratinocyte Differentiation (GO:0030216),0.2631350285220117,0.7499536944367493,0.7719298245614035,0.8974525216768843,1.0,2/5,15.31%,AKR1C3;KRT10
1169,prerank,Protein Depolymerization (GO:0051261),0.2502273365772658,0.7497771883923375,0.7759259259259259,0.8965680724334765,1.0,2/6,10.52%,GSN;WDR1
1170,prerank,Protein Localization To Membrane (GO:0072657),0.13570806045719372,0.7488341112112771,0.7743589743589744,0.8968026234142399,1.0,12/23,40.44%,AGRN;FLNA;SPTBN1;EZR;PIGR;EHD3;RAB11B;AP3D1;CDH1;ROCK2;EHD1;CPE
1171,prerank,Positive Regulation Of Interleukin-8 Production (GO:0032757),0.19635508524397405,0.7486422772840796,0.7763401109057301,0.8959302412462482,1.0,10/10,80.48%,HSPA1A;CNTN1;SERPINE1;CD74;CHI3L1;APOA2;RAB1A;HMGB1;PARK7;STAT3
1172,prerank,Glycoprotein Biosynthetic Process (GO:0009101),-0.24374039732407823,-0.7476972187832519,0.7547568710359408,1.0,1.0,2/6,7.07%,ST3GAL1;ST3GAL6
1173,prerank,Fructose Metabolic Process (GO:0006000),0.24574780058651036,0.7474189698117768,0.7735124760076776,0.896528346765172,1.0,6/6,75.51%,ALDOC;ALDOA;SORD;FBP1;ALDOB;KHSRP
1174,prerank,Positive Regulation Of Lamellipodium Organization (GO:1902745),-0.16902237926972907,-0.7468894362733173,0.7931034482758621,1.0,1.0,13/13,83.28%,SRC;TWF2;NCKAP1;ACTR2;CORO1B;ENPP2;CDC42;VIL1;ARPC2;FSCN1;ACTR3;RAC1;CORO1C
1175,prerank,Endoplasmic Reticulum To Golgi Vesicle-Mediated Transport (GO:0006888),0.13144771620713586,0.7457571790152886,0.7961335676625659,0.897847677395425,1.0,20/24,71.19%,HYOU1;COPA;USO1;LMAN2;COPB1;ARF4;COPB2;SEC24C;ARCN1;COPG1;SEC31A;RAB1B;SAR1A;SEC24A;RAB1A;RAB2A;COPE;SCFD1;SAR1B;SEC13
1176,prerank,Stem Cell Differentiation (GO:0048863),-0.2678780773739742,-0.7446570717198702,0.7580299785867237,1.0,1.0,5/5,73.35%,NELFB;CTNNB1;UFL1;PSMD11;HMGA2
1177,prerank,Cellular Response To Glucose Stimulus (GO:0071333),-0.23211301107786306,-0.744319503869151,0.7813852813852814,1.0,1.0,4/7,32.44%,PRKAA1;PCK1;TRA2B;PRKACA
1178,prerank,Positive Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001244),0.20757898733316665,0.7438464364437264,0.7794117647058824,0.8995364163148049,1.0,6/9,47.98%,RACK1;RPS3;SFPQ;DNM1L;RPS7;EIF5A
1179,prerank,Neuron Migration (GO:0001764),-0.19432946433002654,-0.7433280710909248,0.7915742793791575,1.0,1.0,8/10,59.26%,KIAA0319L;TUBB2B;VEGFA;ELP3;SEMA3A;USP9X;PAFAH1B1;NEO1
1180,prerank,Positive Regulation Of Actin Filament Polymerization (GO:0030838),0.2713950762016413,0.7430180836314929,0.7809694793536804,0.8995965492646981,1.0,5/5,72.94%,PFN1;PFN2;VASP;ARF6;NCKAP1
1181,prerank,Protein Localization To Organelle (GO:0033365),-0.11297883106195863,-0.7422895363903252,0.7990543735224587,1.0,1.0,12/28,30.27%,IPO4;OBSCN;GBF1;PRKAA1;DNAJA1;DDX3X;TOLLIP;TOR1B;RPA2;ARL3;ARF6;BMP4
1182,prerank,Cytoplasmic Translational Initiation (GO:0002183),0.14606828789136436,0.742161888107049,0.7760942760942761,0.8997276376346998,1.0,10/19,39.45%,EIF5;EIF4A1;EIF6;EIF3C;EIF3K;EIF3F;EIF3L;EIF3B;EIF3E;EIF4A2
1183,prerank,Protein Localization To Cell Surface (GO:0034394),0.24370723322600465,0.7413688511936967,0.800383877159309,0.899779973986896,1.0,2/6,11.10%,FLNA;FBLN5
1184,prerank,Myeloid Cell Differentiation (GO:0030099),-0.22411275575349918,-0.7407599486169147,0.782051282051282,1.0,1.0,5/7,48.10%,JAK2;SLC1A5;UFL1;RPS19;PRDX3
1185,prerank,Positive Regulation Of Lamellipodium Assembly (GO:0010592),0.21491485613623026,0.7388656008270676,0.8059701492537313,0.9021713142834148,1.0,8/8,78.61%,RAC1;ACTR3;FSCN1;ARPC2;CDC42;ACTR2;NCKAP1;TWF2
1186,prerank,Regulation Of Interferon-Alpha Production (GO:0032647),0.2651009471073412,0.7385667983341698,0.7919847328244275,0.9014913636358352,1.0,3/5,35.18%,DHX9;HSPD1;PTPRS
1187,prerank,Cellular Response To Ionizing Radiation (GO:0071479),-0.22424143295215662,-0.7382962983708623,0.8113207547169812,1.0,1.0,5/7,47.81%,BABAM2;MAPK14;EEF1D;RPL26;FIGNL1
1188,prerank,Circulatory System Development (GO:0072359),-0.16168559501832175,-0.7381503665823227,0.8086021505376344,1.0,1.0,10/14,53.59%,NOTCH4;PDLIM5;SRI;CACYBP;COL3A1;PTPN11;CDH5;PDLIM1;PCSK5;FBN1
1189,prerank,Membrane Assembly (GO:0071709),-0.24236633029584628,-0.7372770675235335,0.8187633262260128,1.0,1.0,2/6,7.66%,ANXA2;NRXN1
1190,prerank,Regulation Of Actin Filament-Based Process (GO:0032970),0.18059506124231228,0.7366467342006349,0.7673992673992674,0.9031374748144823,1.0,6/12,33.49%,EZR;RAC1;LRP1;CORO1A;FSCN1;ROCK2
1191,prerank,Regulation Of Proteolysis (GO:0030162),0.2480938416422287,0.7353642959743705,0.8,0.9038358310021348,1.0,6/6,75.28%,F2;CST3;KNG1;CYFIP2;ASPH;BAG6
1192,prerank,Pyrimidine Nucleobase Metabolic Process (GO:0006206),0.26627823036063564,0.7352290428635684,0.8029465930018416,0.9028652698891466,1.0,2/5,15.02%,DPYSL5;DPYSL2
1193,prerank,Negative Regulation Of Apoptotic Signaling Pathway (GO:2001234),0.17284594581049806,0.7348480405692458,0.7907801418439716,0.9022759897802771,1.0,3/13,7.60%,CLU;HSPA1A;THBS1
1194,prerank,Negative Regulation Of Protein Catabolic Process (GO:0042177),0.18143659465823195,0.7343889271730523,0.8214936247723132,0.9017483281180925,1.0,9/11,65.05%,HSP90AB1;FLNA;CST3;SF3B3;TIMP1;NQO1;TIMP3;CTSA;TIMP2
1195,prerank,Regulation Of Cell Size (GO:0008361),0.22452835356891357,0.7337924660002613,0.8162878787878788,0.9014490094804412,1.0,4/7,36.29%,EZR;RAC1;PLEK;MSN
1196,prerank,Response To Interleukin-1 (GO:0070555),-0.2114419135050244,-0.7336461095711512,0.7995495495495496,1.0,1.0,3/8,14.96%,SMPD1;UPF1;SRC
1197,prerank,Vesicle-Mediated Transport To The Plasma Membrane (GO:0098876),0.20554228553254805,0.7324968621824682,0.7992766726943942,0.9020836496902578,1.0,5/9,36.59%,EHD3;RAB11B;VPS35;RAB14;EHD1
1198,prerank,Negative Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090101),-0.14476872114743647,-0.7317784902501357,0.8134831460674158,1.0,1.0,16/17,79.31%,ADAMTSL2;SNX6;FKBP1A;STRAP;PEG10;RBBP7;LRP2;SORL1;DKK1;CHRD;CD109;HDAC1;SF3B3;RBBP4;EMILIN1;LRP1
1199,prerank,Protein Deacylation (GO:0035601),-0.23917139763231854,-0.7307778816737819,0.8244444444444444,1.0,1.0,4/6,41.50%,LYPLA2;PPT1;LYPLAL1;LYPLA1
1200,prerank,Regulation Of Stem Cell Differentiation (GO:2000736),-0.2172636523781562,-0.7292571006805524,0.8484848484848485,1.0,1.0,8/8,78.43%,MTA2;NELFB;RBBP7;NUDT21;HNRNPU;HDAC1;PRKDC;RBBP4
1201,prerank,Regulation Of T Cell Proliferation (GO:0042129),-0.2213844561618038,-0.728759845836835,0.8004434589800443,1.0,1.0,5/7,47.98%,HLA-G;JAK2;PNP;TFRC;VCAM1
1202,prerank,Cellular Response To Amyloid-Beta (GO:1904646),0.2394368533298356,0.7287191952096912,0.7944732297063903,0.9062972247745716,1.0,5/6,60.26%,APP;LRP1;CACNA2D1;VCAM1;ICAM1
1203,prerank,"mRNA Cis Splicing, Via Spliceosome (GO:0045292)",0.25731032748965466,0.7285742391333017,0.7920604914933838,0.9053338265847377,1.0,2/5,16.13%,SRSF1;HNRNPC
1204,prerank,Positive Regulation Of Cell Cycle Process (GO:0090068),-0.17249770706920844,-0.7276141767395901,0.8129175946547884,1.0,1.0,9/12,56.81%,RANBP1;RRM2B;CUL3;DYNC1LI1;RRM1;NUMA1;NSFL1C;TPR;CDC42
1205,prerank,Organophosphate Biosynthetic Process (GO:0090407),-0.26027051182970684,-0.7275437129120761,0.8264642082429501,1.0,1.0,3/5,32.38%,GALK2;GPHN;PCYT2
1206,prerank,Negative Regulation Of Intracellular Steroid Hormone Receptor Signaling Pathway (GO:0033144),-0.2617536292225121,-0.7267919147671197,0.8157894736842105,1.0,1.0,2/5,12.39%,SMARCA4;STRN3
1207,prerank,DNA Duplex Unwinding (GO:0032508),0.1987394092781236,0.7237468318311938,0.7937384898710865,0.9110597841190644,1.0,7/9,59.09%,DHX9;HMGA1;DDX1;SSBP1;DTD1;PURA;RECQL
1208,prerank,Actin Nucleation (GO:0045010),0.19732800118185548,0.7232237722461494,0.8181818181818182,0.9094495005031208,1.0,7/9,59.32%,ARPC4;ACTR3;ARPC2;ARPC5;ARPC3;ARPC1B;ARPC5L
1209,prerank,Arp2/3 Complex-Mediated Actin Nucleation (GO:0034314),0.19732800118185548,0.7232237722461494,0.8181818181818182,0.9094495005031208,1.0,7/9,59.32%,ARPC4;ACTR3;ARPC2;ARPC5;ARPC3;ARPC1B;ARPC5L
1210,prerank,Regulation Of Cytokinesis (GO:0032465),-0.26201641266119574,-0.7229029503562955,0.7907488986784141,1.0,1.0,5/5,73.93%,CUL3;PRPF40A;SH3GLB1;CDC42;CALM1
1211,prerank,mRNA Splice Site Recognition (GO:0006376),0.25873440855209534,0.7220403408267967,0.8089887640449438,0.9100025292008355,1.0,2/5,16.13%,SRSF1;HNRNPC
1212,prerank,mRNA Stabilization (GO:0048255),-0.16531069584877078,-0.7214221890806166,0.8435374149659864,1.0,1.0,5/13,20.92%,FUS;IGF2BP2;MAPK14;CIRBP;IGF2BP1
1213,prerank,Proton Motive Force-Driven ATP Synthesis (GO:0015986),0.2251245365443934,0.72088048777878,0.7937956204379562,0.9081404370387103,1.0,6/7,63.82%,ATP5F1B;NDUFA9;NDUFS1;SDHA;NDUFV1;SDHB
1214,prerank,Proton Motive Force-Driven Mitochondrial ATP Synthesis (GO:0042776),0.2251245365443934,0.72088048777878,0.7937956204379562,0.9081404370387103,1.0,6/7,63.82%,ATP5F1B;NDUFA9;NDUFS1;SDHA;NDUFV1;SDHB
1215,prerank,Oxidative Phosphorylation (GO:0006119),0.2251245365443934,0.72088048777878,0.7937956204379562,0.9081404370387103,1.0,6/7,63.82%,ATP5F1B;NDUFA9;NDUFS1;SDHA;NDUFV1;SDHB
1216,prerank,Cellular Response To Transforming Growth Factor Beta Stimulus (GO:0071560),-0.13258136881649626,-0.7203038783545151,0.8288288288288288,1.0,1.0,4/20,5.49%,PTPRK;LTBP2;USP15;FERMT2
1217,prerank,Epithelial Cell Migration (GO:0010631),-0.25281078400303914,-0.7183451825318129,0.8132780082987552,1.0,1.0,3/5,33.08%,LOXL2;STAT1;DPP4
1218,prerank,Rho Protein Signal Transduction (GO:0007266),-0.23695014662756597,-0.7181135826423319,0.8263598326359832,1.0,1.0,6/6,76.45%,ARHGDIA;ARHGAP1;COL1A2;CDC42;ROCK2;CFL1
1219,prerank,Negative Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903051),0.221244131455399,0.7171578652035568,0.8461538461538461,0.9121040425432578,1.0,7/7,77.97%,HSP90AB1;RPL11;RPL5;RPS7;RPL17;CSNK2A1;SGTA
1220,prerank,Regulation Of Dendrite Morphogenesis (GO:0048814),-0.2553219792389991,-0.7157327351004993,0.8298755186721992,1.0,1.0,2/5,12.27%,CAPRIN1;NEDD4
1221,prerank,Negative Regulation Of mRNA Catabolic Process (GO:1902373),-0.18547201123710774,-0.7150684397101962,0.8211764705882353,1.0,1.0,9/10,71.19%,FUS;CIRBP;IGF2BP1;ELAVL1;PABPC1;HNRNPU;YBX1;HNRNPD;HNRNPAB
1222,prerank,Regulation Of Early Endosome To Late Endosome Transport (GO:2000641),-0.22441886564342275,-0.7145233854759746,0.8218884120171673,1.0,1.0,5/7,48.16%,SRC;MAPK1;RAB21;MAP2K1;MAPK3
1223,prerank,Positive Regulation Of Protein Localization To Membrane (GO:1905477),0.19460928099346525,0.7142249834402229,0.8,0.9149959899795974,1.0,8/9,70.72%,CEMIP;SPTBN1;LRP1;KIF5B;CD81;NMT1;ITGB1;ARF6
1224,prerank,Spliceosomal snRNP Assembly (GO:0000387),0.1643959563009299,0.7130953378030698,0.8094435075885329,0.915297349901637,1.0,7/14,35.36%,SNRPD3;PRPF19;HNRNPC;SNRPD1;SNRPD2;PRMT5;WDR77
1225,prerank,Positive Regulation Of Stem Cell Population Maintenance (GO:1902459),-0.21713615023474178,-0.7128041331870322,0.8273092369477911,1.0,1.0,7/7,78.43%,SMARCA4;RBBP7;ACTL6A;HDAC1;SF3B3;BRD9;RBBP4
1226,prerank,Positive Regulation Of Intracellular Transport (GO:0032388),-0.21734650220102866,-0.7127145892581074,0.8343949044585988,1.0,1.0,6/7,63.53%,NEDD4;B3GAT3;NUMA1;SORL1;TPR;EHD1
1227,prerank,Cellular Response To Peptide Hormone Stimulus (GO:0071375),0.19442361423422078,0.7116179080072875,0.8395522388059702,0.9160440546882108,1.0,7/9,59.44%,PKM;PCK2;PARP1;PRKDC;PKLR;EPRS1;PCSK9
1228,prerank,Response To Type II Interferon (GO:0034341),0.21162818369954176,0.7103587627705756,0.8080614203454894,0.916546010509319,1.0,4/8,30.74%,GAPDH;CD74;CALM1;CCL20
1229,prerank,Protein Heterooligomerization (GO:0051291),0.21889671361502333,0.7086416824944877,0.832089552238806,0.9177845366188198,1.0,7/7,78.20%,KRT1;KRT10;MAT2A;FARSB;CPSF6;NUDT21;FARSA
1230,prerank,Cell-Substrate Junction Assembly (GO:0007044),0.2058033976564616,0.707070624835994,0.8207024029574861,0.9187017166240448,1.0,2/8,6.78%,FN1;LAMC1
1231,prerank,Maintenance Of Protein Localization In Organelle (GO:0072595),-0.24816369828503151,-0.7046009755836706,0.854389721627409,1.0,1.0,3/5,33.78%,SKP1;HK2;HK1
1232,prerank,Positive Regulation Of Stress-Activated MAPK Cascade (GO:0032874),0.18930041152263377,0.7042228590978002,0.824468085106383,0.9214480043588698,1.0,10/10,81.18%,SERPINF2;CCN2;APP;SORD;SDCBP;SEMA3A;PRMT1;BMP4;HMGB1;VEGFA
1233,prerank,Synapse Organization (GO:0050808),0.13540845580834143,0.7037329259554835,0.8415672913117547,0.920916826451941,1.0,11/20,43.31%,SPOCK2;AGRN;PTPRF;APP;TNC;CDH1;PTPRD;PTK7;PTPRS;DCTN1;CDC42
1234,prerank,Positive Regulation Of RNA Splicing (GO:0033120),0.18468080688495148,0.7032695441422815,0.8385321100917431,0.920361251506347,1.0,3/10,13.15%,HSPA1A;NCL;PRDX6
1235,prerank,Clathrin-Dependent Endocytosis (GO:0072583),0.23230992064800127,0.7028898055980508,0.8467432950191571,0.9197186002899852,1.0,4/6,44.71%,CLTC;AP2M1;AP2B1;CLTA
1236,prerank,Carboxylic Acid Catabolic Process (GO:0046395),0.2527702754615153,0.7027717328023066,0.874,0.9187540991833937,1.0,3/5,35.77%,ETFB;TST;ETFA
1237,prerank,Pentose-Phosphate Shunt (GO:0006098),-0.22889296946303447,-0.701523411493952,0.8473118279569892,1.0,1.0,2/6,8.83%,SHPK;DERA
1238,prerank,Positive Regulation Of Signaling Receptor Activity (GO:2000273),-0.25081089716935634,-0.7007503666139523,0.8354978354978355,1.0,1.0,3/5,32.73%,JAK2;PARK7;ITGB1
1239,prerank,Cellular Response To Type II Interferon (GO:0071346),-0.2140651661356199,-0.6992396449790915,0.8503118503118503,1.0,1.0,3/7,19.58%,JAK2;STAT1;RPL13A
1240,prerank,Regulation Of Insulin Receptor Signaling Pathway (GO:0046626),0.231756656683576,0.6990194089800087,0.8261682242990654,0.9222248301329714,1.0,2/6,11.86%,GRB7;IGF2
1241,prerank,Neuron Projection Development (GO:0031175),-0.1284039042610755,-0.6943868161279223,0.8775510204081632,1.0,1.0,10/19,38.34%,MAP4K4;NEDD4;CNTN4;LGI1;CDK16;HMGB1;NCKAP1;PTPRM;MAP4;PRMT1
1242,prerank,Cell-Cell Junction Assembly (GO:0007043),0.1663056916256017,0.6940178635272009,0.8443649373881932,0.9275588981284523,1.0,6/12,34.83%,TLN1;WDR1;FSCN1;CDH1;CDH11;RHOC
1243,prerank,Actin Filament Bundle Assembly (GO:0051017),0.23884522580712594,0.6940055268175552,0.8444022770398482,0.9264321670251582,1.0,3/6,28.35%,HSP90B1;EZR;FSCN1
1244,prerank,Regulation Of Lamellipodium Morphogenesis (GO:2000392),-0.2260543148689472,-0.690845693964179,0.8512035010940919,1.0,1.0,5/6,60.02%,CD44;SRC;CORO1B;ENPP2;VIL1
1245,prerank,Positive Regulation Of Organelle Assembly (GO:1902117),-0.1634128859143693,-0.6908002722828673,0.8590308370044053,1.0,1.0,4/12,15.31%,CAPRIN1;PIP4K2A;RAB3GAP2;G3BP1
1246,prerank,Antigen Receptor-Mediated Signaling Pathway (GO:0050851),-0.23382375833731053,-0.6891879857117194,0.8471074380165289,1.0,1.0,2/6,8.47%,EIF2B4;CSK
1247,prerank,T Cell Receptor Signaling Pathway (GO:0050852),-0.23382375833731053,-0.6891879857117194,0.8471074380165289,1.0,1.0,2/6,8.47%,EIF2B4;CSK
1248,prerank,Positive Regulation Of Dephosphorylation (GO:0035306),-0.18851321611626753,-0.6884344509548597,0.8501118568232662,1.0,1.0,6/9,46.29%,SMPD1;SRC;PTPA;PPP1R7;CDH5;PTBP1
1249,prerank,Glutamate Metabolic Process (GO:0006536),0.22932386509483327,0.6877302344014109,0.8605577689243028,0.9330367900045273,1.0,2/6,12.51%,GLUD1;OAT
1250,prerank,Protein Targeting To Mitochondrion (GO:0006626),0.21709127827813943,0.6874733884076061,0.8670520231213873,0.9322176476462395,1.0,4/7,37.11%,HSP90AA1;HSPD1;HSPA4;PMPCA
1251,prerank,Regulation Of Double-Strand Break Repair Via Homologous Recombination (GO:0010569),-0.17740545607130748,-0.686632270058626,0.8650442477876106,1.0,1.0,9/10,71.42%,MMS19;FUS;RPA2;ACTL6A;ACTR2;FIGNL1;RUVBL2;RUVBL1;PARP1
1252,prerank,Negative Regulation Of Canonical Wnt Signaling Pathway (GO:0090090),-0.14542964920044316,-0.6861696434973252,0.8830022075055187,1.0,1.0,10/15,50.50%,SLC9A3R1;IGFBP4;SDHAF2;LRP4;IGFBP1;DKK3;RBX1;IGFBP2;DKK1;DKK4
1253,prerank,Maturation Of 5.8S rRNA (GO:0000460),-0.23856975381008205,-0.6861034874298564,0.8625498007968128,1.0,1.0,5/5,76.27%,NEDD4;EXOSC4;MTREX;PRKDC;EIF6
1254,prerank,Cellular Response To Growth Factor Stimulus (GO:0071363),0.11852125374352798,0.6846304264551379,0.8336192109777015,0.9344908844481931,1.0,24/25,84.57%,EEF1A1;TGFB1;RACK1;CLEC3B;APLP2;LIMS1;IQGAP1;EHD1;HSPB1;VIL1;HDAC1;HYAL1;MARS1;LRP2;CORO1B;PTPN11;CPNE3;BMP4;CTNNB1;PDE2A;TWF2;VEGFA;MAPK14;STAT5B
1255,prerank,Negative Regulation Of Protein-Containing Complex Assembly (GO:0031333),-0.16839597578723514,-0.6845136016375838,0.8924485125858124,1.0,1.0,5/11,27.12%,SRC;DDX3X;RPL13A;PARK7;HMGB1
1256,prerank,Collagen Fibril Organization (GO:0030199),0.1366630661553204,0.6844973309430121,0.866785079928952,0.9334883253969333,1.0,7/18,27.00%,LUM;SERPINF2;COL18A1;COL1A1;PLOD3;COL2A1;SERPINH1
1257,prerank,mRNA Transport (GO:0051028),0.17166407496023156,0.6843752231704033,0.8628884826325411,0.9324995018365563,1.0,7/11,47.81%,DDX39B;SRSF3;EIF4A3;HNRNPA2B1;TPR;XPO1;MAGOH
1258,prerank,Regulation Of Cell-Cell Adhesion (GO:0022407),0.228185054007348,0.6841379034965044,0.856401384083045,0.9316328707054594,1.0,3/6,28.87%,TGFB1;FERMT3;CDH1
1259,prerank,Positive Regulation Of DNA Metabolic Process (GO:0051054),-0.14908662345315263,-0.6832848635583638,0.8704545454545455,1.0,1.0,14/14,85.27%,BABAM2;RAD50;HMGB1;ACTL6A;TRIM28;USP9X;USP7;UBE2N;RUVBL2;RUVBL1;HNRNPAB;PCNA;RPS3;DHX9
1260,prerank,Regulation Of Fat Cell Differentiation (GO:0045598),-0.22043123628735678,-0.682402340751553,0.8552631578947368,1.0,1.0,4/6,42.96%,FERMT2;CARM1;SULT1E1;FTO
1261,prerank,Negative Regulation Of Cellular Response To Growth Factor Stimulus (GO:0090288),-0.18688021652138345,-0.6822954477236277,0.8537117903930131,1.0,1.0,6/9,46.76%,NEDD4;NIBAN2;GPC1;LRP2;SORL1;CHRD
1262,prerank,Cellular Response To Glucose Starvation (GO:0042149),-0.24141972824541325,-0.6812162670383703,0.8625792811839323,1.0,1.0,2/5,14.03%,TBL2;PRKAA1
1263,prerank,Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043122),-0.10729468186289301,-0.6809237276443694,0.8682352941176471,1.0,1.0,8/26,18.76%,BRD4;LGALS1;CPNE1;APOL2;TRIM25;TFG;FKBP1A;STAT1
1264,prerank,Negative Regulation Of Nucleic Acid-Templated Transcription (GO:1903507),-0.08551389129238307,-0.679958932883737,0.8611111111111112,1.0,1.0,22/43,41.20%,PTPRK;CTBP1;LOXL2;MTA2;HMGB2;SMARCA4;BCLAF1;UBE2I;SNX6;NIBAN2;CCAR2;ILF3;MIDEAS;RBBP7;CTNNB1;BMP4;PDCD4;GCLC;DKK3;HNRNPL;TRIM28;CALR
1265,prerank,Nucleocytoplasmic Transport (GO:0006913),-0.19516656603862415,-0.679447232543206,0.8598726114649682,1.0,1.0,4/8,28.93%,NUP93;UBE2I;RANGAP1;SEC13
1266,prerank,Negative Regulation Of Catalytic Activity (GO:0043086),0.21034172279724844,0.6791999034698228,0.8538011695906432,0.9363841475115793,1.0,4/7,37.81%,SERPINA5;CAND1;HP;TIMP1
1267,prerank,Serine Family Amino Acid Biosynthetic Process (GO:0009070),-0.2450175849941383,-0.6781519540281464,0.8893528183716075,1.0,1.0,5/5,75.63%,PSPH;GGT1;SERINC5;MTHFD1;PSAT1
1268,prerank,Primary Alcohol Catabolic Process (GO:0034310),-0.2437608519104116,-0.6742659941026228,0.882,1.0,1.0,4/5,54.65%,SULT1A3;SULT1E1;SULT2A1;SULT1A1
1269,prerank,Regulation Of RNA Export From Nucleus (GO:0046831),0.24384525205158256,0.673780293054115,0.8747628083491461,0.9414724914262633,1.0,5/5,75.69%,DHX9;KHDRBS1;TPR;CPSF6;SUPT6H
1270,prerank,Mitotic Metaphase Plate Congression (GO:0007080),0.20657276995305168,0.6718362191006785,0.850828729281768,0.942590460000985,1.0,7/7,79.43%,EML4;KPNB1;PDCD6IP;NUDC;MAPRE1;DCTN2;CUL3
1271,prerank,Regulation Of Translation (GO:0006417),0.07542562768136735,0.6717552445014598,0.8631921824104235,0.9415573246832541,1.0,44/65,61.78%,GAPDH;NPM1;EIF5;EEF2;RACK1;THBS1;NCL;GRB7;SHMT2;DHX9;RPS3;APP;EIF6;PLXNB2;EIF3C;RPS4X;EIF4A3;PRKDC;HNRNPD;YBX1;RPL5;SSB;KRT13;HSPB1;EIF3B;SHMT1;EIF3E;ETF1;EIF4A2;DDX1;EIF2S1;DDX6;SERBP1;EPRS1;TCOF1;RPL26;EIF3D;EIF4E;ELP1;CALR;ELP3;NOLC1;ELAVL1;PRMT1
1272,prerank,Neuron Projection Morphogenesis (GO:0048812),-0.14595397110214897,-0.66952104021804,0.8812785388127854,1.0,1.0,6/13,30.04%,MAP4K4;CPNE1;CNTN4;LRP4;NCKAP1;CTNNB1
1273,prerank,"Regulation Of DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0043516)",-0.2379835873388042,-0.6694689606361732,0.8833693304535637,1.0,1.0,5/5,76.33%,CD44;EEF1E1;COPS3;DDX5;CD74
1274,prerank,Ribosomal Large Subunit Biogenesis (GO:0042273),-0.1399159387710645,-0.6692875282861784,0.8651162790697674,1.0,1.0,13/16,66.34%,PAK1IP1;EBNA1BP2;NEDD4;MRTO4;RPL23A;RPL6;NOP2;RPL35A;RPL26;RPL7;RPL14;RPL5;RPL11
1275,prerank,Protein Localization To Cell Periphery (GO:1990778),0.1519212053731543,0.6684135678898134,0.8772241992882562,0.9441165439374172,1.0,7/14,36.59%,FLNA;SPTBN1;EZR;EHD3;CDH1;ROCK2;EHD1
1276,prerank,Cellular Response To Peptide (GO:1901653),-0.18331374853113983,-0.6682360303061008,0.8990825688073395,1.0,1.0,9/9,81.82%,VIM;SNX6;SRC;RPL17;ICAM1;VCAM1;CACNA2D1;LRP1;APP
1277,prerank,"Retrograde Vesicle-Mediated Transport, Golgi To Endoplasmic Reticulum (GO:0006890)",-0.16470588235294117,-0.6671557819610194,0.8682505399568035,1.0,1.0,11/11,83.69%,RAB6D;GBF1;COPZ1;TAPBP;SCFD1;RAB6A;COPB2;ARF5;ARF4;LMAN2;COPA
1278,prerank,Phosphate-Containing Compound Metabolic Process (GO:0006796),0.10616414389959172,0.6665119772257354,0.8698630136986302,0.9450341962260733,1.0,18/29,53.01%,PGK1;TGFB1;ALDOC;ALDOA;G6PD;PLA2G2A;LCAT;PPA2;PTPRD;PPA1;GFPT1;GPI;TOP1;PFKL;ANGPTL3;FBP1;MAPK3;PPP1CA
1279,prerank,Cellular Response To Light Stimulus (GO:0071482),-0.14699923467157394,-0.6659791910913981,0.8853211009174312,1.0,1.0,4/14,12.27%,PTPRK;CUL4A;SMPD1;NEDD4
1280,prerank,Protein Heterotetramerization (GO:0051290),0.21876832844574773,0.6659218411133254,0.8916349809885932,0.9445314139468196,1.0,6/6,78.20%,KRT1;KRT10;FARSB;CPSF6;NUDT21;FARSA
1281,prerank,Regulation Of Cell Cycle G1/S Phase Transition (GO:1902806),0.20863907928335867,0.6658958907220924,0.8966789667896679,0.9434283558866678,1.0,3/7,23.55%,PPP2CA;APLP2;PSME2
1282,prerank,Protein Import Into Nucleus (GO:0006606),0.1444861814736052,0.6651909759671956,0.8754578754578755,0.9430932021678797,1.0,6/16,24.72%,RAN;FAM53C;NUTF2;KPNB1;APLP2;CSE1L
1283,prerank,DNA Replication (GO:0006260),-0.20065378309141282,-0.6649967147378089,0.8862660944206009,1.0,1.0,3/7,21.45%,UPF1;CDK1;RPA2
1284,prerank,Heparan Sulfate Proteoglycan Biosynthetic Process (GO:0015012),0.2073716230999214,0.6615116964267038,0.8930581613508443,0.9459859899371776,1.0,2/7,9.41%,EXT1;UGDH
1285,prerank,Heterochromatin Organization (GO:0070828),-0.1788607744559704,-0.6613636614396734,0.8837209302325582,1.0,1.0,2/9,2.86%,CTBP1;LOXL2
1286,prerank,Spliceosomal Complex Assembly (GO:0000245),-0.1165680473372781,-0.6613554661832798,0.9226932668329177,1.0,1.0,21/21,88.54%,SRSF10;SRPK1;DDX23;NCBP1;SF3B2;SF3A3;SNRPB;SF3A1;SNRPF;SNRPE;SNRPA1;SNRNP200;DDX1;SF3B3;SNRPD2;SF3B1;SNRPD1;PRPF19;SRSF1;SNRPD3;DDX39B
1287,prerank,Aminoglycan Catabolic Process (GO:0006026),-0.23270808909730362,-0.6605420458391029,0.8933333333333333,0.9997739550214338,1.0,5/5,76.86%,GUSB;GNS;HYAL1;FUCA1;CHIA
1288,prerank,intra-Golgi Vesicle-Mediated Transport (GO:0006891),-0.16470588235294117,-0.6581780983470007,0.8459770114942529,1.0,1.0,11/11,83.69%,COG2;RAB6D;NAPA;COPZ1;COPE;RAB6A;COPG1;COPB2;NSF;COPB1;COPA
1289,prerank,Regulation Of Developmental Growth (GO:0048638),0.24055240914616044,0.6580485763540131,0.8672897196261682,0.948575632455791,1.0,2/5,18.29%,APOE;APP
1290,prerank,Semaphorin-Plexin Signaling Pathway (GO:0071526),0.1716417004446597,0.650966945095017,0.8945454545454545,0.9545562002454718,1.0,4/10,24.55%,FLNA;SEMA3B;RAC1;PLXNB2
1291,prerank,Regulation Of DNA-templated Transcription (GO:0006355),-0.05215642616069297,-0.6504433923863757,0.9090909090909091,1.0,1.0,99/114,81.24%,PTPRK;BRD4;CTBP1;LOXL2;SRSF10;NOTCH4;MTA2;HMGB2;SMARCA4;MMS19;BCLAF1;WDR5;UBE2I;SNX6;PRKAA1;FUS;STAT5B;MAPK14;TIAL1;NIBAN2;HCFC1;STAT1;STAT3;ARRB1;ZNF239;MED6;CCAR2;DEK;ILF3;MIDEAS;CDK16;RPL6;RPS6KA3;HMGB1;CDC5L;SRRT;CARM1;RBBP7;CTNNB1;BMP4;PDCD4;NAA15;PRKAR1A;HMGB3;ACTL6A;GCLC;DKK3;CDK11A;HNRNPL;MAP2K1;TRIM28;ELP3;CALR;HP1BP3;ZKSCAN1;SNX5;PURA;UBA2;TFAM;NONO;YWHAH;KARS1;DDX17;GARS1;DDX5;HDAC1;QARS1;PSPC1;GPI;DNM2;ILF2;SF3B3;UBE2V1;ANXA4;AKR1B1;KHDRBS1;HINT1;PRMT5;RUVBL2;YBX1;HNRNPD;RUVBL1;ILK;HNRNPAB;CDH1;BRD9;PARP1;LIMS1;HMGA2;PPP2R1A;SFPQ;CD74;RBBP4;HNRNPK;COL1A1;PPIE;HMGA1;YWHAQ;AGT
1292,prerank,Platelet Dense Granule Organization (GO:0060155),-0.18790369935408102,-0.6491627855083046,0.9037199124726477,1.0,1.0,8/8,81.36%,AP3M1;AP1S1;AP1S2;AP3B1;AP1G1;AP1M1;AP3D1;AP1B1
1293,prerank,Melanosome Assembly (GO:1903232),-0.18790369935408102,-0.6491627855083046,0.9037199124726477,1.0,1.0,8/8,81.36%,AP3M1;AP1S1;AP1S2;AP3B1;AP1G1;AP1M1;AP3D1;AP1B1
1294,prerank,Secretory Granule Organization (GO:0033363),-0.18790369935408102,-0.6491627855083046,0.9037199124726477,1.0,1.0,8/8,81.36%,AP3M1;AP1S1;AP1S2;AP3B1;AP1G1;AP1M1;AP3D1;AP1B1
1295,prerank,Apical Junction Assembly (GO:0043297),0.1974247816267722,0.6457497557070957,0.8847583643122676,0.9587898058504145,1.0,6/8,56.63%,PARD3;WDR1;PDCD6IP;RHOC;VCL;CDH5
1296,prerank,Negative Regulation Of Lipid Catabolic Process (GO:0050995),0.2355650818540222,0.645622891339754,0.8676748582230623,0.9577593332726625,1.0,4/5,57.39%,APOC3;APOC1;APOA2;SORL1
1297,prerank,Regulation Of Transcription By RNA Polymerase I (GO:0006356),0.2338804220398594,0.6442709923358083,0.8839779005524862,0.9580003373162737,1.0,5/5,76.68%,FLNA;SF3B1;DDX21;CARM1;DEK
1298,prerank,Receptor-Mediated Endocytosis (GO:0006898),-0.1051301316595203,-0.6434824418812639,0.9021479713603818,1.0,1.0,21/26,69.26%,ASGR1;SCARB2;NEDD4;AP1S1;AP2A2;PPT1;VLDLR;CLTB;SNX1;ITGB1;DPP4;LRP2;SORL1;TFRC;CD81;CLTA;DNM2;AP2A1;AP2B1;LDLR;AP2M1
1299,prerank,protein-DNA Complex Disassembly (GO:0032986),0.233081754349321,0.643245851181861,0.88268156424581,0.9578661847323549,1.0,3/5,38.22%,HMGA1;SSRP1;SUPT16H
1300,prerank,Positive Regulation Of Immune Effector Process (GO:0002699),0.23153575615474808,0.641422813962153,0.8841121495327103,0.958578637739217,1.0,5/5,76.91%,COLEC10;APLP2;CD81;RPS19;PCK1
1301,prerank,Positive Regulation Of Endopeptidase Activity (GO:0010950),-0.23563892145369283,-0.6398937005997208,0.9139072847682119,1.0,1.0,5/5,76.56%,STAT3;PSME1;PSME3;ROCK2;PSME2
1302,prerank,Nitrogen Compound Transport (GO:0071705),0.16481482570936412,0.6396332269167874,0.9157509157509157,0.9592328548489627,1.0,3/10,15.66%,HBB;HSP90B1;MYH9
1303,prerank,Establishment Of Protein Localization To Organelle (GO:0072594),-0.12921903324119421,-0.6383589142646109,0.927400468384075,1.0,1.0,16/17,81.01%,IPO4;IPO5;NUP93;TNPO3;STAT3;HK2;SEC13;HK1;TNPO1;TPR;IPO7;CSE1L;APLP2;KPNB1;NUTF2;FAM53C
1304,prerank,Negative Regulation Of MAP Kinase Activity (GO:0043407),-0.17893191769672934,-0.6380747462134708,0.9119638826185101,1.0,1.0,5/8,42.72%,SMPD1;DNAJA1;BMP4;PDCD4;SORL1
1305,prerank,Lipid Transport (GO:0006869),-0.15112164624437896,-0.6331270422058664,0.9154929577464789,1.0,1.0,10/12,67.15%,ACSL1;APOL2;ESYT1;FABP1;SCARB1;LYPLA1;MTTP;APOA5;APOA4;LDLR
1306,prerank,Response To Epidermal Growth Factor (GO:0070849),-0.1732933556346975,-0.6305633905292148,0.8946236559139785,1.0,1.0,8/9,71.01%,STAT5B;MAPK1;PTPN11;MARS1;MAPK3;TPR;VIL1;IQGAP1
1307,prerank,Stress Granule Assembly (GO:0034063),-0.17800882582258976,-0.6305175949479817,0.9164835164835164,1.0,1.0,6/8,56.17%,G3BP1;DDX3X;CIRBP;RPS23;DDX6;EIF2S1
1308,prerank,Response To Glucose (GO:0009749),-0.16119327670890743,-0.6300791927746542,0.9213973799126638,1.0,1.0,5/10,32.44%,EIF2B4;PRKAA1;PCK1;TRA2B;PRKACA
1309,prerank,Connective Tissue Development (GO:0061448),-0.2256740914419695,-0.6299014561690994,0.9285714285714286,1.0,1.0,5/5,77.56%,CD44;NAMPT;HYAL1;CHI3L1;COL2A1
1310,prerank,protein-DNA Complex Organization (GO:0071824),-0.17678550220262015,-0.6292586128728075,0.913135593220339,1.0,1.0,2/8,6.02%,MTA2;HMGB2
1311,prerank,Protein Targeting To Lysosome (GO:0006622),0.2090286348650596,0.625335216186114,0.9078694817658349,0.9717603506844004,1.0,2/6,14.55%,CLU;HSPA8
1312,prerank,Serine Family Amino Acid Metabolic Process (GO:0009069),0.22711291146116666,0.6244590667817422,0.8917431192660551,0.9713944816858415,1.0,3/5,38.81%,SHMT2;MTHFD1;SHMT1
1313,prerank,Positive Regulation Of mRNA Processing (GO:0050685),0.1814445096887845,0.6237184258566736,0.9247311827956989,0.9697129296973367,1.0,8/8,81.94%,NCL;PRDX6;PRMT5;WDR77;RBMX;TRA2B;CIRBP;NCBP1
1314,prerank,"Positive Regulation Of mRNA Splicing, Via Spliceosome (GO:0048026)",0.1814445096887845,0.6237184258566736,0.9247311827956989,0.9697129296973367,1.0,8/8,81.94%,NCL;PRDX6;PRMT5;WDR77;RBMX;TRA2B;CIRBP;NCBP1
1315,prerank,Leukocyte Cell-Cell Adhesion (GO:0007159),0.18952183438105064,0.6236829431734436,0.9237588652482269,0.9685927740091541,1.0,6/7,67.39%,EZR;FERMT3;MSN;VCAM1;ICAM1;ITGB1
1316,prerank,Tricarboxylic Acid Metabolic Process (GO:0072350),0.22375214193948176,0.6225079566870726,0.9153846153846154,0.968485677888785,1.0,2/5,19.93%,GLUD1;IDH1
1317,prerank,Receptor Internalization (GO:0031623),0.14732067386962233,0.6213570980790226,0.9085923217550275,0.9683255030449882,1.0,10/12,69.43%,DMBT1;CLTC;LRP1;AP2M1;DNM2;RAB5A;CD81;TFRC;ITGB1;SNX1
1318,prerank,Negative Regulation Of Innate Immune Response (GO:0045824),0.16549893403501903,0.6211885587367941,0.9216417910447762,0.9673256931103392,1.0,8/10,64.52%,YWHAZ;SERPING1;PARP1;PRKDC;TTLL12;PCBP2;RPS19;GRN
1319,prerank,"Wound Healing, Spreading Of Cells (GO:0044319)",-0.22455196922695883,-0.6211607486823416,0.9299781181619255,1.0,1.0,3/5,35.94%,CD44;ITGB1;COL5A1
1320,prerank,"Maturation Of SSU-rRNA From Tricistronic rRNA Transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.21961615020561273,0.6204251524554194,0.9144981412639405,0.9668534854184999,1.0,4/5,59.03%,RPS16;RPS14;RPS8;RPS19
1321,prerank,Regulation Of Stress-Activated MAPK Cascade (GO:0032872),-0.1777475697914141,-0.6160849791121815,0.9144144144144144,1.0,1.0,7/8,68.97%,MAP4K4;MAPK1;COPS5;MAP2K1;MAPK3;QARS1;GSTP1
1322,prerank,Metaphase Plate Congression (GO:0051310),0.2064516129032259,0.6160182606059766,0.9206642066420664,0.9696418612710789,1.0,6/6,79.43%,EML4;KPNB1;PDCD6IP;NUDC;DCTN2;CUL3
1323,prerank,'De Novo' AMP Biosynthetic Process (GO:0044208),0.2012410409006138,0.6149170243025652,0.9190647482014388,0.969459302467484,1.0,5/6,64.06%,ATIC;PAICS;GART;PFAS;ADSS1
1324,prerank,Golgi To Plasma Membrane Transport (GO:0006893),0.2102846660994319,0.608552936939054,0.9308300395256917,0.9736804264914529,1.0,3/6,31.44%,KRT18;SPTBN1;NSF
1325,prerank,Negative Regulation Of Protein Polymerization (GO:0032272),-0.17025336149862824,-0.6071412767535856,0.926829268292683,1.0,1.0,5/8,43.89%,TWF1;TBCD;TWF2;CDH5;MAPRE1
1326,prerank,Nicotinamide Nucleotide Metabolic Process (GO:0046496),-0.19589442815249267,-0.6071124009515106,0.9446902654867256,1.0,1.0,6/6,80.54%,GPD1L;MDH1;ME1;IDH2;IDH1;G6PD
1327,prerank,Mitotic Sister Chromatid Segregation (GO:0000070),0.1554665730942905,0.6067724714805598,0.9157509157509157,0.9739715145801474,1.0,4/11,22.62%,FLNA;RAN;EML4;KPNB1
1328,prerank,Regulation Of Cell Fate Specification (GO:0042659),-0.21688159437280186,-0.6043735806863464,0.9313929313929314,1.0,1.0,5/5,78.43%,MTA2;RBBP7;DKK1;HDAC1;RBBP4
1329,prerank,Response To Amyloid-Beta (GO:1904645),-0.18309859154929578,-0.6042182875714347,0.9406392694063926,1.0,1.0,7/7,81.82%,MMP2;SNX6;ICAM1;VCAM1;CACNA2D1;LRP1;APP
1330,prerank,Negative Regulation Of DNA Biosynthetic Process (GO:2000279),-0.22062178100482271,-0.6037044071076871,0.9370786516853933,1.0,1.0,2/5,16.48%,SRC;NIBAN2
1331,prerank,Regulation Of Viral Genome Replication (GO:0045069),0.15648022615897644,0.6026935466101583,0.9463955637707948,0.97621899847248,1.0,2/10,5.96%,LTF;PPIA
1332,prerank,Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045),-0.14339208641410747,-0.6019949759554439,0.9420289855072463,1.0,1.0,7/12,42.78%,SMARCA4;DDX3X;FHL1;ACTL6A;RRM1;PSME1;PSME3
1333,prerank,Negative Regulation Of Stem Cell Population Maintenance (GO:1902455),-0.21688159437280186,-0.6017231458935107,0.9527720739219713,1.0,1.0,5/5,78.43%,LOXL2;RBBP7;HDAC1;SF3B3;RBBP4
1334,prerank,miRNA Processing (GO:0035196),-0.18507419443709808,-0.6004114022463363,0.9375,1.0,1.0,6/7,66.69%,NCBP1;ZC3H7A;SRRT;GARS1;DDX5;HNRNPA2B1
1335,prerank,CRD-mediated mRNA Stabilization (GO:0070934),0.18898308869368147,0.5997072435785991,0.9280575539568345,0.977442503036241,1.0,5/7,53.71%,DHX9;HNRNPD;YBX1;HNRNPU;PABPC1
1336,prerank,Regulation Of Cellular Component Size (GO:0032535),0.17700364779214736,0.5994934781443838,0.9381044487427466,0.9764752103819133,1.0,6/8,58.56%,EZR;RAC1;MSN;PPP1CA;LARS1;HP1BP3
1337,prerank,Regulation Of RNA Metabolic Process (GO:0051252),-0.12185317565493647,-0.5983461976195767,0.9617021276595744,1.0,1.0,3/16,5.61%,RBM12;ILDR2;SNRNP70
1338,prerank,Regulation Of Calcium Ion Transmembrane Transporter Activity (GO:1901019),-0.21864009378663538,-0.5977760942244009,0.9243119266055045,1.0,1.0,5/5,78.26%,FKBP1A;PRKACA;AHNAK;CALM1;YWHAE
1339,prerank,Protein Maturation (GO:0051604),0.1120826047845816,0.5962715214692639,0.9507042253521126,0.977929362503674,1.0,4/20,10.05%,XPNPEP3;CNTN1;ADAMTS13;CPN1
1340,prerank,Negative Regulation Of Immune Response (GO:0050777),-0.16373560091761089,-0.5962436659250538,0.9287356321839081,1.0,1.0,3/9,15.60%,HLA-G;SRC;MAPK14
1341,prerank,Glycerophospholipid Biosynthetic Process (GO:0046474),0.17204932472108053,0.5956708737678867,0.9377162629757786,0.9772755925289205,1.0,8/8,82.88%,APOA1;LCAT;PMPCA;APOA2;PCYT2;PCYT1A;LIPC;SFI1
1342,prerank,Regulation Of Heart Contraction (GO:0008016),0.20032003245732755,0.5949641210280381,0.94921875,0.9766435734371247,1.0,3/6,31.68%,AGT;CALM1;TPM1
1343,prerank,Positive Regulation Of Cell Development (GO:0010720),0.20343715050917438,0.5948383405484331,0.924865831842576,0.9756143828158965,1.0,3/6,31.50%,SERPINF1;TGM2;NAP1L1
1344,prerank,Lipid Droplet Organization (GO:0034389),-0.21341946494755665,-0.594174294143432,0.9474835886214442,1.0,1.0,2/5,17.24%,PRKAA1;SFI1
1345,prerank,Inflammatory Response (GO:0006954),0.12008422828700979,0.5939069875093254,0.9372759856630825,0.9752090731690469,1.0,4/19,10.46%,TGFB1;THBS1;LYZ;HSPG2
1346,prerank,Negative Regulation Of Calcium Ion Transmembrane Transporter Activity (GO:1901020),0.18306329607678803,0.5907388924129834,0.9568480300187617,0.9764896317072936,1.0,3/7,26.18%,GSTO1;YWHAE;CALM1
1347,prerank,Regulation Of Nitric-Oxide Synthase Activity (GO:0050999),0.21219226260257912,0.5892618349374937,0.9428571428571428,0.9764895552399292,1.0,5/5,78.84%,APOE;GLA;SCARB1;DDAH2;S100A1
1348,prerank,Protein Secretion (GO:0009306),0.14168499564746787,0.5878683614888904,0.9489603024574669,0.9763473834762803,1.0,8/12,53.95%,FGG;AP1B1;PRF1;COPG1;PDIA4;AP1G1;PCSK5;MTTP
1349,prerank,Positive Regulation Of Cell Cycle (GO:0045787),-0.1795774647887324,-0.5862419408707241,0.9393939393939394,1.0,1.0,7/7,82.17%,ASNS;HCFC1;CALR;EIF4E;RPS15A;APP;ANKRD17
1350,prerank,Cardiac Ventricle Morphogenesis (GO:0003208),0.21050777815843547,0.5861053251168207,0.9351851851851852,0.9764304881565157,1.0,3/5,40.44%,TGFB1;TPM1;CPE
1351,prerank,Tight Junction Assembly (GO:0120192),0.21043376318874568,0.5843810152818344,0.9422718808193669,0.976508050783712,1.0,5/5,79.02%,PARD3;PDCD6IP;CDH5;LSR;TBCD
1352,prerank,Sphingolipid Metabolic Process (GO:0006665),-0.1650830089225993,-0.5824081205928624,0.9576837416481069,1.0,1.0,5/8,44.71%,SMPD1;PPT1;GAL3ST1;FUT3;ENPP2
1353,prerank,Regulation Of Neuron Differentiation (GO:0045664),0.1751337653045796,0.5812405639122974,0.9424460431654677,0.977556614562728,1.0,6/8,58.91%,RELN;KCTD11;YWHAG;YWHAH;DKK1;CALR
1354,prerank,Cellular Response To Epidermal Growth Factor Stimulus (GO:0071364),0.19294221202601386,0.5799940764085287,0.9440298507462687,0.9773004491303067,1.0,5/6,64.87%,EEF1A1;IQGAP1;VIL1;MARS1;PTPN11
1355,prerank,Positive Regulation Of T Cell Activation (GO:0050870),0.1401534965498671,0.5796336872270522,0.9641509433962264,0.976403801418653,1.0,4/12,21.22%,ACTB;MDK;HLA-A;HSPD1
1356,prerank,Protein Localization To Chromosome (GO:0034502),0.21395076201641272,0.5792867310455326,0.9447619047619048,0.9755025634303193,1.0,5/5,78.67%,XRCC5;PARP1;RPA1;TPP1;RPA2
1357,prerank,Regulation Of Cellular Catabolic Process (GO:0031329),-0.2092614302461899,-0.578897071052337,0.9609544468546638,1.0,1.0,5/5,79.19%,PIP4K2A;VPS29;MAPK15;HSPB1;PSAP
1358,prerank,Protein Deacetylation (GO:0006476),0.21010577798247146,0.5755308385183968,0.952,0.9767522354074408,1.0,3/5,40.97%,FLNA;RBBP4;HDAC1
1359,prerank,mRNA Export From Nucleus (GO:0006406),-0.12525879241252103,-0.5726264673024595,0.9595744680851064,1.0,1.0,5/13,24.66%,UPF1;NUP93;PABPN1;NCBP1;DDX19A
1360,prerank,Acylglycerol Catabolic Process (GO:0046464),-0.20369225254963103,-0.5713487050844632,0.9331896551724138,1.0,1.0,4/5,58.68%,LYPLA2;LIPC;APOA2;APOA5
1361,prerank,Membrane Fusion (GO:0061025),-0.19002932551319648,-0.5705780992107967,0.9433106575963719,1.0,1.0,6/6,81.12%,NAPA;DPP4;NSFL1C;DNM1L;NSF;USO1
1362,prerank,Positive Regulation Of DNA-templated Transcription (GO:0045893),-0.04919871546911758,-0.5703102635008418,0.9861111111111112,1.0,1.0,85/96,83.23%,BRD4;NOTCH4;MTA2;PPP1R12A;ANXA2;STXBP2;HMGB2;SMARCA4;MMS19;BCLAF1;WDR5;PRKAA1;STAT5B;DDX3X;NIBAN2;HCFC1;STAT1;VEGFA;STAT3;ARRB1;MED6;PARK7;DEK;PPP3CA;ILF3;RPS6KA3;HMGB1;CDC5L;CARM1;RBBP7;CTNNB1;BMP4;COPS5;NAA15;ACTL6A;ACTR2;NAMPT;TCERG1;MAP2K1;ALYREF;TRIM28;DDX21;SNX5;RBMX;UBA2;TFAM;MAPK3;YWHAH;EIF5A;KARS1;PCBP1;CD81;DDX17;GARS1;HNRNPU;HDAC1;DNM2;ILF2;SUPT16H;SF3B3;UBE2V1;APEX1;AKR1B1;RUVBL2;YBX1;HNRNPD;PRKDC;RUVBL1;ILK;HNRNPAB;CDH1;PARP1;SF3B1;HMGA2;ARF4;SFPQ;CD74;ACTR3;RBBP4;COL1A1;HMGA1;AGT;APP;PSMC3;PSMC5
1363,prerank,Transport Across Blood-Brain Barrier (GO:0150104),-0.18843364112286176,-0.5688404970721077,0.9443254817987152,0.9985812862824858,1.0,4/6,46.58%,SLC9A3R1;SLC1A5;LRP2;TFRC
1364,prerank,Vascular Transport (GO:0010232),-0.18843364112286176,-0.5688404970721077,0.9443254817987152,0.9985812862824858,1.0,4/6,46.58%,SLC9A3R1;SLC1A5;LRP2;TFRC
1365,prerank,Positive Regulation Of Lamellipodium Morphogenesis (GO:2000394),0.20539267802531735,0.5665136702583146,0.9630996309963099,0.9813699977630842,1.0,4/5,60.32%,CORO1C;VIL1;ENPP2;CORO1B
1366,prerank,Positive Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043123),0.10533040493720028,0.5665028690777956,0.9621621621621622,0.980257874737271,1.0,14/21,57.92%,GAPDH;LTF;FLNA;ANKRD17;CD74;PARP1;RHOC;UBE2V1;ECM1;DDX1;UBE2N;TFRC;DDX21;EEF1D
1367,prerank,Regulation Of p38MAPK Cascade (GO:1900744),-0.20497826157925114,-0.5664338481060428,0.9584245076586433,0.9978499466890773,1.0,3/5,38.34%,VEGFA;BMP4;PRMT1
1368,prerank,Transition Metal Ion Transport (GO:0000041),0.2088620519939124,0.5659437532001524,0.9644760213143873,0.979457062486869,1.0,2/5,21.39%,LTF;FTH1
1369,prerank,Wnt Signaling Pathway (GO:0016055),-0.18297310633192887,-0.5658723299985813,0.9798387096774194,0.9961703534448507,1.0,3/6,30.04%,FERMT2;DDX3X;CTNNB1
1370,prerank,miRNA-mediated Gene Silencing (GO:0035195),-0.19939163694432321,-0.5587693402571484,0.9608695652173913,0.9979549034534105,1.0,2/5,18.18%,MOV10;NCBP1
1371,prerank,Prostanoid Metabolic Process (GO:0006692),-0.16921306684745077,-0.5582822892883397,0.96529284164859,0.9962201736895323,1.0,2/7,10.34%,CES1;PTGR2
1372,prerank,Selective Autophagy (GO:0061912),0.20023946560633837,0.550131586007905,0.9621928166351607,0.9872127212896169,1.0,4/5,60.96%,TGFB1;RAB7A;CALR;UFL1
1373,prerank,Negative Regulation Of DNA-binding Transcription Factor Activity (GO:0043433),0.1989905903118726,0.5493830108699019,0.9671179883945842,0.986475856324243,1.0,4/5,60.96%,FLNA;ANXA4;USP7;UFL1
1374,prerank,Nuclear Envelope Organization (GO:0006998),-0.1933660488633101,-0.5486259642037444,0.9789029535864979,0.9989284243242756,1.0,2/5,19.11%,NUP93;TOR1B
1375,prerank,Camera-Type Eye Development (GO:0043010),-0.19417424944497433,-0.5476236293648972,0.9770354906054279,0.9974135643852615,1.0,2/5,18.94%,FBN2;VEGFA
1376,prerank,DNA Recombination (GO:0006310),0.16624010668231767,0.5432172704943337,0.978021978021978,0.9884716908771772,1.0,2/7,13.21%,XRCC5;XRCC6
1377,prerank,Positive Regulation Of Neural Precursor Cell Proliferation (GO:2000179),-0.16458300256691988,-0.540866158404836,0.9872611464968153,0.9985283643736907,1.0,6/7,68.61%,HAPLN1;VEGFA;CTNNB1;LRP2;VCAN;NAP1L1
1378,prerank,Myeloid Leukocyte Differentiation (GO:0002573),0.1556077510275981,0.5379945899020282,0.9679144385026738,0.9899168615587987,1.0,8/8,84.51%,DHRS2;MYH9;PARP1;CDC42;GLO1;BMP4;VEGFA;MAPK14
1379,prerank,Positive Regulation Of Protein Localization To Cell Periphery (GO:1904377),0.16462406501450177,0.5354778655264507,0.9818840579710145,0.9899027936715283,1.0,6/7,70.72%,SPTBN1;LRP1;KIF5B;NUMA1;ITGB1;ARF6
1380,prerank,Regulation Of Neurogenesis (GO:0050767),0.14942285577765174,0.5324782791663719,0.9733096085409253,0.9901467123840042,1.0,4/9,31.50%,SERPINF1;APLP2;TGM2;NAP1L1
1381,prerank,Cellular Response To Alcohol (GO:0097306),-0.16077484878457135,-0.5304939215323566,0.9806451612903225,1.0,1.0,2/7,11.22%,CES1;CTNNA1
1382,prerank,Calcium-Mediated Signaling (GO:0019722),-0.16996602591220997,-0.5264801190682276,0.9743589743589743,1.0,1.0,4/6,47.98%,PRKAA1;PPP3CA;PRKACA;VCAM1
1383,prerank,Regulation Of Release Of Sequestered Calcium Ion Into Cytosol By Sarcoplasmic Reticulum (GO:0010880),0.1880192900199206,0.5160745135256124,0.9810964083175804,0.995435500933891,1.0,3/5,42.90%,GSTO1;CALM1;GSTM2
1384,prerank,Negative Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071901),0.1335356076327252,0.5160542970141849,0.9732620320855615,0.9943161421601558,1.0,9/11,69.84%,APOE;MACROH2A1;AGT;GSTP1;PRKAR2A;IPO7;SORL1;PRKAR1A;BMP4
1385,prerank,Glycosaminoglycan Metabolic Process (GO:0030203),0.1312793858731292,0.5142524287186017,0.9854014598540146,0.9937895503783617,1.0,10/11,78.32%,EXT1;UGDH;HEXB;EXT2;FUCA1;HYAL1;XYLT2;HEXA;B3GAT3;GNS
1386,prerank,Actin Filament Bundle Organization (GO:0061572),-0.18456475446367532,-0.5141841421391795,0.9787234042553191,1.0,1.0,3/5,39.80%,PLS1;ADD2;CORO1B
1387,prerank,Primary miRNA Processing (GO:0031053),0.18380479636076674,0.5123136255251829,0.9869402985074627,0.9932811843200099,1.0,3/5,42.96%,SRSF3;HNRNPA2B1;GARS1
1388,prerank,Positive Regulation Of Ras Protein Signal Transduction (GO:0046579),0.1674490424802852,0.5034828454384058,0.9868667917448405,0.9948913528917296,1.0,1/6,1.64%,APOA1
1389,prerank,Regulation Of Cell Division (GO:0051302),-0.17806593907317306,-0.5003952530485719,0.9915254237288136,1.0,1.0,3/5,40.62%,WDR5;PRPF40A;SH3GLB1
1390,prerank,Gland Development (GO:0048732),-0.13471178282686347,-0.4991355861369228,0.9870689655172413,1.0,1.0,5/9,40.68%,NOTCH4;SLC9A3R1;LSR;DKK3;PCSK9
1391,prerank,Negative Regulation Of Cytoskeleton Organization (GO:0051494),-0.15849668392413102,-0.49640793718410775,0.9893617021276596,1.0,1.0,3/6,32.32%,TWF1;TWF2;FKBP4
1392,prerank,Ventricular Cardiac Muscle Tissue Morphogenesis (GO:0055010),0.17936694021101998,0.4953745661386134,0.9872727272727273,0.9958795909711737,1.0,5/5,82.12%,TGFB1;TPM1;LRP2;DSP;FKBP1A
1393,prerank,Cellular Response To Starvation (GO:0009267),0.11481486666729854,0.4925055922210914,0.987410071942446,0.9954541503919495,1.0,9/13,59.50%,ALB;HSPA5;HSPA8;HNRNPA1;EIF2S1;MAPK3;LARS1;PCSK9;SH3GLB1
1394,prerank,Protein-Containing Complex Disassembly (GO:0032984),0.12995645013629484,0.49107407950492543,0.9826589595375722,0.9947310058121799,1.0,3/10,18.47%,VCP;HSPA8;SEPTIN9
1395,prerank,Regulation Of Ryanodine-Sensitive Calcium-Release Channel Activity (GO:0060314),-0.16002039471198043,-0.4874169376574588,0.9829059829059829,1.0,1.0,3/6,32.44%,SRI;FKBP1A;PRKACA
1396,prerank,T Cell Activation (GO:0042110),-0.1245627008004863,-0.4867949788475795,0.9891774891774892,0.9994261284793513,1.0,5/10,36.24%,CD44;FKBP1A;PPP3CA;DPP4;CTPS1
1397,prerank,Regulation Of Nucleocytoplasmic Transport (GO:0046822),0.1725442475690251,0.48265582104993315,0.9942307692307693,0.9956183766978423,1.0,3/5,44.30%,TGFB1;KHDRBS1;TPR
1398,prerank,Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901990),0.12883976916785886,0.4639903626485123,0.9962825278810409,0.9977711896618188,1.0,7/9,65.98%,PPP2CA;APLP2;PSME2;DDB1;PSME3;PSME1;ACTL6A
1399,prerank,Regulation Of Axon Extension (GO:0030516),0.13249744214960427,0.44655288287392536,0.9922928709055877,0.998785725056194,1.0,4/8,38.63%,APOE;RTN4;PTPRS;DNM2
1400,prerank,Regulation Of JUN Kinase Activity (GO:0043506),-0.15767878077373973,-0.44613441708296125,0.9978947368421053,1.0,1.0,5/5,84.34%,DNAJA1;PDCD4;DKK1;GSTP1;RPS3
1401,prerank,Regulation Of Cell Cycle (GO:0051726),0.07020209004511652,0.445141463649652,0.9982935153583617,0.9978270859501295,1.0,4/30,7.42%,ACTB;HSP90AB1;TGFB1;RACK1
1402,prerank,Cellular Response To Reactive Oxygen Species (GO:0034614),-0.12508369082704207,-0.43949943407554737,0.9978213507625272,1.0,1.0,5/8,48.16%,PTPRK;MAPK1;FABP1;PRDX3;MAPK3
1403,prerank,Barbed-End Actin Filament Capping (GO:0051016),-0.11952002403456262,-0.4264525609375264,0.9978401727861771,0.998522662483502,1.0,7/8,74.58%,TWF1;TWF2;ADD2;CAPZA2;VIL1;CAPZB;CAPZA1
1404,prerank,Actin Filament Capping (GO:0051693),-0.11952002403456262,-0.4264525609375264,0.9978401727861771,0.998522662483502,1.0,7/8,74.58%,TWF1;TWF2;ADD2;CAPZA2;VIL1;CAPZB;CAPZA1
1405,prerank,Positive Regulation Of Viral Genome Replication (GO:0045070),0.12712069597410197,0.40741016820174636,1.0,0.9990247369253794,1.0,5/7,60.20%,PPIA;PPIE;DDB1;PABPC1;PPID
